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Abstract	  
	  
Obesity	   induced,	   non-­‐alcoholic	   fatty	   liver	   disease	   (NAFLD),	   describes	   the	  
spectrum	   from	   steatosis-­‐to-­‐cirrhosis.	   NAFLD	   is	   now	   the	   commonest	   cause	   of	  
chronic	   liver	   disease	   in	   affluent	   populations.	   Its	   prevalence	   is	   increasing	   in	  
tandem	  with	  rising	  obesity	  rates.	  However,	  given	  the	  exponential	  rise	  in	  obesity	  
and	   NAFLD	   disease	   prevalence,	   availability	   of	   cheap	   energy	   dense	   foods	  may	  
not	   alone	   be	   the	   sole	   determinant	   of	   these	   rising	   rates:	   maternal	   obesity	   –	  
through	  developmental	  programming	  -­‐	  may	  also	  be	  involved.	  	  
	  
A	  growing	  body	  of	  epidemiological	  evidence	  suggests	  that	  perinatal	  factors	  may	  
contribute	   to	   chronic	  disease	   in	   adulthood	  via	  programming.	   	   Programming	   is	  
the	  process	  whereby	  an	  insult/stimulus	  during	  a	  critical	  period	  of	  development	  
induces	   permanent	   structural	   and/or	   physiological	   changes.	   	   The	   role	   of	  
developmental	  programming	   in	  NAFLD	   is	  unknown.	   	  The	  aims,	   therefore	  were	  
to	  determine	   if	  maternal	  obesity	  during	  gestation	  and/or	   lactation	  transmits	  a	  
predisposition	  to	  NAFLD	  in	  offspring,	  to	  evaluate	  the	  natural	  progression	  of	  such	  
programmed	  disease,	  to	  examine	  the	  relative	  contributions	  of	  maternal	  obesity	  
and	   the	   post-­‐natal	   environment	   on	   offspring	   NAFLD	   and	   to	   investigate	   the	  
mechanisms	  therein.	  	  	  
	  
Using	   a	   rodent	   diet	   induced	   obesity-­‐programming	   model,	   our	   initial	   studies	  
confirmed	   that	   maternal	   obesity,	   through	   developmental	   programming,	   was	  
indeed	   involved	   in	   the	  pathogenesis	   of	  NAFLD	  with	   the	   lactation	  period	  most	  
	   5	  
susceptible	  to	  these	  programming	  effects.	  	  Moreover,	  there	  was	  an	  interaction	  
between	   in	  utero	  exposure	  to	  an	  obesogenic	  environment	  and	  a	  post-­‐weaning	  
obesogenic	   environment	   to	   cause	   exacerbated	   offspring	   NAFLD.	  	  
Mechanistically,	   perturbed	   hepatic	   innate	   immune	   function	   and	   disrupted	  
peripheral	   circadian	   rhythms	   were	   observed	   in	   offspring	   with	   NAFLD	  
programmed	   by	  maternal	   obesity.	   	   Finally,	   these	   results	   also	   provide	   a	   novel	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Th1	   	   	   T	  Helper	  1	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1	  Introduction	  
	  
1.1	  The	  Obesity	  Epidemic	  
The	   population	   prevalence	   of	   obesity	   is	   rising	   worldwide,	   most	   notably	   in	  
affluent	   countries	   such	   as	   the	   United	   Kingdom	   with	   some	   30%	   of	   adults,	  
presently	  obese	  (1).	  	  It	  is	  estimated	  that	  the	  incidence	  of	  obesity	  will	  continue	  to	  
escalate,	  reaching	  50%	  by	  2050	  in	  the	  UK	  alone	  (1).	  	  Childhood	  obesity	  rates	  are	  
similarly	   rising,	   with	   approximately	   30%	   of	   children,	   aged	   between	   2	   and	   15,	  
classed	   as	   overweight	   or	   obese	   in	   the	   UK	   (2).	   	   This	   is	   projected	   to	   reach	   an	  
alarming	  60%	  by	  2050	  (1).	  	  Obesity	  is	  associated	  with	  significant	  morbidity	  and	  
mortality,	  both	   independently,	   and	   in	  association	  with	  other	  diseases.	   	   	  Given	  
that	  many	  obesity	  related	  medical	  complications	  begin	  manifestation	  in	  children	  
and	  young	  adults,	   the	  projected	   incidence	  of	  obesity	  becomes	  of	  even	  greater	  
concern	  (3).	  	  Besides	  being	  a	  significant	  contributor	  to	  ill-­‐health,	  it	  also	  presents	  
a	  substantial	  fiscal	  burden	  on	  healthcare	  systems	  with	  projected	  costs	  to	  the	  UK	  
National	  Health	  Service	  of	  £2	  billion	  a	  year	  by	  2030	  (1).	  	  	  
	  
The	   terms	   ‘overweight’	   and	   ‘obese’	   are	   defined	   as	   a	   ‘Body	  Mass	   Index’	   (BMI)	  
greater	   than	   25	   kg/m2	   and	   30	   kg/m2,	   respectively.	   	   	   However,	   these	   values	  
should	   be	   interpreted	   with	   caution	   since	   the	   BMI	   is	   an	   indirect	   measure	   of	  
adiposity.	  	  The	  National	  Institute	  of	  Clinical	  Excellence	  (NICE)	  recommends	  that	  
besides	   BMI,	   other	   indices	   of	   adiposity,	   such	   as	  waist	   circumference	   be	   used	  
when	   characterising	   the	   extent	   of	   obesity	   and	   determining	   associated	   health	  
risks	  (4).	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The	  causes	  of	  obesity	  are	  multiple	  attributed	  to	  complex	  biological	  systems	  and	  
societal	  frameworks,	  in	  which	  no	  individual	  disease	  determinant	  predominates.	  	  	  
Therefore,	  it	   is	  necessary	  to	  invoke	  both	  preventative	  measures	  and	  combined	  
interventions	  to	  curb	  the	  obesity	  epidemic	  (3).	  	  	  
	  
Genetic	   factors,	   known	   to	   predispose	   individuals	   to	   obesity,	   were	   likely	  
advantageous	   in	   previous	   resource-­‐deficient	   environments,	   where	   energy	  
conservation	   was	   essential	   to	   survival.	   	   However,	   the	   availability	   of	   cheap	  
energy-­‐dense	   foods	  combined	  with	  a	   sedentary	   lifestyle	  generates	  an	  adverse	  
energy	  imbalance;	  the	  catalyst	  behind	  our	  modern	  day	  obese	  society	  (2).	  	  
	  
Visceral	   deposition	   of	   adipose	   tissue	   in	   the	   intra-­‐abdominal	   cavity	   is	   strongly	  
associated	   with	   type	   2	   diabetes,	   hypertension	   and	   hyperlipidaemia.	   	   Such	  
complications	   collectively	   characterise	   the	   metabolic	   syndrome	   (3).	  	  
Unsurprisingly,	   the	   incidence	   of	   metabolic	   disorders	   is	   rising	   in	   tandem	   with	  
obesity	  rates.	  	  In	  light	  of	  genome	  wide	  association	  studies	  (GWAS),	  which	  have	  
highlighted	   an	   individual’s	   genetic	   susceptibility	   to	   obesity,	   it	   has	   also	   been	  
suggested	   that	   the	   inexorable	   rise	   of	   dysmetabolism	   is	   in	   part	   attributable	   to	  
environmental	  factors	  (5).	  
	  
Rates	  of	  obesity	  amongst	  women	  of	  reproductive	  age	  are	  concomitantly	  rising	  
with	  a	   current	  prevalence,	   in	   the	  USA,	  of	  31.5%	   in	   those	  aged	  20-­‐39	   (6).	   	   The	  
consequences	  of	  maternal	  obesity	  are	  not	  limited	  to	  obstetric	  complications.	  A	  
growing	   body	   of	   evidence	   suggests	   that	   the	   nutritional	   milieu,	   during	   critical	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periods	   of	   development,	   can	   permanently	   alter	   the	   offspring’s	   physiology.	  	  
These	  alterations	  have	  been	  shown	  to	  induce	  an	  increased	  propensity	  towards	  
dysmetabolism,	   and	   its	   sequelae,	   in	   later	   life.	   	   Given	   that	   offspring	   rely	   upon	  
maternal	  metabolic	  signals	  to	  guide	  their	  early	  developmental	  trajectory,	  in	  the	  
absence	   of	   direct	   environmental	   experience,	   it	   is	   plausible	   that	   maternal	  
nutrition	  evokes	  permanent	  change	  in	  foetal	  physiology.	  Such	  a	  phenomenon	  is	  
termed	  ‘Developmental	  Programming’	  or	  the	  ‘Developmental	  Origins	  of	  Health	  
&	  Disease’	  (5).	  	  	  	  
	  
1.2	  Developmental	  Origins	  of	  Health	  and	  Disease	  
	  
1.2.1	   Maternal	   Under-­‐nutrition	   and	   Developmental	   Programming:	  
Epidemiological	  Evidence	  
Epidemiological	   research,	   from	   the	   late	   1980s,	   indicates	   that	   chronic,	  
degenerative	   illnesses	   presenting	   in	   adulthood	   may	   originate	   from,	   or	   be	  
influenced	  by,	  the	   intra-­‐uterine	  environment	  (7).	   	  The	  Hertfordshire	  study	  was	  
pivotal	  to	  our	  observations	  and	  understanding	  of	  the	  ‘foetal	  origins	  of	  disease’	  
hypothesis.	   	   It	   revealed	   an	   increased	   prevalence	   of	   cardiovascular	   disease	   in	  
offspring	  with	  lower	  birth	  weights	  (8).	  	  Using	  a	  population	  cohort	  of	  16,000	  men	  
and	  women,	  born	  between	  1911	  and	  1930,	  David	  Barker	  and	  his	  colleagues	  also	  
demonstrated	   an	   increased	   associated	   risk	   between	   growth	   patterns	   in	   early	  
life	  and	  glucose	  intolerance	  and	  type	  2	  diabetes	  (9,	  10).	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The	   Dutch	   Famine	   of	   1944-­‐45,	   which	   provided	   an	   invaluable	   opportunity	   to	  
investigate	   the	   effects	   of	   a	   deprived	   hypo-­‐calorific	   peri-­‐natal	   environment,	  
further	   supported	   these	   observations.	   	   It	   was	   observed	   that	   individuals	   born	  
with	   low	  birth	  weights	   also	   had	   an	   increased	   risk	   of	   cardiovascular	   disease	   in	  
adulthood,	   as	   well	   as	   its	   associated	   comorbidities	   such	   as	   hypertension	   and	  
stroke.	   	   More	   specifically,	   Roseboom	   and	   colleagues	   reported	   that	   maternal	  
under-­‐nutrition,	   during	  mid	   to	   late	   gestation,	   in	   humans	  was	   associated	  with	  
lower	   birth	   weight	   (exposed	   3175g	   v	   unexposed	   3373g,	   p	   <	   0.05);	   length	  
(exposed	   49.6cm	   v	   unexposed	   50.5cm,	   p	   <	   0.05);	   and	   a	   reduced	   head	  
circumference	  (exposed	  32.2cm	  v	  unexposed	  32.8cm,	  p	  <	  0.05).	  	  Consequently,	  
this	  reduced	  birth	  weight	  was	  thought	  to	  increase	  the	  offspring’s	  susceptibility	  
to	  development	  of	  type	  2	  diabetes	  (11).	  	  	  
	  
In	  the	  same	  cohort,	  it	  was	  observed	  that	  maternal	  under-­‐nutrition	  during	  early	  
gestation	  resulted	  in	  offspring	  with	  higher	  birth	  weights.	  	  However,	  this	  data	  did	  
not	   reach	   statistical	   significance	   (exposed	   3470g	   v	   unexposed	   3373g).	  	  
Additionally,	   these	   offspring	   have	   been	   associated	   with	   a	   larger	   body	   mass	  
index	  and	  greater	  atherogenic	  lipid	  profile	  in	  adulthood,	  as	  demonstrated	  by	  a	  
raised	   LDL/HDL	   cholesterol	   (exposed	   3.26	  mmol/l	   v	   unexposed	   2.91	  mmol/l);	  
fibrinogen	   (exposed	   3.21g/l	   v	   unexposed	   3.02g/l)	   and	   reduced	   Factor	   VII	  
(exposed	   117%	   v	   unexposed	   128%	   of	   standard)	   (7).	   	   These	   associations	  were	  
replicated	   in	  many	  other	  cohorts	   from	   industrialised	  and	  developing	  countries	  
(12).	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1.2.2	  Thrifty	  Phenotype	  Hypothesis	  
From	   these	   epidemiological	   studies,	   the	   ‘thrifty	   phenotype’	   hypothesis	   was	  
borne.	   	   Put	   forward	   by	   Barker	   and	   his	   colleagues,	   it	   was	   theorised	   that	   the	  
plasticity	  of	  biological	   systems	   in	  early	  development	  allows	   for	  a	   susceptibility	  
to	   permanent	   genetic,	   and	   epigenetic	   alterations	   as	   a	   consequence	   of	  
nutritional	  insult	  (13).	  	  Such	  permanent	  alterations	  are	  thought	  to	  occur	  in	  order	  
to	  maximise	  utilisation	  and	  conservation	  of	  available	  nutrients.	  	  It	  was	  thought	  
that	   this	   would	   confer	   a	   survival	   advantage,	   should	   similar	   nutritionally	  
challenging	   environments	   recur.	   	   In	   relation	   to	   the	   development	   of	   type	   2	  
diabetes,	  it	  was	  proposed	  that	  foetal	  malnutrition	  reduced	  pancreatic	  beta	  cell	  
mass	  and	  islet	  function.	  	  These	  changes	  persist	  into	  post-­‐natal	  life	  and	  thus	  pose	  
significant	   risks	   if	   BMI,	   or	   any	   other	   factor	   known	   to	   potentiate	   insulin	  
resistance,	   were	   to	   increase.	   	   The	   notion	   that	   the	   ‘thrifty	   phenotype’	   is	   a	  
survival	   mechanism	   is	   further	   corroborated	   by	   evidence	   demonstrating	   that	  
both	   liver	   and	   muscle	   tissue	   are	   sacrificed	   in	   order	   to	   sustain	   the	   metabolic	  
requirements	  imposed	  by	  the	  brain	  (13).	  	  	  
	  
1.2.3	  Predictive	  Adaptive	  Response	  Hypothesis	  
Mechanistically,	   these	  permanent	  survival	  changes	  are	  also	   termed,	  Predictive	  
Adaptive	  Responses	   (PARs)	   (14).	   	   If,	  however,	  nutritional	  adequacy	   is	   restored	  
after	  birth,	   the	  offspring	  will	  have	   reduced	  biological	   capacity	   to	  metabolise	  a	  
normo-­‐calorific	  or	  hyper-­‐calorific	  diet,	  increasing	  their	  propensity	  to	  obesity	  and	  
the	   metabolic	   syndrome	   (13).	   	   Essentially,	   a	   mismatch	   occurs	   between	   the	  
metabolic	  load	  and	  the	  offspring’s	  metabolic	  capacity.	  	  A	  broader	  application	  of	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this	   hypothesis	   implies	   that	   disease	   manifests	   when	   the	   predicted	   in	   utero	  
environment	   (plastic	   phase)	  does	  not	   correlate	  with	   the	  post-­‐natal	   nutritional	  
status	  (post-­‐plastic	  phase).	  
	  
It	   has	   been	   argued	   that	   early	   post-­‐natal	   growth	   patterns	   are	   responsible	   for	  
increased	  disease	  risk	  in	  adulthood	  and	  that,	  subsequently,	  such	  diseases	  do	  not	  
originate	  as	  a	  result	  of	  an	  adverse	  foetal	  environment	  (15).	  	  However,	  extensive	  
epidemiological	   data	   suggests	   that	   both	   foetal	   and	   post-­‐natal	   environments	  
contribute	   to	   increased	   disease	   risk.	   	   Additionally,	   given	   that	   hyperplasia,	   the	  
increase	   in	  cell	  number,	  ceases	  during	  early	   infancy,	  development	  of	  offspring	  
organ	  structure	  and	  physiology	  is	  dependent	  upon	  foetal	  development	  (16).	  	  
	  
1.2.4	   Maternal	   Under-­‐nutrition	   and	   Developmental	   Programming:	  
Experimental	  Evidence	  
Despite	  establishing	  a	  causal	  link	  between	  foetal	  nourishment	  and	  chronic	  adult	  
disease,	   retrospective	   epidemiological	   studies	   pose	   numerous	   limitations.	   	   In	  
the	  first	  instance,	  the	  application	  of	  these	  studies	  to	  present	  society	  may	  not	  be	  
clinically	  relevant.	  	  Moreover,	  much	  of	  the	  evidence	  concerning	  the	  influence	  of	  
maternal	   nutrition	   arises	   from	   populations	   that	   constitute	   a	   minority	   of	   the	  
birth	   cohort	   and	   probably	   incorporate	   selection	   bias.	   	   Most	   fundamentally,	  
infant	  anthropometry	  is	  inferred	  as	  a	  proxy	  for	  foetal	  nutrition,	  although	  other	  
perinatal	   factors	   can	   affect	   such	   measurements	   (17).	   	   Coupled	   with	  
uncontrollable	   variables	   of	   genetic	   and	   environmental	   origin,	   experimental	  
models	  of	  maternal	  under-­‐nutrition	  were	  developed.	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These	  models,	   tabulated	  below	   (Table	  1.1),	   in	  essence,	   suggest	  an	  association	  
between	  maternal	  under-­‐nutrition	  and	  development	  of	  metabolic	  disorders.	  	  	  
	  
Table	   1.1	   Experimental	   Rodent	   Models	   of	   Maternal	   Under-­‐nutrition	   and	  
Offspring	  Chronic	  Disease	  
Feature	  of	  Met	  
Syndrome	  
Breeding	  Protocol	   Readouts	   Reference	  
Abnormal	  glucose	  
homeostasis	  
70%	  of	  ad	  libitum	  
from	  0-­‐18	  days	  
gestation	  in	  
Wistar	  rats	  
Plasma	  glucose	  measured	  
28	  weeks	  (M+F)	  
↑	  plasma	  glucose	  





50%	  of	  ad	  libitum	  
day	  11	  until	  
delivery	  in	  Wistar	  
rats	  
Plasma	  glucose	  &	  insulin	  
measured	  at	  80	  days	  (F)	  
↑	  glucose,	  ↓insulin	  
Holemans	  	  
et	  al.	  (37)	  
Hypertension	   30%	  of	  ad	  libitum	  
during	  gestation	  
in	  Wistar	  rats	  
Tail	  cuff	  measurement	  	  
at	  100	  days	  (F)	  
↑	  blood	  pressure	  
Vickers	  et	  	  
Al.	  (243)	  
Plasma	  Leptin	   30%	  of	  ad	  libitum	  	  
during	  gestation	  in	  	  
Wistar	  rats	  
Plasma	  leptin	  measured	  	  
at	  175	  days	  (F)	  
↑	  plasma	  leptin,	  ↑	  leptin	  	  
receptor	  pancreatic	  β	  cells	  




1.2.5	   Maternal	   Over-­‐nutrition	   and	   Developmental	   Programming:	  
Epidemiological	  Evidence	  
As	   the	   prevalence	   of	   obesity,	   including	   maternal	   obesity	   reaches	   epidemic	  
proportions	   in	  both	   the	  developing	  and	  developed	  world,	   recent	   studies	  have	  
focused	   on	   the	   potential	   detrimental	   effects	   of	   maternal	   over-­‐nutrition	   and	  
offspring	   health.	   	   Numerous	   epidemiological	   studies	   have	   shown	   a	   positive	  
correlation	   between	   maternal	   BMI	   and	   gestational	   diabetes	   with	   offspring	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adiposity	   (18,	   19).	   	   It	   has	   been	   suggested	   that	   maternal	   obesity	   transmits	  
susceptibility	   to	   their	   offspring,	   enabling	   a	   physiological	   predisposition	   for	  
efficacious	   fat	   storage	   compared	   to	   offspring	   of	   normal	   weight	   mothers	   in	  
animal	  models	  (20).	  	  	  
	  
Maternal	  obesity	  is	  associated	  with	  elevated	  concentrations	  of	  cholesterol	  and	  
triglycerides.	   	   Such	   maternal	   hypercholesterolemia	   has	   been	   significantly	  
correlated	  with	  increased	  lipid	  accumulation	  in	  offspring	  arterial	  walls,	  inducing	  
fatty	  streak	   formation,	  compared	  with	  normocholesterolemic	  mothers.	   	   It	  was	  
therefore	  suggested	  that	  the	  appearance	  of	  advanced	  atherosclerotic	  lesions	  in	  
young	   adults	   was	   a	   consequence	   of	   exposure	   to	   maternal	   obesity	   during	  
perinatal	  development	  (21).	  
	  
In	   a	   retrospective	   population	   based	   study	   of	  men	   and	  women	   born	   between	  
1948	  and	  1954	  in	  Aberdeen,	  Scotland,	  impaired	  glucose	  metabolism	  and	  insulin	  
resistance	  was	  reported	  in	  offspring	  exposed	  to	  high	  protein,	  high	  fat	  diet	  in	  late	  
gestation.	   	   It	   was	   suggested	   that	   maternal	   obesity,	   through	   unknown	  
mechanisms,	   impaired	   development	   of	   pancreatic	   ß-­‐cells.	   	   Additionally,	  
offspring	  exhibiting	   insulin	   resistance	  were	  also	   found	   to	  be	  hypertensive	   (22,	  
23).	  	  	  
	  
Moreover,	  maternal	  weight	  gain	  and	  increased	  BMI	  between	  pregnancies	  have	  
been	  associated	  with	  an	  increased	  risk	  of	  obesity	  in	  offspring,	  compared	  to	  their	  
siblings	   (24).	   	   Interestingly,	   an	   interventional	   study,	   comparing	   the	   risk	   of	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obesity	   and	   other	   adverse	   consequences	   amongst	   offspring	   born	   to	   mothers	  
pre-­‐	   and	   post-­‐bariatric	   surgery,	   reported	   ameliorated	   outcomes	   in	   offspring	  
born	   following	   maternal	   weight	   reduction	   (25).	   	   The	   importance	   of	   these	  
findings	  is	  exemplified	  by	  the	  disproportionate	  risk	  in	  offspring	  born	  to	  the	  same	  
mother,	   but	   exposed	   to	   differential	   in	   utero	   nutritional	   environments.	   	   Such	  
observations	  therefore	  support	  the	  suggestion	  that	  the	  maternal	  environment,	  
in	   addition	   to,	   or	   independent	   of	   genetic	   susceptibilities,	   is	   able	   to	  
physiologically	  program	  offspring	  during	  development.	  	  	  
	  
Given	  that	  obesity	  amongst	  women	  of	  reproductive	  age	  is	  exponentially	  rising,	  
the	   implications	   of	   maternal	   over-­‐nutrition	   on	   offspring	   obesity,	   and	   its	  
metabolic	   complications	   such	   as	   hypertension,	   type	   II	   diabetes	   and	  
hepatosteatosis,	  have	  become	  pertinent.	  
	  
1.2.6	  Maternal	  Over-­‐nutrition	  and	  Developmental	  Programming:	  Experimental	  
Evidence	  
Unarguably,	   there	   is	   a	   profound	   association	   between	  maternal	   over-­‐nutrition	  
and	   offspring	   chronic	   disease,	   evidenced	   from	   epidemiological	   studies.	  	  
However,	  animal	  models	  are	  necessary	  to	  investigate	  the	  mechanisms	  by	  which	  
maternal	   obesity,	   and	   its	   contributing	   factors,	   program	   offspring	   disease.	   	   A	  
variety	   of	   experimental	   models	   have	   been	   established,	   of	   which	   rodents	   are	  
most	  commonly	  used.	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In	   an	   early	   non-­‐human	   primate	   model,	   baboons	   exposed	   to	   maternal	   over-­‐
nutrition	   in	   the	   pre-­‐weaning	   period,	   developed	   elevated	   serum	   triglyceride	  
levels	   and	   adiposity,	   through	  adipocyte	  hypertrophy,	   in	   adulthood	   (26).	   	   	   In	   a	  
high	  fat	  diet	  induced	  obesity	  model	  using	  rhesus	  macaques,	  it	  was	  reported	  that	  
foetal	   offspring	   developed	   non-­‐alcoholic	   fatty	   liver	   disease,	   coupled	   with	  
lipotoxicity,	  which	  persisted	  into	  post-­‐natal	  life	  (27).	  	  
	  
Using	   sheep	   models,	   it	   has	   been	   shown	   that	   maternal	   diet	   induced	   obesity	  
evokes	  alteration	   in	  placental	  morphology	  and	   function.	   	  More	  specifically,	  an	  
increase	  in	  placental	  fatty	  acid	  transporter	  expression	  was	  reported,	  resulting	  in	  
raised	   triglyceride	   levels	   in	   foetuses.	   	   In	   the	   same	   study,	   it	   was	   additionally	  
reported	   that	   placental	   inflammatory	   signalling	   pathways	   were	   up-­‐regulated	  
(28,	  29).	  	  	  	  Skeletal	  muscle	  is	  a	  large	  glucose	  store,	  which	  if	  impaired,	  contributes	  
to	   insulin	   resistance	  and	  aberrant	  glucose	  homeostasis.	   	   It	  has	  been	  shown	   in	  
ewes	  born	  to	  obese	  dams	  that	  myogenesis	  is	  down-­‐regulated	  in	  foetal	  skeletal	  
muscle.	   	   Altered	   signalling	   pathways,	   involving	   toll-­‐like	   receptors,	   further	  
impede	   adequate	   skeletal	   muscle	   development,	   whilst	   propagating	   increased	  
fat	  deposition	  in	  offspring	  exposed	  to	  maternal	  obesity	  (30,	  31).	  	  	  	  	  	  	  	  
	  
Rodents	   are	   commonly	   used	   animals	   when	   studying	   the	   effects	   of	   maternal	  
obesity	   on	   offspring	   health.	   	   Rodents	   have	   a	   short	   gestation	   period	   and	   life	  
expectancy,	  although	  gestational	  development	  is	  dissimilar	  to	  humans.	  	  Rodents	  
are	   born	   with	   an	   immature	   neuroendocrine	   system.	   	   	   Therefore,	   significant	  
maturation	  of	  the	  hypothalamic-­‐pituitary-­‐adrenal	  axis	  does	  not	  occur	  until	   the	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post-­‐natal	   weaning	   period	   (14).	   	   These	   signalling	   systems,	   however,	   are	  
significantly	  established	  in	  humans	  during	  late	  gestation	  (32).	  	  	  	  
	  
Dietary	   restriction	   of	   rodents	   is	   more	   achievable	   than	   over-­‐feeding,	   as	   they	  
stringently	  regulate	  food	  consumption	  and	  energy	  expenditure.	  	  Such	  metabolic	  
homeostasis	   ensures	   maintenance	   of	   a	   ‘body	   weight	   set-­‐point’.	   	   Pregnant	  
rodents,	   fed	   a	   high-­‐fat	   diet	   with	   normal	   carbohydrate	   levels,	   reduce	   their	  
consumption	   of	   energy	   releasing	   nutrients;	   thereby	   regulating	   calorie	   intake	  
(33).	  	  To	  overcome	  this	  limitation	  in	  maternal	  over-­‐nutrition	  studies,	  litter	  size	  is	  
reduced	   to	  encourage	  over-­‐feeding	   in	   the	  weaning	  period	   (34).	   	  Alternatively,	  
making	   the	   diet	   highly	   palatably,	   through	   the	   addition	   of	   sweeteners,	   is	  
favourable;	   especially	   given	   that	   the	   modern	   day	   obesogenic	   diet	   is	   high	   in	  
sugar	  as	  well	  as	  fat	  (35).	  	  	  
	  
In	  a	  model	  of	  maternal	  diet	  induced	  obesity,	  offspring	  born	  to	  rats	  fed	  a	  high	  fat	  
diet	  prior	  to	  and	  throughout	  pregnancy	  and	  lactation	  had	  higher	  body	  and	  liver	  
weights	   with	   concomitant	   elevated	   plasma	   glucose	   and	   triglyceride	   levels.	  	  
Additionally,	  these	  offspring	  exhibited	  insulin	  resistance	  compared	  to	  offspring	  
of	  lean	  or	  normal	  weight	  mothers	  (36).	  	  Such	  perturbation	  of	  metabolic	  function	  
has	  been	  observed	  in	  a	  similar	  model,	  using	  nine-­‐month-­‐old	  offspring,	  whereby	  
exposure	  to	  maternal	  obesity	  during	  development	  programmed	  reduced	  insulin	  
secretion	   from	  pancreatic	  ß-­‐cells	   compared	   to	   controls.	   	   It	  was	  proposed	   that	  
the	   observed	   impaired	   glucose	   homeostasis	   was	   the	   result	   of	   hypertrophied	  
islet	  cells	  and	  mitochondrial	  abnormalities	  (37).	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Exposure	  to	  maternal	  obesity	  during	  in	  utero	  development	  has	  also	  been	  shown	  
to	  cause	  vascular	  dysfunction.	  	  It	  was	  reported	  by	  Koukkou	  et	  al.	  that	  offspring	  
exposed	   to	   maternal	   obesity	   displayed	   reduced	   endothelium	   dependent	  
relaxation	  of	   femoral	   arteries	   compared	   to	   controls.	   	  Moreover,	   an	   enhanced	  
vasoconstrictor	   response	   was	   observed	   in	   these	   offspring	   (38).	   	   Vascular	  
function	   was	   further	   examined	   in	   the	   context	   of	   gestational	   diabetes;	   a	  
common	   complication	   of	   maternal	   obesity.	   	   Unsurprisingly,	   vascular	   function	  
was	   impaired	   to	   a	   greater	   degree	   in	   the	  presence	  of	   both	   comorbidities	   (38).	  	  
An	   association	   between	   exposure	   to	   high	   saturated	   fatty	   acids	   during	  
development	   and	   hypertensive	   phenotypes	   in	   adulthood,	   has	   also	   been	  
reported	  in	  the	  rodent	  (39).	  
	  
Central	  adiposity	  is	  positively	  correlated	  with	  the	  development	  of	  the	  metabolic	  
syndrome.	   	   Offspring	   of	   sprague-­‐Dawley	   rats	   fed	   a	   diet	   constituting	   40%	   fat	  
during	   pregnancy,	   displayed	   increased	   body	  weights	   and	   visceral	   fat	   deposits	  
(36).	   	   Parallel	   findings	   have	   been	   reported	   in	   rodent	   models	   comprising	  
maternal	   diets	   of	   21%	   and	   24%	   fat	   (40).	   	   Concurrently,	   offspring	   exposed	   to	  
maternal	   over-­‐nutrition	   exhibit	   abnormal	   serum	   lipid	   profiles,	   alongside	  
hyperleptinaemia,	   which	   are	   fundamental	   components	   of	   the	   metabolic	  
syndrome	  (33).	  	  It	  was	  postulated	  that	  increased	  fat	  pad	  mass	  in	  these	  offspring	  
was	   a	   consequence	   of	   a	   reduced	   basal	   metabolic	   rate,	   as	   opposed	   to	  
hyperphagia	   or	   reduced	   locomotor	   activity.	   	   However,	   studies	   using	   more	  
palatable	   obesogenic	   diets	   have	   reported	   a	   strong	   relationship	   between	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exposure	   to	  maternal	   obesity	   and	   offspring	   hyperphagia	   and	   food	   preference	  
with	  subsequent	  weight	  gain	  (41).	  	  
	  
From	  experimental	  evidence,	  there	  is	  an	  association	  between	  offspring	  of	  dams	  
fed	   an	   obesogenic	   diet,	   and	   hyperphagia,	   adiposity,	   insulin	   resistance,	  
hyperlipidaemia	   and	   hypertension	   in	   adulthood.	   	   These	   comorbidities	  
collectively	   encompass	   the	   metabolic	   syndrome,	   suggesting	   that	   an	   adverse	  
exposure	   to	   maternal	   over-­‐nutrition	   evokes	   a	   dysmetabolic	   phenotype	   in	  
offspring.	  
	  
1.2.7	  Maternal	  Over-­‐nutrition	  and	  Developmental	  Programming:	  Contributing	  
Factors	  
	  
1.2.7.1	  Maternal	  Weight	  Gain	  
It	   is	   difficult	   to	   ascertain	   whether	   maternal	   obesity,	   and	   its	   associated	  
comorbidities,	   or	   maternal	   over-­‐nutrition	   is	   responsible	   for	   the	   imprinted	  
metabolic	  phenotype	  observed	  in	  offspring.	  	  Over-­‐nutrition	  inevitably	  results	  in	  
obesity	   and,	   once	   established,	   the	   hyper-­‐calorific	   environment	   is	  maintained.	  	  
Consequently	  the	  mechanistic	  relationship	  between	  maternal	  obesity	  and	  over-­‐
nutrition,	   with	   offspring	   risk	   of	   obesity	   and	   dysmetabolism,	   is	   poorly	  
understood.	  	  
	  
However,	  epidemiological	  evidence	  suggests	  that	  maternal	  weight	  gain	  imparts	  
risk	  for	  large	  for	  gestational	  age	  babies	  and	  offspring	  obesity	  at	  3	  years	  of	  age,	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independent	   of	   maternal	   BMI	   and	   glucose	   tolerance	   (42).	   	   Moreover,	   it	   has	  
been	   reported	   that	   gestational	   weight	   gain,	   at	   levels	   greater	   than	  
recommended	  by	  the	   Institute	  of	  Medicine,	  exponentially	   increases	  the	  risk	  of	  
producing	   offspring	   with	   greater	   adiposity	   and	   dysmetabolic	   traits	   (43).	   	   In	  
rodent	  models,	  however,	  it	   is	  difficult	  to	  isolate	  the	  effects	  of	  maternal	  weight	  
gain	  as	  the	  dams	  are	  fed	  an	  obesogenic	  diet.	  	  	  
	  
1.2.7.2	  Maternal	  Obesity	  
A	   number	   of	   rodent	   models	   have	   attempted	   to	   delineate	   the	   effects	   of	  
maternal	   obesity,	   independent	   of	   maternal	   dietary	   fat	   consumption,	   on	  
offspring	  propensity	  to	  obesity	  and	  dysmetabolism.	  	  Using	  a	  novel	  programming	  
model,	  White	  and	  colleagues	  fed	  dams	  either:	  a	  diet	  either	  high	  or	  low	  in	  fat	  ad	  
libitum	  or	  a	  pre-­‐determined	  quantity	  of	  the	  high	  fat	  diet	  which	  wouldn’t	  cause	  
excess	  weight	  gain	  4	  weeks	  prior	  to	  mating,	  throughout	  gestation	  and	  lactation.	  	  
Offspring	  body	  weight	  was	  greater	  in	  those	  born	  to	  obese	  dams,	  whilst	  results	  
from	   offspring	   pair	   fed	   a	   high	   fat	   diet	   or	   a	   low	   fat	   diet	   were	   similar.	  	  
Additionally,	  it	  was	  observed	  that	  maternal	  adiposity,	  and	  not	  dietary	  fat	  per	  se,	  
induced	  hyper-­‐leptinaemia	  and	  insulin	  resistance	  in	  offspring	  (44).	  	  	  
	  
Other	  groups	  have	  corroborated	  the	  contention	  that	  maternal	  obesity	  programs	  
offspring	  obesity	  and	  dysmetabolism,	   independent	  of	  maternal	  diet.	   	  Using	  an	  
intra-­‐gastric	  over-­‐feeding	  model,	  Shankar	  et	  al.,	  were	  able	  to	  demonstrate	  that	  
exposure	  to	  maternal	  obesity	  during	  gestation	  alone,	  increased	  offspring	  risk	  of	  
obesity	  and	  its	  associated	  comorbidities;	  when	  later	  exposed	  to	  a	  hyper-­‐calorific	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diet	  postnatally	   (45).	   	  However,	   these	   findings	  do	  not	  suggest	  a	  definitive	  role	  
for	   maternal	   obesity	   over	   maternal	   diet	   per	   se,	   but	   simply	   highlight	   their	  
relative	   contributions	   to	   the	   imprinted	   phenotype	   in	   offspring,	   and	   perhaps	  
their	   differential	   effects.	   	   Experimental	   evidence	   suggests	   that	   exposure	   to	  
maternal	  obesity	   in	  utero	  reduces	  foetal	  weight,	  whereas	  exposure	  to	  a	  hyper-­‐
calorific	   environment	   in	   the	   same	   developmental	   period	   causes	   abnormal	  
placental	  growth	  (46).	  	  
	  
1.2.7.3	  Maternal	  Diet	  
Alterations	   in	  maternal	  nutrition	  may	   induce	  permanent	  metabolic	   changes	   in	  
offspring,	  namely	   the	  propensity	   to	  obesity	  and	   its	  adverse	  sequelae.	   	  Using	  a	  
rodent	   model	   of	   programming,	   the	   effects	   of	   a	   maternal	   high	   fat	   diet	   (45%)	  
either	  throughout	  the	  mother’s	  lifetime,	  thus	  rendering	  the	  dam	  obese,	  or	  only	  
throughout	   gestation	   and	   lactation;	   offspring	   metabolic	   parameters	   were	  
investigated.	  	  A	  lifetime	  exposure	  to	  hyper-­‐calorific	  nutrition	  in	  dams	  produced	  
a	   similar	  offspring	  phenotype,	   compared	  with	   restricted	  exposure	   in	  gestation	  
and	   lactation	  only.	   	  The	   resulting	  phenotype,	   in	  offspring,	  was	   increased	  body	  
weights	  and	  adiposity	  (47).	  	  	  
	  
Further	   experimental	   evidence	   from	   non-­‐human	   primates	   corroborate	   the	  
aforementioned	   findings,	   as	   maternal	   high	   fat	   diet	   consumption	   increased	  
foetal	   free	  fatty	  acids	  with	   increased	  risk	  of	   insulin	  resistance	  postnatally	   (27).	  	  
Such	   findings	   suggest	   that	   the	   maternal	   diet	   has	   the	   potential	   to	   program	  
offspring	  phenotype,	  independent	  of	  obesity	  (Figure	  1.1).	  












Figure	  1.1	  Effects	  of	  developmental	  programming	  by	  maternal	  over-­‐nutrition	  
on	  offspring	  phenoytpe	  
	  
1.2.7.4	  Maternal	  Over-­‐nutrition	  and	  the	  Early	  Postnatal	  Period	  
The	  early	  postnatal	  period	  is	  another	  critical	  developmental	  window	  as	  growth	  
and	  organ	  system	  maturation	  continues.	   	  This	  period	   is,	   therefore,	  susceptible	  
to	  maternal	  influences.	  	  	  
	  
Rapid	   growth	   or	   exposure	   to	   an	   adverse	   environment	   in	   the	   immediate	  
postnatal	   period	   can,	   therefore,	   increase	   risk	   of	   obesity	   and	   dysmetabolism.	  	  
Previous	   studies	   reported	   rapid	   early	   postnatal	   growth,	   following	   exposure	   to	  
nutrient	   deficient	   in-­‐utero	   environments,	   leading	   to	   adult	   onset	   obesity.	  	  
Similarly,	   rapid	  weight	   gain	   in	   this	   period	   has	   been	   associated	  with	   increased	  
	   53	  
adiposity,	   hypertension,	   cardiovascular	   disease	   and	   hepatosteatosis	   in	   young	  
adults,	  independent	  of	  birth	  weight	  (48).	  	  
	  
Essentially,	   factors	   that	   influence	   early	   postnatal	   growth	   can	   also	   potentiate	  
obesity	  and	  dysmetabolic	  risk	  in	  adulthood.	  	  A	  common	  observation	  is	  the	  effect	  
of	  a	  nutrient	  enriched	  formula	  feed	  in	  increasing	  the	  risk	  of	  childhood	  and	  adult	  
obesity,	   along	   with	   hyper-­‐cholesterolaemia,	   compared	   to	   breastfeeding	   (49,	  
50).	   	   Epidemiological	   evidence	   suggests	   that	   the	   energy	   dense	   formula	   feed	  
causes	  increased	  dietary	  intake	  at	  4	  months	  of	  age,	  thereby	  potentiating	  obesity	  
risk	   (49).	   	   Therefore,	   the	   effects	   of	   maternal	   over-­‐nutrition	   in	   programming	  
offspring	  phenotype	  are	  not	  limited	  to	  gestation	  alone.	  
	  
1.2.7.5	  Maternal	  Over-­‐nutrition	  and	  the	  Relative	  Contributions	  of	  In	  utero	  and	  
Postnatal	  Exposure	  
Standard	  rodent	  models	  of	  programming	   involve	  dams	  fed	  an	  obesogenic	  diet	  
throughout	  the	  gestation	  and	  lactation	  period.	  	  Readouts	  in	  offspring,	  therefore,	  
are	  a	   reflection	  of	   the	   interaction	  between	  both	  developmental	  periods.	   	   It	   is	  
now	   well	   established	   that	   exposure	   to	   maternal	   over-­‐nutrtion,	   during	   both	  
these	   periods,	   predisposes	   offspring	   to	   adult	   onset	   obesity	   and	   dysmetabolic	  
traits	  (35).	  	  	  
	  
However,	   by	   cross-­‐fostering	   offspring	   initially	   born	   to	   obese	   dams,	   with	   lean	  
dams	   in	   the	   post-­‐partum	   suckling	   period,	   and	   vice	   versa,	   one	   is	   able	   to	  
investigate	  the	  role	  of	  the	  in	  utero	  environment,	  independent	  of	  the	  immediate	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postnatal	  period.	  	  In	  such	  a	  study,	  where	  offspring	  exposure	  to	  maternal	  obesity	  
was	   limited	   to	   the	   gestational	   period,	   it	   was	   observed	   that	   there	   were	   no	  
changes	   in	   offspring	   body	  weight	   or	   adiposity;	   as	   determined	   by	   CT	   analysis,	  
although	  hyper-­‐leptinaemia,	  hyper-­‐lipidaemia	  and	   insulinaemia	  were	   recorded	  
(45).	   	   In	  a	  similar	  experimental	  paradigm,	  offspring	  body	  weight,	   fat	  pad	  mass	  
and	   hepatosteatosis,	   were	   reported	   in	   rodents	   exposed	   to	   maternal	   obesity	  
during	  gestation	  alone	  (51).	  	  	  
	  
Interestingly,	  a	  profound	  dysmetabolic	  and	  fatty	   liver	  phenotype	  was	  reported	  
in	   the	   same	   study	   in	   offspring	   exposed	   to	   maternal	   obesity	   in	   the	   lactation	  
period	  alone	  (51).	  	  These	  findings	  corroborate	  earlier	  reports	  by	  Gorski	  et	  al.,	  in	  
rodent	   models	   of	   diet	   resistance,	   and	   diet	   induced	   obesity.	   	   Cross-­‐fostering	  
offspring	   of	   diet	   resistant	   dams	   to	   diet	   induced	   obese	   dams	   during	   lactation	  
appeared	   to	  program	   for	  obesity	  and	   insulin	   resistance.	   	  Conversely,	  offspring	  
suckled	  by	  diet	  resistant	  dams,	  irrespective	  of	  maternal	  over-­‐nutrition	  exposure	  
in	  utero,	  displayed	  ameliorated	  insulin	  sensitivity	  (52).	  	  	  
	  
Reducing	   litter	   size	  post-­‐partum,	   to	   increase	   food	  availability	  during	   lactation,	  
has	  also	  provided	  evidence	  of	  increased	  obesity	  risk	  in	  offspring	  exposed	  to	  an	  
adverse	   extra-­‐uterine	   environment	   (53).	   	   	   The	   effects	   of	   a	   hyper-­‐nutritional	  
environment	   during	   lactation	   have	   been	   shown	   to	   be	   trans-­‐generational	   in	  
rodents.	  Providing	  offspring	  with	  high	   carbohydrate	   formula	  milk	  post-­‐partum	  
generated	   adult	   onset	   obesity,	   which	  was	   then	   transmitted	   to	   their	   progeny,	  
despite	   being	   weaned	   on	   to	   standard	   chow	   (54).	   	   Therefore,	   it	   could	   be	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suggested	  that	  the	  immediate	  postnatal	  environment	  is	  able	  to	  override	  genetic	  
and	  pre-­‐natal	  factors,	  ultimately	  influencing	  offspring	  metabolic	  outcome.	  	  	  
	  	  
There	   are	   additional	   studies	   demonstrating	   accelerated	   adiposity	   and	   weight	  
gain	   in	   offspring	   born	   to	   obese	   dams	   and	  maintained	   on	   an	   obesogenic	   diet,	  
both	  post-­‐weaning	  and	  throughout	  post-­‐natal	  life.	  	  These	  findings	  are	  met	  with	  
reports	   of	   hyperphagia	   in	   rodents	   exposed	   to	   a	   continued	   adverse	   maternal	  
environment	  post-­‐partum,	  compared	  to	  control	  offspring	  or	  those	  exposed	  only	  
during	  gestation	  and/or	  lactation	  (55).	  	  It	  can,	  therefore,	  be	  suggested	  that	  the	  
effects	   of	   programming	   interact	   with	   the	   post-­‐natal	   diet,	   and	   not	   only	   the	  
immediate	   post-­‐partum	   period	   to	   influence	   offspring	   risk	   of	   obesity	   and	  
dysmetabolism	  in	  adulthood.	  	  
	  	  	  
1.2.8	  Mechanisms	  of	  Developmental	  Programming	  
	  
1.2.8.1	  Programming	  at	  the	  organ	  or	  cellular	  level	  
Many	   factors	   have	   been,	   mechanistically,	   implicated	   in	   the	   development	   of	  
offspring	   obesity	   and	   dysmetabolism	   in	   response	   to	   maternal	   over-­‐nutrition.	  	  
Experimentally,	   it	   has	   been	   shown	   that	   offspring	   born	   to	   obese	   dams	   are	  
hyperphagic	   irrespective	  of	  diet	  palatability.	   	   It	  was,	   therefore,	   suggested	   that	  
the	  regulatory	  appetite	  centres	  in	  the	  hypothalamus	  were	  permanently	  altered	  
causing	   adiposity,	   and	   its	   associated	   comorbidities.	   	   More	   specifically,	  
neuropeptide	   Y	   (NPY),	   an	   orexigenic	   hormone,	   has	   been	   reported	   to	   be	   up-­‐
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regulated	   (5,	   56).	   	   Changes	   to	   these	   neuropeptides	   are	   thought	   to	   be	   the	  
consequence	  of	  perturbed	  levels	  of	  insulin	  and	  leptin.	  
	  
Leptin	   is	   involved	   in	  the	   long-­‐term	  regulation	  of	  food	  intake.	   	  Recent	  evidence	  
supports	   the	   role	   of	   leptin	   in	   neuronal	   differentiation,	   within	   hypothalamic	  
circuitry,	   suggesting	   that	   programming	   could	   be	   the	   result	   of	   aberrant	   leptin	  
levels	  during	  critical	  developmental	  periods	  (57).	  	  Reconstitution	  of	  leptin	  in	  the	  
ob/ob	   leptin	   deficient	   mouse	   has	   been	   shown	   to	   reduce	   hyperphagia	   and	  
adiposity	  through	  down	  regulation	  of	  NPY,	  and	  other	  orexigenic	  peptides	  (58).	  	  
Moreover,	  physiological	  doses	  of	  leptin,	  during	  lactation,	  have	  been	  reported	  to	  
protect	   against	   high-­‐fat	   diet-­‐induced	   leptin	   and	   insulin	   resistance	   in	   adult	  
rodents	  (59).	  
	  
Insulin,	   like	   leptin,	   possesses	   neurotrophic	   actions	   and	   is	   developmentally	  
regulated.	   	   It	   is	   well	   documented	   that	   insulin	   administration	   reduces	   NPY	  
expression,	   thereby	  protecting	   against	  diet-­‐induced	  obesity	   in	   adulthood	   (60).	  	  
Neonatal	  hyper-­‐insulinaemia	  may	  be	  a	  programming	  cue.	  	  This	  hypothesis	  is	  as	  
a	   result	   of	   reports	   that	   neonatal	   insulin	   treatment	   induces	   permanent	  
alterations	   in	  hypothalamic	   structure,	  associated	  with	  adult	  onset	  obesity	  and	  
hyper-­‐insulinaemia	  (61).	  
	  
Impaired	   glucose	   homeostasis	   in	   offspring	   is	   observed	   in	   many	   models	   of	  
maternal	   over-­‐nutrition	   and	   often	   precedes	   the	   development	   of	   type	   II	  
diabetes.	   	   Glucose	   homeostasis	   is	   a	   balance	   between	   insulin	   production	   by	  
	   57	  
pancreatic	   β	   cells	   and	   the	   responsiveness	   of	   peripheral	   tissues	   to	   insulin.	   	   	   A	  
growing	   body	   of	   evidence	   suggests	   that	   programming,	   by	   maternal	   over-­‐
nutrition,	   may	   be	   the	   result	   of	   permanent	   alterations	   in	   insulin	   signalling	  
molecules	   in	   insulin	   responsive	   tissues,	   such	   as	   skeletal	   muscle.	   	   Permanent	  
alterations	  in	  insulin	  receptor	  substrate-­‐1	  and	  reduced	  serine	  473	  protein	  kinase	  
B/Akt	   phosphorylation,	   the	   main	   downstream	   signalling	   molecule	   in	   insulin	  
signalling,	  have	  been	  reported	  in	  offspring	  of	  ewes	  fed	  an	  obesogenic	  diet	  (31).	  
	  
Another	  putative	  mechanism,	  by	  which	  programming	  may	  occur,	   is	  via	  altered	  
adipose	  physiology.	  	  More	  precisely,	  altered	  body	  composition	  and	  excessive	  fat	  
deposition	   are	   observed	   in	   offspring	   exposed	   to	   maternal	   over-­‐nutrition,	  
implicating	   perturbed	   adipocyte	   differentiation	   and	   function.	   	   It	   has	   been	  
reported,	   at	   3	   months	   of	   age,	   that	   offspring	   born	   to	   obese	   dams	   have	  
hypertrophic	  adipocytes	  with	  increased	  PPARγ	  expression,	  suggesting	  increased	  
lipogenesis	   and	   reduced	   lipolysis	   (35).	   	  Additionally,	   it	  has	  been	   reported	   that	  
genes	   governing	   adipogenesis	   are	   up-­‐regulated	   in	   peri-­‐conceptional	   and	  
gestational	  models	  of	  over-­‐nutrition	  (62).	  	  Although	  the	  increased	  fat	  mass	  may	  
be	   compensatory	   to	   ensure	   that	   lipids	   are	   stored	   in	   adipocytes,	   opposed	   to	  
other	   metabolic	   tissues,	   it	   adversely	   propagates	   insulin	   resistance	   and	  
inflammation.	  	  	  
	  
1.2.8.2	  Programming	  at	  the	  sub-­‐cellular	  level	  	  	  	  
Mitochondria	  are	  responsible	  for	  generating	  ATP	  and	  oxidising	  fatty	  acids.	  	  They	  
are	   also	   the	   site	   of	   ROS	   production.	   	   If	   the	   mitochondrial	   electron	   transport	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chain	   (ETC)	   is	   over-­‐stimulated,	   free	   radicals	   are	   produced,	   stimulating	  
inflammation.	   	   In	   obese	   mothers,	   with	   increased	   mitochondrial	   membrane	  
potentials,	   elevated	   levels	   of	   oxidative	   phosphorylation	   and	   ROS,	   aberrant	  
mitochondrial	   function	   has	   been	   reported	   as	   early	   as	   embryogenesis	   in	  mice	  
(63).	  	  Disruption	  of	  mitochondrial	  oxidative	  phosphorylation	  has	  been	  reported	  
in	  	  insulin	  responsive	  tissues,	  such	  as	  the	  liver	  and	  skeletal	  muscle,	  in	  offspring	  
exposed	   to	   maternal	   over-­‐nutrition	   (64,	   65).	   	   Therefore,	   programming	   by	  
maternal	   over-­‐nutrition	   may	   be	   the	   result	   of	   perturbed	   mitochondrial	  
pathways.	  
	  
1.2.8.3	  Programming	  and	  Epigenetic	  Mechanisms	  
Epigenetic	   programming	   involves	   changes	   in	   gene	   expression,	   with	   the	   DNA	  
sequence	   unaltered.	   	   Such	   changes	   include	   DNA	   methylation,	   histone	  
modification	  and	  chromatin	  packaging.	   	   In	  particular,	  DNA	  methylation	  is	  most	  
commonly	  studied.	  Given	  that	  dietary	  intake	  is	  the	  source	  of	  methyl	  donors	  and	  
cofactors,	   it	   is	   hypothesised	   that	   maternal	   nutrition	   could	   alter	   epigenetic	  
patterns,	   thereby	   increasing	   offspring	   susceptibility	   to	   chronic	   disease	   in	  
adulthood.	   	   Additionally,	   methylation	   patterns	   are	   established	   during	  
development,	  making	   it	  more	   plausible	   that	   programming,	   via	  maternal	   over-­‐
nutrition,	  could	  occur	  through	  epigenetic	  modifications	  (66).	  
	  
Early	   evidence	   from	   a	   rodent	   model	   describes	   epigenetic	   alterations	   in	  
pancreatic	   genes	   of	   offspring	   reared	   in	   small	   litters	   i.e.	   over-­‐fed.	   	   This	  
observation	   was	   associated	   with	   reduced,	   glucose	   stimulated,	   insulin	   release	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(67).	   	  Using	  a	   similar	   experimental	   paradigm,	  Plagemann	  et	   al.,	   demonstrated	  
hyper-­‐methylation	   of	   the	   insulin	   receptor	   and	   anorexigenic	   peptide,	   POMC,	  
promoter	   regions;	   correlating	   with	   aberrant	   blood	   glucose	   concentrations	   in	  
offspring	  (68).	  
	  
MicroRNAs	   (short	   ribonucleic	   acids	   found	   in	   eukaryotic	   cells),	   that	   target	  
proteins	   involved	   in	   epigenetic	   regulation,	   have	   also	   been	   shown	   to	   be	  
differentially	  expressed	  in	  offspring	  exposed	  to	  a	  maternal	  high	  fat	  diet;	  namely	  
methylCpG	   binding	   domain	   proteins	   in	   the	   liver	   (69).	   	   Despite	   experimental	  
evidence	   of	   an	   association	   between	   maternal	   over-­‐nutrition	   and	   altered	  
epigenetic	   processes,	   epidemiological	   extrapolation	   of	   these	   findings	   is	   very	  
limited.	  	  	  	  	  
	  
1.2.8.4	  Programming	  and	  Circadian	  Rhythms	  
An	  important	  component	  of	  metabolic	  homeostasis	  is	  the	  coordination	  of	  daily	  
rhythms	   in	   feeding	   behaviour,	   energy	   utilisation,	   rest	   and	   activity.	   	   This	   is	  
achieved	   through	   synchronisation	   of	   the	   external	   environment	   with	   internal	  
physiology,	   made	   permissible	   by	   molecular	   machinery	   generating	   circadian	  
rhythms.	   	   A	   transcriptional/translational	   feedback	   loop	   located	   within	   the	  
hypothalamic	  suprachiasmatic	  nucleus	  (SCN),	  also	  known	  as	  the	  master	  clock,	  is	  
recognised	  at	   the	  pace-­‐setter	   for	   all	   peripheral	   clocks,	   located	   in	  every	   cell	   of	  
the	   body,	   although	   peripheral	   clocks	   can	   under	   certain	   conditions,	   act	  
autonomously	  (70).	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It	   is	   well	   documented	   that	   RNA	   expression	   of	   genes	   encoding	   lipogenesis,	  
lipolysis	  and	  gluconeogenesis	  is	  variable	  over	  a	  24	  hour	  period	  and	  it	  has	  been	  
suggested	   that	   there	   is	   a	   close	   association	   between	   the	   periodicity	   of	  
transcription	   and	   the	   programmable	   effects	   of	   the	   circadian	   clock	   (71).	  	  
Additionally,	   mice	   with	   the	   Clock	   gene	   mutation	   are	   reported	   to	   be	  
hyperphagic,	   obese	   and	   hyper-­‐leptinaemic,	   re-­‐affirming	   the	   link	   between	   the	  
molecular	   circadian	   clock	  and	  metabolic	  processes	   (72).	   	  Moreover,	   a	  high	   fat	  
diet	   in	   rodents	   has	   been	   reported	   to	   alter	   the	   expression	   and	   rhythmicity	   of	  
canonical	   circadian	   clock	   genes	   and	   nuclear	   receptors,	   which	   regulate	   clock	  
transcription	  factors	  (73).	  
	  
So,	   therefore,	   it	   appears	   that	   a	   hyper-­‐calorific	   nutritional	   environment	   can	  
disrupt	  molecular	  circadian	  rhythms.	  	  A	  similar	  nutritional	  environment,	  during	  
critical	   periods	   of	   development,	   might	   permanently	   alter	   circadian	   molecular	  
circuitry	   in	  offspring.	   	   It	   is	   thus	  plausible	   that	  programming	  via	  maternal	  over-­‐
nutrition	  implicates	  disruption	  of	  circadian	  rhythms	  mechanistically.	  
	  	  	  	  
1.3	  The	  Metabolic	  Syndrome	  
The	  metabolic	   syndrome	   is	   a	   constellation	   of	   risk	   factors,	   primarily	   including:	  
abdominal	   adiposity;	   hyperglycemia;	   type	   II	   diabetes;	   hypertension	   and	  
hyperlipidaemia.	   	   A	   growing	   body	   of	   evidence	   suggests	   that	   excess	   central	  
adiposity	  initiates	  insulin	  resistance.	  	  Consequently,	  this	  gives	  rise	  to	  an	  array	  of	  
comorbidities	  comprising	  the	  clinical	  entity	  -­‐	  the	  metabolic	  syndrome.	  	  	  Obesity	  
itself	   is	   considered	   to	   be	   a	   chronic	   low	   grade	   inflammatory	   state	   which	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accelerates	   tissue	   injury,	   especially	   the	   vasculature	   to	   increase	   cardiovascular	  




Table	  1.2	  Criteria	  for	  Clinical	  Diagnosis	  of	  the	  Metabolic	  Syndrome	  
Measure	   Ranges	  
Increased	  waist	  circumference*	   Population-­‐specific	  and	  
country-­‐specific	  definitions	  
Increased	  triglycerides	  (drug	  treatment	  for	  
elevated	  TG	  is	  alternate	  indicator†)	  
≥150	  mg/dL	  (1·∙7mmol/L)	  
Reduced	  HDL	  cholesterol	  (drug	  treatment	  for	  
reduced	  HDL	  cholesterol	  is	  alternate	  indicator†)	  
<40	  mg/dL	  (1·∙0	  mmol/L)	  in	  
men;	  <50	  mg/dL	  (1·∙3	  
mmol/L)	  in	  women	  
Increased	  blood	  pressure	  (antihypertensive	  drug	  
treatment	  in	  patient	  with	  history	  of	  hypertension	  
is	  alternate	  indicator)	  
Systolic	  ≥130	  and/or	  
diastolic	  ≥85	  mm Hg	  
Increased	  fasting	  glucose‡	  (drug	  treatment	  of	  
increased	  glucose	  is	  alternate	  indicator)	  
>	  100	  mg/dL	  (5·∙5	  mmol/L)	  
*	   It	   is	   recommended	   that	   the	   IDF	   cutpoints	   be	   used	   for	   non-­‐Europeans	   and	   either	   the	   IDF	   or	  
AHA/NHLBI	  cutpoints	  used	  for	  people	  of	  European	  origin	  until	  more	  data	  are	  available.	  
†	   Most	   commonly	   used	   drugs	   for	   increased	   triglycerides	   and	   reduced	   HDL	   cholesterol	   are	  
fibrates	   and	   nicotinic	   acid.	   A	   patient	   on	   one	   of	   these	   drugs	   can	   be	   presumed	   to	   have	   high	  
triglycerides	  and	  low	  HDL.	  Use	  of	  high-­‐dose	  ω-­‐3	  fatty	  acids	  presumes	  high	  triglycerides.	  
‡	  Most	  patients	  with	  type	  2	  diabetes	  will	  have	  the	  metabolic	  syndrome	  by	  the	  proposed	  criteria.	  
	  
The	   prevalence	   of	   the	   metabolic	   syndrome	   is	   increasing	   proportionally	   with	  
obesity	  rates	  in	  developed	  and	  developing	  countries.	  	  In	  2003,	  it	  was	  estimated	  
that	  the	  syndrome	  affected	  between	  24	  and	  34%	  of	  individuals	  in	  the	  US	  and	  up	  
to	  36%	  of	  Europeans	  (14).	  	  	  	  A	  major	  complication	  of	  the	  metabolic	  syndrome	  is	  
non-­‐alcoholic	  fatty	  liver	  disease	  (NAFLD).	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Development	  of	  the	  metabolic	  syndrome	  has	  been	  attributed	  to	  environmental	  
risk	   factors	  such	  as	  dietary	   imbalance.	   	  However,	  a	  growing	  body	  of	  evidence,	  
from	   population-­‐based	   and	   experimental	   studies,	   suggest	   a	   predisposition	   to	  
development	   of	   the	   syndrome	   following	   exposure	   to	   adverse	   maternal	  
environments	   during	   neonatal	   development	   (5).	   	   In	   light	   of	   this,	   it	   becomes	  
necessary	   to	   investigate	   the	   association	   between	  maternal	   over-­‐nutrition	   and	  
NAFLD	  in	  offspring,	  for	  which	  a	  paucity	  of	  data	  exists.	  
	  
1.4	  Non-­‐Alcoholic	  Fatty	  Liver	  Disease	  (NAFLD)	  
	  
1.4.1	  Introduction	  to	  NAFLD	  
NAFLD	  was	  first	  described	  as	  a	  clinical	  entity	  by	  Ludwig	  and	  colleagues	  (75).	  	  The	  
term	   implicitly	   acknowledges	   that	   the	   characteristics	   of	   NAFLD	   resemble	  
alcoholic	   fatty	   liver,	   but	   without	   a	   history	   of	   immoderate	   alcohol	   use.	   	   An	  
Alcohol	  consumption	  of	  <140g	  for	  men	  and	  <70g	  per	  week	  for	  women	  has	  been	  
deemed	   accepted	   as	   ‘little	   or	   no	   alcohol’	   by	   some	   authorities	   and	   in	   recent	  
times	  NAFLD	   has	   been	   defined	   as	   the	   hepatic	  manifestation	   of	   the	  metabolic	  
syndrome	  (76).	  
	  
NAFLD	  is	  a	  spectrum	  of	  liver	  disease	  ranging	  from	  hepatosteatosis	  (fatty	  liver),	  
to	   non-­‐alcoholic	   steatohepatitis	   (NASH)	   (fat	   with	   inflammation),	   through	   to	  
fibrosis,	   cirrhosis	  and	  potentially	  hepatocellular	   carcinoma	   (77).	   	  Patients	  with	  
NAFLD	   who	   become	   cirrhotic	   usually	   exhibit	   a	   reduction	   in	   their	   degree	   of	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steatosis	   (78).	   	   The	   terms	   NASH	   and	   NAFLD	   are	   often	   wrongly	   used	   as	  
synonymous.	  More	  correctly,	  NASH	  is	  a	  more	  severe	  stage	  of	  NAFLD.	  
	  
1.4.2	  Prevalence	  of	  NAFLD	  
The	   population	   prevalence	   of	   NAFLD	   has	   been	   estimated	   at	   7-­‐35%,	   using	  
alanine	   transaminase	   level,	   ultrasound	   scanning	   or	   magnetic	   resonance	  
spectroscopy	   (MRS),	   as	  diagnostic	   techniques;	   of	  which	  MRS	   is	  most	   sensitive	  
for	  detecting	  liver	  fat	  (79,	  80).	  NAFLD	  prevalence	  is	  about	  15%	  in	  Asian	  (81)	  and	  
20-­‐30%	   in	   Western	   adults	   (82).	   	   The	   Dionysos	   Study,	   reported	   25%	   of	   adult	  
Italians	   with	   NAFLD,	   of	   which	   55%	   had	   normal	   transaminase	   levels.	   This	   is	  
suggestive	   that	   liver	   enzymes	   alone,	   as	   a	   diagnostic	   marker	   of	   NAFLD,	  
underestimate	   the	   true	   population	   prevalence	   (83).	   	   	   Estimates	   of	   NASH	  
prevalence	   are	   at	   around	   2.5%	   (84,	   85),	  making	  NASH	  more	  widespread	   than	  
chronic	   hepatitis	   B	   and	   C,	   alcoholic	   liver	   disease	   and	   other	   metabolic	   liver	  
diseases.	   The	   rising	   rates	   of	   obesity	   worldwide	   (86)	   parallel	   rising	   rates	   of	  
NAFLD.	   	   As	   a	   result,	   it	   is	   	   projected	   that	   within	   the	   next	   decade	   a	   greater	  
number	  of	  patients	  will	  be	   transplanted	   for	  NAFLD	  than	   for	  end	  stage	  chronic	  
hepatitis	  C	  (87).	  	  	  
	  
1.4.3	  Risk	  Factors	  
Risk	   factors	   associated	   with	   NAFLD	   are,	   predominantly,	   the	   features	   of	   the	  
metabolic	  syndrome	  (obesity,	  type	  2	  diabetes,	  insulin	  resistance,	  hypertension,	  
and	  dyslipidaemia).	   	  Male	  sex	  and	   increased	  waist	  circumference	  are	  also	  well	  
established	   risk	   factors	   (76,	  88).	   	  NAFLD	   is	  primarily	  associated	  with	   increased	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intra-­‐abdominal	   fat	  mass.	   	  However,	  NAFLD	   can	  occur	   in	   lean	   subjects	   and	   in	  
patients	  with	  forms	  of	  lipodystrophia	  (89).	  	  Additionally,	  NAFLD	  has	  been	  shown	  
to	   cluster	  within	   families	   (90)	   and	  patterns	   of	   inter-­‐ethnic	   variation	   have	   also	  
been	   described	   (82).	   	   There	   is	   emerging	   evidence	   moreover,	   that	   maternal	  
obesity,	  by	  means	  of	  programming	  during	  offspring	  physiological	  development,	  
increases	  susceptibility	  to	  NAFLD	  in	  adulthood	  (91).	  
	  
1.4.4	  Natural	  History	  of	  NAFLD	  
The	   natural	   history	   of	   NAFLD	   is	   imprecisely	   defined.	   The	   present	   literature,	  
examining	   NAFLD	   manifestation,	   can	   be	   divided	   into	   two	   main	   categories;	  
cohort	  studies	  using	  patients	  diagnosed	  ultrasonographically	  with	  investigation	  
of	   their	   clinical	   outcomes	   and	   sequential	   biopsy	   studies	   investigating	  
histological	  progression.	  
	  
An	  observational	  study	  reported	  that	  40	  patients	  with	  steatosis,	  over	  a	  median	  
follow	   up	   period	   of	   11	   years,	   did	   not	   progress	   to	   NASH	   or	   cirrhosis	   (92).	   	   A	  
subsequent	  study,	  with	  132	  patients	  diagnosed	  with	  NAFLD	  and	  a	  mean	  follow	  
up	  period	  of	   8	   years,	   found	   that	   cirrhosis	  was	  more	   common	  with	  ballooning	  
degeneration,	   Mallory	   hyaline	   inclusions	   and/or	   fibrosis,	   than	   pure	   steatosis	  
alone	  (93).	  
	  
The	  most	  recent	  study	  from	  two	  Scandinavian	  hospitals,	  with	  a	  mean	  follow	  up	  
period	   of	   14	   years,	   demonstrates	   a	   low	   risk	   of	   progression	   to	   cirrhosis	   from	  
steatosis	   alone.	   	   However,	   around	   20%	   of	   patients	   with	   NASH	   developed	  
	   65	  
cirrhosis	  over	   the	  14	  years	   follow-­‐up	  period.	   	   It	  was	   found	   that	  patients	  more	  
often	  died	   from	  cardiovascular	  and	   liver	   related	  co-­‐morbidities.	   	   Furthermore,	  
5.4%	  of	  patients,	  with	  NASH	  at	  inception	  of	  the	  study,	  developed	  end-­‐stage	  liver	  
disease	  including	  hepatocellular	  carcinoma	  (94).	  
	  
In	  a	  sequential	  biopsy	  study,	  with	  a	  mean	  interval	  between	  biopsies	  of	  3.2	  ±	  3.0	  
years,	   fibrosis	   progression	   occurred	   in	   37%;	  whilst	   34%	   remained	   stable	  with	  
regression	  occurring	  in	  29%.	  	  Additionally,	  co-­‐morbid	  cardiovascular	  disease	  and	  
diabetes	   increased	   risk	  of	   fibrosis	  progression	  and	  mortality	  after	  exclusion	  of	  
cirrhotic	  patients	  (95).	  	  	  
	  
It	   appears	   that	  NAFLD	  disease	   progression	   is	   largely	   dependent	   on	   co-­‐morbid	  
insulin	   resistance,	   as	   evidenced	   by	   a	   large	   prospective	   cohort	   study	   involving	  
around	   1	   million	   patients.	   	   This	   study	   demonstrated	   an	   increased	   risk	   of	  
hepatocellular	  carcinoma	  in	  patients	  with	  type	  2	  diabetes	  and	  NAFLD	  (96).	  	  
	  
1.4.5	  Diagnosis	  
Presently,	   there	   is	   no	   single	   diagnostic	   test	   that	   reliably	   detects	   NAFLD.	   	   Its	  
diagnosis	  is	  dependent	  on	  identification	  of	  hepatic	  triglyceride	  accumulation,	  at	  
the	   tissue	   level,	   in	   an	   obese,	   insulin	   resistant	   and	   dyslipidaemic	   patient;	  with	  
little	   or	   no	   alcohol	   history.	   	   Diagnosis	   of	   NAFLD	   is,	   largely,	   by	   exclusion.	   	   Its	  
presence	  is	  confirmed	  in	  the	  absence	  of	  focal	  liver	  lesions,	  positive	  serology	  for	  
hepatitis	  A,	  B	  and	  C,	  aberrant	  autoimmune	  profile,	  copper,	  caeruloplasmin	  and	  
ferritin	  (97).	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The	  majority	  of	  NAFLD	  patients	  have	  abnormal	   liver	   function	   tests.	   	  However,	  
elevated	   transaminase	   and	   gamma	   glutamyltransferase	   (GGT)	   levels	   lack	  
sensitivity	   and	   specificity	   for	   NAFLD.	   	   It	   has	   been	   reported	   that	   alanine	  
transaminase	   levels	   may	   be	   normal	   in	   the	   presence	   of	   hepatosteatosis,	   as	  
evidenced	   radiologically	   (82).	   	   Furthermore,	   aberrant	   liver	   enzymes	   may	  
normalise	   with	   disease	   progression.	   	   The	   aspartate	   transaminase	   to	   alanine	  
transaminase	   ratio	   is	   usually	   <1	   unlike	   alcoholic	   liver	   disease	   where	   it	   is	   >1.	  	  
However,	  reversal	  of	  the	  AST/ALT	  ratio	  to	  >1	  implies	  advanced	  fibrosis	  in	  NAFLD	  
(97).	  
	  	  	  
Serum	   albumin	   and	   bilirubin	   remain	   within	   physiological	   ranges	   in	   NAFLD	  
patients.	  	  However,	  these	  levels	  become	  perturbed	  with	  disease	  progression	  to	  
cirrhosis.	   	  A	  low	  level	   inflammatory	  state	  exists	  in	  obesity	  and	  NAFLD,	  which	  is	  
reflected	  by	  increased	  ferritin	  levels	  in	  the	  presence	  of	  normal	  iron	  indices.	  	  The	  
increased	   serum	   ferritin	   in	   this	  pathophysiological	   setting	   is	  believed	   to	  be	  an	  
acute	   phase	   reactant	   (98).	   	   Raised	   anti-­‐smooth	   muscle	   and	   anti-­‐nuclear	  
antibodies,	  seen	  in	  up	  to	  25%	  of	  NAFLD	  patients,	  are	  indicative	  of	  more	  severe	  
inflammation	  and	  injury	  (95).	  	  	  
	  
Histological	   classification	   of	   hepatosteatosis	   is	   diagnostic	   of	   NAFLD.	  	  
Macrovesicular	   steatosis	   is	   the	   hallmark	   histological	   lesion	   present	   in	   NAFLD.	  	  
Fat	  accumulation	  commences	  in	  zone	  3	  but	  may	  spread	  depending	  on	  severity	  
to	   encompass	   the	   entire	   acinus.	   	   The	   extent	   of	   hepatosteatosis	   is	   broadly	  
graded	   into	   3	   categories;	   0-­‐33%,	   33-­‐66%	   and	   >66%,	   with	   >5%	   considered	   as	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NAFLD.	   	   Haemotoxylin	   and	   eosin	   staining	   illustrate	   acute	   or	   chronic	  
inflammatory	  cell	  infiltrates	  and	  Mallory’s	  hyaline.	  	  Pericellular	  fibrosis	  may	  also	  
be	  evident	  on	  connective	  tissue	  staining	  (97).	  
	  
Histopathological	   features	   of	   NASH	   include	   the	   presence	   of	   lobular	  
inflammation,	  hepatocellular	  ballooning,	  lytic	  necrosis	  and/or	  apoptotic	  bodies,	  
predominately	  in	  zone	  3.	  	  Moreover,	  portal	  inflammation	  and	  dispersed	  lobular	  
lipogranulomas	  and	  microgranulomas	  may	  be	  present	  (98).	  
	  	  	  
The	  NAFLD	  Activity	  Score	   (NAS)	   is	  a	  quantitative	  scoring	  system	  developed	  for	  
the	  grading	  and	   staging	  of	  histological	   lesions.	   	   It	   is	  based	  on	   the	  presence	  of	  
steatosis,	   hepatocellular	   ballooning	   and	   lobular	   inflammation,	   providing	   a	  
composite	  score.	  	  A	  score	  above	  5	  is	  classified	  as	  NASH	  and	  below	  3	  is	  not	  NASH	  
(98).	  	  Fibrosis	  is	  scored	  separately	  with	  an	  attainment	  of	  4	  equating	  to	  cirrhosis.	  	  
The	   NASH	   Clinical	   Research	   Network	   (CRN)	   have	   more	   recently	   proposed	   a	  
scoring	   system	   encompassing	   the	   entire	   spectrum	   of	   NAFLD,	   which	   is	   also	  
applicable	  to	  paediatric	  NAFLD	  (99).	  	  Typical	  histological	  features	  of	  NAFLD,	  and	  
its	  more	  severe	  form,	  non-­‐alcoholic	  steatohepatitis	  (NASH),	  are	  tabulated	  below	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Table	  1.3	  Histological	  Features	  of	  Steatohepatitis	  
Feature	   Description	  
Hepatocellular	  Injury	   • Ballooning	  
• Apoptosis/necrosis	  
• Mallory’s	  hyaline	  
• Giant	  mitochondria	  
Inflammation	   • Neutrophil	  polymorphs	  
• Other	  cells	  e.g.	  T-­‐lymphocytes,	  
macrophages	  





1.4.6.1	  Two	  Hit	  Hypothesis	  
The	   pathogenesis	   of	   NAFLD	   is	   poorly	   understood.	   	   Both	   obesity	   and	   insulin	  
resistance	  are	   thought	   crucial	   to	   the	  development	  of	  NAFLD.	   	   The	  association	  
between	   fat	   accumulation	   and	   hepatic	   injury,	   until	   recently,	   was	   explained	  
using	  the	  ‘Two-­‐Hit	  Hypothesis’.	  	  This	  hypothesis	  proposed	  that	  increased	  supply	  
of	   free	   fatty	   acids	   (FFA),	   due	   to	   obesity,	   and	   enhanced	   de	   novo	   lipogenesis,	  
from	   extra-­‐hepatic	   insulin	   resistance,	   led	   to	   hepatic	   fat	   accumulation	   –	   the	  
‘First-­‐Hit’.	   	   Subsequently	   the	   liver	  becomes	   sensitised	   to	   ‘Second-­‐Hits’	   such	  as	  
oxidative,	   cytokine-­‐mediated	   and	   endoplasmic	   reticulum	   mediated	   stress.	  	  
Hepatic	  inflammation	  and	  injury,	  as	  observed	  in	  NAFLD,	  ensue	  (100).	  Excess	  fat	  
deposition	  within	   the	   liver	  was	  also	   thought	   to	  arise	   from	  a	  variety	  of	   insults.	  
These	   include	   impaired	   FFA	   oxidation,	   due	   to	   hyperinsulinaemia	   and	  
mitochondrial	   damage,	   reduced	   export	   of	   triacylglycerol	   (TAG)	   as	   very-­‐low-­‐
density-­‐lipoproteins	  (VLDLs),	  and	  increased	  esterification	  of	  FFAs	  to	  TAGs	  (101).	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A	   growing	   body	   of	   evidence	   suggests	   that	   steatosis	   is	   not	   a	   prerequisite	   for	  
disease	  development,	  as	  inhibition	  of	  TAG	  synthesis	  has	  been	  shown	  to	  increase	  
hepatic	  injury	  (102).	  	  	  	  
	  
1.4.6.2	  Hepatosteatosis	  
Hepatosteatosis	   is	   a	   consequence	   of	   altered	   lipid:	   uptake;	   synthesis;	  
degradation	  and	  secretion	  (103).	   	  More	  specifically,	   there	  are	  two	  mechanistic	  
pathways,	  responsible	  for	  hepatosteatosis,	  initiated	  by	  insulin	  resistance.	  	  In	  the	  
first	  instance,	  lipolysis	  increases	  the	  concentration	  of	  free	  fatty	  acids,	  which	  are	  
removed	   from	   the	   circulation	   by	   hepatocytes.	   	   The	  mitochondrial	   ß-­‐oxidation	  
pathway	   consequently	   becomes	   saturated,	   leading	   to	   accumulation	   of	  
triglycerides	  in	  the	  liver.	  	  Fatty	  acids	  are	  inducers	  and	  substrates	  of	  microsomal	  
lipooxygenases,	  which	  may	  evoke	  production	  of	  reactive	  oxygen	  species.	  	  These	  
free	  radicals	  in	  turn	  induce	  lipid	  peroxidation	  of	  hepatocyte	  membranes	  (103).	  	  	  
	  
The	   alternative	   pathway	   is	   governed	   by	   hyperinsulinemia,	   which	   augments	  
hepatic	   fatty	   acid	   synthesis	   by	   promoting	   glycolysis.	   	   Insulin	   resistance	   also	  
diminishes	   synthesis	   of	   apolipoprotein	   B-­‐100,	   which	   is	   required	   for	   the	  
incorporation	  of	   triglycerides	   into	   very	   low	  density	   lipoproteins	   (VLDLs)	   (103).	  	  
Reduced	   expression	   of	   apolipoprotein	   B-­‐100	   mRNA	   in	   the	   liver	   has	   been	  
identified	   in	   several	   NASH	   patients	   (104).	   	   These	   putative	   pathways	   are	  
supported	   by	   epidemiological	   studies	   which	   have	   demonstrated	   that	   insulin	  
resistance	   is	   a	   stronger	   predictor	   of	   NAFLD	   outcome	   compared	   to	   other	   risk	  
factors,	  such	  as	  body	  mass	  index,	  central	  adiposity	  or	  glucose	  intolerance	  (105).	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Although	   hepatosteatosis	  may	   not	   be	   a	   prerequisite	   for	   NAFLD	   development,	  
the	  resulting	  lipotoxicity	  clearly	  plays	  a	  fundamental	  role	  in	  disease	  progression,	  
as	  evidenced	  by	  the	  strong	  correlation	  between	  steatosis	  severity	  and	  prognosis	  
(106).	  
	  
1.4.6.3	  Lipid	  Peroxidation	  
Studies	   have	   demonstrated	   increased	   lipid	   peroxidation,	   secondary	   to	  
accumulation	   of	   hepatic	   triglycerides.	   	   Consequently,	   pro-­‐fibrogenic	   and	   pro-­‐
inflammatory	   cytokine	   pathways,	   with	   adiponectin	   and	   TNF-­‐α	   being	   key	  
mediators,	   are	   activated	   (107).	   	   Additionally,	   increased	   oxidation	   of	   FFAs	   by	  
peroxisomes,	  the	  microsomal	  oxidising	  system	  in	  hepatocytes	  and	  mitochondria	  
all	   contribute	   to	   direct	   liver	   injury	   by	   up-­‐regulation	   of	   cytokine	   gene	  
transcription	  (108).	  	  	  
	  
1.4.6.4	  Oxidative	  Stress	  
Experimental	   evidence	   suggests	   a	   strong	   association	   between	  oxidative	   stress	  
markers	   and	   obesity,	   insulin	   resistance	   and	   diabetes	   (109).	   	   As	   expected,	  
therefore,	   elevated	   intra-­‐hepatic	   fatty	   acids	   are	   a	   source	   of	   reactive	   oxygen	  
species	   (ROS).	   	   	   Interestingly,	   the	   production	   of	   ROS	   and	   oxidative	   stress	   has	  
been	   observed	   to	   precede	   the	   onset	   of	   insulin	   resistance.	   	   The	   expression	   of	  
oxidative	   stress	   related	   genes	   is	   increased	   in	   the	   placenta	   of	   obese	   women	  
(110),	  suggesting	  that	  maternal	  obesity	  can	  program	  offspring	  susceptibility,	  to	  
dysmetabolism	  and	  NAFLD,	  through	  chronic	  up-­‐regulation	  of	  inflammatory	  and	  
oxidative	  stress	  pathways.	  
	   71	  
Oxidative	   stress	   is	   often	   observed	   in	   tandem	  with	   impaired	   insulin	   signalling.	  	  
Up-­‐regulation	   of	   lipogenic	   genes,	   in	   correlation	  with	   oxidative	   stress	  markers,	  
were	  reported	  in	  a	  rodent	  programming	  model	  of	  high	  fat	  diet	  induced	  obesity.	  	  
These	  findings	  are	  suggestive	  of	  proportionate	  fatty	  acid	  accumulation	  and	  ROS	  
production	   (64).	   	   The	   putative	   role	   of	   oxidative	   stress,	   in	   maternal	   over-­‐
nutrition	  models,	   is	   exemplified	   through	   observation	   of	   reversed,	   or	   reduced,	  
dysmetabolic	   traits	   in	   offspring;	   following	   anti-­‐oxidant	   intervention	   in	   obese	  
dams	  (111).	  
	  
1.4.6.5	  Mitochondrial	  Dysfunction	  
Free	   fatty	   acids	   undergo	   mitochondrial	   β-­‐oxidation	   producing	   ROS,	   thereby	  
illuminating	   hepatic	   mitochondria	   as	   major	   sources	   of	   oxidative	   stress.	  	  
Mitchondrial	   dysfunction,	   which	   is	   implicated	   in	   diabetes	   and	   other	  
dysmetabolic	   disorders,	   is	   therefore	   thought	   to	   be	   pivotal	   in	   progressing	  
steatosis	   to	   steatohepatitis	   and	   fibrosis.	   	   Ultrastructural	  mitochondrial	   lesions	  
and	   linear	   crystalline	   inclusions	   in	  megamitochondria	   are	   found	   exclusively	   in	  
NASH	  patients,	  as	  opposed	  to	  steatotic	  or	  healthy	  individuals.	  	  It	  is	  thought	  that	  
this	  mitochondrial	   injury	   is	   consequent	   to	   impaired	   ATP	   recovery	   in	   the	   liver	  
(103).	  	  	  	  
	  
When	   the	   oxidative	   capacity	   of	   mitochondria	   becomes	   impaired,	   alternative	  
pathways	   are	   recruited	   to	   prevent	   hepatic	   fatty	   acid	   accumulation.	   	   Such	  
pathways	   include	   peroxisomal	   ß-­‐oxidation	   and	   ω-­‐oxidation	   in	   microsomes,	  
which	   generate	   additional	   ROS	   (112).	   	   With	   regards	   to	   maternal	   obesity,	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mitochondrial	   dysfunction	   has	   been	   reported	   in	   embryos	   which	   have	   higher	  
levels	   of	   oxidative	   phosphorylation	   and	   ROS	   production	   when	   compared	   to	  
those	  of	  lean	  mothers	  (63).	  	  Moreover,	  disruption	  of	  the	  hepatic	  mitochondrial	  
electron	   transport	   chain	   has	   been	   reported	   in	   offspring	   exposed	   to	  maternal	  
obesity	  and	  is	  proposed	  as	  potential	  mechanism	  of	  programmed	  NAFLD	  (64).	  
	  
1.4.6.6	  Cytokine	  Induction	  
NAFLD,	   and	   ensuing	   fibrogenesis,	   may	   be	   triggered	   by	   cytokines.	   	   ROS	   can	  
stimulate	  release	  of	  pro-­‐inflammatory	  cytokines	  such	  as	  tumour	  necrosis	  alpha	  
(TNF-­‐α),	   interleukin	   6	   (IL-­‐6)	   and	   the	   pro-­‐fibrogenic	   cytokine,	   transforming	  
growth	   factor	   ß	   (TGF-­‐ß).	   	   TNF-­‐α	   and	   TGF-­‐ß	   induce	   caspase	   activation	   and	  
therefore	  hepatocyte	  cell	  death	  via	  the	  apoptotic	  pathway.	  	  As	  a	  double	  edged	  
sword,	   TNF-­‐α	   also	   impairs	   redox	   reactions	   of	   the	   electron	   transport	   chain,	  
further	  promoting	  ROS	  production(103).	  	  Adipocytes	  are	  another	  source	  of	  the	  
immunomodulatory	   cytokine	   TNF-­‐α,	   which	   also	   been	   implicated	   in	   molecular	  
mechanisms	   influencing	   insulin	  resistance.	   	  TNF-­‐α	   is	   thought	  to	  down-­‐regulate	  
insulin-­‐receptor	   substrate-­‐1	   and	   reduce	   expression	   of	   GLUT-­‐4,	   an	   insulin	  
dependent	  glucose	  transport	  molecule	  (113).	  	  The	  mechanistic	  role	  of	  TNF-­‐α	  in	  
NAFLD	   pathogenesis	   is	   highlighted	   by	   observation	   of	   improved	   histological	  
features	   in	   the	   ob/ob	   mouse	   model	   where	   TNF-­‐a	   antagonism	   inhibited	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1.4.6.7	  Activation	  of	  Fibrogenesis	  	  
	  
1.4.6.7.1	  Alpha	  Smooth	  Muscle	  Actin	  (αSMA)	  
Alpha	   smooth	   muscle	   actin	   (αSMA)	   is	   an	   actin	   isoform,	   indicative	   of	   smooth	  
muscle	   cell	   differentiation.	   	   It	   is	   expressed	   permanently	   in	   activated	   hepatic	  
stellate	   cells	   (HSCs)	   in	   fibrocontractive	   diseases.	   	   It	   is	   thought	   that	   an	  
appreciable	  threshold	  of	  αSMA	  expression	  may	  be	  a	  hallmark	  of	   liver	   injury	  or	  
fibrogenesis.	   	   ASMA	   relative	   expression	   in	   NAFLD	   is	   therefore	   predictive	   of	  
fibrosis	  risk	  (115).	  	  	  
	  
1.4.6.7.2	  Transforming	  Growth	  Factor	  Beta	  (TGF-­‐ß)	  
Up-­‐regulation	   of	   TGF-­‐ß	   has	   been	   demonstrated	   in	   human	   and	   animal	   hepatic	  
fibrosis	   (116).	   	   Principal	   production	   of	   TGF-­‐ß	   occurs	   in	   the	   HSCs,	   however,	  
platelets,	   Kupffer	   cells	   and	   inflammatory	   cells	   possess	   TGF-­‐ß	   synthesising	  
capacity,	   thereby	   implicating	   the	   hepatic	   innate	   immune	   system	   in	   NAFLD	  
pathogenesis	  and	  progression	  to	  fibrosis.	  	  TGF-­‐ß	  induces	  transdifferentiation	  of	  
HSCs	  to	  myofibroblasts,	  evoking	  increased	  synthesis	  of	  the	  extracellular	  matrix	  
(ECM)	  (117).	  	  	  
	  
1.4.6.7.3	  Collagen	  Type	  1α2	  
mRNA	  expression	   of	   collagen	   type	   1α2	   	   is	   thought	   to	   be	   up-­‐regulated,	   at	   the	  
transcriptional	   and	   post-­‐transcriptional	   level,	   in	   activated	   HSCs	   (Stefanovic	   et	  
al.,	  1997).	   	  Alterations	  in	  the	  quantity	  and	  composition	  of	  the	  ECM	  initiate	  the	  
fibrogenic	  process.	  	  Further	  supporting	  this,	  increased	  predominance	  of	  collage	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type	  1α2	  in	  chronic	  fibrosis	  has	  been	  demonstrated	  in	  immunoassays	  of	  hepatic	  
ECM	  (118).	  	  	  
	  
1.4.6.8	  The	  Hepatic	  Innate	  Immune	  System	  
	  
1.4.6.8.1	  Introduction	  
The	   liver	   is	   a	   major	   immune	   organ,	   predominately	   synthesising	   the	   body’s	  
innate	  immune	  proteins.	  	  The	  hepatic	  innate	  immune	  system	  largely	  comprises	  
of	  Kupffer	   (phagocytic	  cells),	  natural	  killer	   (NK)	  and	  natural	  killer	  T	   (NKT)	  cells.	  
Other	   components	   include	   acute-­‐phase	   proteins	   (APP),	   pattern	   recognition	  
receptors	   and	   complement	   factors	   (119).	   	   From	   epidemiological	   and	  
experimental	  evidence,	  it	  is	  well	  documented	  that	  innate	  immunopathogenesis	  
is	   implicated	   in	   hepatic	   pathophysiology	   (120).	   	  More	   specifically,	   it	   has	   been	  
suggested	  that	  an	  imbalance	  of	  hepatic	  Th1	  cytokines,	  produced	  by	  these	  innate	  
immune	   cells,	   are	   a	   common	  pathogenic	  mechanism	   in	   insulin	   resistance	   and	  
NAFLD	  (121).	  	  	  	  
	  
1.4.6.8.2	  Kupffer	  Cells	  
Kupffer	  cells	  (KC)	  constitute	  the	  majority	  of	  the	  body’s	  macrophage	  population.	  	  
These	   cells	   are	   mature	   and	   specialised	   derivatives	   of	   blood	   monocytes,	   that	  
originate	   from	  bone	  marrow	  progenitors.	   	  KCs	  make	  up	  approximately	  20%	  of	  
hepatic	  non-­‐parenchymal	   cells	   (i.e	   cells	   other	   than	  hepatocytes)	   and	   reside	   in	  
liver	   sinusoids.	   	   KCs	   are	   responsible	   for	   eliminating	   blood	   borne	   pathogens,	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clearance	   of	   bacteria	   and	   generating	   ROS	   and	   pro-­‐inflammatory	   cytokines,	  
which	  potentiate	  immune	  responses	  indicative	  of	  hepatocyte	  injury	  (119).	  	  	  
	  
The	  characteristics	  of	  macrophages	  include	  functional	  polarisation	  to	  either	  an	  
M1	  or	  M2	  phenotype.	  	  M1	  macrophages	  produce	  copious	  amounts	  of	  cytokines,	  
including	  IL-­‐6,	  IL-­‐12,	  IL-­‐18,	  IL-­‐23,	  TNF-­‐α	  and	  ROS,	  as	  a	  result	  of	  pro-­‐inflammatory	  
mediator	   induction.	   	   These	   pro-­‐inflammatory	   cytokines	   are,	   in	   turn,	   able	   to	  
activate	  polarised	  Th1	  responses.	  	  	  
	  
Th1	   cells	   are	   a	   sub-­‐group	   of	   T	   helper	   lymphocytes	   capable	   of	   producing	   pro-­‐
inflammatory	  cytokines	  and	  inducing	  cellular	  immunity.	  	  T	  helper	  cells	  are	  able	  
to	   regulate	   immune	   responses	   through	   activation	   of	   the	   Th1	   cells	   and	   anti-­‐
inflammatory	  cytokine	  producing	  cells,	  Th2	  (119).	  	  An	  imbalance	  of	  these	  states	  
or	   a	   Th1	   predominated	   cytokine	   response	   is	   thought	   to	   be	   crucial	   in	   NAFLD	  
pathogenesis.	  
	  
M2	   macrophages,	   conversely,	   produce	   large	   quantities	   of	   anti-­‐inflammatory	  
cytokines	   such	   as	   IL-­‐10,	   thereby	   promoting	   the	   Th2	   response.	   	   Corroborating	  
this,	   experimental	   studies	   show	   that	   adipose	   tissue	   macrophages	   from	   lean	  
animals	  express	   the	  M2	   (anti-­‐inflammatory)	  phenotype	  and	   those	   from	  obese	  
animals	   express	   the	  M1	   (pro-­‐inflammatory)	   phenotype	   (119).	   	   Additionally,	   it	  
has	  been	  reported	  that	  KC	  ablation	  improves	  histological	  outcome	  of	  NASH	  in	  a	  
rodent	  model	  (122).	  	  	  These	  findings	  were	  preceded	  by	  reports	  of	  increased	  KC	  
recruitment	  and	  activation	  in	  a	  similar	  experimental	  paradigm	  (123).	  	  Therefore,	  
	   76	  
it	  can	  be	  suggested	  that	  KCs	  play	  a	  pivotal	  role	  in	  pathogenesis	  and	  are	  not	  just	  
a	  phenomenological	  observation	  in	  the	  context	  of	  chronic	  liver	  injury.	  	  	  	  
	  
1.4.6.8.3	  Natural	  Killer	  T	  (NKT)	  Cells	  	  	  
NKT	   cells	   are	   a	   unique	   lymphocytic	   sub-­‐population,	   that	   co-­‐express	   NK	   cell	  
surface	  markers	  and	  the	  T	  cell	  receptor	  (TCR),	  originating	  from	  the	  thymus	  and	  
bone	  marrow	   (124).	   	   NKT	   cells	   can	   be	   further	   categorised	   into	   3	   sub-­‐classes;	  
class	  I-­‐	  classical	  or	  invariant,	  class	  II-­‐	  non-­‐classical	  or	  non-­‐invariant	  and	  class	  III-­‐	  
NKT-­‐like	  cells	   (119).	   	  Through	  their	  T	  cell	   receptor,	   invariant	  and	  non-­‐invariant	  
NKT	   cells	   are	   able	   to	   recognise	   exogenous	   and	   endogenous	   (self-­‐antigen)	  
glycolipids	  presented	  by	  the	  MHC	  class	  I	  like	  molecule,	  CD1d	  (124).	  	  	  
	  
Upon	   activation,	   these	   cells	   have	   the	   unique	   ability	   to	   produce	   pro-­‐
inflammatory	   and	   anti-­‐inflammatory	   cytokines	   also	   known	   as	   Th1	   and	   Th2	  
cytokines,	  respectively.	  	  This	  results	  in	  direct	  cellular	  effects	  and	  recruitment	  of	  
other	   immune	   cells	   through	   indirect	   downstream	   signalling	   pathways.	   	   Thus	  
CD1d	   restricted	  NKT	   cells	   have	   diverse	   immunoregulatory	   properties	   enabling	  
them	  to	  modulate	  the	  eventual	   inflammatory	  response	  (124).	   	  NKT	  cells	  are	  in	  
turn	  regulated	  by	  KC	  derived	  cytokines,	  dietary	  factors	  and	  sympathetic	  nervous	  
system	  outputs	  such	  as	  noradrenaline	  (121).	  
	  
Within	  the	  murine	  liver,	  over	  80%	  of	  the	  NKT	  cell	  population	  is	  of	  the	  invariant	  
subtype	   (iNKT).	   	   iNKT	   cells	   can	   be	   distinguished	   from	   the	   non-­‐invariant	   sub-­‐
population	  because	   they	   express	   a	   semi-­‐variant	   TCR	   and	   are	   activated	  by	   the	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glycolipid	  α-­‐galacto-­‐sylceramide	  (α-­‐GalCer).	  	  The	  TCR	  of	  non-­‐invariant	  NKT	  cells	  
is	   far	   more	   diverse	   and	   the	   lack	   of	   α-­‐GalCer	   reactivity	   makes	   this	   subtype	  
difficult	  to	  study	  (124).	  	  	  iNKT	  cells	  reside	  within	  liver	  sinsuoids	  and	  are	  activated	  
early	   during	   an	   immune	   response,	   making	   these	   cells	   key	   players	   in	   liver	  
inflammation	   and	   therefore	   NAFLD	   pathogenesis.	   	   Moreover,	   greatest	  
expression	  of	  CD1d	  in	  the	  liver	  occurs	  on	  hepatocyte	  cell	  membranes	  and	  given,	  
that	  hepatocytes	  are	  putative	  regulators	  of	  intermediary	  lipid	  metabolism,	  it	   is	  
plausible	   that	   hepatosteatosis	   and	   ensuing	  NAFLD	   are	   closely	   associated	  with	  
NKT	  cell	  defects	  (125).	  
	  	  	  	  
Recently,	   evidence	   has	   emerged	   for	   abnormalities	   in	   the	   NKT	   cell	   population	  
and/or	   function	   in	   NAFLD	   patients.	   	   Results	   from	   a	   variety	   of	   diet-­‐induced	  
obesity	  models	   of	   NAFLD	   have	   reported	   an	   inverse	   relationship	   between	   the	  
degree	  of	  injury	  and	  NKT	  cell	  number.	  	  More	  specifically,	  it	  has	  been	  shown,	  in	  
the	   ob/ob	   mouse	   model,	   that	   NKT	   cells	   are	   selectively	   reduced	   (126)	   and	  
biopsied	   NASH	   livers	   have	   declining	   NKT	   cell	   numbers	   proportionate	   to	   the	  
extent	  of	  hepatosteatosis	   (127).	   	  Previously,	   inoculation	  of	  a	   small	  quantity	  of	  
NKT	   cells	   in	   leptin	   deficient	   mice	   was	   shown	   to	   induce	   a	   12%	   reduction	   in	  
hepatosteatosis	   within	   12	   hours,	   suggesting	   a	   putative	   role	   for	   NKT	   cells	   in	  
NAFLD	  pathogenesis	  (128).	  	  	  
	  
1.4.6.8.4	  Natural	  Killer	  (NK)	  Cells	  
Natural	   killer	   (NK)	   cells	   are	   large	   and	   granular	   cytotoxic	   lymphocytes,	   of	   the	  
innate	   immune	   system,	   that	   play	   a	   major	   role	   in	   tumour	   rejection	   and	   viral	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infected	  cells.	  	  	  These	  cells	  too	  originate	  from	  bone	  marrow	  progenitor	  cells.	  	  NK	  
cells	  release	  small	  cytotoxic	  granules	  of	  proteins,	  called	  perforin,	  that	  cause	  the	  
cell	   to	  die	  by	  either	  apoptosis	  or	  osmotic	   cell	   lysis.	   	   The	  cells	  are	  activated	  by	  
cytokines	  released	  from	  viral	  infected	  cells,	  interferon	  and	  macrophage-­‐derived	  
cytokines.	  	  NK	  cells	  can	  also	  be	  activated	  by	  the	  KC	  ligand,	  NKG2D	  (129).	  	  
	  
A	  growing	  body	  of	  evidence	  suggests	  that	  NK	  cells	  are	  involved	  in	  various	  types	  
of	  liver	  pathology	  such	  as	  NAFLD	  and	  fibrosis.	  	  In	  an	  experimental	  model	  of	  diet-­‐
induced	   obesity,	   significantly	   reduced	  NK	   cytotoxic	   activity,	   compared	   to	   lean	  
animals,	  was	  reported	  with	   later	  corroboration	   in	  obese	  human	  subjects	   (130,	  
131).	   	   It	   is	  thought	  that	  NK	  cells	  are	  positively	  correlated	  with	  reduced	  fibrosis	  
as	  they	  induce	  hepatic	  stellate	  cell	  apoptosis,	  the	  liver’s	  principal	  fibrogenic	  cell.	  	  
However,	   the	   inverse	   is	   true	   of	   hepatic	   injury	   as	   NK	   cells	   induce	   hepatocyte	  
apoptosis	  via	  interferon	  γ	  (IFN-­‐γ)	  (132).	  	  	  
	  
1.4.6.9	  Dietary	  Constituents	  
The	   effect	   of	   diet	   on	   NAFLD	   pathogenesis	   has	   recently	   been	   investigated.	  	  
Rapidly	   absorbed	   carbohydrates	   (RAC)	   i.e.	   those	   with	   a	   high	   glycaemic	   index	  
were	   shown	   to	   promote	   hyperinsulinaemia	   and	   hepatic	   TAG	   accumulation,	  
compared	  to	  slowly	  absorbed	  carbohydrates	  (133).	   	  RAC	  consumption	  has	  also	  
been	   shown	   to	   decrease	   beta	   oxidation	   and	   increase	   hepatic	   de	   novo	  
lipogenesis,	   inevitably	   increasing	   risk	   of	   hepatosteatosis	   (134).	   Common	  
therapeutics	  may	  also	   induce	  hepatosteatosis.	   	  Examples	   include	  non-­‐steroidal	  
anti-­‐inflammatory	  drugs	   (NSAIDs),	   tetracycline,	   amiodarone,	   sodium	  valporate	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and	   anti-­‐virals	   such	   as	   zidovudin	   and	   interferon.	   	   Fat	   accumulation	   in	   this	  
context	  arises	  from	  inhibition	  of	  the	  mitochondrial	  beta-­‐oxidation	  of	  fatty	  acids	  
(135).	  	  	  
1.4.6.10	  Sympathetic	  Nervous	  System	  
It	  has	  also	  been	  proposed	  that	  the	  sympathetic	  nervous	  system	  (SNS),	  both	  via	  
direct	   and	   indirect	   mechanisms	   of	   action,	   enhance	   fibrogenesis	   in	   NAFLD.	  	  
Animal	   models	   of	   NASH	   lacking	   a	   functional	   SNS,	   either	   through	  
pharmacological	   or	   genetic	   manipulation	   or	   reduced	   angiotensin-­‐1	   signalling,	  
are	  poorly	  fibrogenic	  (136,	  137).	  
	  
1.4.7	  Treatment	  of	  NAFLD	  
There	   is	   presently	   no	   single	   therapeutic	   intervention.	   	   NAFLD	   is	   largely	   the	  
consequence	   of	   obesity,	   malnutrition	   and	   sedentary	   behaviour	   and	   thus	  
primary	   prevention	   are	   lifestyle	   modifications.	   	   However,	   given	   the	   growing	  
body	  of	  evidence	  reporting	  a	  foetal	  origin	  of	  adult	  onset	  disease,	  intervention	  in	  
early	  life,	  or	  even	  pre-­‐conception,	  may	  be	  effective;	  if	  not	  preventative.	  
	  
1.4.8	  Experimental	  Models	  of	  NAFLD	  
Experimental	   models	   characterising	   clinical	   disease	   presentation	   can	   improve	  
our	   comprehension	   of	   aetiology,	   prognosis	   and	   intervention	   possibilities.	  	  
Presently,	  two	  pathophysiologically	  imperfect	  models	  of	  NAFLD	  are	  in	  existence,	  
necessitating	   creation	   of	   a	   more	   representative	   animal	   model.	   	   These	  
experimental	   models,	   however,	   have	   uncovered	   several	   basic	   mechanisms	  
perturbed	  in	  dysmetabolism	  and	  NAFLD.	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1.4.8.1	  The	  ob/ob	  Mouse	  Model	  
This	  model	   is	   generated	   via	  mutation	  of	   the	  obesity	   (ob)	   gene	  which	  disrupts	  
leptin	   synthesis,	   a	   satiety	   hormone.	   	   Leptin	   is	   an	   adipokine	   that	   acts	   on	   the	  
hypothalamus	   to	   decrease	   appetite	   and	   elevate	   energy	   expenditure.	  	  
Consequently,	   in	   the	   absence	   of	   leptin,	   the	  mouse	   develops	   hyperphagia	   and	  
obesity.	   	   The	   ob/ob	   mouse	   goes	   on	   to	   develop	   a	   liver	   phenotype	   similar	   to	  
human	   NAFLD,	   although	   poorly	   fibrogenic.	   	   This	   lack	   of	   a	   robust	   fibrogenic	  
response,	   despite	   evident	  hepatosteatosis	   and	   inflammation,	   is	   thought	   to	  be	  
due	   to	   the	   absence	   of	   leptin	   and	   consequent	   reduced	   sympathetic	   nervous	  
system	  tone	  (138).	  	  	  
	  
The	  pitfalls	  of	  this	  model	  are	  further	  highlighted	  by	  the	  hypo-­‐leptinaemic	  state	  
of	  the	  ob/ob	  mouse	  as	  excessive	  leptin	  and	  its	  resistance	  is	  well	  characterised	  in	  
human	  NAFLD.	   	  The	  ob/ob	  model	   therefore	   is	  of	   limited	  utility	   in	   the	  study	  of	  
NAFLD	  pathogenesis.	   	  However,	   this	   insulin	   resistant	  model	  has	  demonstrated	  
that	  hepatocytes	  become	  steatotic	  and	  apoptose	  at	  greater	  rates,	  propagating	  
development	  of	  the	  more	  severe	  form,	  non-­‐alcoholic	  steatohepatitis	  (NASH).	  	  It	  
has	   also	   been	   well	   documented	   in	   the	   ob/ob	   mouse	   model	   that	   leptin	  
potentiates	  fibrosis	  by	  innate	  immune	  cells,	  through	  direct	  activation	  of	  hepatic	  
stellate	   cells	   and	   regulation	   of	   pro-­‐	   and	   anti-­‐fibrogenic	   cytokine	   production,	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1.4.8.2	  The	  Methionine	  Choline	  Deficient	  (MCD)	  Diet	  Model	  
	  A	   diet	   deficient	   in	   methionine	   and	   choline	   induces	   depletion	   of	   hepatic	  
oxidants,	   such	   as	   glutathione.	   	   This	   increases	   oxidative	   stress,	   which	   in	   turn	  
evokes	   lipid	   peroxidation	   and	   induction	   of	   pro-­‐inflammatory	   cytokines.	   	   The	  
MCD	  diet	  model	   is	  more	   commonly	   used	   to	   study	   steatohepatitis	   (140).	   	   Like	  
the	  ob/ob	  mouse	  model,	  the	  MCD	  diet	  model	  is	  imperfect,	  as	  these	  animals	  do	  
not	   become	   obese	   which	   is	   pivotal	   in	   human	   NAFLD;	   otherwise	   known	   as	  
obesity	  induced	  liver	  disease.	  	  Additionally,	  the	  MCD	  fed	  rodents	  are	  not	  insulin	  
resistant,	  as	  commonly	  observed	  in	  human	  NAFLD	  (141).	  	  	  
	  
1.5	  Developmental	  Programming	  and	  NAFLD:	  Current	  Knowledge	  
	  
The	  role	  of	  developmental	  programming	  in	  offspring	  NAFLD,	  via	  maternal	  over-­‐
nutrition,	   has	   been	   long	   speculated	   as	   suggested	   by	   reports	   of	   Guo	   et	   al.	  	  
Experimentally,	   they	   show	   hepatomegaly,	   in	   the	   context	   of	   dysmetabolism,	  
attributable	   to	   hepatic	   fat	   accumulation	   in	   offspring	   rodents	   born	   to	   obese	  
mothers	  (142).	  	  	  Such	  an	  association	  between	  maternal	  obesity,	  offspring	  hyper-­‐
triglyceridaemia	   and	   propensity	   to	   NAFLD	   development,	   has	   been	   shown	   in	  
various	  models	  (27,	  35).	  	  	  
	  
However	   the	   role	   of	   programming	   in	   offspring	   NAFLD	   has	   only	   been	  
comprehensively	  investigated	  using	  a	  physiologically	  relevant	  model	  recently,	  in	  
this	  PhD,	  and	  the	  novel	   findings	  published.	   	  Using	  a	  rodent	  model	  of	  maternal	  
obesity	   (crude	   fat	   17.9%,	   simple	   sugars	   55%,	   energy	   7.8	   kcal/g;	   ad	   libitum	   6	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weeks	   prior	   to	   and	   during	   gestation	   and	   lactation),	   we	   reported	   our	   novel	  
findings	   of	   hepatosteatosis,	   marked	   liver	   injury	   and	   induction	   of	   liver	  
fibrogenesis,	  in	  offspring	  exposed	  to	  maternal	  obesity.	  	  	  
	  
Markers	   such	   as	   interleukin-­‐6	   (IL-­‐6),	   TNF-­‐α,	   α-­‐smooth	   muscle	   actin	   (ASMA),	  
TGF-­‐β,	  collagen,	  hepatic	  tissue	  triglyceride	  content	  and	  macrovesicular	  steatosis	  
were	   even	   more	   pronounced	   in	   offspring	   exposed	   to	   maternal	   obesity	   only	  
during	   lactation.	   	   Therefore,	   it	   was	   concluded	   that	   although	   exposure	   to	  
maternal	   obesity	   during	   gestation	   and	   lactation	   programmed	   a	   NAFLD	  
phenotype,	   maternal	   over-­‐nutrition	   limited	   to	   the	   lactation	   period	   was	  more	  
critical	   to	   disease	   potentiation.	   	   These	   findings,	   in	   part,	   may	   explain	   the	  
inexorable	  rise	  of	  obesity	  induced	  liver	  disease	  (143).	  	  
	  
Using	   a	   similar	   experimental	   paradigm,	   the	   observed	   phenotype	   in	   the	  
aforementioned	  study	  corroborates	  the	  findings	  of	  Bouanane	  et	  al.	  	  They	  report	  
a	   permanent	   reduction	   in	   hepatic	   β-­‐oxidation	   and	   increased	   lipogenesis,	  with	  
altered	   composition	   of	   saturated	   fatty	   acids	   in	   VLDL	   lipids,	   as	   a	   potential	  
mechanism	   for	   hepatosteatosis;	   as	   observed	   in	   offspring	   born	   to	   high-­‐fat	   fed	  
dams	   (144).	   	  Additionally,	   increased	   lipogenesis,	  as	  evidenced	  by	  up-­‐regulated	  
SREBP-­‐1	   and	   impaired	   lipolysis	   due	   to	   PPARa	   down	   regulation,	   has	   been	  
reported	  in	  a	  rodent	  model	  of	  maternal	  over-­‐nutrition	  (145).	  	  	  
	  
However,	   there	   is	   emerging	   evidence	   suggesting	   that	  maternal	   obesity	   is	   not	  
the	   only	   determinant	   of	   programmed	   offspring	   NAFLD.	   High	   calorific	   intake	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during	   pregnancy,	   independent	   of	   maternal	   obesity,	   may	   also	   be	   involved	   in	  
programming	  hepatic	  injury	  as	  has	  recently	  been	  shown	  in	  non-­‐human	  primates	  
(146).	   	   Similarly,	   Bayol	   and	   colleagues	   report	   hepatosteatosis	   and	   increased	  
oxidative	   stress,	   in	   offspring	   born	   to	  mothers	   fed	   a	   hyper-­‐calorific	   ‘junk’	   diet	  
during	  gestation	  and	  lactation,	  independent	  of	  prior	  maternal	  obesity	  (147).	  
	  
Experimental	  research	  indicates	  that	  nutritional	  perturbations	  in	  the	  intra-­‐	  and	  
extra-­‐uterine	  environment,	  prime	  offspring	   liver	   to	  an	   increased	  risk	  of	  NAFLD	  
in	   adulthood.	   	   However,	   the	   underlying	   mechanisms	   responsible	   for	   the	  
observed	  phenotype	  are	  unknown.	  	  It	  has	  been	  suggested	  that	  maternal	  breast	  
milk	   factors	  may	  act	  on	  central	  neonatal	  energy	  homeostasis	   centres,	  evoking	  
hyperphagia	   and	   subsequent	   obesity	   and	   obesity	   induced	   liver	   disease	   (143).	  	  
However,	   there	   is	   a	   paucity	   of	   data	   on	   the	   direct	   effects	   of	   maternal	   over-­‐
nutrition	   on	   hepatic	   function.	   	   It	   has	   been	   recently	   suggested	   that	   maternal	  
over-­‐nutrition,	  during	  developmental	  plasticity,	  perturbs	  hepatic	  mitochondrial	  
electron	   transport	   chain	   reactions;	   increasing	   oxidative	   stress	   and	   fat	  
accumulation	  with	  resultant	  hepatosteatosis	  (64).	  
	  
Additionally,	   evidence	   from	   animal	   models	   has	   demonstrated	   diet	   induced	  
alterations	  in	  the	  hepatic	  epigenomic	  profile,	  of	  offspring	  exposed	  to	  maternal	  
over-­‐nutrition,	  namely	  hyper-­‐acetylation	  and	  -­‐methylation	  (148).	  	  Godfrey	  et	  al.,	  
have	   recently	   corroborated	   these	   findings	   in	   a	   human	   study,	   examining	   the	  
methylation	   status	   of	   umbilical	   cord	   tissue	   DNA	   from	   healthy	   neonates	   with	  
their	   adiposity	   at	   age	  9	   years.	   	   Consequently,	   a	   correlation	  between	  perinatal	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epigenetic	   changes	   and	   childhood	   adiposity,	   owing	   to	   altered	   maternal	  
nutritional	  status,	  was	  reported	  (149).	  	  	  	  	  	  
	  
In	  summary,	  a	  strong	  association	  between	  exposure	  to	  maternal	  obesity	  during	  
development	  and	  offspring	  propensity	  to	  develop	  NAFLD	  exists.	  	  Although	  there	  
is	   accumulating	   evidence	   for	   this	   observed	   correlation,	   further	   research	   is	  
required	  to	  dissect	  the	  downstream	  hepatic	  regulatory	  pathways	  perturbed	  and	  
responsible	  mechanisms.	  	  
	  
1.6	  General	  Hypothesis	  
	  
NAFLD	  is	  an	  increasingly	  prevalent	  disorder	  and	  now	  the	  most	  common	  cause	  of	  
chronic	   liver	   disease	   in	   affluent	   countries.	   	   Additionally,	   obesity,	   which	   is	  
regarded	  as	  pivotal	  in	  the	  aetiopathogenesis	  of	  NAFLD,	  incorporating	  a	  familial	  
component,	   is	   rising	   in	   tandem.	   	   	   Therefore,	   a	   better	   understanding	   of	   the	  
underpinning	   pathophysiology	   is	   required	   for	   improved	   diagnosis	   and	  
intervention.	   	   The	   growing	   body	   of	   evidence	   suggesting	   that	   perinatal	   factors	  
affect	   health	   outcomes	   in	   adult	   life	   warrants	   enquiry	   into	   offspring	   liver	  
phenotypes	   following	   exposure	   to	   maternal	   over-­‐nutrition.	   	   The	   prevailing	  
hypothesis	   is	   that	  maternal	   obesity	   programs	   offspring	   dysmetabolism	  with	   a	  
pre-­‐disposition	   to	   NAFLD	   in	   adulthood,	   an	   association	   presently	   unknown.	  	  
Additionally,	   it	   is	   hypothesised	   that	   the	   adverse	  maternal	  milieu	   permanently	  
alters	  physiological	  processes	  governing	  liver	  repair	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1.7	  Aims	  
	  
The	   aim	   of	   this	   thesis,	   therefore,	   is	   to	   determine	   if	   maternal	   obesity	   during	  
gestation	   and/or	   lactation	   transmits	   a	   predisposition	   to	   dysmetabolism	   and	  
NAFLD	   in	  offspring	  and	  secondarily	   to	   investigate	   the	  mechanisms	   therein.	   	   In	  
order	   to	   delineate	   the	   effects	   of	  maternal	   over-­‐nutrition	   on	   offspring	   hepatic	  
outcome,	  this	  thesis	  specifically	  aims	  to	  examine	  the	  following:	  
	  
a.	   The	   effect(s)	   of	   exposure	   to	   maternal	   obesity	   on	   offspring	  
dysmetabolism	  and	  NAFLD	  in	  adulthood.	  
	  
b.	  The	  independent	  effect(s)	  of	  the	  in	  utero	  and	  immediate	  post-­‐partum	  
period	   i.e.	   lactation,	   on	   offspring	   susceptibility	   and	   development	   of	  
dysmetabolism	  and	  NAFLD	  in	  adulthood.	  	  
c.	  To	  develop	  a	  uniquely	  pathophysiologically	  relevant	  model	  of	  NAFLD	  
in	  which	  to	  further	  study	  the	  interaction	  between	  in	  utero	  exposure	  and	  
the	   post-­‐weaning	   environment	   in	   programming	   development	   of	  
offspring	  dysmetabolism	  and	  NAFLD	  in	  adulthood.	  
	  
d.	   To	   investigate	   the	   natural	   progression	   of	   NAFLD	   in	   programmed	  
offspring	   and	   ascertain	   whether	   exposure	   to	   maternal	   obesity	   primes	  
accelerated	  disease	  development,	  cirrhosis	  or	  malignancy.	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e.	   To	   examine	   the	   role	   of	   the	   hepatic	   innate	   immune	   system	   as	   a	  
putative	   mechanistic	   pathway	   through	   which	   maternal	   over-­‐nutrition	  
programs	   offspring	   propensity	   to	   dysmetabolism	   and	   NAFLD	   in	  
adulthood.	  
	  
f.	   To	   examine	   the	   role	   of	   the	   peripheral	   circadian	   system	   as	   an	  
alternative,	   but	   putative	  mechanistic	   pathway	   through	  which	  maternal	  
over-­‐nutrition	   programs	   offspring	   propensity	   to	   dysmetabolism	   and	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2	  General	  Methods	  
	  
2.1	  The	  Developmental	  Programming	  Model	  
	  
Overview	  
Using	   female	   C57BL/6J	  mice,	   dietary	  manipulation	   in	   the	   pre-­‐conception	   and	  
post-­‐partum	   periods	   offspring	   exposed	   to	   differing	   in	   utero	   and	   post-­‐partum	  
dietary	   environments	   were	   generated	   to	   allow	   investigation	   of	   nutritional	  
influences	  in	  programming	  NAFLD	  in	  adult	  offspring.	  	  	  
	  
2.1.1	  Pilot	  Protocols	  
Experimental	   diets	   were	   rendered	   obesogenic	   by	   varying	   their	   fatty	   acid	   and	  
sugar	  contents	  and	  further	  supplemented	  with	  soy	  oil	  to	  ensure	  essential	  fatty	  
acid	   requirements.	   These	   diets	   were	   then	   further	   supplemented	   with	  
sweetened	   condensed	   milk	   fed	   ad	   libitum.	   	   This	   model	   has	   previously	   been	  
shown	  to	  rapidly	  increase	  and	  sustain	  body	  weights	  throughout	  pregnancy	  (35).	  	  	  
	  
In	   a	   pilot	   study,	   two	   similar	   obesogenic	   diets	   obtained	   from	   Special	   Diet	  
Services,	  Whitham,	   UK,	   varying	   only	   in	   the	   simple	   sugar	   content	  were	   fed	   to	  
female	   mice	   post-­‐weaning	   (n	   =	   5)	   (Table	   2.1).	   	   Additionally,	   the	   diets	   were	  
supplemented	  with	  a	  highly	  palatable	  condensed	  milk,	  rich	  in	  sugar.	  	  The	  aim	  of	  
the	   pilot	   study	   was	   to	   ascertain	   which	   diet	   enhanced	   appetite	   thereby	  
potentiating	  accelerated	  weight	  gain.	  	  A	  30%	  increase	  in	  body	  weight,	  within	  6-­‐8	  
weeks,	  was	  attained	  in	  mice	  fed	  the	  SDS	  obesogenic	  diet	  #2.	  
	   89	  
Table	  2.1	  Dietary	  Constituents	  of	  Obesogenic	  Diets	  	  
	  
All	   percentage	   values	   are	   given	   as	   w/w.	   *total	   vitamin/	   mineral	   mix	   is	   3.5%.	  
Note	   that	   due	   to	   varying	  moisture	   and	   nitrogen	   free	   extract	   (polysaccharide)	  
content,	   rows	  will	   not	   sum	   to	  100%.	  Abbreviations:	  CHOW	   is	  RM	  3	   from	  SDS.	  
EARNEST	   obesogenic#1	   is	   diet	   824127	   from	   SDS	   and	   EARNEST	   obesogenic#2	   is	  
DIET	  824053	  from	  SDS	  and	  sweetened	  condensed	  milk	  is	  from	  Nestle.	  
	  
Similarly,	   a	   condensed	   milk	   diet	   from	   Open	   Source	   Diets	   (D12266B)	   was	  
additionally	  piloted	  in	  female	  C57BL/6J	  mice.	  	  This	  diet	  is	  all	  encompassing,	  not	  
requiring	   additional	   supplementation	   with	   mineral	   mixes	   or	   sweetened	  
condensed	   milk.	   	   The	   contention	   was	   that	   a	   composite	   diet	   would	   render	  
measurement	   of	   food	   intake	   and	   management	   of	   animal	   husbandry	   more	  
efficient.	   	   However,	   adequate	   increase	   in	   adiposity	   was	   not	   attained	   (Figure	  
Dietary	  
Constituent	  












16.8%	   8.1	  %	  
Polysaccharides	   48.80%	   18.5%	   25%	   	   	  
Simple	  sugars	   5.40%	   17.6%	   10%	   51.4%	   55	  %	  
Fiber	   4.50%	   5%	   5%	   	   	  
Lipid	   Corn	  oil	  
4.3%	  
Soy	  oil	  4.3%,	  
Lard17.9%	  
Soy	  oil	  4.3%,	  
Lard17.9%	  
31.8%	   9	  %	  
Methionine	   0.20%	   0.20%	   0.20%	   	   	  
Energy	  (kcal/g)	   3.3	   4.6	   4.5	   4.4	   3.3	  
	   90	  




Figure	   2.1	   Effects	   of	   different	   experimental	   diets	   on	   pre-­‐conception	   body	  
weights	  
	  
As	   discussed,	   addition	   of	   sweetened	   condensed	  milk	   increases	   palatability	   of	  
the	  feed.	  	  Moreover,	  this	  introduced	  a	  high	  sugar	  component	  to	  the	  obesogenic	  
diet,	  typically	  observed	  in	  cheap,	  energy	  dense	  western	  diets.	  
	  
2.1.2	  Breeding	  Protocols	  
Experimental	   mice	   C57BL/6J	   outbred	   strain	   (Charles	   River	   Laboratories	   (UK)	  
were	  used	  for	  all	  animal	  studies.	  	  Female	  mice	  of	  first	  order	  parity	  were	  allowed	  
seven	   days	   to	   habituate	   to	   the	   animal	   facilities,	   during	   which	   time,	   standard	  
chow	  RM1	  (rat	  and	  mouse	  maintenance	  diet	  from	  SDS,	  Whitham	  Essex,	  UK)	  ad	  
libitum	  was	  provided.	   	  Subsequent	   to	   this,	   female	  mice,	   randomly	  assigned	   to	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the	   obesogenic	   arm	   of	   the	   study,	   were	   fed	   an	   obesogenic	   diet	   #2	   (SDS	   Diet	  
Batch	  824053)	  with	   sweetened	   condensed	  milk	   (Nestle)	   as	   above,	  mixed	  with	  
mineral	  mix	  (SDS	  Batch	  31801,	  125	  mg/pot)	  and	  control	  female	  mice,	  the	  RM1	  
diet,	   ad	   libitum,	   for	   6-­‐8	   weeks.	   	   Female	   mice	   were	   then	   entered	   into	   the	  
breeding	   protocol	   upon	   attainment	   of	   the	   target	   weight	   i.e.	   30%	   increase	   in	  
weight	  from	  baseline.	  	  All	  animals	  were	  treated	  in	  accordance	  with	  The	  Animals	  
(Scientific	  Procedures)	  Act	  1986	  guidelines.	  
	  
Breeding	  males,	  selected	  from	  the	  same	  litter,	  were	  simultaneously	  introduced	  
and	  the	  animals	  were	  allowed	  to	  freely	  mate.	  	  Selection	  of	  breeding	  males	  from	  
one	   litter	  minimised	   genetic	   variability	   of	   offspring.	   	   Day	   0	   of	   pregnancy	  was	  
noted	  by	  the	  formation	  of	  a	  vaginal	  plug.	  	  	  Dams	  were	  allowed	  to	  re-­‐mate	  upon	  
if	   they	   failed	   to	   conceive	   after	   first	  mating.	  However,	   if	   successful	   conception	  
was	   not	   achieved	   on	   subsequent	  matings,	   the	   females	  were	   fasted	   overnight	  
and	   then	   humanely	   sacrificed	   by	   CO2	   inhalation	   (schedule-­‐1	   method)	   (Figure	  
2.2).	  	  	  
	  
Pregnant	  mice	  were	  maintained	  on	  their	  respective	  diets	  throughout	  pregnancy	  
and	  lactation	  with	  maternal	  weight	  and	  dietary	  intake	  recorded	  weekly.	  	  Dams	  
were	  allowed	  to	  deliver	  spontaneously	  and	  left	  undisturbed	  with	  their	  litters	  for	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Figure	  2.2	  Schematic	  Representation	  of	  General	  Mouse	  Breeding	  Protocol	  
	  
Additionally,	  this	  breeding	  protocol	  was	  manipulated	  to	  permit	  investigation	  of	  
the	  effects	  of	  maternal	  obesity	   -­‐	  during	  pregnancy	  and/or	   lactation	  and	   in	  the	  
post-­‐natal	  environment	  on	  programming	  offspring	  dysmetabolism	  and	  NAFLD.	  	  
This	   was	   achieved	   by	   restricting	   exposure	   to	   the	   obesogenic	   diet	   in	   separate	  
windows	  of	  developmental	  plasticity.	  	  
	  
2.1.2.1	  Breeding	  Protocol	  -­‐	  Phase	  1	  
At	  48	  hours	  post-­‐partum,	  the	  litter	  size	  was	  reduced	  to	  6	  pups	  in	  an	  attempt	  to	  
standardise	  milk	  availability	  during	  the	  suckling	  period.	  	  Offspring	  were	  suckled	  
by	   their	   mothers	   for	   21	   days	   post-­‐partum.	   Importantly,	   the	   mothers	   were	  
maintanined	  on	   the	   same	  diet	   as	   they	  had	  whilst	  pregnant.	   	   Female	  offspring	  
were	   then	   weaned	   on	   to	   a	   standard	   chow	   diet,	   ad	   libitum,	   at	   3	   weeks	   and	  
continued	  on	  this	  diet	  until	  adulthood	  (3	  months	  of	  age).	  	  Parameters	  indicative	  
of	  dysmetabolism	  and	  NAFLD	  were	  then	  assayed	  as	  detailed	  (Figure	  2.3).	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Figure	  2.3	  Schematic	  Representation	  of	  Breeding	  Protocol	  –	  Phase	  1	  
	  
2.1.2.2	  Breeding	  Protocol	  –	  Phase	  2	  
In	   ‘Phase	   2’	   of	   the	   breeding	   protocol,	   offspring	   born	   to	   dams	   consuming	   a	  
control	  RM1	  diet	  (lean	  dams)	  were	  cross-­‐fostered	  to	  obese	  dams	  to	  suckle	  at	  48	  
hours	   post-­‐partum.	   Conversely,	   offspring	   born	   to	   obese	   dams	   were	   cross-­‐
fostered	   and	   suckled	   by	   lean	   dams.	   	   Therefore,	   exposure	   of	   offspring	   to	  
maternal	  over-­‐nutrition	  was	  limited	  to	  either	  gestation	  or	  lactation,	  permitting	  
investigation	  of	  the	  effects	  of	  the	  intra-­‐uterine	  and	  extra-­‐uterine	  environments	  
on	   offspring	   phenotype.	   	   As	   previous,	   all	   offspring	   were	   weaned	   on	   to	   a	  
standard	  chow	  diet	  at	  3	  weeks	  post-­‐partum	  and	  continued	  on	  this	  control	  diet	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Figure	  2.4	  Schematic	  Representation	  of	  Breeding	  Protocol	  –	  Phase	  2	  
	  
2.1.2.3	  Breeding	  Protocol	  –	  Phase	  3	  
Although,	   ‘Phase	   2’	   of	   the	   model	   allowed	   investigations	   of	   the	   relative	  
contributions	  of	   the	   intra-­‐	  and	  extra-­‐uterine	  environments	  on	  development	  of	  
offspring	  hepatic	  phenotypes,	  cross-­‐fostering	  is	  a	  stressor	  and	  has	  been	  shown	  
to	   increase	   anxiety	   states	   in	   rodents	   (150).	   Additionally,	   it	   has	   been	   reported	  
that	   cross-­‐fostering	   stress	   may	   alter	   complex	   epigenetic	   traits	   in	   rodent	  
offspring	   and	   compromise	   investigations	   into	   the	   independent	   effects	   of	  
maternal	   over-­‐nutrition	   (151).	   	   Moreover,	   cross-­‐fostering	   is	   non-­‐physiological	  
and	  its	  clinical	  relevance	  is	  therefore	  limited.	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In	   light	   of	   the	   above,	   a	   more	   physiologically	   applicable	   model	   was	   designed,	  
termed	   ‘Phase	   3’.	   In	   this	   model,	   offspring	   continued	   to	   be	   suckled	   by	   their	  
mothers	   and	   were	   then	   weaned	   on	   to	   either	   a	   control	   or	   high	   fat	   diet	   as	  
consumed	   by	   the	   dams	   during	   pregnancy	   and	   lactation.	   	   The	   rationale	   for	  
‘Phase	  3’	   is	  based	  on	  the	  observation	  that	  mothers	  who	  expose	  their	  offspring	  
to	   over-­‐nutrition	   in	   utero	   are	   likely	   to	   nurture	   them	   in	   a	   similar	   environment	  
post-­‐partum.	  	  Additionally,	  offspring	  were	  continued	  on	  their	  allocated	  diets	  in	  
to	   adulthood	  with	   readouts	   obtained	   at	   3	   and	   12	  months	   of	   age,	   in	   order	   to	  
investigate	  the	  natural	  progression	  of	  programmed	  liver	  disease	  (Figure	  2.5).	  
	  
	  
Figure	  2.5	  Schematic	  Representation	  of	  Breeding	  Protocol	  –	  Phase	  3	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2.1.2.4	  Breeding	  Protocol	  –	  Phase	  4	  
In	  attempt	  to	  generate	  a	  uniquely	  pathophysiological	  model	  of	  NAFLD	  in	  which	  
to	  investigate	  underlying	  mechanisms,	  a	  further	  revision	  of	  the	  ‘Phase	  3’	  model	  
was	  implemented.	  	  Much	  of	  the	  literature	  documenting	  the	  effects	  of	  maternal	  
over-­‐nutrition,	  focus	  on	  the	  implications	  of	  offspring	  exposure	  to	  a	  high	  fat	  diet.	  	  
However,	  it	  is	  necessary	  to	  examine	  the	  effects	  of	  a	  high	  fat	  and	  high	  sugar	  diet,	  
which	   is	   propelling	   the	  present	  obesity	   epidemic	   (6).	   	   As	   such,	   offspring	  were	  
weaned	  onto	  either	  a	  control	  or	  a	  high	  fat	  diet	  supplemented	  with	  sweetened	  
condensed	   milk	   i.e.	   a	   truly	   obesogenic	   diet	   (Figure	   2.6).	   	   Offspring	   were	  
continued	  on	  their	  respective	  diets	   into	  adulthood	  and	  readouts,	  pertaining	  to	  
mechanistic	  pathways,	  obtained	  at	  6	  months.	  	  	  	  	  	  
	  
	  
Figure	  2.6	  Schematic	  Representation	  of	  Breeding	  Protocol	  –	  Phase	  4	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2.1.3	  Reproductive	  Rates	  and	  Cannibalism	  
Dams	  entered	  into	  the	  breeding	  protocol	  were	  of	  first	  order	  parity	  to	  reduce	  the	  
risk	  of	  cannibalisation,	  although	  this	  encroached	  upon	  the	  desired	  breeding	  age	  
of	   8-­‐16	  weeks.	   	   	   Cannibalism	  was	   recorded	   to	  be	   greater	   in	  offspring	  born	   to	  
control	   or	   lean	   mothers.	   	   As	   expected,	   fertility	   rates	   were	   reduced	   in	   obese	  
dams,	  alongside	  compromised	  successful	  pregnancies,	  as	  the	  incidence	  of	  foetal	  
re-­‐absorption,	   early	   spontaneous	   and	   complicated	   deliveries	   increased	   (Table	  
2.2).	  
	  
Table	  2.2	  Reproductive	  Rates	  and	  Incidence	  of	  Cannibalisation	  	  
	   Control	  Dams	   Obese	  Dams	  
Fertility	  Rate*	  (%)	   94.4	   72.2	  
Successful	  Pregnancies	  (%)	   77.8	   44.4	  
Cannibalisation	  (%)	   16.7	   5.6	  
*Calculated	   as	  %	   formation	   of	   copulation	   plugs	   for	   all	   dams	   entered	   into	   the	  
breeding	  protocol	  
	  
Litters	   were	   reduced	   to	   6	   pups	   post	   partum,	   by	   random	   selection,	   to	  
standardise	   litter	   sizes	   and	   ensure	   an	   adequate	   milk	   supply.	   	   The	   remaining	  
offspring	   were	   sacrificed	   by	   a	   schedule-­‐1	   method	   on	   day	   2	   post-­‐partum.	  	  
Mothers	  with	  litters	  of	  less	  than	  4	  pups	  after	  48	  hours	  were	  also	  not	  used	  even	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2.1.4	  Maternal	  Anthropometry	  	  
Pre-­‐conception	   maternal	   body	   weights	   were	   recorded	   on	   a	   weekly	   basis	   to	  
ascertain	   suitability	   for	   entry	   into	   the	  breeding	  programme.	   	   Food	   intake	  was	  
measured	   thrice	   weekly	   during	   condensed	   milk	   changes.	   	   From	   this,	   calorie	  
intake	  was	  also	  calculated.	   	  As	  expected,	  calorie	   intake	  was	  directly	   related	  to	  
maternal	  obesity	  (Figure	  2.7).	  
	  
	  
Figure	  2.7	  Pre-­‐Conception	  Maternal	  Body	  Weights	  and	  Calorific	  Intake	  	  
	  
Body	  weight	  was	  similarly	  recorded	  throughout	  gestation.	   	   Increments	   in	  body	  
weight	  during	  this	  period	  were	  used	  to	  monitor	  whether	  the	  breeding	  colonies	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Figure	  2.8	  Gestational	  Maternal	  Body	  Weights	  
	  
2.2	  Tissue	  Harvesting	  	  
All	  offspring	  were	  housed	   in	  a	  group	  of	  2	  or	  3	  per	  cage	  and	  subjected	  to	  a	  12	  
hour	  light/dark	  cycle.	  	  In	  ‘Phase	  1’	  of	  the	  programming	  model,	  all	  offspring	  were	  
fasted	   for	  24	  hours	  prior	   to	  being	   sacrificed,	  using	  CO2	   inhalation	  and	  cervical	  
dislocation	   -­‐	   schedule	  1	  method,	   to	   allow	  measurement	  of	   fasting	   insulin	   and	  
glucose	  levels.	  	  In	  subsequent	  phases	  of	  the	  model,	  offspring	  were	  sacrificed	  in	  
the	  non-­‐fasted	  state	   so	   that	  accurate	   leptin	   levels	   could	  be	  measured.	   	  Organ	  
weights	  were	  determined	  before	  being	  preservation.	  
	  
2.2.1	  Liver	  Tissue	  Preservation	  
Liver	   tissue	   was	   differentially	   preserved	   for	   use	   in	   gene	   expression	   analysis,	  
protein	   and	   lipid	   extraction,	   flow	   cytometry,	   histology	   and	  
immunohistochemistry.	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Formalin	  Fixing	  (Histology)	  
a) Whole	  liver	  was	  dissected	  using	  middle	  orientation	  on	  aluminium	  foil.	  	  	  
b) Liver	   slices	   were	   placed	   in	   pre-­‐labelled	   cassettes	   and	   stored	   in	   10%	  
neutral	  buffered	  formalin.	  
c) To	   ensure	   adequate	   saturation	   of	   tissue	   sections	  with	   formalin,	   tissue	  
was	  stored	  at	  4ºC	  for	  at	  least	  24	  hours	  before	  paraffin	  embedding.	  
	  
	  Cryopreservation	  (Protein	  Analysis,	  Triglyceride	  Quantification)	  
a) Approximately	   1/5	   liver	   tissue	   was	   dissected	   into	   5mm3	   cubes	   and	  
placed	  into	  2ml	  cryotubes.	  
b) The	   tubes	   were	   immediately	   placed	   in	   liquid	   nitrogen	   causing	  
instantaneous	  freezing.	  	  	  
c) All	  tissue	  was	  then	  stored	  at	  -­‐80ºC	  until	  further	  processed.	  
	  
RNAlater	  Fixing	  (Gene	  Expression	  Analysis)	  
a) Approximately	   1/5	   liver	   tissue	   was	   dissected	   into	   5mm3	   cubes	   and	  
placed	  into	  1.5ml	  cryotube	  containing	  1ml	  of	  RNAlater	  solution.	  
b) Samples	   were	   stored	   at	   4°C	   for	   at	   least	   24	   hours	   to	   permit	   adequate	  
tissue	  saturation	  prior	  to	  long	  term	  storage	  at	  -­‐20°C.	  
	  
2.2.2	  Blood	  Collection	  
Offspring	   blood	   was	   collected	   via	   cardiac	   puncture	   or	   inferior	   vena	   cava	  
cannulation	   using	   heparinised	   syringes.	   	   The	   blood	   was	   transferred	   to	  
endotoxin-­‐free	   eppendorf	   vials	   and	   centrifuged	   at	   3000	   x	   g	   for	   10	  minutes	   at	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4˚C.	   	   The	  decanted	  plasma	  was	   then	   stored	   in	   vials	   at	   -­‐20˚C	  until	   biochemical	  
analysis.	   	   Serum	   alanine	   transaminase	   levels	   were	   analysed	   by	   the	   clinical	  
biochemistry	  department,	  Royal	  Free	  Hospital,	  University	  College	  London.	  
	  
2.3	  RNA	  Extraction	  	  
Total	   RNA	   was	   isolated	   from	   murine	   whole	   liver	   tissue	   using	   TRIzol	   Reagent	  
(Invitrogen	   Life	   Technologies).	   	   TRIzol	   Reagent	   is	   a	   mono-­‐phasic	   solution	   of	  
phenol	   and	   guanidine	   isothiocyanate.	   	   During	   tissue	   homogenisation,	   the	  
reagent	   maintains	   RNA	   integrity	   whilst	   disrupting	   cells	   and	   dissolving	   cell	  
components.	   	   	   RNA	   was	   isolated	   in	   accordance	   with	   the	   manufacturer’s	  
recommended	  protocol	  detailed	  below.	  
	  
Homogenisation	  
50-­‐100mg	  of	  murine	  liver	  tissue	  from	  each	  sample	  was	  homogenised	  in	  
1ml	   of	   TRIzol	   Reagent	   using	   an	   autoclaved	   pestle	   and	   mortar.	   	   The	  




a) The	   homogenised	   samples	   were	   incubated	   for	   5	   minutes	   at	   room	  
temperature	   to	   permit	   complete	   dissociation	   of	   nucleoprotein	  
complexes.	  
b) 0.2ml	  of	  chloroform	  was	  added	  to	  the	  homogenised	  samples.	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c) The	  samples	  were	  vortexed	  for	  15	  seconds	  prior	  to	   incubation	  at	  room	  
temperature	  for	  2-­‐3	  minutes.	  
d) The	  samples	  were	  then	  centrifuged	  at	  11,600	  x	  g	  for	  10	  minutes	  at	  4˚C.	  	  
Following	  centrifugation,	  the	  mixture	  separated	  into	  a	  lower	  red	  phenol-­‐
chloroform	  phase,	  an	  interphase	  and	  an	  upper	  aqueous	  phase.	  	  The	  RNA	  
remained	  exclusively	  in	  the	  upper	  aqueous	  phase.	  
	  
RNA	  Precipitation	  
a) 0.5	   ml	   of	   isopropyl	   alcohol	   was	   added	   to	   precipitate	   RNA	   from	   the	  
aqueous	  phase.	  
b) The	   samples	   were	   incubated	   at	   room	   temperature	   for	   10	   minutes	  
followed	  by	  centrifugation	  at	  11,600	  x	  g	  for	  10	  minutes	  at	  4˚C.	  	  The	  RNA	  
precipitate	  formed	  a	  gel-­‐like	  pellet	  on	  the	  bottom	  of	  the	  tube.	  
	  
RNA	  Wash	  
a) The	  supernatant	  was	  removed	  and	  the	  RNA	  pellet	  was	  washed	  with	  1	  ml	  
of	  75%	  ethanol.	  
b) The	  sample	  was	  vortexed	  and	  centrifuged	  at	  7,500	  x	  g	  for	  5	  minutes	  at	  
4˚C.	  
	  
Re-­‐dissolution	  of	  RNA	  	  
a) RNA	   pellet	   was	   briefly	   air-­‐dried	   for	   5-­‐10	   minutes,	   taking	   care	   not	   to	  
completely	  dry	  the	  pellet	  and	  reduce	  its	  solubility.	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b) RNA	  pellet	  was	  re-­‐dissolved	  in	  RNase-­‐free	  water	  by	  passing	  the	  solution	  
a	   few	   times	   through	   a	   pipette	   tip	   prior	   to	   incubation	   at	   60˚C	   for	   10	  
minutes.	  	  
	  
The	  concentration	  of	  RNA	  in	  ng/μL	  was	  determined	  using	  a	  NanoDrop	  ND-­‐1000	  
Spectrometer.	   	   A	   “260/280”	   ratio	   was	   also	   recorded	   to	   ensure	   adequate	   re-­‐
dissolution	   of	   RNA	   and	   ascertain	   RNA	  quality	   and	   purity.	   	   To	   ensure	   accurate	  
loading	   of	   RNA	   during	   the	   polymerase	   chain	   reactions	   (PCRs),	   RNA	  
concentrations	  were	  standardised	  to	  100ng/μL	  by	  diluting	  samples	  with	  RNAse	  
free	  H2O.	  	  
	  	  
2.4	  Primer	  Design	  
Gene	   specific	   primers	  were	   designed	   using	   nucleotide	   base	   sequences	   of	   the	  
genes	   of	   interest	   obtained	   from	   NCBI	   Reference	   Sequence	   database	  
(www.ncbi.nlm.nih.gov/RefSeq)	  (Table	  2.3).	  	  These	  sequences	  were	  analysed	  for	  
optimum	  primer	  sequences	  using	  Primer	  3	  Software.	   	  Primer	  mouse	  specificity	  
and	  efficacy	  was	  determined	  using	  Basic	  Local	  Alignment	  and	  Search	  Tool.	  	  The	  
primers	  were	  designed	  to	  effectively	  anneal	  to	  exon-­‐intron-­‐exon	  complexes	  or	  
cross	   exon/exon	  boundaries	   of	  mRNA,	   in	   order	   to	   prevent	   co-­‐amplification	  of	  
genomic	  DNA.	   	   	   It	  was	  also	  verified,	  during	  primer	  design,	   that	   the	   sequences	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Table	   2.3	  Primer	   Sequences,	   Expected	  Weights	   and	  Annealing	   Temperatures	  
of	  Target	  Genes	  
	  
	  
2.4.1	  Primer	  Assay	  
Additionally,	   ready-­‐to-­‐use	   Quantitect	   Primer	   Assays	   (Qiagen),	   which	   allow	  
accurate	   real-­‐time	   quantification	   of	   target	   RNA,	   using	   SYBR	   green	   based	  
detection,	  were	  utilised	   (Table	  2.4).	   	   Each	  assay	   contains	   forward	  and	   reverse	  
primers	   that	   are	   generated	   from	   the	   NCBI	   Reference	   Sequence	   database,	  




F:	  	  5’-­‐TTCACAGAGGATACCACTCC-­‐3’	  
R:	  5’-­‐GTTTGGTAGCATCCATCATT-­‐3’	  	  	  	  	  	  
203bp	   55˚C	  
TNF-­‐α	  
F:	  	  5’-­‐TCCAGCTGACTAAACATCCT-­‐3’	  
R:	  	  5’-­‐CCCTTCATCTTCCTCCTTAT-­‐3’	  
220bp	   55˚C	  
ASMA	  
F:	  	  5’-­‐ATCTGGCACCACTCTTTCTA-­‐3’	  
R:	  	  5’-­‐GTACGTCCAGAGGCATAGAG-­‐3’	  
191bp	   59˚C	  
TGF-­‐β	  
F:	  	  	  5’-­‐AAAATCAAGTGTGGAGCAAC-­‐3’	  
R:	  	  5’-­‐CCACGTGGAGTTTGTTATCT-­‐3’	  
224bp	   59˚C	  
Collagen	  1-­‐α2	  
F:	  	  5’-­‐GAACGGTCCACGATTGCATG-­‐3’	  
R:	  	  5’-­‐GGCATGTTGCTAGGCACGAAG-­‐3’	  
167bp	   55˚C	  
Adrenoceptor	  
α1-­‐D	  
F:	  	  5’	  TTGAATTCCTACAGAGACCCACGACCCAG-­‐3’	  	  
R:	  5’-­‐CGGAATTCTTAAATGTCAGTCTCCCGGAG-­‐3’	  





440bp	   55˚C	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optimised	   and	   bioinformatically	   validated.	   	   The	   annealing	   temperatures	   also	  
remain	  unchanged	  across	  target	  genes	  in	  primer	  assays.	  	  For	  use	  in	  a	  two-­‐step	  
RT-­‐PCR	  reaction	  using	  a	  Rotor	  Gene	  cycler,	  the	  annealing	  temperature	  is	  55°C.	  
	  
Table	   2.4	   Primer	   Assay	   References	   and	   Annealing	   Temperatures	   of	   Target	  
Genes	  	  
	  
Primer	   Assay	  Reference	   Annealing	  Temp	  
Circadian	  Locomotor	  Output	  
Cycles	  Kaput	  (CLOCK)	  
QT00197547	   55°C	  
Brain	  and	  Muscle	  Arnt	  Like-­‐1	  
(Bmal-­‐1)	  
QT00101647	   55°C	  
Period	  1	  (Per	  1)	   QT00113337	   55°C	  
Period	  2	  (Per	  2)	   QT00198366	   55°C	  
Cryptochrome	  1	  (Cry	  1)	   QT00117012	   55°C	  
Cryptochrome	  2	  (Cry	  2)	   QT00168868	   55°C	  
REV-­‐ERBα	   QT00164556	   55°C	  
IL-­‐12	   QT00153643	   55°C	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2.5	  Reverse	  Transcription	  Polymerase	  Chain	  Reaction	  (RT-­‐PCR)	  
	  
2.5.1	  Semi-­‐Quantitative	  RT-­‐PCR	  
The	   SuperScript™	   III	  One-­‐Step	  RT-­‐PCR	   System	  with	   Platinum®	  Taq	  High	   Fidelity	  
(Invitrogen	   Life	   Technologies)	  was	   used	   to	   perform	   semi-­‐quantitative	   RT-­‐PCR.	  	  
This	   one	   step	   formulation	   incorporates	   DNase	   treatment,	   to	   remove	   residual	  
DNA	   from	   RNA	   isolation,	   cDNA	   synthesis	   and	   PCR	   amplification	   using	   gene	  
specific	  primers.	  	  This	  system	  comprises	  two	  main	  components:	  SuperScript™	  III	  
RT/	  Platinum®	  Taq	  High	  Fidelity	  Enzyme	  Mix	  and	  2X	  Reaction	  Mix.	  	  The	  enzyme	  
mix	   reduces	   RNase	   H	   activity	   thereby	   increasing	   thermal	   stability	   and	   blocks	  
polymerase	   activity	   at	   ambient	   temperatures.	   	   The	   2X	   Reaction	  Mix	   includes	  
Mg2+,	  deoxyribonucleotide	  triphosphates	  (dNTPs),	  and	  stabilizers.	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   	   	   	   	   	   	  	   	  
Master	   mixes	   for	   the	   target	   and	   reference	   genes	   were	   prepared	   using	   the	  
appropriate	  ratios	  of	  the	  components	  detailed	  in	  Table	  2.5	  in	  order	  to	  minimise	  
pipetting	  errors	  and	  reagent	  loss.	  	  The	  master	  mixes	  were	  vortexed	  briefly	  prior	  
to	  centrifugation	  at	  500	  x	  g	  for	  15	  seconds.	  	  Following	  aliquot	  of	  the	  appropriate	  
master	  mix,	   the	   RNA	   template	  was	   added	   to	   a	   0.5	  ml	   amplification	   tube	   and	  
placed	   in	  a	   thermal	  cycler,	  BIO-­‐RAD	   iCyclerTM	  96	  Well	  Reaction	  Module	   (Table	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Table	  2.5	  SuperScript™	  III	  One-­‐Step	  RT-­‐PCR	  Components	  
	  
Component	   Volume	  
2X	  Reaction	  Mix	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   10μl	  
Template	  RNA	  (200ng)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   1μl	  
Target	  Forward	  primer	  (10	  µM)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1μl	  
Target	  Reverse	  primer	  (10	  µM)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1μl	  
Reference	  F/R	  primer	  (10uM	  of	  each)	   1μl	  
SuperScript™	  III	  RT/	  Platinum®	  Taq	  High	  Fidelity	  Enzyme	  Mix	   0.5μl	  
RNase	  Free	  Water	  (GIBCO)	   10.5μl	  
Total	   25μl	  
	  
Table	  2.6	  Thermal	  Cycling	  Conditions	  Specific	  For	  SuperScript™III	  One-­‐Step	  RT-­‐
PCR	  and	  BIO-­‐RAD	  iCycler	  
	  
cDNA	  Synthesis	  &	  
Pre-­‐denaturation	  
PCR	  Amplification	   Final	  Extension	  
1	  cycle:	   35	  cycles:	   1	  cycle:	  
• 45°C	  for	  30	  
mins	  
• 95°C	  for	  5	  mins	  
• Denature:	  95°C	  for	  
30	  sec	  
• Anneal:	  Primer	  
dependent	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2.5.1.1	  Gel	  Electrophoresis	  
Amplification	  products	  of	   the	   semi-­‐quantitative	  RT-­‐PCR	  were	  prepared	   for	   gel	  
electrophoresis.	   	   Typically,	   1.5%	   agarose	   gels	   were	   used,	   whereby	   0.4	   g	   of	  
agarose	  powder	  was	  added	  to	  4	  ml	  of	  50X	  TBE	  (Tris/Borate/EDTA)	  buffer	  and	  46	  
ml	  of	  water	  before	  being	  heated	  to	  generate	  a	  molten	  mixture.	  	  Following	  this,	  
2.5μL	  of	  10	  mg/ml	  ethidium	  bromide	  was	  added	  to	  the	  agarose	  and	  poured	  into	  
the	   gel	   apparatus.	   	   The	   gel	  was	   submerged	   in	   1x	   TAE	   (Tris/Acetic	   acid/EDTA)	  
buffer	  prior	  to	  loading	  and	  electrophoresis.	  	  
	  
A	  DNA	  ladder	  of	  50	  base	  pairs	   (New	  England	  Biolabs)	  was	   loaded	  onto	  the	  gel	  
with	  2μl	  of	  6x	  loading	  buffer	  mixed	  with	  12μl	  of	  amplified	  complementary	  DNA.	  	  
The	   RT-­‐PCR	   products	   were	   then	   electrophoresed	   for	   1	   hour	   at	   90V,	   60mA.	  	  
These	  settings	  ensured	  that	  the	  Bromophenol	  Blue	  did	  not	  run	  off	  the	  gel.	  	  The	  
electric	   field	   created	   across	   the	   gel	   causes	   nucleic	   acid	  molecules	   to	   separate	  
with	   smaller	   molecules	   migrating	   faster	   towards	   the	   charged	   nodes.	   	   Gene	  
expression	   of	   the	   target	   sequence	   was	   normalised	   to	   the	   expression	   of	   the	  
reference	   gene	   i.e.	   GAPDH,	   18s	   or	   β-­‐actin	   to	   control	   for	   variable	   DNA	  
concentrations	  in	  each	  sample.	  	  Subsequent	  to	  electrophoresis,	  the	  bands	  were	  
visualised	   under	   an	   ultraviolet	   transilluminator	   (UVP	   Laboratory	   Products,	   EPI	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2.5.2	  Two-­‐Step	  Real-­‐Time	  PCR	  
2.5.2.1	  cDNA	  Synthesis	  
Real	   time	   PCR	   provides	   direct	   quantification	   of	   both	   DNA	   and	   cDNA	   targets.	  	  
Real	   time	   2	   step	   RT-­‐PCR	   of	   RNA	   targets	   was	   performed	   following	   reverse	  
transcription	  with	   the	   Quantitect	   Reverse	   Transcription	   Kit	   (Qiagen).	   	   This	   kit	  
not	  only	   synthesises	   cDNA	  but	  also	  effectively	  eliminates	  genomic	  DNA.	   	   	   The	  
Quantitect	  Reverse	  Transcription	  procedure	  comprises	  of	  2	  main	  steps.	  
	  
Elimination	  of	  Genomic	  DNA	  
Incubation	   of	   purified	   RNA	   samples	   with	   gDNA	   wipeout	   buffer	   eliminates	  
genomic	   DNA.	   	   This	   is	   imperative	   in	   instances	   where	   primers	   or	   probes	   for	  




Using	  a	  master	  mix	  containing	  a	  reverse	  transcriptase	  enzyme,	  RT	  buffer	  and	  RT	  
primer	   mix,	   additional	   RNA	   denaturation	   and	   RNase	   H	   digestion	   are	   not	  
necessary	  (Table	  2.7).	   	  Due	  to	  the	  high	  affinity	  of	  the	  reverse	  transcriptase	  for	  
RNA,	  cDNA	  yields	  from	  templates	  with	  high	  GC	  nucleotide	  content	  or	  complex	  
secondary	  structures	  are	  also	  possible.	   	  The	  RT	  primer	  mix	  ensures	   that	  cDNA	  
synthesis	   occurs	   along	   all	   areas	   of	   the	   RNA	   transcripts	   including	   5’	   regions.	  	  
Collectively,	  these	  processes	  ensure	  sensitive	  and	  higher	  yields	  of	  cDNA.	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Table	  2.7	  Reverse	  Transcription	  Master	  Mix	  Reaction	  Components	  
Component	   Volume/Reaction	  
Quantiscript	  Reverse	  Transcriptase	   1μl	  
Quantiscript	  RT	  Buffer,	  5x	   4μl	  
RT	  Primer	  Mix	   1μl	  
Template	  RNA	  from	  gDNA	  elimination	  Reaction	   14μl	  
Total	   20μl	  
	  
2.5.2.2	  Real-­‐time	  PCR	  	  
Real-­‐time	   PCR	   was	   performed	   using	   the	   QuantiTect	   SYBR	   Green	   PCR	   System	  
with	  HotStar	  Taq	  DNA	  Polymerase	  (Qiagen).	  	  SYBR	  Green	  I	  is	  a	  fluorescent	  dye,	  
which	  enables	  analysis	  of	  targets	  without	  needing	  to	  synthesise	  target-­‐specific	  
labelled	  probes.	   	   It	   binds	   to	  all	   double	   stranded	  DNA	  molecules.	   	   The	  HotStar	  
Taq	  DNA	  Polymerase	  enzyme	  achieves	  high	  specificity	  and	  sensitivity	  in	  the	  PCR,	  
by	   preventing	   the	   formation	   of	  mis-­‐primed	  products	   and	   primer-­‐dimers.	   	   The	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Table	  2.8	  Two-­‐Step	  Real-­‐Time	  PCR	  Reaction	  Setup	  
Component	   Volume/Reaction	  
2x	  Quantitect	  SYBR	  Green	  PCR	  Master	  Mix	   12.5μl	  
Target/Reference	  Forward	  Primer	   0.25μl	  
Target/Reference	  Reverse	  Primer	   0.25μl	  
Template	  cDNA	  (as	  per	  Table	  2.5)	   1μl	  
RNase	  free	  water	   11μl	  
Total	   25μl	  
	  	  	  
2.5.2.3	  ΔΔCt	  Method	  for	  qRT-­‐PCR	  Data	  Analysis	  
Relative	   quantification	   was	   used	   to	   analyse	   data	   from	   real-­‐time	   PCR	  
experiments.	  	  This	  was	  achieved	  through	  use	  of	  the	  ΔΔCt	  algorithm.	  	  The	  house-­‐
keeping	  gene,	  GAPDH,	  was	  assumed	  to	  be	  uniformly	  and	  constantly	  expressed	  
in	  all	  samples	  and	  compared	  to	  relative	  changes	  in	  target	  gene	  expression.	  	  The	  
ΔΔCt	  algorithm	   is	  an	  approximation	  method	  relying	  upon	  various	  assumptions	  
unlike	  the	  standard	  curve	  and	  Pfaffl	  methods.	  	  However,	  the	  output	  results	  are	  
not	  dissimilar	  to	  other	  non-­‐approximation	  methods	  and	  is	  easier	  to	  apply	  (152).	  
	  	  	  	  	  
2.6	  Western	  Blotting	  
Western	  blotting	  identifies	  proteins	  that	  have	  been	  size	  dependently	  separated	  
by	   gel	   electrophoresis	   using	   specific	   antibodies.	   	   Total	   liver	   protein	   was	  
extracted	  in	  ice-­‐cold	  RIPA	  buffer	  (150nM	  sodium	  chlorise,	  1%	  Triton-­‐X	  100,	  0.5%	  
sodium	   deoxycholate,	   50mM	   Tris,	   pH	   8.0	   and	   0.1%	   SDS)	   and	   lysate	   protein	  
concentrations,	   determined	  using	   the	   copper/bicinchoninic	   assay	   (Sigma),	   and	  
	   112	  
standardised	   to	   2	   mg/ml	   by	   dilution	   into	   Laemmli	   buffer.	   	   RIPA	   buffer	   was	  
chosen	   for	   its	   ability	   to	   lyse	   membrane-­‐bound,	   nuclear	   and	   mitochondrial	  
proteins.	   	   20μg	   total	   protein	   was	   loaded	   for	   SDS-­‐PAGE	   (Sodium	   Dodecyl	  
Sulphate	  PolyAcrylamide	  Gel	  Electrophoresis).	  	  
	  
Separated	   proteins	   were	   transferred	   onto	   PVDF	   Immobilon-­‐P	   membrane	  
(Millipore,	  Billerica,	  MA)	  and	  incubated	  in	  blocking	  buffer	  for	  1	  hr	  (0.5%	  non-­‐fat	  
dehydrated	  milk,	  0.5%	  TBS-­‐Tween).	  	  Following	  thrice	  washing	  using	  wash	  buffer	  
(0.5%	  non-­‐fat	  dehydrated	  milk,	  0.5%	  TBS-­‐Tween),	  membranes	  were	   incubated	  
for	  either	  an	  hour	  or	  overnight	  depending	  on	  the	  antibody.	  	  Antibodies	  against	  
IRS-­‐1,	   phospho-­‐IRS1	   (Ser307),	   (Upstate	   Biotechnology,	   Lake	   Placid,	   USA);	   IRβ	  
(Santa	   Cruz	   Biotechnology,	   Santa	   Cruz,	   USA);	   ASMA	   (Sigma,	  UK)	   and	   Collagen	  
Type	   1	   (Millipore,	   UK)	   diluted	   in	   wash	   buffer	   were	   applied	   to	   the	   blots.	  	  
Subsequent	   incubation	  with	   secondary	   antibodies	   followed	   by	   ECL	   (enhanced	  
chemiluminescence)	   detection	   allowed	   assessment	   of	   protein	   expression	  




Immunohistochemical	  detection	  was	  performed	  on	  paraffin	  embedded	  sections	  
treated	  with	  proteinase	  K,	  a	  primary	  rat	  anti-­‐mouse	  F4/80	  monoclonal	  antibody	  
(1/100,	   Serotec)	   and	   a	   secondary	   rabbit	   anti-­‐rat	   immunoglobulin	   (ImmPRESS	  
anti-­‐rat	  Ig	  (Peroxidase)	  Polymer	  Detection	  Kit,	  Vector	  Laboratories).	  Peroxidase	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activity	   was	   demonstrated	   using	   ImmPact	   DAB	   (diaminobenzidine-­‐based)	  
peroxidise	  substrate	  kit	  (Vector	  Laboratories)	  as	  detailed	  in	  Table	  2.9).	  
	  
Table	  2.9	  Immunohistochemistry	  Protocol	  for	  Paraffin	  Embedded	  Sections	  
Step	   Method	  
Deparaffinsation	   In	   xylene	   followed	   by	   hydration	   using	  
descending	  concentrations	  of	  ethanol	  
Antigen	  Retrieval	   Proteinase	   K	   for	   5	   minutes	   followed	   by	   thrice	  
washing	  with	  TBS	  
Endogenous	  Peroxidase	  
Quenching	  
3%	   endogenous	   peroxidise	   quenching	   solution	  
incubated	  with	  slides	  for	  10	  minutes	  at	  rtp.	  
Blocking	   Blocked	   using	   ImmPact	   normal	   goat	   serum	   for	  
20	  minutes	  at	  rtp.	  
Primary	  Antibody	  
Incubation	  
Primary	   antibody	   diluted	   to	   desired	  
concentration	   using	   1%	   BSA	   prior	   to	   an	   hour	  
incubation	  at	  rtp.	  
Secondary	  Antibody	  
Incubation	  
Incubate	  with	   ImmPress	  reagent	  for	  30	  minutes	  
at	  rtp.	  
Colour	  Development	   Add	   1μl	   of	   ImmPACT	   DAB	   chromogen	   to	   1ml	  
ImmPACT	   Diluent	   to	   make	   the	   DAB	   working	  
solution.	   	   Add	   to	   the	   slide,	   incubating	  up	   to	   20	  
minutes	   checking	   colour	   intensity	   under	   a	   light	  
microscope.	  
Counter	  Staining	   When	   desired	   colour	   intensity	   is	   reached,	  
immerse	  in	  TBS	  to	  prevent	  further	  development.	  	  
Counter	  stain	  in	  Vector	  haematoxylin	  QS	  
Dehydration	   Dehydrate	   sections	   in	   incremental	  
concentrations	   of	   ETOH	   and	   coverslip	   using	  
VectaMount	  medium	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2.8	  Histology	  
Offspring	   liver	   sections	   were	   formalin	   fixed	   and	   paraffin	   embedded	   prior	   to	  
sectioning.	   	  All	  sections	  were	  then	  stained	  with	  haematoxylin	  and	  eosin	   (H&E)	  
using	  the	  following	  protocol:	  
I. Sections	  were	  immersed	  in	  filtered	  Harris	  Haematoxylin	  for	  60	  seconds	  
II. Sections	  were	  rinsed	  with	  water	  until	  the	  water	  remained	  free	  of	  dye.	  
III. Sections	  were	  then	  immersed	  in	  Eosin	  stain	  for	  2	  minutes.	  
IV. Subsequent	   to	   washing,	   slides	   were	   dehydrated	   in	   ascending	   alcohol	  
solutions	  –	  50%,	  70%,	  80%,	  90%	  (x2)	  and	  100%	  (x2).	  
V. To	  remove	  impurities,	  stained	  slides	  were	  soaked	  in	  xylene.	  
VI. Slides	  were	  coverslipped	  with	  VectaMount	  gel	  as	  an	  adhesive.	  
	  
All	   slides	   stained	   with	   H&E	   were	   assessed	   for	   hepatosteatosis	   and	  
inflammation,	   by	   an	   expert	   liver	   pathologist	   blinded	   to	   the	   identity	   of	   the	  
groups,	   using	   the	   Brunt-­‐Kleiner	   NAFLD	   Activity	   Score	   (Table	   2.10).	   	   NAS	   is	   a	  
feature	   based	   scoring	   system	   of	   histological	   lesions	   observed	   in	   NAFLD.	   	   A	  
composite	   score	   >	   5	   is	   considered	   to	   be	   the	  more	   severe	   form,	   non-­‐alcoholic	  
steatohepatitis	   (NASH).	   	   H&E	   stains	   basophilic	   structures	   blue	   and	   cytoplasm	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Table	  2.10	  Brunt-­‐Kleiner	  NAFLD	  Activity	  Score	  
Histological	  Feature	   Definition	   Score	  
Steatosis	  	   <	  5%	  
5	  –	  33%	  






Lobular	  Inflammation	  	   No	  Foci	  
<	  2	  foci	  per	  200	  x	  field	  
2	  –	  4	  foci	  per	  200	  x	  field	  





Ballooning	  	   None	  
Few	  Balloon	  cells	  





To	  assess	   the	  presence	  and	  degree	  of	   fibrosis,	  paraffin	  embedded	  slides	  were	  
sectioned	   and	   stained	  with	  Masson’s	   Trichrome	   (Histopathology	   Department,	  
Royal	  Free	  Hospital,	  UCL)	  and	  scored	  by	  a	  pathologist,	  blind	  to	  the	  experimental	  
groups	  (Table	  2.11).	  
	  
Table	  2.11	  Histological	  Scoring	  System	  for	  Fibrosis	  
Definition	   Score	  
None	   0	  
Perisinusoidal	  or	  Periportal	   1	  
Persinusoidal	  &	  Periportal	   2	  
Bridging	  Fibrosis	   3	  
Cirrhosis	   4	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2.9	  Hepatic	  Tissue	  Triglyceride	  Extraction	  
Murine	   whole	   liver	   tissue	   triglyceride	   content	   was	   determined	   using	   an	  
adaptation	  of	  the	  Folch	  Method	  (153).	  	  	  
	  
Homogenisation	  
a) Snap	  frozen	  liver	  tissue	  weighing	  between	  0.01-­‐0.05g	  was	  homogenised	  
in	  a	  2:1	  chloroform-­‐methanol	  mixture	  to	  a	  final	  dilution	  of	  20	  times	  the	  
volume	  of	  the	  tissue.	  	  All	  samples	  were	  homogenised	  in	  a	  2ml	  eppendorf	  
with	  an	  autoclaved	  pestle.	  
b) The	  mixture	  was	  agitated	   in	  an	  orbital	  shaker	  at	  room	  temperature	  for	  
20	  minutes	  then	  centrifuged	  at	  4.7	  Krpm	  for	  30	  seconds	  at	  20˚C.	  




a) The	  crude	  extract	  was	  washed	  with	  0.2ml	  0.9%	  NaCl	  solution	  	  
b) The	  solution	  was	  weighed,	  vortexed,	  and	  centrifuged	  at	  4.7	  Krpm	  for	  60	  
seconds	  at	  20˚C.	  Consequently,	  the	  solution	  separated	  into	  upper	  phase	  
and	  a	  lower	  phase	  without	  any	  interfacial	  fluff.	  
c) The	   lower	   phase	   contained	   92.75%	   of	   tissue	   lipids.	   The	   upper	   phase	  
contained	   gangliosides	   (high-­‐molecular-­‐weight,	   water-­‐soluble	  
glycolipids)	  and	  all	  non-­‐lipid	  impurities	  dissolved.	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Incubation	  
The	  lower	  phase	  was	  incubated	  at	  55°C	  for	  3	  hours	  to	  allow	  evaporation	  
of	  the	  chloroform	  and	  precipitation	  of	  the	  lipid.	   	  The	  lipid	  was	  weighed	  
using	  digital	  scales	  accurate	  to	  at	  least	  4	  decimal	  places.	  
	  
Reconstitution	  and	  Calculation	  
a) The	  solid	   lipid	  was	  reconstituted	  with	  1ml	  0.9%	  NaCl	  and	  heated	  to	  aid	  
reconstitution.	  
b) The	   reconstituted	   solution	   was	   analysed	   using	   a	   Roch	   Modular	   P	  
Analyser.	   	   Triglyceride	   concentration	   (mmol/l)	   was	   determined	   using	  
enzymatic	  colorimetric	  assays	  (UNIMATE	  5	  TRIG,	  Roche	  BC1.	  Sussex,	  UK).	  	  	  
The	   readout	   was	   then	   applied	   to	   the	   formula	   below	   to	   ascertain	   the	  
triglyceride	  content	  of	  hepatic	  tissue:	  
	  
TG	  concentration	  (mmol/l)	  x	  Dilution	  Factor	  x	  Lipid	  Weight	  after	  incubation	  (g)	  	  
Weight	  of	  homogenized	  hepatic	  tissue	  prior	  to	  lipid	  extraction	  (g)	  
	  
2.10	  ELISA	  Protocols	  
	  
ELISAs	   (enzyme	   linked	   immunosorbent	  assay)	  were	  used	   for	  analysis	  of	   serum	  
leptin	   (CrystalChem,	   Catalog	   #90030)	   and	   insulin	   (CrystalChem,	   Catalog	  
#90080).	  	  Using	  wide	  range	  assays,	  the	  antibody-­‐coated	  microplate	  was	  affixed	  
to	  the	  frame	  with	  95μl	  of	  sample	  diluent	  dispensed	  per	  well.	  	  5μl	  of	  serum	  was	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then	  added	  to	  the	  microplate,	  prior	  to	  incubation	  at	  4°C,	  for	  2	  hours.	  	  The	  plates	  
were	  washed	   5	   times	   with	   wash	   buffer	   before	   the	   addition	   of	   100μl	   of	   anti-­‐
insulin	  enzyme	  conjugate	  per	  well.	  	  Following	  another	  course	  of	  incubation	  and	  
washing,	  a	  further	  100μl	  of	  enzyme	  substrate	  solution,	  per	  well,	  was	  dispensed.	  	  	  
	  
As	   wide	   range	   assays	   (0.1-­‐12.8ng/ml)	   were	   used,	   final	   incubation	   at	   room	  
temperature	  was	   for	   40	  minutes.	   	   The	   enzyme	   reaction	  was	   stopped	   using	   a	  
stop	   solution	   and	   the	   A450	  wavelength	  measured	  with	   A630	   values	   subtracted.	  	  





Radiotelemetric	   probes	   (TA11PA-­‐C10,	   O.D	   0.4mm,	   Data	   Science	   International,	  
DSI)	  were	   implanted	  under	  general	  anaesthetic	   (isoflurane	   in	  O2)	  at	  3	  months.	  	  
Due	  to	  the	  small	  size	  and	  light	  weight	  of	  the	  transmitter,	  an	  indwelling	  catheter	  
was	   inserted	   into	   either	   the	   descending	   aorta,	   carotid	   or	   femoral	   artery,	  
eliminating	  the	  need	  for	  flushing	  and	  other	  catheter	  maintenance	  issues	  (Figure	  
2.9).	  	  	  
	  
Immediately	   after	   surgery	   but	   prior	   to	   recovery	   from	   anaesthesia,	   the	   mice	  
were	  given	   subcutaneous	  buprenorphine	  as	  an	  analgesic.	   	   Following	   recovery,	  
systolic	   blood	   pressure	   (SBP)	   was	   measured	   for	   1	   week	   in	   freely	   moving	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offspring	   by	   reception	   of	   data	   transmitted	   via	   digital	   telemetry	   (RPC-­‐1,	   Data	  
Science	  International,	  DSI)	  (Figure	  2.9).	  
Figure	  2.9	  Radiotelemetry	  Equipment	  
	  
	  	  	  
2.12	  Mononuclear	  Cell	  (MNC)	  Isolation	  
Hepatic	   mononuclear	   cells	   were	   isolated	   is	   accordance	   with	   the	   protocol	  
detailed	  below.	  	  Reagents	  and	  their	  composition	  are	  as	  detailed	  in	  Table	  2.12.	  
	  
Homogenisation	  
a) The	  supra-­‐	  and	   infra-­‐hepatic	   inferior	  vena	  cavae	  were	   isolated	  and	   the	  
liver	  perfused	  with	  5ml	  PBS	  via	  the	  portal	  vein.	  	  	  
b) The	   liver	   was	   then	   excised	   and	   homogenised	   in	   perfusate	   buffer	  
containing	  HBSS	  (Ca2+,	  Mg2+),	  collagenase	  (0.01%)	  and	  DNase	  I	  (0.001%)	  
using	  a	  stomacher	  (400	  circulator,	  Seward,	  USA).	  
	  
Incubation	  &	  Filtration	  
a) The	  homogenate	  was	  incubated	  at	  37°C	  for	  20	  minutes	  in	  a	  water	  bath.	  
22/05/2012 17:11Implantable Wireless Monitoring - DSI Mouse Blood Pressure Transmitter
Page 1 of 2http://www.datasci.com/products/implantable-telemetry/Mouse-Implantable-Telemetry/Blood-Pressure-Transmitter.asp
DSI PhysioTel® PA-C10 for Mice
Scientists measure pressure and activity in mice using DSI’s PhysioTel® PA series
transmitter model PA-C10. The PA-C10 model is the smallest and lightest of the
PhysioTel® PA series. Other models in the PhysioTel® PA series transmitter series
include PA-C40 for small animals and PA-D70 for large animals.
This model is capable of measuring arterial, ocular, uterine, penile, bladder, pleural
and left ventricular pressure. Other parameters such as heart rate, systolic, diastolic
and mean pressure are also possible. Similar to all models in the PA transmitter
series, the PA-C10 is completely implantable, eliminating the need for flushing and
other catheter maintenance issues.
DSI's Latest Wireless BP Monitor
 





Minimum Animal Weight 17 grams - May vary depending on researcher
preferences
Maximum Cage Size 33 x 33 x 14 cm May vary depending on research
preferences
Battery Life (Months) Warranted for 1.5 months
Parameter Measured Pressure and activity
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b) The	  homogenate	  was	  then	  filtered	  through	  70μm	  cell	  strainer	  (BD	  falcon	  
#352350)	  and	  centrifuged	  at	  500rpm	  for	  2	  minutes	  at	  4°C.	  
Optiprep	  Density	  Gradient	  Cell	  Separation	  	  
a) The	   pelleted	   cells	   were	   re-­‐suspended	   in	   RPMI	   and	   layered	   with	   24%	  
optiprep	  and	  1ml	  RPMI,	  a	  culture	  medium.	  
b) Subsequent	   to	   centrifugation,	   mononuclear	   cells	   were	   isolated	   at	   the	  
40/60%	  interface.	   	  The	  cells	  were	  washed	  once	  with	  a	  perfusate	  buffer	  
containing	   	   HBSS	   (free	   Ca2+,	  Mg2+),	   BSA	   (0.25%)	   and	   DNase	   I	   (0.001%)	  
and	   supplemented	   with	   complete	   culture	   media	   (RPMI,	   FBS	   (foetal	  
bovine	   serum)	   (10%),	   PCN	   (penicillin)	   100U/ml,	   Strep	   100μg/ml,	   L-­‐
glutamine	  200mM).	  	  	  
c) Cell	  types	  were	  determined	  using	  microscopy.	  
	  
Cell	  counting	  &	  validation	  
Following	   cell	   isolation,	   cell	   viability	   and	   number	   were	   determined	   using	   a	  
NucleoCounter	  (NC	  100,	  Chemometec,	  Denmark)	  as	  described:	  
a) 100ul	   cell	   fraction	   was	   added	   to	   reagents	   A	   and	   B	   as	   supplied	   by	   the	  
manufacturer	  to	  cause	  	  cell	  lysis	  as	  per	  the	  manufacturer’s	  protocol.	  
b) Using	  a	  nucleo-­‐cassette	  (chemometec,	  Denmark),	  a	  small	  volume	  of	  cell	  
suspension	  was	  aspirated	  and	  transferred	  to	  the	  automatic	  counter.	  
c) Using	  the	  readout,	  total	  cell	  number	  was	  calculated	  with	  the	  formula:	  
	  
	   121	  
Cell	  number	  readout/ml	  x	  3	  x	  initial	  cell	  suspension	  volume	  (ml)	  
	  
d) Cell	   viability	   was	   determined	   by	   counting	   the	   cell	   fraction	   directly	   and	  
inputting	  into	  the	  following	  formula:	  
	  
100	  –	  (Dead	  cell	  number/ml	  /	  total	  cell	  number/ml)	  x	  100	  
	  
Table	  2.12	  Reagents	  used	  in	  Mononuclear	  Cell	  Isolation	  
	  
Perfusate	  buffer	  3	  (PF3):	  	   50ml	   	   100ml	   	   250ml	   	   500ml	  
HBSS	  (+Ca+2,	  Mg+2)	   	   50ml	   	   100ml	   	   250ml	   	   500ml	  
Collagenase	  (0.01%	  final)	   0.5ml	  	   	   1ml	   	   	  2.5ml	   	   	  5.0ml	  
DNase	  I	  (0.001%)	   	   50ul	   	   0.1ml	   	   0.25ml	  	   0.50ml	  
	  
Perfusate	  buffer	  4	  (PB4):	  	   50ml	   	   100ml	   	   200ml	   	   500ml	  
HBSS	  (free	  Ca+2,	  Mg+2)	  	   50ml	   	   100ml	   	   200ml	   	   500ml	  
DNase	  I	  (0.001%	  final)	  	   50ul	   	   0.1ml	   	   0.20ml	  	   0.50ml	  
BSA	  (0.25%	  final)	   	   1.25ml	  	   2.5ml	   	   5.00ml	  	   12.5ml	  
	  
Complete	  Cell	  Media:	  	   500ml	  	  	  
RPMI	   	   	   	   435ml	  
FBS	  (10%)	   	   	   	  50ml	  
(PCN	  100U/ml/	  
Strep	  100mg/ml)	   	  	   10ml	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L-­‐Glutamine	  200mM	   	   	  5	  ml	  
	  
2.13	  Flow	  Cytometric	  Analysis	  
	  
Cell	   preparations	   (as	   per	   2.12)	   were	   stained	   with	   CD3-­‐FITC/NK1.1-­‐PerCp	   and	  
F4/80	   clone	   BM8-­‐PerCP-­‐Cy5.5	   antibodies	   (Biolegend),	   for	   identification	   of	  
Natural	  Killer	  T	  (NKT)	  and	  Kupffer	  Cells	  (KC)	  respectively.	  	  Cells	  were	  incubated	  
with	   Fc	   block	   (anti	   mouse	   CD16/32)	   at	   4°C	   for	   10	   minutes	   to	   prevent	   non-­‐
specific	   Fc-­‐mediated	   adherence	   of	   antibodies,	   thereby	   assuring	   that	   any	  
staining	   is	   due	   to	   the	   interaction	   between	   the	   antigen	   portion	   of	   the	   desired	  
antibody	   and	   the	   cell	   (Figure	   2.10).	   	   This	   was	   followed	   by	   addition	   of	   the	  




Figure	  2.10	  Mechanism	  of	  Action	  of	  BD	  Fc	  Block	  in	  Immunophenotyping	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After	   incubation,	   1ml	   FACS	   buffer	   (Biolegend)	   was	   added	   and	   the	   vials	  
centrifuged	  at	  2000rpm	  for	  5	  minutes.	  	  Cells	  were	  then	  re-­‐suspended	  in	  a	  final	  
volume	   of	   100μl	   FACS	   buffer	   and	   analysed	   by	   flow	   cytometry	   (BD	   LSR	   II).	  	  
Quantification	   of	   data	   was	   performed	   using	   FlowJo	   5.6.1.	   	   The	   relative	  
fluorescence	  chart	  for	  the	  conjugates	  used	  is	  tabulated	  below	  (Table	  2.13).	  	  	  	  
	  




Image	   Regent	   Filter	  
Bright	  
	  
Per-­‐CP-­‐Cy5.5	   695/40	  
Moderate	  
	  
FITC	   530/30	  
Dim	  
	  
Per-­‐CP	   695/40	  
	  
	  
2.14	  Kupffer	  Cell	  Phagocytosis	  	  
	  
Fluorescent	  microspheres	  are	  commonly	  used	  in	  phagocytosis	  studies.	  	  For	  the	  
purposes	  of	   the	  KC	  phagocytic	  assay,	  Fluoresbrite@YG	  Microspheres	   (1.00μm)	  
were	   used.	   	   These	   yellow	   green	   microspheres	   have	   excitation	   and	   emission	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spectra	   similar	   to	   FITC	   and	   one	   of	   the	   brightest	   commercially	   available	  









Figure	  2.11	  Fluoresbrite	  YG	  Microshperes	  Excitation	  and	  Emission	  Spectra	  
	  
Microspheres	   were	   incubated	   with	   total	   MNC	   suspension	   for	   20	   minutes	   at	  
37°C.	  	  The	  reaction	  was	  then	  stopped	  by	  addition	  of	  2ml	  ice	  cold	  PBS.	  	  Following	  
centrifugation	   at	   2000rpm	   for	   5	   minutes	   at	   5°C,	   the	   cell	   preparations	   were	  
washed	   and	   incubated	   with	   TruStain	   FcX	   (anti-­‐mouse	   CD16/32)	   and	   stained	  
with	   F4/80	   antibody	   to	   identify	   the	   Kupffer	   cell	   population	   within	   the	   MNC	  
fraction.	   	   The	   cell	   suspension	  was	   then	   reconstituted	   in	   100μl	   of	   FACS	   buffer	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2.15	  Kupffer	  Cell	  Reactive	  Oxygen	  Species	  (ROS)	  Detection	  
	  
KC	   derived	   ROS	  was	   assayed	   using	   the	   Total	   ROS	  Detection	   Kit	   (ENZO-­‐51011)	  
(Table	   2.14	   and	   2.15).	   	   in	   summary,	   cell	   preparations	   were	   stimulated	   using	  
20μg/ml	   LPS	   (E.coli	   0111:B4,	   Sigma	   Aldrich)	   and	   incubated	   for	   30	  minutes	   at	  
37°C.	  	  Samples	  were	  then	  washed	  and	  centrifuged	  at	  2000rpm	  for	  5	  minutes	  at	  
4°C.	  	  	  The	  pelleted	  cells	  were	  re-­‐suspended	  in	  ROS	  detection	  solution,	  incubated	  
with	   TruStain	   FcX	   (anti-­‐mouse	   CD16/32)	   and	   stained	   with	   F4/80	   antibody	   to	  
identify	   the	   KC	   population	   in	   the	   MNC	   fraction	   (AbD	   Serotec).	   	   The	   cell	  
suspension	  was	   then	   reconstituted	   in	   100μl	   of	   FACS	   buffer	   and	   subsequently	  
analysed	  using	  flow	  cytometry	  as	  detailed	  in	  2.13.	  
	  
Table	  2.14	  Total	  ROS	  Detection	  Kit	  Reagents	  
	  
Reagent	   Quantity	  
Oxidative	  Stress	  Detection	  Reagent	  (Green)	   300	  nmol	  
ROS	  Inducer	  (Pyocyanin)	   1	  μmol	  
ROS	  Inhibitor	  (N-­‐actetyl-­‐L-­‐cysteine)	   2	  x	  10	  mg	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• Reconstitute	  ROS	  Inducer	  in	  100μL	  anhydrous	  DMF	  to	  yield	  a	  10mM	  
stock	  solution.	  	  
• Final	  concentration	  of	  200-­‐500M	  as	  per	  manufacturer’s	  
recommendations	  
• ROS	  induction	  occurs	  within	  20-­‐30	  minutes	  upon	  pyocyanin	  treatment	  	  
Negative	  Control	  
• Reconstitute	  ROS	  inhibitor	  in	  123L	  of	  deionised	  water	  to	  yield	  a	  0.5M	  
stock	  
• N-­‐acetyl-­‐L-­‐cysteine	  is	  not	  readily	  soluble	  and	  so	  requires	  vortexing	  
• Final	  concentration	  of	  5mM	  as	  per	  manufacturer’s	  recommendation	  	  
• Endogenous	  fluorescence	  of	  untreated	  cells	  determined	  in	  advance	  of	  
assay	  
Wash	  Buffer	  
• Prepare	  1x	  Wash	  Buffer	  by	  dissolving	  1	  pack	  in	  1L	  of	  deionised	  water	  
• Warm	  to	  room	  temperature	  before	  use	  
ROS	  Detection	  Solution	  
• For	  every	  10mL	  of	  1xWash	  Buffer	  or	  culture	  medium,	  add	  2μL	  of	  
Oxidative	  Stress	  Detection	  Reagent	  and	  mix	  gently	  
Cell	  Preparations	  
• Ensure	  cells	  are	  in	  the	  log	  phase	  of	  growth	  before	  use	  
Preparation	  for	  Flow	  Cytometry	  (Suspension	  Cells)	  
• Cell	  density	  not	  to	  exceed	  1x106	  cells/mL	  
• Induce	  the	  cells	  with	  an	  experimental	  test	  agent	  
• A	  separate	  positive	  control	  sample	  should	  be	  treated	  with	  the	  ROS	  
inducer	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2.16	  Statistical	  Analysis	  
	  
2.16.1	  Unpaired	  Student’s	  t-­‐test	  
The	   unpaired	   student’s	   t-­‐test	   was	   used	   to	   compare	   the	   mean	   differences	  
between	   2	   independent	   but	   identically	   distributed	   data	   sets.	   	   Although	  
randomisation	   is	   not	   a	   prerequisite	   for	   this	   test,	   rodents	   were	   still	   randomly	  
assigned	  to	  either	  the	  control	  or	  treatment	  arm.	  	  The	  paired	  student’s	  t-­‐test	  was	  
considered	  unsuitable	  as	  repeated	  measures,	  from	  the	  same	  sample,	  were	  not	  
being	  analysed.	   	  All	  data	  are	  expressed	  as	  mean	  ±	  SEM	  with	  p	  <	  0.05	  assigned	  
statistical	  significance.	  
	  
2.16.2	  One-­‐Way	  Analysis	  of	  Variance	  (ANOVA)	  
The	  one-­‐way	  ANOVA	  was	  used	  to	  compare	  means	  of	  two	  or	  more	  data	  sets	  that	  
are	   independent	   but	   identically	   distributed.	   	   One-­‐way	   ANOVA	   tests	   the	   null	  
hypothesis	  that	  the	  samples	  in	  2	  or	  more	  groups	  are	  from	  the	  same	  population.	  	  
All	   data	   are	   expressed	   as	   mean	   ±	   SEM	   with	   a	   p	   <	   0.05	   assigned	   statistical	  
significance.	  	  
	  
2.16.3	  Factorial	  or	  Two-­‐Way	  Analysis	  of	  Variance	  (ANOVA)	  
A	   two-­‐way	  ANOVA	  was	   used	   to	   study	   the	   interaction	   effects	   between	   two	  or	  




	   128	  
2.16.4	  Cosinor	  Analysis	  
In	   living	  organisms,	   there	  are	  several	  phenomena	  that	  are	  always	  present	  and	  
measurable	  although	  variable	  as	  a	  function	  of	  time.	  	  As	  such,	  the	  magnitude	  of	  
any	  given	  phenomena	  reaches	  that	  same	  level	  following	  a	  given	  period	  of	  time,	  
an	  example	  being	  24	  hours	  (circadian).	  	  Effectively	  a	  rhythm	  is	  produced	  which	  
can	  be	  quantitatively	  assessed	  using	  cosinor	  analysis.	  	  	  
	  
Cosinor	   analysis	  quantifies	   the	  best	   fitting	   sinusoidal	  wave	   in	  parameters	   that	  
represent	  rhythms	  within	  a	  circadian	  period,	  thereby	  evaluating	  the	  period	  for	  
its	  mean	  level,	  extent	  of	  oscillation	  and	  timing	  of	  the	  oscillatory	  crest.	  	  Again,	  p	  
<	  0.05	  was	  considered	  statistically	  significant.	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3.	  Investigation	  of	  dysmetabolism	  and	  NAFLD	  in	  offspring	  exposed	  to	  maternal	  




Non-­‐alcoholic	   fatty	   liver	  disease,	  NAFLD,	   is	  presently	   the	  commonest	   cause	  of	  
chronic	   liver	  dysfunction	   in	  affluent	  countries.	   	  The	  spectrum	  of	  NAFLD	  ranges	  
from	  hepatosteatosis	  (fatty	  liver),	  through	  non-­‐alcoholic	  steatohepatitis	  (NASH,	  
i.e.	   fat	   with	   inflammation)	   to	   fibrosis,	   cirrhosis	   and	   potentially	   hepatocellular	  
carcinoma.	   	   The	   predominant	   cause	   of	   NAFLD	   is	   obesity.	   	   Its	   pathogenesis	  
implicates	   increased	   oxidant	   stress	   with	   consequent	   activation	   of	   matrix	  
producing	   cells	   and	   propagation	   of	   fibrogenesis	   (154).	   	   Some	   23-­‐34%	   of	   the	  
United	  States	  population	  is	  estimated	  to	  have	  NAFLD,	  and	  about	  2.5%	  the	  more	  
severe	  form	  of	  the	  disease,	  NASH	  (155).	  
	  
The	  rising	  rates	  of	  obesity	  and	  NAFLD	  may	  be	  partially	  explained	  by	   increasing	  
availability	   of	   cheap	   energy	   dense	   foods,	   perhaps	   compounded	   by	   a	  
developmental	   programming	   effect	   of	   maternal	   obesity	   (156).	   	   In	   support	   of	  
this,	   obesity	   amongst	   women	   of	   reproductive	   age	   is	   similarly	   increasing	   with	  
some	  31.5%	  of	  women,	  aged	  20-­‐39	  years,	  in	  the	  USA	  reported	  to	  be	  obese	  (6).	  
	  
Earlier	  studies	  have	  elicited	  relationships	  between	  in	  utero	  under-­‐nutrition,	  low	  
birthweight	  and	  adult	  hypertension,	  type	  2	  diabetes	  and	  metabolic	  dysfunction	  
(157-­‐159),	   leading	   to	   the	   hypothesis	   that	   nutritional	   insults	   during	   early	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development	  may	  induce	  permanent	  alterations	  in	  plastic	  regulatory	  systems	  to	  
induce	   adult	   disease	   (157).	   	   Such	   physiological	   perturbations	   are	   the	  
consequences	  of	  developmental	  programming.	  	  Developmental	  programming	  is	  
the	  process	  whereby	  a	  stimulus	  or	  insult	  during	  a	  critical	  period	  of	  development	  
initiates	   permanent	   structural	   and/or	   physiological	   changes	   as	   protective	  
adaptive	   responses	   (160).	   	   The	   developmental	   over-­‐nutrition	   hypothesis,	  
conversely,	  suggests	  that	  maternal	  obesity	  predisposes	  offspring	  to	  obesity	  and	  
metabolic	  dysfunction	  in	  adulthood	  (161-­‐163).	  	  	  
	  
In	  support	  of	  this	  developmental	  over-­‐nutrition	  hypothesis,	  reports	  of	  elevated	  
cholesterol	   and	   triglyceride	   concentrations	   in	   the	   plasma	   of	   obese	   pregnant	  
women	   have	   been	   positively	   correlated	   with	   lipid	   accumulation	   in	   offspring	  
arterial	   vasculature,	   early	   fatty	   streak	   development	   and	   advanced	  
atherosclerosis	  in	  young	  adults	  (164).	  Additionally,	  epidemiological	  studies	  have	  
reported	   impairment	   of	   glucose-­‐insulin	   metabolism	   with	   accompanying	  
hypertension	   in	   offspring	   exposed	   to	   high	   protein	   and	   fat	   intake	   in	   late	  
gestation	  (165,	  166).	  	  	  
	  
Such	   epidemiological	   findings	   have	   led	   to	   the	   development	   of	   experimental	  
models	   of	   maternal	   over-­‐nutrition	   to	   understand	   pathogenesis,	   multiple	  
adverse	   sequelae	   and	   determine	   involved	   mechanisms.	   	   A	   growing	   body	   of	  
evidence	   from	   these	   models	   of	   maternal	   diet	   induced	   obesity	   suggest	   a	  
programmed	  dysmetabolic	  phenotype	  in	  offspring.	  	  More	  specifically,	  reports	  of	  
insulin	   resistance,	   hyper-­‐leptinaemia	   and	   abnormal	   glucose	   homeostasis	   have	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been	  documented	  in	  offspring	  born	  to	  obese	  mothers	  (167,	  168).	  	  Furthermore,	  
cardiovascular	   perturbations,	   including	   hypertension	   and	   vascular	   dysfunction	  
have	  been	  reported	  in	  offspring	  of	  obese	  mothers	  (169,	  170).	  	  	  
	  
The	   aims	   therefore,	   were	   to	   test	   the	   hypothesis	   that	   maternal	   diet	   induced	  
obesity	   in	   pregnancy	   and	   lactation	   transmits	   a	   predisposition	   to	   offspring	  




3.2.1	  Animal	  Experimentation	  	  
Female	   C57BL/6J	  mice	   (n	   =	   20	   per	   group)	   (Charles	   River	   Laboratories,	  UK),	   of	  
first	  order	  parity,	  approximately	  100	  days	  old	  were	  allowed	  7	  days	  to	  habituate	  
following	  transfer	  to	  the	  facility	  and	  fed	  standard	  laboratory	  chow	  (RM1,	  Special	  
Dietary	  Services,	  energy	  3.5	  kcal/g)	  ad	  libitum.	  	  
	  
Following	  acclimatisation,	  female	  mice	  were	  randomised	  to	  either	  a	  control	  or	  
experimental	   group	   and	   fed	   standard	   chow	   or	   a	   semi-­‐synthetic	   energy-­‐rich,	  
highly	   palatable	   obesogenic	   diet	   	   (Special	   Dietary	   Services,	   energy	   4.5	   kcal/g)	  
supplemented	  with	   sweetened	  condensed	  milk	   (Nestle)	   admixed	  with	  mineral	  
mix	  (AIN93G,	  Special	  Dietary	  Services,	  125	  mg/pot)	  ad	  libitum.	  	  	  
Dams	   were	   maintained	   on	   their	   respective	   diets	   for	   6-­‐8	   weeks.	   	   Upon	  
attainment	   of	   an	   average	   30%	   increase	   in	   body	   weight	   of	   the	   experimental	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group,	  mice	  were	  entered	  into	  the	  breeding	  protocol.	  	  All	  animals	  were	  treated	  
in	  accordance	  with	  The	  Animals	  (Scientific	  Procedures)	  Act,	  UK,	  1986	  guidelines.	  
	  
Pregnant	   dams	   were	   continued	   on	   their	   pre-­‐conception	   diets	   throughout	  
pregnancy	  and	  lactation.	  	  During	  pregnancy,	  maternal	  weight	  and	  dietary	  intake	  
were	  recorded	  weekly.	  	  Dams	  were	  allowed	  to	  deliver	  spontaneously	  and	  litter	  
size	  standardised.	  	  All	  female	  offspring	  (n	  =	  10)	  born	  to	  lean	  (OffCon)	  and	  obese	  
(OffOb)	   dams	   were	   weaned	   onto	   standard	   chow	   at	   3	   weeks	   postpartum.	  	  
Markers	  of	  dysmetabolism	  and	  NAFLD	  were	  assayed	  at	  3	  months	  of	  age	  (Figure	  
2.3).	  
	  
3.2.2	  Offspring	  Calorific	  Intake	  and	  Body	  Weight	  
Pelleted	   food	   intake	   was	   measured	   weekly	   to	   assess	   calorific	   intake.	  	  
Bodyweight	  of	  offspring	  aged	  3	  months	  was	  measured	  prior	  to	  sacrificing	  using	  
a	   schedule-­‐1	  method.	   	  Weights	  were	   recorded	   using	   a	   balance	   accurate	   to	   4	  
decimal	  places.	  	  	  
	  
3.2.3	  Tissue	  Collection	  
Offspring	   liver	   tissue	   was	   differentially	   preserved	   for	   use	   in	   gene	   expression	  
analysis,	   protein	   and	   lipid	   extraction	   and	  histology.	   	   Briefly,	  whole	   liver	   tissue	  
was	   snap	   frozen	   in	   liquid	   nitrogen	   or	   dissected	   using	  middle	   orientation	   and	  
stored	  in	  10%	  neutral	  buffered	  formalin	  prior	  to	  paraffin	  embedding.	  	  Offspring	  
blood	  was	  collected	  via	  cardiac	  puncture	  or	  inferior	  vena	  cava	  cannulation	  using	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heparinised	  syringes.	  	  The	  blood	  was	  centrifuged	  at	  3000	  x	  g	  for	  10	  minutes	  at	  
4˚C	  and	  decanted	  plasma	  stored	  at	  -­‐20˚C	  until	  biochemical	  analysis.	  	  	  
	  
3.2.4	  Serum	  Analysis	  
ELISAs	  were	  used	  for	  analysis	  of	  serum	  leptin	  (Biovender	  R&D	  1301)	  and	  insulin	  
(CrystalChem,	   Catalog	   #90080).	   	   Wide	   range	   assays	   were	   used	   for	   adequate	  




Remote	   radiotelemetric	   probes	   (TA11PA-­‐C10,	   O.D	   0.4	   mm,	   Data	   Science	  
International)	  were	  implanted	  under	  general	  anaesthetic	  (isofluorane	  in	  O2)	  and	  
an	   indwelling	   catheter	   was	   inserted	   into	   the	   left	   carotid	   artery.	   	   Following	  
recovery,	   offspring	   were	   subjected	   to	   30	   minutes	   restraint	   and	   120	   minutes	  
recovery	   during	   which	   time,	   the	   systolic	   blood	   pressure	   (SBP)	   was	   measured	  
and	  expressed	  as	  a	  change	  from	  baseline.	  	  	  
	  
3.2.6	  Liver	  Tissue	  Triglyceride	  
Whole	   liver	   tissue	   triglyceride	  was	   determined	   by	   an	   adaptation	   of	   the	   Folch	  
Method	   using	   an	   enzymatic	   colorimetric	   assay	   (UNIMATE	   5	   TRIG,	   Roche	   BC1.	  	  
Sussex,	  UK).	   	  Approximately	  0.05g	  of	   liver	   tissue	  per	   sample	  was	  used	  and	  all	  
results	  normalised	  to	  sample	  quantity.	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3.2.7	  Gene	  Expression	  of	  Liver	  Injury	  Markers	  
Semi-­‐quantitative	  reverse	  transcriptase	  polymerase	  chain	  reaction	  (RT-­‐PCR)	  was	  
performed	   using	   SuperScript™	   III	   One-­‐Step	   RT-­‐PCR	   System	   with	   Platinum®	  
Taq	  High	   Fidelity	   (Invitrogen	   Life	   Technologies).	   	   Gene	   specific	   primers	   were	  
designed	   for	   interleukin-­‐6	   (Il-­‐6)	   and	   tumour	   necrosis	   factor-­‐α	   (TNF-­‐α).	  
Expression	  of	  target	  genes	  was	  normalised	  to	  GAPDH	  expression.	  	  
	  
3.2.8	  Protein	  Expression	  of	  Insulin	  Signalling	  Molecules	  
Total	   liver	   protein	   was	   extracted	   in	   ice-­‐cold	   RIPA	   buffer	   (150nM	   sodium	  
chlorise,	   1%	   Triton-­‐X	   100,	   0.5%	   sodium	  deoxycholate,	   50mM	  Tris,	   pH	   8.0	   and	  
0.1%	   SDS),	   lysate	   protein	   concentrations,	   determined	   using	   the	  
copper/bicinchoninic	   assay	   (Sigma),	   and	   standardised	   to	   2	   mg/ml	   by	   dilution	  
into	  Laemmli	  buffer.	   	  20μg	  total	  protein	  was	   loaded	  for	  SDS-­‐PAGE	  followed	  by	  
overnight	   incubation	  with	   antibody	   against	   IRS-­‐1,	   phospho-­‐IRS1	   (Ser307),	   IRβ,	  
(Santa	  Cruz	  Biotechnology,	  Santa	  Cruz,	  USA).	   	  Protein	  expression	  was	  assessed	  
densitometrically	  using	  AlphaEase	  software	  (AlphaImager).	  	  
	  
3.2.9	  Liver	  Histology	  
Offspring	  liver	  sections	  at	  3	  months	  were	  stained	  with	  haematoxylin	  and	  eosin	  
(H&E)	  and	  assessed	   for	  steatosis,	  by	  an	  expert	   liver	  pathologist	  blinded	  to	   the	  
identity	  of	  the	  groups.	  	  Steatosis	  was	  characterised	  into	  4	  groups,	  extrapolated	  
from	   the	   steatosis	   scoring	   methods	   as	   per	   the	   Brunt-­‐Kleiner	   NAFLD	   Activity	  
Score	  (Table	  3.1).	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Table	  3.1	  Histological	  Assessment	  of	  Steatosis	  
Parameter	   Score	  
<	  5%	   0	  
5	  –	  33%	   1	  
>	  33	  –	  66%	   2	  
>	  66%	   3	  
	  
3.2.10	  Breast	  Milk	  Leptin	  
Breast	   milk	   samples	   were	   obtained	   from	   suckling	   dams	   after	   anaesthesia	   via	  
direct	  aspiration	  of	  the	  mammary	  glands.	  	  Leptin	  content	  was	  determined	  using	  
ELISA	  (Biovender	  R&D	  1301).	  
	  
3.2.11	  Statistical	  Analysis	  
Multiple	   comparisons	   on	   a	   single	   data	   set	  were	   performed	   using	  ANOVA	   and	  
expressed	  as	  mean	  ±	  SEM	  unless	  otherwise	  stated.	   	  p	  <	  0.05	  was	   regarded	  as	  
significant.	  	  Sample	  size	  per	  group;	  n	  =	  5,	  1	  from	  each	  litter.	  
	  
3.3	  Results	  	  
	  
3.3.1	   Exposure	   to	  maternal	   obesity	   during	   gestation	   and	   lactation	   does	   not	  
influence	  offspring	  adiposity	  and	  calorific	  intake	  at	  3	  months	  
At	  3	  months	  post-­‐partum,	  offspring	  exposed	   to	  maternal	  diet	   induced	  obesity	  
throughout	  gestation	  and	  lactation	  had	  similar	  bodyweights	  as	  offspring	  of	  lean	  
dams	  (OffCon;	  21.9	  ±	  0.45	  v.	  OffOb;	  22.4	  ±	  0.21	  gm).	  	  Corroboratively,	  calorific	  
intake	   between	   these	   two	   groups	   was	   comparable	   (OffCon;	   70.95	   ±	   3.51	   v.	  
OffOb;	   78.87	   ±	   4.10	   kcal/gm),	   as	   was	   serum	   leptin	   (OffCon;	   1036	   ±	   46.02	   v.	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OffOb;	   1266	   ±	   129.60	   pg/ml)	   (Figure	   3.1).	   	   It	   is	   important	   to	   note	   that	   post-­‐
weaning,	   all	   offspring	   were	   maintained	   on	   a	   standard	   chow	   to	   permit	  
investigation	  of	  the	  effects	  of	  maternal	  obesity	  during	  periods	  of	  developmental	  
plasticity	  only.	  	  In	  summary	  therefore,	  at	  3	  months	  post-­‐partum,	  no	  statistically	  
significant	  difference	  was	  observed	  between	  offspring	  of	  OffCon	  and	  OffOb	   in	  
body	  weights,	  calorific	  intake	  and	  serum	  leptin.	  	  
	  
	  
Figure	  3.1	  Offspring	  Adiposity	  and	  Calorific	   Intake	  at	  3	  months	  post-­‐partum:	  
(A)	   Bodyweight,	   (B)	   Calorific	   Intake	   per	   week	   and	   (C)	   Serum	   Leptin	  
Concentrations.	   	   A	   similar	   pattern	   was	   observed	   in	   all	   measured	   indices	   of	  
adiposity,	   with	   no	   statistically	   significant	   differences	   observed	   (unpaired	  
student’s	   t-­‐test,	   p	   <	   0.05)	   between	  offspring	   of	   lean	   suckled	   by	   lean	   (OffCon)	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and	  offspring	  of	  obese	  suckled	  by	  obese	  (OffOb).	  	  n	  =	  4	  -­‐6/group,	  values	  shown	  
are	  mean	  ±	  SEM.	  
	  
3.3.2	   Offspring	   exposure	   to	  maternal	   obesity	   during	   gestation	   and	   lactation	  
induces	  hyper-­‐insulinaemia	  and	  increased	  SNS	  tone	  at	  3	  months	  
Serum	   insulin	   concentration	   was	   measured	   as	   a	   biochemical	   indicator	   of	  
metabolic	  perturbation.	   	   Insulin	   levels	  were	  significantly	   increased	   in	  offspring	  
exposed	   to	   maternal	   obesity	   compared	   to	   offspring	   of	   lean	   dams	   (OffCon;	  
0.1533	  ±	  0.001	  v.	  OffOb;	  0.1267	  ±	  0.083	  μg/l).	  	  Additionally,	  the	  mean	  nocturnal	  
systolic	  blood	  pressure	  was	  raised	  alongside	  the	  response	  to	  restraint	  stress	  in	  
OffOb,	  indicating	  increased	  sympathetic	  nervous	  system	  (SNS)	  tone	  (Figure	  3.2).	  	  
	  
	  
Figure	   3.2	   Serum	   Insulin	   and	   Systolic	   Blood	  Pressure	   responses	   at	   3	  months	  
post-­‐partum:	   (A)	   Serum	   Insulin	   Concentrations,	   (B)	   Nocturnal	   Systolic	   Blood	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Pressure	  and	  (C)	  Cardiovascular	  Reactivity	  to	  Stress.	   	   	  Offspring	  of	  obese	  dams	  
displayed	   hyper-­‐insulinaemia	   and	   raised	   SNS	   tone	   compared	   to	   controls.	  	  
Offspring	   of	   lean	   suckled	   by	   lean	   (OffCon)	   and	   offspring	   of	   obese	   suckled	   by	  
obese	  (OffOb);	  n	  =	  4	  –	  6/group,	  values	  shown	  as	  mean	  ±	  SEM;	  *	  p	  <	  0.05,	  **	  p	  <	  
0.001,	  ***	  p	  <	  0.0001,	  unpaired	  student’s	  t-­‐test.	  
	  
3.3.3	   Offspring	   exposure	   to	  maternal	   obesity	   during	   gestation	   and	   lactation	  
reduces	  hepatic	  insulin	  signalling	  at	  3	  months	  
Expression	   of	   IRβ	   in	   the	   livers	   of	   offspring	   exposed	   to	   maternal	   obesity	  
throughout	   gestation	   and	   lactation	  was	   not	   altered	   compared	   to	   offspring	   of	  
lean	  dams.	  However,	  expression	  of	  IRS-­‐1	  protein	  was	  significantly	  decreased	  in	  
the	   offspring	   of	   obese	   dams,	   while	   phosphorylation	   of	   IRS-­‐1	   at	   Ser	   307,	   an	  
inhibitory	  signal	  of	   insulin	  action	  was	  significantly	   increased.	  Reduced	   liver	   IRS	  
expression	  and	  hyper-­‐phosphorylation	  of	   IRS	  serine	  residues	  are	  key	  factors	   in	  
the	  development	  of	  insulin	  resistance	  and	  type	  2	  diabetes	  (Figure	  3.3).	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Figure	   3.3	   Impaired	   hepatic	   insulin	   signalling	   at	   3	   months	   post-­‐partum:	  
Maternal	  obesity	  led	  to	  a	  post	  receptor	  defect	  in	  insulin	  signalling	  in	  offspring.	  	  
IR-­‐beta	  was	   unaffected,	   IRS-­‐1	   down-­‐regulated	   and	   IRS-­‐1	   Ser307	   up-­‐regulated.	  	  
Offspring	   of	   lean	   suckled	   by	   lean	   (OffCon)	   and	   offspring	   of	   obese	   suckled	   by	  
obese	  (OffOb);	  n	  =	  4	  –	  6/group,	  values	  are	  expressed	  as	  a	  %	  of	  control	  ±	  SEM;	  *	  
p	  <	  0.05,	  **	  p	  <	  0.001;	  unpaired	  student’s	  t-­‐test.	  
	  
3.3.4	   Offspring	   exposure	   to	  maternal	   obesity	   during	   gestation	   and	   lactation	  
induces	  hepatosteatosis	  at	  3	  months	  
Histological	  evidence	  of	  hepatic	  macrovesicular	  steatosis	  was	  observed	  in	  OffOb	  
compared	  to	  OffCon	  at	  3	  months	  post-­‐partum.	  	  Morphometrical	  quantification	  
of	   the	   stained	   surface	   was	   performed	   on	   microphotographs	   taken	   from	   ten	  
random	  field	  sections	  per	  liver,	  corroborating	  these	  findings.	  	  Additionally,	  liver	  
tissue	   triglyceride	   content	   was	   raised,	   although	   not	   statistically	   significant	  
(OffCon;	  4.76	  ±	  0.89	  v.	  OffOb;	  7.22	  ±	  0.53	  mmol/l)	  (Figure	  3.4).	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Figure	   3.4	   Histological	   and	   Biochemical	   Evidence	   of	   Hepatosteatosis	   at	   3	  
months	  post-­‐partum:	  	  (A)	  Representative	  H&E	  sections,	  (B)	  Steatosis	  Score	  and	  
(C)	   Hepatic	   Tissue	   Triglyceride.	   Maternal	   obesity	   led	   to	   offspring	  
hepatosteatosis	   compared	   to	   control	   offspring,	   although	   hepatic	   triglyceride	  
content	  was	  not	  statistically	  significant	  between	  the	  groups.	   	  Offspring	  of	   lean	  
suckled	  by	  lean	  (OffCon)	  and	  offspring	  of	  obese	  suckled	  by	  obese	  (OffOb);	  n	  =	  4	  
–	   6/group,	   values	   shown	   as	  mean	   ±	   SEM;	   *	   p	   <	   0.05,	   **	   p	   <	   0.001,	   ***	   p	   <	  
0.0001;	  unpaired	  student’s	  t-­‐test.	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3.3.5	   Offspring	   exposure	   to	  maternal	   obesity	   during	   gestation	   and	   lactation	  
induces	  moderate	  liver	  injury	  at	  3	  months	  
Serum	  aspartate	  aminotransaminase	  (AST),	  a	  putative	  biochemical	   indicator	  of	  
liver	   injury,	   was	   significantly	   raised	   in	   offspring	   exposed	   to	   maternal	   obesity	  
compared	  to	  offspring	  of	  lean	  dams	  (OffCon;	  214.8	  ±	  21.0	  v.	  OffOb;	  416.7	  ±	  11.5	  
IU/L).	   	   Additionally,	   relative	   mRNA	   expression	   of	   IL-­‐6	   and	   TNF-­‐α,	   cytokines	  
implicated	   in	  NAFLD	  pathogenesis,	  was	  raised	   in	  OffOb	  compared	  with	  OffCon	  
(Figure	  3.5).	  	  	  	  	  	  
	  
	  
Figure	   3.5	   Biochemical	   Evidence	   of	   Liver	   Injury	   at	   3	   months	   post-­‐partum:	  	  	  	  	  	  
(A)	   Serum	   AST,	   (B)	   mRNA	   TNFα	   expression	   and	   (C)	   mRNA	   Il-­‐6	   expression.	  	  
Maternal	  obesity	  led	  to	  up-­‐regulation	  of	  hepatic	  pro-­‐inflammatory	  markers	  and,	  
AST,	  an	  indicator	  of	  liver	  injury	  compared	  to	  control	  offspring.	  	  Offspring	  of	  lean	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suckled	  by	  lean	  (OffCon)	  and	  offspring	  of	  obese	  suckled	  by	  obese	  (OffOb);	  n	  =	  4	  
–	   6/group,	   values	   shown	   as	  mean	   ±	   SEM;	   *	   p	   <	   0.05,	   **	   p	   <	   0.001;	   unpaired	  
student’s	  t-­‐test.	  
	  
3.3.6	   Breast	   milk	   leptin	   as	   a	   mediator	   of	   programmed	   offspring	  
dysmetabolism	  and	  NAFLD	  
Mechanistically,	   it	  was	   thought	   that	   the	  hyperleptinaemic	   status	  of	   the	  obese	  
mother	   during	   gestation	   and	   lactation	   could	   alter	   physiological	   functioning	   of	  
the	   developing	   offspring.	   	   In	   order	   to	   investigate	   this	   possibility,	   breast	   milk	  
content	  of	   leptin	   in	  the	  obese	  and	  lean	  dams	  were	  measured	  and	  found	  to	  be	  
markedly	  raised	  in	  OffOb	  (OffCon;	  3527	  ±	  142.3	  v.	  OffOb;	  36468	  ±	  5082.4	  pg/ml)	  
(Figure	  3.6).	  
	  
Figure	  3.6	  Maternal	  Breast	  Milk	  Leptin:	  Breast	  milk	  leptin	  was	  raised	  in	  obese	  
dams	  compared	  to	   lean	  dams.	   	  Offspring	  of	   lean	  suckled	  by	   lean	  (OffCon)	  and	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offspring	  of	  obese	  suckled	  by	  obese	  (OffOb);	  n	  =	  4	  –	  6/group,	  values	  shown	  as	  




This	   study	   has	   demonstrated	   that	   offspring	   exposure	   to	   maternal	   obesity	   in	  
infancy	   induces	  dysmetabolism	  with	  priming	  of	  NAFLD	   in	  adulthood.	   	  This	  was	  
evidenced	  by	  hyper-­‐insulinaemia	  and	   impaired	   insulin	  signalling,	  hypertension,	  
raised	   SNS	   tone,	   increased	   serum	  AST	   and	   up-­‐regulation	   of	   pro-­‐inflammatory	  
cytokines	  implicated	  in	  NAFLD	  aetiopathogenesis.	  	  	  
	  
3.4.1	  Offspring	  Adiposity	  and	  Calorific	  Intake	  
Adiposity	  remained	  unaffected	  in	  female	  offspring	  exposed	  to	  maternal	  obesity	  
at	  3	  months	  as	  calorific	   intake,	  bodyweight	  and	  the	  adipokine,	   leptin,	  were	  all	  
similar	   to	   control	   values.	   	   Conversely,	   it	   has	   been	   reported	   that	   offspring	  
anthropometry	   in	   those	   exposed	   to	   maternal	   obesity	   is	   significantly	   adverse	  
compared	   to	   offspring	   of	   lean	   dams	   (35).	   	   These	   readouts	   however,	   are	   not	  
directly	   comparable	   as	   both	   male	   and	   female	   offspring	   were	   collectively	  
represented	   and	   as	   such,	   incorporate	   gender	   influences	   of	   programming	   by	  
maternal	  obesity.	  	  Here,	  to	  exclude	  any	  potential	  gender	  induced	  variability,	  the	  
effects	   of	   programming	   by	   maternal	   obesity	   on	   hepatic	   outcome	   in	   either	  
female	  and/or	  male	  offspring	  have	  been	   investigated	  separately.	   	  However,	   in	  
support	   of	   the	   aforementioned	   findings,	   it	   has	   been	   previously	   reported	   that	  
offspring	  adiposity	  in	  those	  exposed	  to	  maternal	  obesity	  only	  become	  apparent	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at	   1	   year	   in	   rodents	   (14).	   	   It	   may	   therefore	   be	   argued	   that	   investigation	   of	  
offspring	  adiposity	  at	  3	  months	  is	  experimentally	  premature.	  	  	  	  	  
	  
Irrespective,	   obesity	   is	   considered	   a	   fundamental	   criterion	   in	   the	  
characterisation	  of	  the	  dysmetabolic	  syndrome	  although	  adiposity	  is	  a	  stronger	  
correlate	  in	  developmental	  programming	  (14).	  	  Epidemiologically,	  a	  longitudinal	  
cohort	   study	  of	   children	   aged	  up	   to	   11	   years	   has	   reported	   an	   increased	  odds	  
ratio	   for	   development	   of	   the	   dysmetabolic	   syndrome	   in	   those	   born	   large	   for	  
gestational	   age	   (18).	   	   Despite	   the	   association	   between	   overt	   adiposity	   and	  
dysmetabolism,	   it	   is	   shown	   here,	   for	   the	   first	   time,	   that	   maternal	   obesity	  
programs	  offspring	  dysmetabolism	  and	  hepatic	   injury	   independent	  of	   obesity.	  	  
So	   therefore,	   the	   observed	   phenotype	   is	   not	   a	   secondary	   consequence	   of	  
programmed	   offspring	   obesity	   and	   hyperphagia,	   but	   rather	   a	   direct	   effect	   of	  
programming	  on	  the	  liver	  by	  maternal	  obesity.	  
	  
3.4.2	  Offspring	  Dysmetabolism	  
Hyper-­‐insulinaemia	  was	  observed	   in	  OffOb	  compared	   to	  OffCon.	   	   It	   is	   thought	  
that	   the	   increased	   fetal	   nutrient	   supply	   from	   exposure	   to	   maternal	   obesity	  
during	   development	   plasticity	   impairs	   glucose	   induced	   insulin	   release	   from	  
pancreatic	   ß-­‐cells	   through	   enlargement	   of	   secretory	   granules	   (37).	  	  
Consequently,	   an	   imbalance	   in	   glucose	   and	   insulin	   homeostasis	   evokes	  
abnormally	   higher	   levels	   of	   insulin	   in	   adversely	   exposed	   offspring.	   	   Similar	  
findings	   have	   been	   reproduced	   in	   rodent	   models	   of	   maternal	   over-­‐nutrition,	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whereby	   offspring	   born	   to	   and	   suckled	   by	   an	   obese	   dam	   have	   significantly	  
elevated	  levels	  of	  insulin	  compared	  to	  controls	  (35,	  36).	  	  	  
	  
3.4.3	  Offspring	  Hypertension	  
Offspring	  exposure	   to	  maternal	  obesity	   induced	   raised	   systolic	  blood	  pressure	  
compared	   to	   control	   offspring.	   	   These	   findings	   are	   corroborated	   in	   similar	  
rodent	  models	  of	  developmental	  programming	  by	  maternal	  obesity	  (35,	  40).	  	  It	  
is	   thought	   that	   perturbed	   cardiovascular	   function	   is	   due	   to	   sympathetic	  
activation,	   altered	   vascular	   responses,	   hormonal	   changes	   and	   elevation	   of	  
inflammatory	  mediators	  (171).	  	  It	  has	  been	  suggested	  that	  exposure	  to	  maternal	  
obesity	   accelerates	   maturation	   and	   permanently	   up-­‐regulates	   the	  
hypothalamo-­‐pituitary-­‐adrenal	  (HPA)	  axis	  in	  rodents.	  	  Consequently,	  disruption	  
of	  the	  offspring	  endocrine	  status	  induces	  metabolic	  dysfunction	  and	  raised	  SNS	  
tone	  (32).	  	  	  	  	  	  	  
	  
3.4.4	  Offspring	  Liver	  Injury	  
The	  current	  paradigm	  for	  the	  pathogenesis	  of	  NAFLD,	  invokes	  insulin	  resistance	  
as	  the	  primary	  driver	  for	  steatosis	   in	  the	  livers	  of	  obese	  individuals	  (172),	  with	  
IL-­‐6	  and	  TNF-­‐α	  involved	  in	  the	  inflammatory	  responses	  (173).	  Increased	  hepatic	  
expression	   of	   these	   inflammatory	   cytokines	   could	   also	   be	   related	   to	   the	  
observed	  altered	  insulin	  signalling	  observed	  in	  OffOb,	  as	  they	  induce	  an	  increase	  
in	  Ser	  307	  phosphorylation	  on	   IRS-­‐1.	   It	   is	  shown	  here	  that	  OffOb	   insulin	   levels	  
are	  raised	  with	  evidence	  of	  insulin	  resistance	  as	  demonstrated	  by	  a	  reduction	  of	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IRS-­‐1	  in	  the	  presence	  of	  normal	  levels	  of	  IR-­‐β	  (173,	  174).	  	  
	  	  	  
Serum	  AST	  was	  significantly	  raised	  in	  OffOb	  compared	  to	  OffCon,	  indicating	  the	  
presence	   of	   liver	   injury.	   	   Although	   limited	   studies	   examining	   the	   effects	   of	  
maternal	  over-­‐nutrition	  on	  development	  of	  liver	  injury	  exist,	  it	  is	  accepted	  that	  
dysmetabolism	   precedes	   liver	   injury	   	   which	   is	   consistent	   with	   the	   present	  
findings	  (36).	  	  	  
	  
3.4.5	  Offspring	  Hepatosteatosis	  
Hepatic	  tissue	  triglyceride	  content	  was	  raised	  in	  offspring	  exposed	  to	  maternal	  
obesity	   compared	   to	   controls,	   although	   the	   difference	   was	   not	   statistically	  
significant.	  	  	  Mild	  hepatosteatosis	  was	  evidenced	  by	  histological	  assessment	  and	  
quantification.	  	  Given	  that	  hepatic	  triglycerides	  originate	  as	  non-­‐esterified	  fatty	  
acids,	   a	   product	   of	   adipose	   tissue,	   it	   is	   in	   keeping	   with	   the	   recorded	  
bodyweights	   (175).	   	   These	   findings	   are	   the	   first	   reports	   of	   quantified	  
hepatosteatosis	   in	   NAFLD	   programmed	   by	   maternal	   obesity,	   although	  
associations	   between	   offspring	   exposure	   to	   maternal	   obesity	   and	   serum	  
cholesterol	  and	  triglycerides	  have	  been	  reported	  (35,	  64).	  	  The	  observed	  insulin	  
resistance	  may	  be	  mechanistically	   responsible	   for	   the	  ensuing	  hepatosteatosis	  
through	   increased	   lipolysis	   and	   saturation	   of	   the	   mitochondrial	   ß-­‐oxidation	  
pathway,	   generating	   reactive	   oxygen	   species;	   or	   through	   enhancing	   de	   novo	  
hepatic	  lipogenesis	  through	  promotion	  of	  glycolysis	  (64,	  103).	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3.4.6	  Breast	  Milk	  Derived	  Leptin	  
This	  experimental	  protocol	   involved	  weaning	  all	  offspring	  onto	  standard	  chow	  
ensuring,	   that	  any	  phenotypic	  changes	  were	   the	   result	  of	  maternal	  nutritional	  
differences	  during	  pregnancy	  and	  lactation	  only.	  	  The	  findings	  here	  confirm	  that	  
the	   observed	   development	   of	   the	   dysmetabolic	   and	   NAFLD	   phenotype	   in	  
offspring	   of	   obese	   dams	   is	   driven	   by	   exposure	   to	   maternal	   obesity,	   with	  
maternal	   breast	   milk	   factors,	   being	   possible	   mechanistic	   candidates	   via	   their	  
inducing	   this	   phenotype,	   through	   effects	   on	   plastic	   central	   neonatal	   energy	  
homeostasis	  centres	  (176).	  	  	  
	  
Breast	  milk	  leptin	  in	  obese	  dams	  has	  been	  shown	  here	  to	  be	  elevated	  compared	  
to	   that	   in	   lean	   dams.	   	   Moreover,	   oral	   leptin	   is	   absorbed	   by	   the	   neonatal	  
stomach	  (177),	  is	  biologically	  active	  and	  involved	  in	  energy	  homeostasis	  (59).	  	  It	  
is	  plausible,	  therefore,	  that	  exposure	  of	  the	  developing	  neonatal	  hypothalamic	  
appetite	   regulating	   centres,	   to	   raised	   levels	   of	   absorbed	   breast	   milk	   leptin	  
mediates	   the	   observed	   phenotype	   by	   engendering	   a	   leptin	   resistant	   state	   to	  
further	   promote	   hyper-­‐insulinaemia	   (178).	   	   Given	   the	   technical	   difficulties	  
involved	   in	   extracting	   mouse	   breast	   milk	   leptin,	   its	   role	   in	   developmental	  
programming	  has	  not	  been	  further	  delineated.	  	  However,	  the	  role	  of	  leptin	  has	  
been	  shown	  to	  alter	  energy	  homeostatic	  mechanisms	  through	  attenuated	  leptin	  
induced	  appetite	  suppression	  and	  signalling	  in	  a	  similar	  experimental	  paradigm	  
involving	  rats	  with	  hyperphagic	  and	  dysmetabolic	  traits	  (179).	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3.5	  Conclusion	  
In	   conclusion,	   offspring	   exposure	   to	   maternal	   obesity	   during	   gestation	   and	  
lactation	  programs	  a	  dysmetabolic	  and	  NAFLD	  phenotype,	  perhaps	  through	  the	  
effects	   of	   breast	   milk	   leptin	   on	   plastic	   neonatal	   hypothalamic	   centres	   or	  
perturbed	   hepatic	   insulin	   signalling.	   Therefore,	   developmental	   programming	  
may	  be	   involved	   in	   the	  rising	   rates	  of	  NAFLD.	   	  The	  critical	  periods	  of	  neonatal	  
development,	   whether	   in	   utero	   or	   lactation,	   responsible	   for	   the	   observed	  
phenotype,	  remains	  unknown.	  	  Chapter	  4	  investigates	  the	  relative	  contributions	  
of	   the	   in	   utero	   and	   lactation	   periods	   on	   the	   development	   of	   offspring	  
dysmetabolism	   and	   NAFLD,	   in	   an	   attempt	   to	   better	   understand	   the	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4.	  Investigation	  of	  dysmetabolism	  and	  NAFLD	  in	  offspring	  exposed	  to	  maternal	  
obesity	   during	   gestation	   or	   lactation	   –	   identification	   of	   the	   critical	  




Rising	   rates	   of	   obesity	   and	   non-­‐alcoholic	   fatty	   liver	   disease,	   NAFLD	   may	   be	  
partially	   explained	  by	   the	   increasing	   availability	   of	   cheap	   energy	  dense	   foods,	  
perhaps	   compounded	   by	   a	   developmental	   programming	   effect	   of	   maternal	  
obesity	   (51,	   64,	   180).	   NAFLD	   is	   now	   the	   commonest	   cause	   of	   chronic	   liver	  
disease	   in	   affluent	   countries,	  with	   23-­‐34%	   of	   the	  US	   population	   estimated	   to	  
have	   NAFLD,	   and	   about	   2.5%	   the	   more	   severe	   form	   of	   the	   disease,	   non-­‐
alcoholic	  steatohepatitis	  (NASH)	  (155).	  Obesity	  amongst	  women	  of	  reproductive	  
age	  is	  similarly	  rising	  with	  some	  31.5%	  of	  women,	  aged	  20-­‐39	  years,	  in	  the	  USA	  
reported	  to	  be	  obese	  (6).	  
	  
Earlier	   studies	   elicited	   relationships	   between	   in	   utero	  mal-­‐nutrition	   and	   adult	  
onset	   metabolic	   and	   cardiovascular	   dysfunction	   (5,	   20,	   181),	   leading	   to	   the	  
hypothesis	   that	   nutritional	   insults	   during	   early	   development	   may	   induce	  
permanent	   alterations	   in	   plastic	   regulatory	   systems	   to	   induce	   adult	   disease	  
(157).	   It	   has	   now	   been	   shown	   for	   the	   first	   time	   that	   maternal	   obesity	  
predisposes	   offspring	   to	   metabolic	   dysfunction	   with	   induction	   of	   NAFLD	   in	  
adulthood,	   as	   described	   in	   Chapter	   3	   (51,	   182).	   	   These	   findings	   were	  
subsequently	   corroborated	   in	   a	   similar	   experimental	   paradigm	   (64).	   	   The	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relative	  contributions	  of	  the	  gestation	  and	  lactation	  periods	  to	  the	  programmed	  
phenotype	  are,	  however,	  unknown.	   	  Standard	  rodent	  models	  of	  programming,	  
as	  in	  Chapter	  3,	  involve	  dams	  fed	  an	  obesogenic	  diet	  throughout	  gestation	  and	  
lactation	   such	   that	   readouts	   in	   offspring	   are	   a	   reflection	   of	   the	   interaction	  
between	  both	  developmental	  periods.	  	  By	  cross-­‐fostering	  offspring	  born	  to	  lean	  
dams	  to	  be	  suckled	  by	  obese	  dams,	  in	  the	  immediate	  post-­‐partum	  period,	  and	  
vice	  versa,	  allows	  an	  investigation	  of	  the	  independent	  roles	  of	  the	  in	  utero	  and	  
ex	  utero	  environment,	  on	  the	  observed	  adult	  phenotype.	  	  	  
	  
The	   importance	  of	   the	  post-­‐natal	  environment	   in	   influencing	  offspring	  obesity	  
and	  insulin	  resistance	  has	  been	  demonstrated	  in	  a	  cross-­‐fostering	  experimental	  
paradigm	  involving	  rats.	  	  It	  has	  previously	  been	  reported	  that	  offspring	  born	  to	  
lean	  dams	  but	  cross-­‐fostered	  to	  genetically	  obese	  dams	  to	  suckle,	  programs	  for	  
obesity	  and	   insulin	  resistance	   in	  adulthood.	   	  Conversely,	  offspring	  born	  to	  diet	  
induced	  obese	  dams,	  but	  suckled	  by	  a	   lean	  dam	  maintained	  on	  a	   low	  fat	  diet,	  
improved	  insulin	  resistance	  in	  the	  context	  of	  persisting	  obesity	  (52).	  	  	  
	  
Reducing	   litter	   size	  post-­‐partum,	   to	   increase	   food	  availability	  during	   lactation,	  
has	   also	   provided	   evidence	   of	   increased	   obesity	   and	   dysmetabolism	   risk	   in	  
offspring.	   	   In	   an	   attempt	   to	   investigate	   the	   long	   term	   consequences	   of	   early	  
post-­‐natal	  over-­‐feeding,	  normal	  litter	  size	  of	  Wistar	  rats	  (n	  =	  10)	  was	  reduced	  to	  
3	   pups	   per	   dam	   during	   the	   lactation	   period.	   	   These	   offspring	   displayed	  
hyperphagia,	  hypertension	  and	  impaired	  glucose	  tolerance	  in	  adulthood	  (53)	  as	  
a	   consequence	   of	   alterations	   to	   the	   hypothalamic	   energy	   circuitry	   (54).	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Additionally,	   it	  has	  been	  suggested	  that	  offspring	  exposure	  to	  over-­‐nutrition	  in	  
lactation	   is	   trans-­‐generational	   as	   rodents	   fed	   carbohydrate	   rich	   formula	   milk	  
during	   this	   period	   develop	   adult	   onset	   obesity,	   with	   transmission	   to	   the	   F2	  
progeny	   despite	   consumption	   of	   a	   standard	   chow	   diet	   post-­‐weaning	   (183).	  	  
Therefore,	   it	   could	   be	   suggested	   that	   the	   lactation	   period	   is	   critical	   and	   that	  
changes	  during	   this	  period	  may	  compound	  or	  even	  over-­‐ride	  genetic	  and	  pre-­‐
natal	   factors	   to	   determine	   the	   eventual	   offspring	   metabolic	   and	   hepatic	  
phenotype.	  	  	  
	  
Insulin	   resistance,	   as	   the	   initiating	  defect	   in	   the	  pathogenesis	  of	  NAFLD	   (172),	  
was	   assayed	   alongside	   other	   implicated	   mediators	   such	   as	   tumour	   necrosis	  
factor-­‐alpha	   (TNF-­‐α)	   and	   interleukin-­‐6	   (IL-­‐6)	   (103).	   	   Consequent	   activation	   of	  
matrix	  producing	  cells	  and	  propagation	  of	  fibrogenesis	  can	  ensue.	  	  	  	  Therefore,	  
markers	   of	   hepatic	   fibrogenesis	   and	   indices	   of	   sympathetic	   nervous	   system	  
(SNS)	  activation,	  known	   to	   regulate	  hepatic	   fibrosis	   in	  NAFLD	   (138),	  were	  also	  
investigated.	  
	  
The	   aim	   in	   this	   current	   series	   of	   experiments	   was,	   therefore,	   to	   test	   the	  
hypothesis	   that	   maternal	   obesity	   in	   either	   gestation	   or	   lactation	   transmits	  
varying	  predispositions	  to	  offspring	  dysmetabolism	  and	  NAFLD	  in	  adulthood	  and	  




	   154	  
4.2	  Methods	  
	  
4.2.1	  Animal	  Experimentation	  	  
Female	   C57BL/6J	  mice	   (n	   =	   20	   per	   group)	   (Charles	   River	   Laboratories,	  UK),	   of	  
first	  order	  parity,	  approximately	  100	  days	  old	  were	  allowed	  7	  days	  to	  habituate	  
following	  transfer	  to	  the	  facility	  and	  fed	  standard	  chow	  RM1	  (7%	  simple	  sugars,	  
3%	   fat,	   50%	  polysaccharide,	   15%	  protein	   [w/w]	  RM1,	   Special	  Dietary	   Services,	  
energy	  3.5	  kcal/g)	  ad	  libitum.	  	  
	  
Following	   acclimatisation,	   the	   dams	   were	   randomised	   to	   either	   a	   control	   or	  
experimental	   group	   and	   fed	   standard	   chow	   or	   a	   semi-­‐synthetic	   energy-­‐rich,	  
highly	   palatable	   obesogenic	   diet	   	   (10%	   simple	   sugars,	   20%	   animal	   lard	   28%	  
polysaccharide,	  23%	  protein	   [w/w],	  Special	  Dietary	  Services,	  energy	  4.5	  kcal/g)	  
supplemented	  with	   sweetened	   condensed	  milk	   (approx	   55%	   simple	   sugar,	  8%	  
fat,	  8%	  protein,	  w/w,	  Nestle)	  admixed	  with	  mineral	  mix	  (AIN93G,	  Special	  Dietary	  
Services,	  125	  mg/pot)	  ad	  libitum.	  	  	  
	  
Dams	   were	   maintained	   on	   their	   respective	   diets	   for	   6-­‐8	   weeks	   and	   macro-­‐
nutrients	   and	   calorific	   intake	   were	   calculated	   from	   measured	   daily	   intake	   of	  
pellets	   and	   milk	   (approx	   16%	   fat,	   33%	   simple	   sugars,	   15%	   protein,	   energy	  
4.0kcal/g).	  	  Upon	  attainment	  of	  an	  average	  30%	  increase	  in	  body	  weight	  of	  the	  
experimental	  group,	  mice	  were	  entered	  into	  the	  breeding	  protocol.	  	  Males	  from	  
the	  same	   litter	  were	  selected	   to	  minimise	  genetic	  variability.	  All	  animals	  were	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treated	   in	   accordance	  with	   The	   Animals	   (Scientific	   Procedures)	   Act,	   UK,	   1986	  
guidelines.	  
	  
Day	   0	   of	   pregnancy	   was	   determined	   by	   formation	   of	   a	   vaginal	   plug.	   	   Dams	  
failing	   to	   become	   pregnant	   after	   development	   of	   a	   copulation	   plug	   were	  
allowed	   to	   re-­‐mate.	   	   	   Pregnant	  dams	  were	   continued	  on	   their	  pre-­‐conception	  
diets	  throughout	  pregnancy	  and	  lactation.	   	  During	  pregnancy,	  maternal	  weight	  
and	   dietary	   intake	   were	   recorded	   weekly.	   	   Dams	   were	   allowed	   to	   deliver	  
spontaneously	  and	  left	  undisturbed	  with	  their	  litters	  for	  48	  hours.	  	  
	  
All	  offspring	  (n	  =	  20)	  were	  weaned	  onto	  standard	  chow	  at	  3	  weeks	  postpartum.	  	  
A	   subgroup	   of	   offspring	   (n	   =	   5)	   born	   to	   lean	   dams	   were	   cross-­‐fostered	   and	  
suckled	  by	  obese	  dams	  (OffCon/Ob).	  	  Conversely,	  a	  subgroup	  of	  offspring	  (n	  =	  5)	  
born	  to	  obese	  dams	  were	  cross-­‐fostered	  and	  suckled	  by	  lean	  dams	  (OffOb/Con)	  
(Figure	  2.4).	  	  All	  readouts	  were	  compared	  to	  the	  control	  group,	  offspring	  of	  lean	  
suckled	   by	   lean	   dams	   (OffCon/Con).	   	   Offspring	   food	   intake	   and	   body	   weight	  
were	   measured	   weekly,	   biochemical	   analysis,	   markers	   of	   liver	   injury	   and	  
fibrogenesis	  and	  liver	  histology	  were	  determined	  at	  3	  months.	  
	  
4.2.2	  Offspring	  Calorific	  Intake	  and	  Body	  Weight	  
Pelleted	   food	   intake	   was	   measured	   weekly	   to	   assess	   calorific	   intake.	  	  
Bodyweight	  of	  offspring	  aged	  3	  months	  was	  measured	  prior	  to	  sacrificing	  using	  
a	   schedule-­‐1	  method.	   	  Weights	  were	   recorded	   using	   a	   balance	   accurate	   to	   4	  
decimal	  places.	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4.2.3	  Tissue	  Collection	  
Offspring	   liver	   tissue	   was	   differentially	   preserved	   for	   use	   in	   gene	   expression	  
analysis,	   protein	   and	   lipid	   extraction	   and	  histology.	   	   Briefly,	  whole	   liver	   tissue	  
was	   snap	   frozen	   in	   liquid	   nitrogen	   or	   dissected	   using	  middle	   orientation	   and	  
stored	  in	  10%	  neutral	  buffered	  formalin	  prior	  to	  paraffin	  embedding.	  	  Offspring	  
blood	  was	  collected	  via	  cardiac	  puncture	  or	  inferior	  vena	  cava	  cannulation	  using	  
heparinised	  syringes.	  	  The	  blood	  was	  centrifuged	  at	  3000	  x	  g	  for	  10	  minutes	  at	  
4˚C	  and	  decanted	  plasma	  stored	  at	  -­‐20˚C	  until	  biochemical	  analysis.	  	  	  
	  
4.2.4	  Serum	  Analysis	  
ELISAs	  were	  used	  for	  analysis	  of	  serum	  leptin	  (Biovender	  R&D	  1301)	  and	  insulin	  
(CrystalChem,	   Catalog	   #90080).	   	   Wide	   range	   assays	   were	   used	   for	   adequate	  




Remote	   radiotelemetric	   probes	   (TA11PA-­‐C10,	   O.D	   0.4	   mm,	   Data	   Science	  
International)	  were	  implanted	  under	  general	  anaesthetic	  (isofluorane	  in	  O2)	  and	  
an	   indwelling	   catheter	   was	   inserted	   into	   the	   left	   carotid	   artery.	   	   Following	  
recovery,	   offspring	   were	   subjected	   to	   30	   minutes	   restraint	   and	   120	   minutes	  
recovery	   during	   which	   time,	   the	   systolic	   blood	   pressure	   (SBP)	   was	   measured	  
and	  expressed	  as	  a	  change	  from	  baseline.	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4.2.6	  Liver	  Tissue	  Triglyceride	  
Whole	   liver	   tissue	   triglyceride	  was	   determined	   by	   an	   adaptation	   of	   the	   Folch	  
Method	   using	   an	   enzymatic	   colorimetric	   assay	   (UNIMATE	   5	   TRIG,	   Roche	   BC1.	  	  
Sussex,	  UK).	   	  Approximately	  0.05g	  of	   liver	   tissue	  per	   sample	  was	  used	  and	  all	  
results	  normalised	  to	  sample	  quantity.	  
	  
4.2.7	  Renal	  Catecholamines	  
Harvested	  kidneys	  were	  snap-­‐frozen	  and	  stored	  at	   -­‐80ºC.	  The	   left	  kidney	  from	  
each	   animal	   was	   homogenised	   on	   ice	   with	   0.1M	   hydrochloric	   acid	   (Sigma-­‐
Aldrich,	   UK)	   containing	   1mM	   EDTA	   (BDH	   Chemicals	   Ltd.,	   Poole,	   England)	   and	  
4mM	   sodium	  metabisulfite.	   Renal	   NE	   content	   was	   assessed	   by	   ELISA	   (ALPCO	  
Immunoassays,	  Salem,	  NH,	  USA)	  as	  per	  the	  manufacturer’s	  instructions.	  	  
	  
4.2.8	  Gene	  Expression	  of	  Liver	  Injury	  and	  Fibrogenic	  Markers	  
Semi-­‐quantitative	  reverse	  transcriptase	  polymerase	  chain	  reaction	  (RT-­‐PCR)	  was	  
performed	   using	   SuperScript™	   III	   One-­‐Step	   RT-­‐PCR	   System	   with	   Platinum®	  
Taq	  High	   Fidelity	   (Invitrogen	   Life	   Technologies).	   	   Gene	   specific	   primers	   were	  
designed	  for	  IL-­‐6,	  TNF-­‐α,	  adrenoceptor	  α1-­‐D	  and	  ß1,	  α–Smooth	  Muscle	  Actin	  (α-­‐
SMA)	  and	  collagen	  Type	  1-­‐α2	  (Col	  1-­‐α2)	  (Table	  2.3).	  Expression	  of	  target	  genes	  
was	  normalised	  to	  GAPDH	  expression.	  	  
	  
4.2.9	  Protein	  Expression	  of	  Fibrogenic	  Markers	  
Total	   liver	   protein	   was	   extracted	   in	   ice-­‐cold	   RIPA	   buffer	   (150nM	   sodium	  
chlorise,	   1%	   Triton-­‐X	   100,	   0.5%	   sodium	  deoxycholate,	   50mM	  Tris,	   pH	   8.0	   and	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0.1%	   SDS),	   lysate	   protein	   concentrations,	   determined	   using	   the	  
copper/bicinchoninic	   assay	   (Sigma),	   and	   standardised	   to	   2	   mg/ml	   by	   dilution	  
into	  Laemmli	  buffer.	   	  20μg	  total	  protein	  was	   loaded	  for	  SDS-­‐PAGE	  followed	  by	  
overnight	   incubation	  with	  antibody	  against	  ASMA	  (Sigma)	  and	  Collagen	  Type	  1	  
(Millipore).	  	  Protein	  expression	  was	  assessed	  densitometrically	  using	  AlphaEase	  
software	  (AlphaImager).	  	  
	  
4.2.10	  Liver	  Histology	  
Offspring	  liver	  sections	  at	  3	  months	  were	  formalin	  fixed	  and	  paraffin	  embedded	  
prior	  to	  sectioning.	  	  All	  sections	  were	  then	  stained	  with	  haematoxylin	  and	  eosin	  
(H&E)	   and	   assessed	   for	   steatosis,	   lobular	   inflammation	   and	   hepatocellular	  
ballooning	   according	   to	   the	   NAFLD	   Activity	   Score	   (NAS),	   by	   an	   expert	   liver	  
pathologist	  blinded	  to	  the	  identity	  of	  the	  groups	  (Table	  2.10).	  
	  
4.2.11	  Statistical	  Analysis	  
Multiple	   comparisons	   on	   a	   single	   data	   set	  were	   performed	   using	  ANOVA	   and	  
expressed	  as	  mean	  ±	  SEM	  unless	  otherwise	  stated.	   	  p	  <	  0.05	  was	   regarded	  as	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4.3	  Results	  
	  
4.3.1	   Offspring	   exposure	   to	   maternal	   obesity	   during	   lactation	   only	   induces	  
hyperphagia	  and	  adiposity	  at	  3	  months	  
Offspring	   exposed	   to	  maternal	   obesity	   during	   lactation	  only	  were	   significantly	  
heavier	   than	   offspring	   exposed	   to	   maternal	   obesity	   in	   utero	   or	   control	  
conditions	  (OffCon/Con;	  20.80	  ±	  0.46	  v.	  OffCon/Ob;	  23.85	  ±	  0.85	  v.	  OffOb/Con;	  
21.95	   ±	   0.47	   gm)	   at	   3	  months	   post-­‐partum.	   	   In	   corroboration	   of	   this,	   calorie	  
intake	   was	   significantly	   increased	   (p	   <	   0.001)	   in	   OffCon/Ob	   compared	   to	   all	  
other	   groups	   (OffCon/Con;	   73.01	   ±	   0.93	   v.	   OffCon/Ob;	   91.67	   ±	   0.98	   v.	  
OffOb/Con;	  69.20	  ±	  1.00	  kcal/g),	  as	  was	  serum	  leptin	  (OffCon/Con;	  1037	  ±	  43.12	  
v.	  OffCon/Ob;	  19334	  ±	  2231	  v.	  OffOb/Con;	  2448	  ±	  192.7	  pg/ml)	  (Figure	  4.1).	  	  	  
	  
Statistically	   significant	  hyperphagia	  and	  accompanying	  adiposity	  was	  observed	  
in	   offspring	   exposed	   to	   maternal	   obesity	   in	   lactation	   alone.	   	   Given	   that	   all	  
offspring	  were	  weaned	  on	  to	  a	  standard	  chow	  diet,	  the	  observed	  effects	  were	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Figure	   4.1	   Offspring	   Adiposity	   and	   Calorific	   Intake	   at	   3	   months:	   (A)	  
Bodyweight,	   (B)	   Calorific	   Intake	   and	   (C)	   Serum	   Leptin	   Concentrations.	  	  
Hyperphagia	   and	   adiposity	   was	   observed	   in	   offspring	   exposed	   to	   maternal	  
obesity	   in	   lactation	   only	   (OffCon/Ob).	   	   Offspring	   of	   lean	   suckled	   by	   lean	   -­‐	  
OffCon/Con;	   offspring	   of	   lean	   suckled	   by	   obese	   –	  OffCon/Ob	   and	   offspring	   of	  
obese	  suckled	  by	  lean	  –	  OffOb/Con.	  	  n	  =	  4-­‐6	  per	  group,	  values	  shown	  are	  mean	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4.3.2	   Offspring	   exposure	   to	   maternal	   obesity	   in	   lactation	   induces	   hyper-­‐
insulinaemia	  and	  hypertension	  at	  3	  months	  
Insulin	  levels	  were	  significantly	  raised	  in	  offspring	  exposed	  to	  maternal	  obesity	  
in	  lactation	  compared	  to	  those	  exposed	  to	  maternal	  obesity	  only	  in	  gestation	  or	  
to	   control	   conditions	   (OffCon/Con;	   0.15	   ±	   0.01	   v.	   OffCon/Ob;	   2.15	   ±	   0.09	   v.	  
OffOb/Con;	   0.42	   ±	   0.05	   μg/L).	   	   Similarly,	   the	   mean	   nocturnal	   systolic	   blood	  
pressure	  was	  raised	  in	  OffCon/Ob	  compared	  to	  all	  other	  groups,	  indicating	  that	  
the	   perturbed	   metabolic	   function	   was	   due	   to	   exposure	   of	   over-­‐nutrition	   in	  
lactation	  alone	  (Figure	  4.2).	  
	  
	  
Figure	  4.2	  Serum	  Insulin	  and	  SBP	  responses	  at	  3	  months:	  (A)	  Serum	  Insulin	  and	  
(B)	   Nocturnal	   Systolic	   Blood	   Pressure	   (SBP).	   	   Offspring	   exposed	   to	   maternal	  
obesity	  in	  lactation	  exhibited	  hyper-­‐insulinaemia	  and	  raised	  SNS	  tone	  compared	  
to	  OffOb/Con	  and	  OffCon/Con.	  	  Offspring	  of	  lean	  suckled	  by	  lean	  -­‐	  OffCon/Con;	  
offspring	  of	  lean	  suckled	  by	  obese	  –	  OffCon/Ob	  and	  offspring	  of	  obese	  suckled	  
by	  lean	  –	  OffOb/Con.	  	  n	  =	  4-­‐6	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM;	  *	  p	  <	  
0.05,	  **	  p	  <	  0.001,	  ***	  p	  <	  0.0001,	  one-­‐way	  ANOVA.	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4.3.3	   Offspring	   exposure	   to	   maternal	   obesity	   during	   lactation	   induces	  
profound	  hepatosteatosis	  at	  3	  months	  
Histological	   evidence	   of	   profound	   hepatic	   macrovesicular	   steatosis	   was	  
observed	  in	  offspring	  exposed	  to	  maternal	  obesity	  in	  lactation	  alone	  compared	  
to	  OffCon/Con	  and	  OffOb/Con	  at	  3	  months.	   	  Morphometrical	  quantification	  of	  
steatosis	  was	   performed	  on	  microphotographs	   from	  10	   random	   field	   sections	  
per	   liver,	   and	   corroborated	   the	   histological	   findings	   (OffCon/Con;	   0.0	   ±	   0.0	   v.	  
OffCon/Ob;	  1.8.	  ±	  0.26	  v.	  OffOb/Con;	  1.0	  ±	  0.45	  arbitrary	  units)	  (Figure	  4.3).	  	  	  
	  
In	   tandem,	   hepatic	   tissue	   triglyceride	   content	   was	   significantly	   increased	   in	  
OffCon/Ob	   compared	   to	   all	   other	   groups	   (OffCon/Con;	   4.76	   ±	   0.89	   v.	  
OffCon/Ob;	   28.76	   ±	   2.09	   v.	   OffOb/Con;	   3.41	   ±	   0.38	   mmol/l).	   	   Therefore	  
exposure	   to	   maternal	   obesity	   in	   lactation	   is	   more	   important	   in	   inducing	  
offspring	   hepatosteatosis	   than	   exposure	   to	  maternal	   obesity	   during	   gestation	  
(Figure	  4.3).	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Figure	   4.3	   Histological	   and	   Biochemical	   Evidence	   of	   Hepatosteatosis	   at	   3	  
months:	  (A)	  Representative	  H&E	  sections,	  (B)	  Hepatic	  Tissue	  Triglyceride	  and	  (C)	  
NAFLD	   Activity	   Score.	   	   Exposure	   to	  maternal	   obesity	   in	   lactation	   only,	   led	   to	  
profound	  hepatosteatosis	  compared	  to	  exposure	  in	  gestation	  alone	  or	  a	  normo-­‐
calorific	   environment	   throughout	   gestation	   and	   lactation.	   	   Offspring	   of	   lean	  
suckled	  by	   lean	  -­‐	  OffCon/Con;	  offspring	  of	   lean	  suckled	  by	  obese	  –	  OffCon/Ob	  
and	  offspring	  of	  obese	  suckled	  by	  lean	  –	  OffOb/Con.	  	  n	  =	  4-­‐6	  per	  group,	  values	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4.3.4	   Offspring	   exposure	   to	   maternal	   obesity	   in	   lactation	   induces	   profound	  
liver	  injury	  at	  3	  months	  
Serum	  aspartate	   transaminase	   (AST)	   (OffCon/Con;	   214.8	   ±	   21.0	   v.	  OffCon/Ob;	  
359.1	  ±	  9.6	  v.	  OffOb/Con;	  166.5	  ±	  23.7	  IU/L),	  IL-­‐6	  mRNA	  (OffCon/Con;	  2.8	  ±	  0.5	  
v.	   OffCon/Ob;	   18.1	   ±	   2.0	   v.	   OffOb/Con;	   4.4	   ±	   0.2	   arbitrary	   units)	   and	   TNF-­‐α	  
mRNA	  (OffCon/Con;	  25.2	  ±	  3.4	  v.	  OffCon/Ob;	  63.6	  ±	  8.2	  v.	  OffOb/Con;	  15.4	  v.	  
6.9	   arbitrary	   units),	   as	   putative	   markers	   of	   liver	   injury,	   were	   all	   raised	   in	  
offspring	   exposed	   to	   maternal	   obesity	   in	   lactation	   compared	   to	   offspring	  
exposed	   only	   in	   gestation	   or	   to	   control	   conditions.	   	   Therefore,	   exposure	   to	  
maternal	  obesity	  in	  lactation	  is	  more	  important	  in	  inducing	  offspring	  liver	  injury	  
than	  exposure	  to	  maternal	  obesity	  during	  gestation	  (Figure	  4.4).	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Figure	  4.4	  Biochemical	  Evidence	  of	  Liver	  Injury	  at	  3	  months:	  (A)	  Serum	  AST,	  (B)	  
mRNA	  TNF-­‐α	  and	  (C)	  mRNA	  IL-­‐6.	  	  Maternal	  obesity	  in	  lactation	  (OffCon/Ob)	  led	  
to	  an	  up-­‐regulation	  of	  hepatic	  pro-­‐inflammatory	  markers	  and	  AST.	  	  Offspring	  of	  
lean	   suckled	   by	   lean	   -­‐	   OffCon/Con;	   offspring	   of	   lean	   suckled	   by	   obese	   –	  
OffCon/Ob	   and	   offspring	   of	   obese	   suckled	   by	   lean	   –	  OffOb/Con.	   	   n	   =	   4-­‐6	   per	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4.3.5	   Offspring	   exposure	   to	   maternal	   obesity	   in	   lactation	   activates	   hepatic	  
fibrogenesis	  at	  3	  months	  
Offspring	  exposed	  to	  maternal	  obesity	  in	  lactation	  had	  significant	  up-­‐regulation	  
of	   α-­‐SMA	   gene	   expression,	   a	   marker	   of	   hepatic	   stellate	   cell	   activation	   –	   the	  
liver’s	  principal	  fibrogenic	  cells	  (OffCon/Con;	  72.4	  ±	  1.6	  v.	  OffCon/Ob;	  91.7	  ±	  2.8	  
v.	  OffOb/Con;	  52.6	  ±	  0.6	  arbitrary	  units).	  	  These	  observations	  were	  corroborated	  
at	  the	  protein	  level	  by	  Western	  Blot	  analysis,	  densitised	  to	  permit	  quantitative	  
analysis	  (OffCon/Con;	  37.2	  ±	  5.7	  v.	  OffCon/Ob;	  194.6	  ±	  15.8	  v.	  OffOb/Con;	  92.1	  
±	  7.4	  arbitrary	  units).	  	  	  
	  
In	   tandem,	   the	   relative	   expression	   of	   collagen	   1α2	   mRNA	   was	   also	   raised	   in	  
OffCon/Ob	  compared	  to	  all	  other	  groups	  (OffCon/Con;	  17.6	  ±	  1.9	  v.	  OffCon/Ob;	  
25.7	  ±	  3.9	  v.	  OffOb/Con;	  14.4	  ±	  0.9	  arbitrary	  units).	  	  This	  was	  also	  corroborated	  
at	   the	   protein	   level	   (OffCon/Con;	   13.0	   ±	   10.9	   v.	   OffCon/Ob;	   1029	   ±	   59.6	   v.	  
OffOb/Con;	  16.8	  ±	  3.4	  arbitrary	  units).	  	  Therefore,	  exposure	  to	  maternal	  obesity	  
in	   lactation	  has	   a	   significant	   effect	   on	  programming	  offspring	   susceptibility	   to	  
hepatic	  fibrogenesis	  in	  the	  context	  of	  NAFLD	  (Figure	  4.5).	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Figure	  4.5	  Biochemical	  Evidence	  of	  Liver	  Fibrogenesis	  at	  3	  months:	  (A)	  α-­‐SMA	  
mRNA,	   (B)	   Collagen	   type	  1	  mRNA,	   (C)	  α-­‐SMA	  protein	   and	   (D)	   Collagen	   type	  1	  
protein.	  	  Maternal	  obesity	  in	  lactation	  (OffCon/Ob)	  led	  to	  up-­‐regulation	  of	  pro-­‐
fibrogenic	   markers	   at	   the	   mRNA	   and	   protein	   levels	   compared	   to	   all	   other	  
groups.	   	   Offspring	   of	   lean	   suckled	   by	   lean	   -­‐	   OffCon/Con;	   offspring	   of	   lean	  
suckled	   by	   obese	   –	   OffCon/Ob	   and	   offspring	   of	   obese	   suckled	   by	   lean	   –	  
OffOb/Con.	  	  n	  =	  4-­‐6	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM;	  *	  p	  <	  0.05,	  **	  p	  <	  
0.001,	  ***	  p	  <	  0.0001,	  one-­‐way	  ANOVA.	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4.3.6	   Offspring	   exposure	   to	   maternal	   obesity	   in	   lactation	   induces	   SNS	  
activation	  at	  3	  months	  
Offspring	  exposure	  to	  maternal	  obesity	  only	  in	  lactation	  led	  to	  up-­‐regulation	  of	  
hepatic	   α-­‐1D	   (OffCon/Con;	   0.063	   ±	   0.002	   v.	   OffCon/Ob;	   0.138	   ±	   0.016	   v.	  
OffOb/Con;	  0.065	  ±	  0.010	  arbitrary	  units)	  and	  β-­‐1	  (OffCon/Con;	  0.0022	  ±	  0.0002	  
v.	  OffCon/Ob;	  0.0032	  ±	  0.0004	   v.	  OffOb/Con;	   0.0010	  ±	  0.0001	  arbitrary	  units)	  
SNS	   adrenoreceptors	   in	   the	   liver	   compared	   to	   those	   offspring	   exposed	   to	  
maternal	   obesity	   only	   in	   gestation	   or	   control	   conditions.	   	   In	   tandem,	   renal	  
catecholamine	  content	  was	  raised	  (Figure	  4.6).	   	  As	  SNS	  activation	   is	  a	  putative	  
driver	   of	   hepatic	   fibrogenesis,	   these	   findings	   are	   in	   keeping	   with	   gene	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Figure	  4.6	  Liver	  Adrenoreceptor	  Expression	  and	  Renal	  Catecholamine	  Content	  
at	  3	  months:	  (A)	  Liver	  adrenoreceptor	  α-­‐1D	  mRNA,	  (B)	  Liver	  adrenoreceptor	  β-­‐1	  
mRNA	  and	  (C)	  Renal	  NE.	  	  All	  markers	  of	  SNS	  activation	  were	  significantly	  raised	  
in	  OffCon/Ob.	  	  Offspring	  of	  lean	  suckled	  by	  lean	  -­‐	  OffCon/Con;	  offspring	  of	  lean	  
suckled	   by	   obese	   –	   OffCon/Ob	   and	   offspring	   of	   obese	   suckled	   by	   lean	   –	  
OffOb/Con.	  	  n	  =	  4-­‐6	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM;	  *	  p	  <	  0.05,	  **	  p	  <	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4.4	  Discussion	  
	  
It	   was	   described	   in	   Chapter	   3	   that	   offspring	   exposure	   to	   maternal	   obesity,	  
throughout	  gestation	  and	   lactation,	   (compared	   to	  exposure	   to	  a	  normal	   intra-­‐
uterine	  and	  peri-­‐natal	  environment),	  induced	  dysmetabolism	  and	  hepatic	  injury	  
in	   the	   form	   of	   NAFLD.	   	   It	   has	   since	   been	   shown	   that	   offspring	   exposure	   to	  
maternal	   over-­‐nutrition	   during	   gestation	   and	   lactation	   programs	   NAFLD	   (64,	  
180).	   	   To	   determine	   the	   period	   of	   development	   most	   responsible	   for	   the	  
observed	  phenotype,	  we	  engendered	  a	  cross-­‐fostering	  protocol,	  which	  involved	  
the	  switching	  of	  offspring	  born	  to	  lean	  dams	  to	  obese	  dams	  to	  suckle	  and	  vice	  
versa.	  
	  
These	  current	  studies	  show	  that	  offspring	  exposure	  to	  maternal	  obesity	  only	  in	  
lactation	  more	  aggressively	  programs	  insulin	  and	  leptin	  resistance,	  marked	  liver	  
injury,	  raised	  SNS	  tone	  and	  induction	  of	  liver	  fibrogenesis	  compared	  to	  exposure	  
during	   gestation.	   	   	   So,	   therefore	   it	   may	   be	   suggested	   that	   the	   most	   critical	  
period	  of	  development	  responsible	  for	  the	  observed	  programmed	  phenotype	  in	  
offspring	  of	  obese	  dams	  is	  the	  immediate	  post-­‐partum	  period.	  
	  
4.4.1	  Offspring	  Adiposity	  and	  Calorific	  Intake	  
Offspring	   exposure	   to	  maternal	   obesity	   in	   lactation	   programmed	   hyperphagia	  
resulting	   in	   increased	   bodyweight.	   	   That	   our	   experimental	   protocol	   involved	  
weaning	  all	  offspring	  onto	  standard	  chow	  ensured	  that	  any	  phenotypic	  changes	  
were	  the	  result	  of	  maternal	  nutritional	  differences	  during	  gestation	  or	  lactation	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only	  and	  any	  increases	  in	  food	  intake	  were	  the	  result	  of	  differential	  appetite	  and	  
not	   food	  palatability.	   	   The	   importance	  of	   assessing	   the	   energy	   content	   of	   the	  
offered	  diet	  is	  highlighted	  by	  the	  fact	  that	  maternal	  obesity	  per	  se,	  may	  not	  be	  
the	   only	   determinant	   of	   programmed	   NAFLD,	   as	   a	   high	   calorie	   intake	   during	  
pregnancy	   independent	   of	   maternal	   obesity	   may	   also	   be	   involved	   in	  
programming	  hepatic	  injury	  as	  recently	  shown	  in	  non-­‐human	  primates	  (27).	  	  
	  
4.4.2	  Offspring	  Liver	  Injury	  
The	  current	  paradigm	  for	  the	  pathogenesis	  of	  NAFLD,	  invokes	  insulin	  resistance	  
as	  the	  primary	  driver	  for	  steatosis	   in	  the	  livers	  of	  obese	  individuals	  (172),	  with	  
IL-­‐6	  and	  TNF-­‐α	  involved	  in	  the	  inflammatory	  responses	  (174).	  	  More	  specifically,	  
TNF-­‐α	  propagates	  hepatic	  inflammation	  and	  injury	  by	  impairing	  redox	  reactions	  
within	  the	  electron	  transport	  chain,	  allowing	  the	  accumulation	  of	  more	  reactive	  
oxygen	  species.	  	  	  	  	  
	  
Increased	  expression	  of	  TNF-­‐α	  and	  IL-­‐6	  were	  observed	  in	  the	  context	  of	  hyper-­‐
insulinaemia	   in	   offspring	   exposed	   to	   maternal	   obesity	   in	   lactation	   alone	  
compared	   to	   those	   exposed	   in	   gestation	   or	   not	   at	   all.	   	   Additionally,	   the	   liver	  
enzyme,	   aspartate	   aminotransferase,	   was	   significantly	   raised	   in	   offspring	  
exposed	   to	   maternal	   obesity	   in	   lactation	   compared	   to	   gestation.	   	   Therefore,	  
profound	   liver	   injury	   is	   observed	   in	   offspring	   adversely	   exposed	   to	   maternal	  
over-­‐nutrition	  in	  the	  immediate	  post-­‐partum	  period.	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4.4.3	  Offspring	  Hepatosteatosis	  
Here,	  hepatic	  tissue	  triglyceride	  content	  was	   increased	   in	  offspring	  exposed	  to	  
maternal	  obesity	  during	  lactation	  compared	  to	  gestation	  or	  control.	   	  There	  are	  
two	  mechanistic	  pathways	  responsible	  for	  hepatocellular	  steatosis,	  initiated	  by	  
insulin	   resistance.	   	   Firstly,	   lipolysis	   increases	   the	   concentration	   of	   free	   fatty	  
acids	   which	   are	   removed	   from	   the	   circulation	   by	   hepatocytes.	   	   The	  
mitochondrial	  ß-­‐oxidation	  pathway	  consequently	  becomes	  saturated	  leading	  to	  
accumulation	   of	   triglycerides	   in	   the	   liver.	   	   Fatty	   acids	   are	   inducers	   and	  
substrates	   of	   microsomal	   lipooxygenases	   which	   may	   evoke	   production	   of	  
reactive	   oxygen	   species.	   	   These	   free	   radicals	   can	   induce	   lipid	   peroxidation	   of	  
hepatocyte	   membranes.	   	   The	   second	   pathway	   is	   governed	   by	   hyper-­‐
insulinemia,	  which	  has	  been	  observed	  in	  offspring	  exposed	  to	  maternal	  obesity	  
in	   lactation.	   	   Subsequent	   promotion	   of	   glycolysis	   increases	   hepatic	   fatty	   acid	  
synthesis	   and	   diminishes	   hepatic	   production	   of	   apolipoprotein	   B-­‐100	  which	   is	  
required	  for	  the	  incorporation	  of	  triglycerides	  into	  very	  low	  density	  lipoproteins	  
(VLDLs)	  (103).	  	  	  	  
	  
Present	   findings	   of	   increased	   hepatic	   tissue	   triglyceride	   content	   in	   offspring	  
exposed	   to	   maternal	   obesity	   in	   lactation	   were	   corroborated	   by	   histological	  
assessment	   of	   steatosis	   using	   H&E	   staining	   and	   morphometric	   analysis.	   	   The	  
gold	   standard	   technique	   employed	   in	   the	   diagnosis	   of	   NAFLD	   is	   histological	  
evaluation	  secondary	  to	  liver	  biopsy.	  	  	  	  A	  fundamental	  assessment	  criterion	  for	  
the	  inference	  of	  NAFLD	  is	  steatosis	  (184).	  	  	  	  Its	  manifestation	  is	  typically	  macro-­‐
vesicular	   and	   it	   frequently	   leads	   to	   hepatic	   injury	   with	   accumulation	   of	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inflammatory	  cells	  (185).	  	  It	  is	  therefore,	  not	  surprising	  that	  the	  markers	  of	  liver	  
injury,	  IL-­‐6	  and	  TNF-­‐α,	  are	  too	  up-­‐regulated	  in	  offspring	  livers	  with	  evident	  fatty	  
infiltration.	  	  	  	  	  
	  
	  
4.4.4	  Offspring	  Liver	  Fibrogenesis	  
Hepatic	  fibrogenesis	  is	  a	  consequence	  of	  hepatic	  injury	  which	  if	  unhindered,	  as	  
occurs	  with	  persistent	  injury	  in	  NAFLD,	  may	  lead	  to	  cirrhosis.	  	  Fibrogenesis	  is	  the	  
result	  of	  over-­‐exuberant	  production	  and	  deposition	  of	  matrix	  proteins	  secreted	  
by	   injury	   activated	   hepatic	   stellate	   cells	   (HSCs),	   a	   phenotype	   characterised	   by	  
abundant	   expression	   of	   α-­‐SMA	   and	   collagen	   type-­‐1,	   the	   predominant	   matrix	  
constituent	  in	  fibrosis	  (186).	  	  α-­‐SMA	  is	  expressed	  by	  activated	  HSCs	  and	  as	  such	  
is	   considered	   a	   hallmark	   of	   hepatic	   injury	   or	   fibrogenesis	   (115).	   	   It	   has	   been	  
shown	   here	   that	   the	   relative	   expression	   of	   α-­‐SMA	   both	   at	   the	   mRNA	   and	  
protein	  level,	  are	  significantly	  raised	  in	  offspring	  exposed	  to	  maternal	  obesity	  in	  
lactation.	   Additionally,	   gene	   and	   protein	   expression	   of	   collagen	   type	   1	   was	  
subsequently	  up-­‐regulated	  in	  offspring	  exposed	  to	  maternal	  obesity	  in	  lactation.	  	  	  
	  
SNS	   signalling	   components	   have	   been	   implicated	   in	   hepatic	   fibrogenesis	  
mediated	   by	   adrenoreceptor	   expressing	   HSCs	   (138,	   140,	   187)	   expressing	  
adrenoreceptors.	   	   Given	   that	   hypertension,	   a	   component	   of	   the	   metabolic	  
syndrome,	   is	   reflective	   of	   SNS	   over-­‐activity	   (35)	   and	   shown	   to	   be	   present	   in	  
these	  offspring,	  changes	   in	  SNS	  signalling	  components	  were	   investigated.	   	  The	  
results	   showed	   that	   exposure	   to	   maternal	   obesity	   in	   lactation	   induces	   SNS	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activation	  in	  offspring	  as	  evidenced	  by	  raised	  systolic	  blood	  pressure,	  increased	  
hepatic	  expression	  of	  adrenoreceptors	  and	  renal	  catecholamine	  content.	  	   	  This	  
may	   in	   part,	   therefore,	   be	   responsible	   for	   the	   observed	   pro-­‐fibrogenic	  
phenotype	  as	  evidenced	  by	  up-­‐regulation	  of	  α-­‐SMA	  and	  collagen.	  	  
	  
4.4.5	  Offspring	  Hyper-­‐leptinaemia	  
Leptin	  is	  similarly	  implicated	  in	  fibrogenesis	  through	  its	  activation	  of	  HSCs,	  since	  
animals	  lacking	  leptin	  are	  poorly	  fibrogenic	  (138,	  187,	  188).	  	  Fibrogenic	  HSCs	  in	  
these	   leptin	   deficient	   animals	   do	   however,	   respond	   to	   catecholamine	  
neurotransmitters	  which	   are	   known	   to	   be	   released	   by	   leptin	   from	   adipocytes	  
and	  HSCs	   themselves	   (138,	   187).	   The	  observed	  hyper-­‐leptinaemia	   in	   offspring	  
exposed	  to	  a	  hyper-­‐calorific	  diet	   in	  the	  post-­‐partum	  period,	  may	  be	  secondary	  
to	  the	  described	  hyper-­‐insulinaemic	  state,	  since	  insulin	  can	  induce	  adipocytes	  to	  
secrete	  leptin	  via	  an	  adipoinsular	  axis	  (189).	  	  Alternatively	  or	  additionally,	  raised	  
adult	   leptin	   levels	  may	  have	  been	   induced	  by	   the	  heightened	  norepinephrine,	  
which	  has	  been	  shown	  to	  induce	  the	  release	  of	  leptin	  in	  adipocytes	  (190).	  
	   	  
4.4.6	  Relative	  Contributions	  of	  the	  in	  utero	  and	  lactation	  periods	  
The	   more	   robust	   dysmetabolic	   and	   NAFLD	   phenotype	   observed	   in	   offspring	  
exposed	   to	   an	   adverse	   ex	   utero	   environment	   only,	   confirms	   the	   relative	  
predominance	   of	   this	   period	   in	   programming	   offspring	   NAFLD.	   	   However,	  
offspring	   exposure	   to	   an	   adverse	   in	   utero	   environment	   only	   had	   negligible	  
effects	   on	   hepatic	   outcome,	   suggesting	   that	   exposure	   during	   this	   period	  
initiates	  protective	  adaptive	  mechanisms	  in	  preparation	  for	  a	  similar	  post-­‐natal	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environment	  as	  a	   survival	   advantage	   (157,	  191).	   	   Evidence	  of	   such	  adaptation	  
has	   been	   reported	   for	   endothelial	   function	   which	   is	   preserved	   in	   rodent	  
offspring	   exposed	   to	   maternal	   over-­‐nutrition,	   although	   hypertension	   ensued	  
(191).	  	  	  
	  
Consequently,	  those	  offspring	  exposed	  to	  an	  adverse	  ex	  utero	  environment	  only	  
are	  more	  vulnerable	  to	  the	  post-­‐natal	  hyper-­‐calorific	  environment	  and	  respond	  
with	  an	  enhanced	  dysmetabolic	  and	  liver	  phenotype.	  	  These	  findings	  moreover,	  
confirm	  that	  development	  of	  the	  dysmetabolic	  and	  NAFLD	  phenotype	  is	  largely	  
driven	   by	   exposure	   to	   maternal	   obesity	   in	   the	   post-­‐partum	   period	   with	  
maternal	  breast	  milk	  factors	  being	  possible	  candidates	  inducing	  this	  phenotype.	  	  
	  
4.4.7	  A	  Novel	  Experimental	  Model	  of	  NAFLD	  
A	  derivative	  of	  this	  study	  is	  the	  creation	  of	  a	  near	  complete	  pathophysiologically	  
relevant	   model	   of	   NAFLD	   as	   it	   demonstrates	   features	   of	   the	   human	   disease	  
which	  all	  current	  available	  experimental	  models	  lack	  (192).	  	  The	  model	  created	  
here	   has	   biochemical	   evidence	   of	   liver	   injury,	   biochemical	   and	   histological	  
evidence	   of	   steatosis,	   hyper-­‐leptinaemia,	   hyper-­‐insulinaemia,	   hypertension,	  
raised	  inflammatory	  cytokines	  and	  induction	  of	  fibrogenesis	  -­‐	  with	  activation	  of	  
the	   SNS	   and	   up-­‐regulation	   of	   its	   signalling	   components.	   	   The	   creation	   of	   this	  
model	  may	  aid	  further	  studies	  in	  NAFLD	  including	  drug	  discovery	  for	  treatment	  
of	  NAFLD	   induced	  fibrosis.	   	  The	  findings	  here	  are	  especially	   relevant	  given	  the	  
rising	   rates	   of	   maternal	   obesity	   and	   increasing	   prevalence	   of	   adult	   and	  
paediatric	  NAFLD	  (6,	  155).	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4.4.8	  Effects	  of	  cross-­‐fostering	  on	  offspring	  phenotype	  
There	  is	  however,	  a	  fundamental	  criticism	  of	  the	  series	  of	  experiments	  involving	  
cross-­‐fostering	  of	  offspring	  born	  to	  lean	  dams	  for	  obese	  dams	  to	  suckle	  and	  vice	  
versa,	   which	   is	   that	   this	   practice	   is	   non-­‐physiological.	   	   Moreover,	   there	   is	  
emerging	   experimental	   evidence	   indicating	   that	   cross-­‐fostering	   can	   induce	   a	  
permanent	   state	   of	   anxiety	   in	   mice	   as	   well	   as	   alter	   genetic	   and	   epigenetic	  
effects	   on	   complex	   traits	   (193).	   	   Additionally,	   the	   stress	   of	   cross-­‐fostering	  
cannot	  be	  controlled	  for	  by	  fostering	  litters	  as	  studies	  in	  both	  mice	  and	  piglets	  
demonstrate	  variable	  levels	  of	  distress	  in	  resident	  and	  fostered	  offspring	  (194).	  	  	  
	  
However,	   for	   the	   purposes	   of	   investigating	   the	   aetiopathogenesis	   of	   NAFLD	  
programmed	   by	   maternal	   obesity,	   the	   present	   experimental	   paradigm	   is	  
preferred	   as	   it	   allows	   a	   dissection	   of	   the	   gestation	   and	   lactation	   periods.	  	  
Through	   these	   studies,	   it	   is	   shown	   that	   the	   critical	  period	  most	   susceptible	   to	  
programming	   effects	   in	   rodents	   is	   lactation.	   	   Caution	   has	   to	   be	   exercised	  
however,	   in	  extrapolating	   these	   findings	   to	  humans	  given	   that	   this	   immediate	  
post-­‐partum	   period	   is	   of	   developmental	   equivalence	   to	   late	   gestation	   in	  




In	   conclusion,	   exposure	   to	   maternal	   obesity	   during	   gestation	   and	   lactation	  
programs	   dysmetabolism	   and	   hepatic	   injury,	   with	   the	   most	   critical	   period	   of	  
offspring	   susceptibility	   to	   programming	   effects	   by	   maternal	   obesity	   being	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lactation.	  	  This	  may	  be	  because	  maturation	  of	  the	  neuroendocrine	  system,	  HPA	  
axis,	  hepatocyte	  differentiation	  and	  hepatic	  maturation	  predominantly	  occur	  at	  
this	  time	  (32,	  195).	  	  
	  
Given	   the	   inherent	   non-­‐physiological	   nature	   of	   the	   cross-­‐fostering	   studies	  
above,	   the	   next	   series	   of	   experiments	   will	   investigate	   the	   role	   of	   maternal	  
obesity	  on	  offspring	  development	  of	  dysmetabolism	  and	  NAFLD	  using	  a	  wholly	  
physiologically	  relevant	  model.	  	  In	  these	  subsequent	  experiments,	  offspring	  will	  
not	  be	  cross-­‐fostered	  post-­‐partum	  but	  be	  maintained	  on	  their	  pre-­‐weaning	  diet	  
in	  to	  adulthood	  to	  permit	  validation	  of	  previous	  findings	  and	  allow	  investigation	  
of	  the	  interactions	  between	  the	  environments	  in	  gestation,	  lactation	  and	  post-­‐






























5	  Investigation	  of	  Dysmetabolism	  and	  
NAFLD	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  Exposed	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Maternal	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5	  Investigation	  of	  dysmetabolism	  and	  NAFLD	  in	  offspring	  exposed	  to	  maternal	  
obesity	   in	   the	   context	   of	   a	   post-­‐weaning	   hyper-­‐calorific	   environment	   –	   A	  




A	  growing	  body	  of	  evidence	  suggests	  that	  the	  rising	  rates	  of	  non-­‐alcoholic	  fatty	  
liver	   disease,	   NAFLD,	   may	   be	   partially	   attributable	   to	   the	   developmental	  
programming	  effect	  of	  maternal	  obesity	  (51,	  64,	  180).	  	  This	  is	  unsurprising	  given	  
that	  NAFLD	   is	   the	  hepatic	  manifestation	  of	   the	  metabolic	   syndrome,	  which	   in	  
turn	  has	  been	  shown	  to	  be	  programmable	  following	  exposure	  to	  maternal	  over-­‐
nutrition	  (5,	  20,	  22,	  23,	  37,	  39).	  	  Programming,	  therefore,	  is	  a	  fundamental	  risk	  
factor	  as	  obesity	  amongst	  women	  of	  reproductive	  age	  (20-­‐39	  years)	  is	  presently	  
31.5%,	  rising	  in	  tandem	  with	  NAFLD	  prevalence	  of	  23-­‐34%	  in	  the	  US	  (6,	  155).	  
	  
Standard	  rodent	  models	  of	  programming	   involve	  dams	  fed	  an	  obesogenic	  diet	  
throughout	  the	  gestation	  and	  lactation	  period.	  	  Readouts	  in	  offspring,	  therefore,	  
are	   a	   reflection	   of	   the	   interaction	   between	   both	   developmental	   periods.	  	  
However,	   by	   cross-­‐fostering	   offspring	   initially	   born	   to	   obese	   dams,	   with	   lean	  
dams	   in	   the	   post-­‐partum	   suckling	   period,	   and	   vice	   versa,	   one	   is	   able	   to	  
investigate	  the	  role	  of	  the	  in	  utero	  environment,	  independent	  of	  the	  immediate	  
post-­‐natal	   period	   as	   in	   Chapter	   4.	   	   In	   order	   to	   delineate	   the	   influences	   of	  
maternal	   over-­‐nutrition	   in	   these	   developmental	   periods,	   all	   offspring	   were	  
weaned	   on	   to	   a	   normal	   chow	   diet.	   	   Arguably,	   this	   is	   of	   limited	   physiological	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relevance	   as	   offspring	   exposed	   to	   maternal	   diet	   induced	   obesity	   during	  
development	  are	   likely	   to	  be	  nurtured	   in	  a	  similar	  hyper-­‐calorific	  environment	  
post-­‐partum.	   	   Therefore,	   it	   is	   necessary	   to	   investigate	   the	   interaction	   of	   the	  
programmed	  phenotype	  with	  a	  post-­‐weaning	  hyper-­‐calorific	  diet.	  
	  
There	   are	   studies	   demonstrating	   accelerated	   adiposity	   and	   weight	   gain	   in	  
offspring	  born	  to	  obese	  dams	  and	  maintained	  on	  an	  obesogenic	  diet,	  both	  post-­‐
weaning	  and	  throughout	  post-­‐natal	  life.	  	  These	  findings	  are	  met	  with	  reports	  of	  
hyperphagia	   in	   rodents	   exposed	   to	   a	   continued	   adverse	   environment	   post-­‐
partum,	  compared	  to	  control	  offspring	  or	  those	  exposed	  only	  during	  gestation	  
and/or	   lactation	   (55).	   	   It	   can,	   therefore,	   be	   suggested	   that	   the	   effects	   of	  
programming	   interact	   with	   the	   post-­‐natal	   diet,	   and	   not	   only	   the	   immediate	  
post-­‐partum	   period	   to	   influence	   offspring	   risk	   of	   obesity,	   dysmetabolism	   and	  
potentially	  NAFLD	  in	  adulthood.	  
	  
As	  the	  initiating	  defect	  in	  the	  pathogenesis	  of	  NAFLD	  is	  insulin	  resistance	  (172)	  
and	   implicated	   factors	   include	   tumour	   necrosis	   factor-­‐alpha	   (TNF-­‐α)	   and	  
interleukin-­‐6	   (IL-­‐6)	   (103),	   these	  mediators	  were	   assayed	   alongside	  markers	   of	  
hepatic	  fibrogenesis.	  
	  
Here,	   the	   aims	   were	   to	   investigate	   the	   interactions,	   if	   any,	   between	  
programmed	  dysmetabolism	  and	  NAFLD	  by	  maternal	  diet	  induced	  obesity,	  and	  
a	  post-­‐weaning	  hyper-­‐calorific	  diet	  in	  early	  and	  late	  adulthood.	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5.2	  Methods	  
5.2.1	  Animal	  Experimentation	  
Female	   C57BL/6J	  mice	   (n	   =	   20	   per	   group)	   (Charles	   River	   Laboratories,	  UK),	   of	  
first	  order	  parity,	  approximately	  100	  days	  old	  were	  allowed	  7	  days	  to	  habituate	  
following	  transfer	  to	  the	  facility	  and	  fed	  standard	  chow	  RM1	  (7%	  simple	  sugars,	  
3%	   fat,	   50%	  polysaccharide,	   15%	  protein	   [w/w]	  RM1,	   Special	  Dietary	   Services,	  
energy	  3.5	  kcal/g)	  ad	  libitum.	  
	  
Following	  acclimatisation,	  female	  mice	  were	  randomised	  to	  either	  a	  control	  or	  
experimental	   group	   and	   fed	   standard	   chow	   or	   a	   semi-­‐synthetic	   energy-­‐rich,	  
highly	   palatable	   obesogenic	   diet	   	   (10%	   simple	   sugars,	   20%	   animal	   lard	   28%	  
polysaccharide,	  23%	  protein	   [w/w],	  Special	  Dietary	  Services,	  energy	  4.5	  kcal/g)	  
supplemented	  with	   sweetened	   condensed	  milk	   (approx	   55%	   simple	   sugar,	  8%	  
fat,	  8%	  protein,	  w/w,	  Nestle)	  admixed	  with	  mineral	  mix	  (AIN93G,	  Special	  Dietary	  
Services,	  125	  mg/pot)	  ad	  libitum.	  
	  
Dams	   were	   maintained	   on	   their	   respective	   diets	   for	   6-­‐8	   weeks	   and	  
macronutrient	  and	  calorific	   intake	  were	  calculated	  from	  measured	  daily	   intake	  
of	   pellets	   and	  milk	   (approx	   16%	   fat,	   33%	   simple	   sugars,	   15%	   protein,	   energy	  
4.0kcal/g).	  	  Upon	  attainment	  of	  an	  average	  30%	  increase	  in	  body	  weight	  of	  the	  
experimental	  group,	  mice	  were	  entered	  into	  the	  breeding	  protocol.	  	  Males	  from	  
the	  same	   litter	  were	  selected	   to	  minimise	  genetic	  variability.	  All	  animals	  were	  
treated	   in	   accordance	  with	   The	   Animals	   (Scientific	   Procedures)	   Act,	   UK,	   1986	  
guidelines.	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Day	  0	  of	  pregnancy	  was	  confirmed	  by	  formation	  of	  a	  vaginal	  plug.	  	  Dams	  failing	  
to	  become	  pregnant	  after	  development	  of	  a	  copulation	  plug	  were	  allowed	  to	  re-­‐
mate.	   	   	   Pregnant	   dams	   were	   continued	   on	   their	   pre-­‐conception	   diets	  
throughout	   pregnancy	   and	   lactation.	   	  During	   pregnancy,	  maternal	  weight	   and	  
dietary	   intake	   were	   recorded	   weekly.	   	   Dams	   were	   allowed	   to	   deliver	  
spontaneously	  and	  left	  undisturbed	  with	  their	  litters	  for	  48	  hours.	  
	  
Subgroups	   of	   female	   offspring	   (n	   =	   20)	   born	   to	   and	   suckled	   by	   lean	   dams	   or	  
born	  to	  and	  suckled	  by	  obese	  dams	  were	  weaned	  on	  to	  either	  normo-­‐calorific	  
or	   semi	   synthetic	   obesogenic	   diet	   without	   condensed	   milk	   supplementation	  
(Figure	   2.5).	   	   This	   is	   different	   to	   previously	   used	  models	   as	   all	   offspring	  were	  
weaned	  on	  to	  only	  a	  standard	  chow	  diet.	   	  All	   readouts	  were	  compared	  to	   the	  
control	   group,	   offspring	   of	   lean	   suckled	   by	   lean	   dams	   and	   weaned	   onto	  
standard	  chow	  (OffCon-­‐SC).	   	  Offspring	  body	  weight,	   fat	  pad	  mass,	  biochemical	  
analysis,	   markers	   of	   liver	   injury	   and	   fibrogenesis	   and	   liver	   histology	   were	  
determined	  at	  3	  and	  12	  months.	  
	  
5.2.2	  Body	  Weight	  and	  Inguinal	  Fat	  Pad	  Mass	  
Offspring	   bodyweight	   was	   measured	   prior	   to	   sacrificing	   using	   a	   schedule-­‐1	  
method.	   	   Inguinal	  fat	  pads	  were	  excised	  and	  weights	  recorded	  using	  a	  balance	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5.2.3	  Tissue	  Collection	  
Offspring	   liver	   tissue	   was	   differentially	   preserved	   for	   use	   in	   gene	   expression	  
analysis,	   protein	   and	   lipid	   extraction	   and	  histology.	   	   Briefly,	  whole	   liver	   tissue	  
was	   snap	   frozen	   in	   liquid	   nitrogen,	   preserved	   in	   RNAlater	   or	   dissected	   using	  
middle	  orientation	  and	  stored	  in	  10%	  neutral	  buffered	  formalin	  prior	  to	  paraffin	  
embedding.	  	  Offspring	  blood	  was	  collected	  via	  cardiac	  puncture	  or	  inferior	  vena	  
cava	  cannulation	  using	  heparinised	  syringes.	  	  The	  blood	  was	  centrifuged	  at	  3000	  
x	  g	  for	  10	  minutes	  at	  4˚C	  and	  decanted	  plasma	  stored	  at	  -­‐20˚C	  until	  biochemical	  
analysis.	  
	  
5.2.4	  Serum	  Analysis	  
ELISA	  was	  used	  for	  analysis	  of	  serum	  leptin	  (Biovender	  R&D	  1301).	  	  Wide	  range	  
assays	  were	  used	  for	  adequate	  detection.	  	  Alanine	  transaminase	  was	  measured	  
by	  the	  local	  clinical	  biochemistry	  department.	  
	  
5.2.5	  Liver	  Tissue	  Triglyceride	  
Whole	   liver	   tissue	   triglyceride	  was	   determined	   by	   an	   adaptation	   of	   the	   Folch	  
Method	   using	   an	   enzymatic	   colorimetric	   assay	   (UNIMATE	   5	   TRIG,	   Roche	   BC1.	  	  
Sussex,	  UK).	   	  Approximately	  0.05g	  of	   liver	   tissue	  per	   sample	  was	  used	  and	  all	  
results	  normalised	  to	  sample	  quantity.	  
	  
5.2.6	  Gene	  Expression	  of	  Liver	  Injury	  and	  Fibrogenic	  Markers	  
Real	  Time	  Polymerase	  Chain	  Reaction	  (RT-­‐PCR)	  was	  performed	  using	  QuantiTect	  
SYBR	   Green	   PCR	   System	   with	   HotStar	   Taq	   DNA	   Polymerase	   (Qiagen).	   	   Gene	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specific	   primers	   were	   designed	   for	   IL-­‐6,	   TNF-­‐α,	   α–Smooth	   Muscle	   Actin	   (α-­‐
SMA),	  transforming	  growth	  factor-­‐β	  (TGF-­‐β)	  and	  collagen	  Type	  1-­‐α2	  (Col	  1-­‐α2).	  
Expression	  of	  target	  genes	  was	  normalised	  to	  GAPDH	  expression.	  
	  
5.2.7	  Liver	  Histology	  
Offspring	   liver	   sections	   at	   3	   and	   12	  months	   were	   formalin	   fixed	   and	   paraffin	  
embedded	   prior	   to	   sectioning.	   	   All	   sections	   were	   then	   stained	   with	  
haematoxylin	   and	   eosin	   (H&E)	   and	   Masson’s	   Trichrome	   and	   assessed	   for	  
steatosis	  and	  fibrosis,	  respectively,	  by	  an	  expert	  liver	  pathologist	  blinded	  to	  the	  
identity	  of	  the	  groups	  (Table	  2.10	  and	  2.11).	  
	  
5.2.8	  Statistical	  Analysis	  
Multiple	   comparisons	   on	   a	   single	   data	   set	   were	   performed	   using	   ANOVA	  
followed	   by	   Tukey’s	   post	   hoc	   test	   and	   expressed	   as	   mean	   ±	   SEM	   unless	  
otherwise	   stated.	   	   Interactions	   between	   maternal	   obesity	   and	   the	   post-­‐natal	  
diet	   were	   investigated	   using	   two-­‐way	   (2x2	   factorial)	   ANOVA	   through	   data	  
analysis	   software	   (GraphPad	  Prism	  5.0).	   	  p	  <	  0.05	  was	   regarded	  as	   significant.	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5.3	  Results	  
	  
5.3.1	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
accelerates	  adiposity	  with	  concomitant	  hyper-­‐leptinaemia	  at	  3	  months.	  
Bodyweight	  was	  significantly	  increased	  in	  offspring	  of	  control	  dams	  fed	  a	  post-­‐
natal	   obesogenic	   diet,	   which	   was	   accelerated	   by	   prior	   exposure	   to	   maternal	  
obesity,	   compared	   to	   those	   fed	   a	   control	   diet	   (OffCon-­‐SC;	   17.78	   ±	   1.61	   v.	  
OffCon-­‐OD;	   23.60	   ±	   0.69	   v.	   OffOb-­‐OD;	   29.69	   ±	   1.44	   gm).	   	   As	   previously	  
observed,	  offspring	  exposed	  to	  maternal	  obesity	  during	  gestation	  and	  lactation	  
had	  similar	  bodyweights	  as	   those	   fed	  a	  control	  diet	  at	  3	  months	  post-­‐partum.	  	  
There	  was	  an	   independent	  effect	  of	  maternal	  obesity	  on	  offspring	  bodyweight	  
with	  a	  significant	  interaction	  between	  maternal	  obesity	  and	  the	  post-­‐natal	  diet.	  
	  
Corroboratively,	  offspring	   inguinal	   fat	  pad	  mass	  (OffCon-­‐OD;	  855.53	  ±	  87.90	  v.	  
OffOb-­‐OD;	  1440.80	  ±	  133.13	  mg)	  and	  serum	  leptin	  (OffCon-­‐OD;	  14.29	  ±	  1.35	  v.	  
OffOb-­‐OD;	  17.90	  ±	  2.35	  ng/ml)	  were	  significantly	   raised	   in	   tandem,	   in	  OffCon-­‐
OD	   with	   exacerbation	   in	   offspring	   additionally	   exposed	   to	   maternal	   obesity	  
(Figure	  5.1).	   	  Moreover,	  a	   two-­‐way	  ANOVA	  revealed	  an	   independent	  effect	  of	  
maternal	  obesity	  on	  offspring	  inguinal	  fat	  pad	  mass	  with	  significant	  interaction	  
between	  maternal	   influences	  and	   the	  post-­‐natal	  diet	   for	  offspring	  bodyweight	  
and	  inguinal	  fat	  pad	  mass.	  	  Therefore	  and	  as	  expected,	  a	  post-­‐natal	  obesogenic	  
diet	   induced	   offspring	   adiposity	   which	   was	   exacerbated	   by	   prior	   exposure	   to	  
maternal	  obesity	  in	  gestation	  and	  lactation.	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Figure	  5.1	  Offspring	  Adiposity	  and	  Serum	  Leptin	  at	  3	  months:	  (A)	  Bodyweight,	  
(B)	  Inguinal	  Fat	  Pad	  Mass	  and	  (C)	  Serum	  Leptin	  Concentrations.	  	  The	  measured	  
indices	   of	   adiposity	  were	   exacerbated	   in	   offspring	  with	   exposure	   to	  maternal	  
obesity	   and	   a	   post-­‐natal	   obesogenic	   diet.	   	   Offspring	   of	   lean	   suckled	   by	   lean	  
weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	   offspring	   of	   lean	   suckled	   by	   lean	  
weaned	  on	  to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	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weaned	   on	   to	   standard	   chow	   –	   OffOb-­‐SC	   and	   offspring	   of	   obese	   suckled	   by	  
obese	  weaned	   on	   to	   obesogenic	   diet	   –	  OffOb-­‐OD.	   	   n	   =	   4-­‐6	   per	   group,	   values	  
shown	  are	  mean	  ±	  SEM,	  one-­‐way	  ANOVA.	   	   	  *Mean	  values	  significantly	  greater	  
than	  OffCon-­‐SC	  (p	  <	  0.01).	  #	  Mean	  values	  significantly	  greater	  than	  OffCon-­‐OD	  
(p	  <	  0.01).	  
	  
5.3.2	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
exacerbates	  hepatosteatosis	  at	  3	  months	  
Histological	  evidence	  of	  hepatosteatosis	  was	  observed	  in	  OffCon-­‐OD	  compared	  
to	   OffCon-­‐SC	   at	   3	  months	   post-­‐partum.	   	  More	   profound	   hepatosteatosis	  was	  
observed	   in	  offspring	  exposed	   to	  maternal	  obesity	   in	  addition	   to	  being	   fed	  an	  
obesogenic	  diet	   in	  post-­‐natal	   life.	   	  Morphometric	  quantification	  of	   the	  stained	  
surface	   was	   performed	   on	   representative	   liver	   sections,	   corroborating	   these	  
findings.	  	  	  Additionally,	  there	  was	  an	  independent	  effect	  of	  maternal	  obesity	  on	  
the	  NAFLD	  Activity	  Score	  with	  evidence	  of	  an	  interaction	  between	  the	  maternal	  
and	  post-­‐weaning	  environments.	  	  	  
	  
An	   interesting	  observation	   is	   that	   fat	   accumulation	   in	   the	   livers	   of	  OffCon-­‐OD	  
was	   predominantly	   micro-­‐vesicular,	   as	   reported	   by	   the	   histopathologist,	  
whereas	   OffOb-­‐OD	   presented	   with	   macro-­‐vesicular	   steatosis,	   as	   commonly	  
observed	  in	  NAFLD.	   	  These	  observations	  are	   in	  tandem	  with	  the	  hepatic	  tissue	  
triglyceride	   content	  which	  was	  most	  marked	   in	  OffOb-­‐OD	   (OffCon-­‐OD;	   3.27	   ±	  
1.22	  v.	  OffOb-­‐OD;	  20.95	  ±	  5.30	  mmol/l/)	  (Figure	  5.2).	  	  Similarly,	  an	  independent	  
effect	  of	  maternal	  obesity	  on	  offspring	  hepatic	  TG	  content	  was	  observed	  with	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evidence	   of	   a	   significant	   interaction	   between	  maternal	   obesity	   and	   the	   post-­‐
natal	   diet.	   	   So	   therefore,	   maternal	   obesity	   induces	   offspring	   hepatosteatosis	  
which	  is	  exacerbated	  in	  the	  context	  of	  a	  post-­‐weaning	  hyper-­‐calorific	  diet.	  
	  
	  
Figure	  5.2	  Histological	  and	  Biochemical	  Evidence	  of	  Hepatosteatosis	  at	  3	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months:	   (A)	   Representative	  H&E	   sections,	   (B)	   Steatosis	   Score	   and	   (C)	   Hepatic	  
Tissue	  Triglyceride.	  	  Offspring	  exposure	  to	  maternal	  obesity	  in	  the	  context	  of	  a	  
post-­‐weaning	   hyper-­‐calorific	   diet	   significantly	   exacerbated	   hepatosteatosis.	  	  
Offspring	   of	   lean	   suckled	   by	   lean	   weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	  
offspring	  of	   lean	   suckled	  by	   lean	  weaned	  on	   to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  
offspring	  of	  obese	   suckled	  by	  obese	  weaned	  on	   to	   standard	  chow	  –	  OffOb-­‐SC	  
and	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐
OD.	   	   n	   =	   4-­‐6	   per	   group,	   values	   shown	   are	   mean	   ±	   SEM,	   one-­‐way	   ANOVA.	  	  	  
*Mean	   values	   significantly	   greater	   than	   OffCon-­‐SC	   (p	   <	   0.01).	   #	  Mean	   values	  
significantly	  greater	  than	  OffCon-­‐OD	  (p	  <	  0.01).	  
	  
5.3.3	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
worsens	   liver	   injury	  and	  exacerbates	  up-­‐regulation	  of	  pro-­‐fibrogenic	  markers	  
at	  3	  months	  
The	   relative	   mRNA	   expression	   of	   IL-­‐6	   and	   TNF-­‐α,	   chemokines	   implicated	   in	  
NAFLD	   pathogenesis,	   was	   significantly	   increased	   in	   offspring	   of	   control	   fed	   a	  
post-­‐natal	   obesogenic	   diet	   compared	   to	   controls.	   	   Prior	   offspring	   exposure	   to	  
maternal	   obesity	   exacerbated	   this	   injury	   as	   evidenced	   by	   greater	   increases	   in	  
relative	  expression	  (OffCon-­‐SC;	  1.00	  ±	  0.15	  v.	  OffCon-­‐OD;	  1.81	  ±	  0.20	  v.	  OffOb-­‐
OD;	  3.03	  ±	  0.34	  arbitrary	  units)	  (Figure	  5.3).	  	  There	  was	  an	  independent	  effect	  of	  
maternal	  obesity	  on	  TNF-­‐α	  expression.	  
	  
Gene	   expression	   of	   α-­‐SMA,	   TGF-­‐β	   and	   collagen	   type	   1,	   as	  markers	   of	   hepatic	  
fibrogenesis	   were	   too	   up-­‐regulated	   in	   offspring	   exposed	   to	   a	   post-­‐natal	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obesogenic	   diet.	   	   Importantly,	   the	   expression	   of	   these	   markers	   was	   further	  
increased	   in	  offspring	  exposed	   to	  maternal	  obesity	   in	   addition	   to	   a	  post-­‐natal	  
obesogenic	   diet	   (Figure	   5.3).	   	   The	   role	   of	   maternal	   obesity	   in	   programming	  
offspring	  NAFLD	  is	  confirmed	  by	  the	  independent	  maternal	  effects	  on	  TGF-­‐β	  and	  
collagen	   expression	  with	   evidence	   of	   interaction	   between	  maternal	   and	   post-­‐
natal	   diets	   for	   these	   markers.	   	   So	   therefore,	   offspring	   exposure	   to	   maternal	  
obesity	  worsens	  hepatic	   injury	  in	  the	  context	  of	  a	  post-­‐weaning	  hyper-­‐calorific	  
diet.	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Figure	  5.3	  Biochemical	  Evidence	  of	  Liver	  Injury	  and	  Fibrogenesis	  at	  3	  months:	  
(A)	   mRNA	   IL-­‐6	   expression	   (B)	   mRNA	   TNF-­‐α	   expression,	   (C)	   mRNA	   α-­‐SMA,	   (D)	  
mRNA	  TGF-­‐β	  and	  (E)	  mRNA	  Collagen	  type	  1.	  	  Maternal	  obesity	  in	  the	  context	  of	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a	   post-­‐weaning	   hyper-­‐calorific	   diet	   worsened	   liver	   injury	   and	   enhanced	  
induction	  of	  hepatic	  fibrogenesis.	  	  Offspring	  of	  lean	  suckled	  by	  lean	  weaned	  on	  
to	  standard	  chow	  –	  OffCon-­‐SC;	  offspring	  of	  lean	  suckled	  by	  lean	  weaned	  on	  to	  
obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  
standard	  chow	  –	  OffOb-­‐SC	  and	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  
to	  obesogenic	  diet	  –	  OffOb-­‐OD.	   	  n	  =	  4-­‐6	  per	  group,	  values	   shown	  are	  mean	  ±	  
SEM,	  one-­‐way	  ANOVA.	  	  	  *Mean	  values	  significantly	  greater	  than	  OffCon-­‐SC	  (p	  <	  
0.01).	  #	  Mean	  values	  significantly	  greater	  than	  OffCon-­‐OD	  (p	  <	  0.01).	  
	  
5.3.4	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
profoundly	  accelerates	  hepatosteatosis	  at	  12	  months	  
Histological	   assessment	   of	   hepatosteatosis	   revealed	   greater	   fat	   infiltration	   in	  
offspring	   exposed	   to	   a	   post-­‐natal	   obesogenic	   diet	   (OffCon-­‐OD)	   compared	   to	  
controls	   (OffCon-­‐SC)	   at	   12	   months	   than	   at	   3	   months.	   	   Prior	   exposure	   to	  
maternal	   obesity	   followed	   by	   a	   post-­‐natal	   obesogenic	   diet	   resulted	   in	  
disproportionately	   exacerbated	   hepatosteatosis	   at	   12	  months	   compared	   to	   3	  
months.	   	   In	   parallel	   with	   hepatosteatosis,	   there	   was	   at	   12	   months,	   clear	  
evidence	  of	  histological	  liver	  injury	  as	  confirmed	  by	  the	  increased	  Brunt-­‐Kleiner	  
NAFLD	  Activity	  Score,	  confirming	  the	  presence	  of	  non-­‐alcoholic	  steatohepatitis	  
(NASH)	  (Figure	  5.4).	  	  Additionally,	  an	  independent	  effect	  of	  maternal	  obesity	  on	  
liver	  injury	  as	  denoted	  by	  the	  NAFLD	  Activity	  Score	  was	  observed.	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Figure	  5.4	  Histological	   Evidence	  of	  Hepatosteatosis	   and	  NASH	  at	  12	  months:	  
(A)	   Representative	   H&E	   sections	   and	   (B)	   NAFLD	   Activity	   Score.	   	   Offspring	  
exposure	   to	  maternal	   obesity	   in	   the	   context	  of	   a	   post-­‐weaning	  hyper-­‐calorific	  
diet	   significantly	   exacerbated	   hepatosteatosis	   and	   development	   of	   NASH.	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Offspring	   of	   lean	   suckled	   by	   lean	   weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	  
offspring	  of	   lean	   suckled	  by	   lean	  weaned	  on	   to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  
offspring	  of	  obese	   suckled	  by	  obese	  weaned	  on	   to	   standard	  chow	  –	  OffOb-­‐SC	  
and	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐
OD.	   	   n	   =	   4-­‐6	   per	   group,	   values	   shown	   are	   mean	   ±	   SEM,	   one-­‐way	   ANOVA.	  	  	  
*Mean	   values	   significantly	   greater	   than	   OffCon-­‐SC	   (p	   <	   0.01).	   #	  Mean	   values	  
significantly	  greater	  than	  OffCon-­‐OD	  (p	  <	  0.01).	  
	  
5.3.5	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
induces	  profound	  liver	  injury	  and	  fibrogenesis	  at	  12	  months	  
At	   12	   months,	   serum	   ALT	   as	   a	   marker	   of	   liver	   injury	   was	   markedly	   and	  
significantly	   raised	   in	   offspring	   exposed	   to	   a	   post-­‐natal	   obesogenic	   diet	   only	  
(OffCon-­‐OD).	   ALT	   was	   further	   increased	   in	   offspring	   exposed	   additionally	   to	  
maternal	  obesity	   (OffOb-­‐OD).	   These	  observations	  were	  paralled	  by	   findings	  of	  
increased	  expression	  of	  IL-­‐6	  and	  TNF-­‐α	  mRNA	  in	  the	  same	  groups.	  	  Importantly,	  
there	  were	  independent	  effects	  of	  maternal	  obesity	  on	  ALT	  levels	  and	  IL-­‐6	  and	  
TNF-­‐α	  expression	  with	  evidence	  of	  interaction	  between	  the	  maternal	  and	  post-­‐
weaning	   environments	   for	   ALT	   and	   IL-­‐6.	   	   As	   with	   observations	   at	   3	   months,	  
ASMA,	   TGF-­‐β	   and	   collagen	  were	   also	   all	   profoundly	   up-­‐regulated	   in	   offspring	  
exposed	  to	  maternal	  obesity	  in	  addition	  to	  a	  post-­‐natal	  obesogenic	  diet	  (Figure	  
5.5).	   	   Similarly,	  main	   effects	  were	   observed	   for	   both	  maternal	   and	   post-­‐natal	  
diets	  with	  a	  significant	  interaction	  between	  these	  two	  variables	  for	  all	  fibrogenic	  
markers.	   	   So	   therefore,	   maternal	   obesity	   clearly	   induces	   offspring	   hepatic	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fibrogenesis	   which	   is	   markedly	   enhanced	   in	   the	   context	   of	   a	   post-­‐weaning	  
obesogenic	  diet.	  
	  
Figure	  5.5	  Biochemical	  Evidence	  of	  Liver	  Injury	  and	  Fibrogenesis	  at	  12	  months:	  
(A)	  Serum	  ALT,	  (B)	  IL-­‐6,	  (C)	  TNF-­‐α,	  (D)	  α-­‐SMA,	  (E)	  TGF-­‐β	  and	  (F)	  Collagen	  type	  1.	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Maternal	   obesity	   in	   the	   context	   of	   a	   post-­‐weaning	   hyper-­‐calorific	   diet	  
accelerated	   liver	   injury	   and	   fibrogenesis.	   	   Offspring	   of	   lean	   suckled	   by	   lean	  
weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	   offspring	   of	   lean	   suckled	   by	   lean	  
weaned	  on	  to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  
weaned	   on	   to	   standard	   chow	   –	   OffOb-­‐SC	   and	   offspring	   of	   obese	   suckled	   by	  
obese	  weaned	   on	   to	   obesogenic	   diet	   –	  OffOb-­‐OD.	   	   n	   =	   4-­‐6	   per	   group,	   values	  
shown	  are	  mean	  ±	  SEM,	  one-­‐way	  ANOVA.	   	   	  *Mean	  values	  significantly	  greater	  
than	  OffCon-­‐SC	  (p	  <	  0.01).	  #	  Mean	  values	  significantly	  greater	  than	  OffCon-­‐OD	  
(p	  <	  0.01).	  
	  
5.3.6	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
induces	  evident	  fibrosis	  at	  12	  months	  
Biochemical	   evidence	   of	   fibrogenic	   pathway	   activation	   was	   corroborated	   by	  
clear	  findings	  of	  pericellular	  fibrosis,	  on	  Masson	  Trichrome	  staining,	  in	  offspring	  
exposed	   to	   a	   maternal	   obesity	   and	   a	   post-­‐natal	   obesogenic	   diet.	   	   Minimal	  
fibrosis	   was	   observed	   in	   offspring	   fed	   only	   a	   post-­‐natal	   obesogenic	   diet	   as	  
confirmed	   by	   the	   fibrosis	   score	   (OffConOD;	   0.6	   ±	   0.4	   v.	   OffOb-­‐OD;	   1.4	   ±	   0.2,	  
arbitrary	  units)	  (Figure	  5.6).	  	  So	  therefore,	  maternal	  obesity	  programs	  offspring	  
NAFLD,	  which	  in	  the	  context	  of	  a	  post-­‐weaning	  hyper-­‐calorific	  diet,	  accelerates	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Figure	   5.6	   Histological	   Evidence	   of	   Hepatic	   Fibrosis	   at	   12	   months:	   (A)	  
Representative	   Masson’s	   Trichrome	   sections	   and	   (B)	   Fibrosis	   Score.	   	   Evident	  
fibrosis	  was	  observed	  in	  OffOb-­‐OD.	  Offspring	  of	  lean	  suckled	  by	  lean	  weaned	  on	  
to	  standard	  chow	  –	  OffCon-­‐SC;	  offspring	  of	  lean	  suckled	  by	  lean	  weaned	  on	  to	  
obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	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standard	  chow	  –	  OffOb-­‐SC	  and	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  
to	  obesogenic	  diet	  –	  OffOb-­‐OD.	   	  n	  =	  4-­‐6	  per	  group,	  values	   shown	  are	  mean	  ±	  
SEM,	  one-­‐way	  ANOVA.	  	  	  *Mean	  values	  significantly	  greater	  than	  OffCon-­‐SC	  (p	  <	  




A	   growing	   body	   of	   evidence	   implicates	   a	   role	   for	   maternal	   obesity	   in	  
programming	   offspring	   NAFLD	   (Chapter	   1)	   (51,	   64,	   180).	   	   Additionally,	   it	   has	  
been	   previously	   observed	   that	   offspring	   exposed	   to	   maternal	   obesity	   in	   the	  
immediate	   post-­‐natal	   environment	   have	   a	   more	   profound	   dysmetabolic	   and	  
NAFLD	   phenotype	   at	   3	  months	   (Chapter	   2)	   (51).	   Using	   a	  more	   physiologically	  
relevant	  and	  translational	  model,	   it	   is	  now	  shown	  that	  the	  maternal	  and	  post-­‐
natal	  environments	  interact	  to	  exacerbate	  the	  progression	  of	  NAFLD	  throughout	  
adulthood.	  	  
	  
A	   post-­‐natal	   obesogenic	   diet	   causes	   offspring	   obesity	   with	   consequent	  
hepatosteatosis	   and	   liver	   injury.	   	   Importantly,	   prior	   exposure	   of	   offspring	   to	  
maternal	   obesity	   followed	   by	   an	   obesogenic	   diet	   results	   in	   an	   enhanced	  
phenotype.	   	   At	   3	   and	   12	   months	   there	   was	   evidence	   of	   offspring	   obesity,	  
hepatosteatosis	   and	   up-­‐regulation	   of	   IL-­‐6	   and	   TNF-­‐α	   and	   ASMA,	   TGF-­‐β	   and	  
collagen	   as	   biochemical	   markers	   of	   liver	   injury	   and	   fibrosis,	   respectively.	  	  
Therefore,	   it	  may	  be	   suggested	   that	   in	   the	   liver,	   developmental	   programming	  
sensitises	   the	   organ	   to	   deleterious	   effects	   in	   the	   context	   of	   continued	   insult	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postnatally.	   	  Such	  phenotypic	  propagation	  has	  been	  reported	   in	  similar	  rodent	  
models	   of	  maternal	   diet	   induced	  obesity	   investigating	  hepatic	   injury	   (64,	   180,	  
196).	  	  It	  has	  been	  suggested	  that	  the	  interaction	  of	  the	  maternal	  and	  post-­‐natal	  
environments	   induce	   hepatic	   mitochondrial	   dysfunction	   and	   lipogenesis	   gene	  
priming,	  evoking	  offspring	  NAFLD	  (64).	  
	  
5.4.1	  Offspring	  Adiposity	  	  
Exposure	  to	  a	  post-­‐weaning	  obesogenic	  diet	  significantly	  increased	  bodyweight	  
in	   offspring	   compared	   to	   controls.	   	   Importantly,	   prior	   exposure	   to	   maternal	  
obesity,	  exacerbated	  weight	  gain.	  	  A	  similar	  pattern	  was	  observed	  for	  offspring	  
inguinal	   fat	   pad	   mass,	   corroborating	   bodyweight	   data.	   	   A	   two-­‐way	   ANOVA	  
revealed	   statistically	   significant	   interaction	  between	  maternal	   obesity	   and	   the	  
post-­‐weaning	   obesogenic	   diet,	   confirming	   the	   additive	   effect	   of	   programming	  
by	  maternal	  obesity	  in	  generating	  the	  enhanced	  phenotype	  at	  3	  months.	  	  These	  
findings	  are	  supported	  by	  a	  previous	  report	  of	  accelerated	  adiposity	  in	  offspring	  
with	  additional	  exposure	  to	  maternal	  obesity	  (55).	  	  	  
	  
5.4.2	  Offspring	  Liver	  Injury	  
The	  current	  paradigm	  for	  the	  pathogenesis	  of	  NAFLD,	  invokes	  insulin	  resistance	  
as	  the	  primary	  driver	  for	  steatosis	   in	  the	  livers	  of	  obese	  individuals	  (172),	  with	  
IL-­‐6	  and	  TNF-­‐α	  involved	  in	  the	  inflammatory	  responses	  (174).	  	  Gene	  expression	  
of	   IL-­‐6	   and	   TNF-­‐α	   were	   both	   significantly	   increased	   in	   offspring	   fed	   an	  
obesogenic	   diet	   post-­‐weaning.	   	   However,	   relative	   expression	   of	   these	  
inflammatory	   mediators	   was	   significantly	   greater	   in	   offspring	   with	   prior	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exposure	   to	   maternal	   obesity	   at	   3	   and	   12	   months	   post-­‐partum.	   	   Expectedly,	  
hepatic	   injury	   was	   more	   marked	   at	   12	   months	   compared	   to	   3	   months.	   	   As	  
observed	   with	   indices	   of	   adiposity,	   a	   significant	   difference	   between	   control	  
offspring	   and	   those	   exposed	   to	   only	   maternal	   obesity	   was	   not	   observed	  
although	   an	   upward	   trend	  was	   noted	   in	  OffOb-­‐SC.	   	   So	   therefore,	   these	   novel	  
findings	   demonstrate	   that	   the	   exacerbated	   phenotype	   of	   OffOb-­‐OD	   was	   the	  
result	  of	  programmed	  NAFLD	  adversely	  interacting	  with	  the	  hyper-­‐calorific	  post-­‐
weaning	   environment	   in	   early	   and	   late	   adulthood,	   as	   confirmed	   by	   two-­‐way	  
ANOVA	  analysis.	  	  
	  
5.4.3	  Offspring	  Hepatosteatosis	  
It	   is	   well	   documented	   that	   saturation	   of	   hepatic	   lipid	   metabolism	   initiates	  
and/or	   propagates	   liver	   injury	   (103).	   	   As	   previous,	   the	   most	   profound	  
phenotype	   was	   observed	   in	   offspring	   exposed	   to	   maternal	   obesity	   and	  
additionally	  fed	  an	  obesogenic	  diet	  post-­‐weaning	  at	  3	  and	  12	  months.	  	  Hepatic	  
tissue	   triglyceride	   content	   was	   significantly	   greater	   in	   this	   group	   (OffOb-­‐OD)	  
compared	  to	  offspring	  fed	  only	  an	  obesogenic	  diet	  post-­‐weaning.	  	  	  
	  
Interestingly,	   micro-­‐vesicular	   presentation	   of	   hepatocellular	   steatosis	   was	  
observed	   in	   OffCon-­‐OD	   as	   evidenced	   histologically	   at	   3	  months.	   	   Steatosis	   in	  
NAFLD	   is	   predominantly	   macro-­‐vesicular	   causing	   cellular	   damage	   and	  
potentiating	  pathogenetic	  mechanisms	   (197).	   	   It	   is	   therefore	  unsurprising	   that	  
the	   extent	   of	   liver	   injury	   is	   greater	   in	   offspring	   presenting	   with	   larger	   lipid	  
vesicles.	   	  The	  steatosis	  score,	  however,	  does	  not	  differentiate	  between	  vesicle	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size	  and	  so	  an	  identical	  score	  based	  on	  morphometrical	  analysis	  was	  observed	  
for	   OffCon-­‐OD	   and	   OffOb-­‐OD	   at	   3	   months.	   	   At	   12	   months	   however,	   hepatic	  
injury	  was	  more	  profound	  and	  steatosis	  in	  addition	  to	  hepatocellular	  ballooning	  
and	  lobular	  inflammation	  were	  observed.	  	  Therefore	  a	  composite	  NAFLD	  activity	  
score	  was	  produced.	  	  A	  score	  greater	  than	  5	  was	  reported	  for	  OffOb-­‐OD	  which	  
is	   indicative	  of	  NASH,	   the	  more	  severe	   form	  of	  NAFLD	  associated	  with	  greater	  
mobidity	  and	  mortality.	  	  Therefore,	  exposure	  to	  maternal	  obesity	  in	  the	  context	  
of	   a	   post-­‐weaning	  hyper-­‐calorific	   diet	   is	   responsible	   for	  NAFLD	  progression	   to	  
NASH.	  
	  
5.4.4	  Offspring	  Liver	  Fibrogenesis	  
Fibrogenesis	  is	  the	  result	  of	  over-­‐exuberant	  production	  and	  deposition	  of	  matrix	  
proteins	  secreted	  by	   injury	  activated	  hepatic	  stellate	  cells	   (HSCs),	  a	  phenotype	  
characterised	  by	  abundant	  expression	  of	  α-­‐SMA,	  TGF-­‐β	  and	  collagen	  type-­‐1,	  the	  
predominant	   matrix	   constituent	   in	   fibrosis	   (186).	   	   Fibrogenic	   induction	   can	  
occur	   following	  unhindered	  and	  continuous	   liver	   injury	  as	  observed	   in	  NAFLD.	  	  
Both	   α-­‐SMA,	  which	   is	   expressed	   permanently	   in	   activated	  HSCs,	   and	   collagen	  
mRNA	   expression	  were	   increased	   in	   offspring	   fed	   a	   post-­‐weaning	   obesogenic	  
diet	  at	  3	  months.	  	  This	  increase	  was	  enhanced	  in	  offspring	  with	  prior	  exposure	  
to	  maternal	   obesity	   although	  a	   significant	   difference	  between	  OffCon-­‐OD	  and	  
OffOb-­‐OD	   was	   not	   reported	   using	   one-­‐way	   ANOVA	   at	   3	   months.	   	   Moreover,	  
two-­‐way	  ANOVA	  analysis	  confirmed	  that	  increased	  gene	  expression	  of	  collagen	  
was	  the	  result	  of	  interaction	  between	  maternal	  obesity	  and	  the	  post-­‐natal	  diet.	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At	  12	  months,	  more	  profound	  induction	  of	  hepatic	  fibrogenesis	  was	  observed	  in	  
offspring	   exposed	   to	  maternal	   obesity	   and	   fed	   a	   post-­‐weaning	   hyper-­‐calorific	  
diet.	   	  The	  exponential	   increase	   in	  gene	  expression	  of	  these	  fibrogenic	  markers	  
was	  due	  to	  the	  interaction	  of	  maternal	  obesity	  with	  the	  post-­‐weaning	  diet.	  
	  
TGF-­‐β,	  a	  pro-­‐fibrogenic	  cytokine,	  was	  only	  found	  to	  be	  significantly	  up-­‐regulated	  
in	  offspring	  exposed	  to	  maternal	  obesity	  and	  fed	  an	  obesogenic	  diet	  postnatally	  
at	  3	  and	  12	  months.	  	  Moreover,	  it	  was	  confirmed	  through	  two-­‐way	  ANOVA,	  that	  
the	  observed	  phenotype	  was	  due	  to	  maternal	  as	  well	  as	  post-­‐weaning	  effects.	  	  
Therefore,	   it	   could	   be	   suggested	   that	   in	   these	   current	   studies,	   priming	   of	  
offspring	   livers	   through	   exposure	   to	   maternal	   obesity	   is	   predominantly	  
responsible	  for	  the	  observed	  fibrogenesis.	  	  	  	  
	  
5.4.5	  Offspring	  Hyper-­‐leptinaemia	  
Leptin,	  an	  adipokine,	  increased	  in	  tandem	  with	  fat	  pad	  mass	  although	  there	  was	  
no	   statistically	   significant	   difference	   between	   OffCon-­‐OD	   and	   OffOb-­‐OD	   or	  
significant	   interaction	   identified	   through	   two-­‐way	   ANOVA	   analysis.	   	   Leptin	   is	  
also	   implicated	   in	   fibrogenesis	   through	   its	   activation	   of	   HSCs,	   since	   animals	  
lacking	   leptin	   are	   poorly	   fibrogenic	   (138,	   187,	   188).	   	   Therefore,	   the	   observed	  
hyper-­‐leptinaemia	   at	   3	  months,	   in	  OffCon-­‐OD	   and	  OffOb-­‐OD,	  may	   be	   in	   part,	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5.4.6	  Relative	  Contributions	  of	  the	  peri-­‐natal	  and	  post-­‐weaning	  periods	  
As	   anticipated,	   all	   indices	   of	   adiposity,	   hepatic	   injury	   and	   fibrogenesis	   were	  
raised	   in	   offspring	   fed	   an	   obesogenic	   diet	   post-­‐weaning.	   	   A	   more	   aggressive	  
dysmetabolic	   and	   NAFLD	   phenotype	   was	   observed	   in	   offspring	   with	   prior	  
exposure	  to	  maternal	  obesity.	  	  Importantly,	  readouts	  for	  OffCon-­‐SC	  and	  OffOb-­‐
SC	   were	   similar	   as	   previously	   reported	   in	   Chapter	   3.	   Therefore,	   it	   cannot	   be	  
argued	   that	   the	  disproportionately	  enhanced	  phenotype	  observed	   in	  offspring	  
exposed	  to	  maternal	  obesity	  and	  continued	  on	  an	  obesogenic	  diet	  throughout	  
post-­‐natal	   life,	   compared	   to	  OffCon-­‐OD,	   is	   simply	  due	   to	   longer	  exposure	  of	  a	  
hyper-­‐calorific	  environment.	  
	  
By	   randomising	   offspring	   post-­‐weaning	   to	   either	   one	   of	   two	   post-­‐natal	   diets,	  
one	  was	  able	  to	  investigate	  any	  possible	  interactions	  of	  maternal	  obesity	  in	  the	  
context	   of	   a	   post-­‐weaning	   obesogenic	   diet	   using	   two-­‐way	   ANOVA	   analysis.	  	  
Interactions	  of	  maternal	  obesity	  with	  the	  post-­‐weaning	  diet	  were	  subsequently	  
confirmed.	   	   Additionally,	   through	   investigation	   of	   early	   and	   late	   adulthood,	   it	  
has	  now	  been	  shown	  that	  the	  natural	  progression	  of	  NAFLD	  is	  accelerated	  and	  
worsened	  in	  offspring	  exposed	  to	  maternal	  obesity	  in	  gestation	  and	  lactation.	  
	  
5.4.7	  A	  More	  Pathophysiological	  Experimental	  Model	  of	  NAFLD	  
Continued	  exposure	  of	  offspring	  to	  maternal	  obesity	  and	  a	  hyper-­‐calorific	  diet	  
has	   provided	   a	   complete	   pathophysiologically	   relevant	  model	   of	  NAFLD.	   	   This	  
novel	  model	  of	  NAFLD	  encompasses	  prominent	  features	  of	  the	  human	  disease	  
along	  with	  biochemical	  and	  histological	  evidence	  of	  hepatosteatosis,	  liver	  injury	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and	   fibrosis,	   raised	   inflammatory	   cytokines	   and	   hyper-­‐leptinaemia,	   unlike	   the	  
ob/ob	   and	   MCD	   mouse	   models	   of	   NAFLD	   which	   are	   leptin	   deficient	   and	  




In	  conclusion,	  a	  post-­‐natal	  obesogenic	  diet,	   in	  the	  context	  of	  prior	  exposure	  to	  
maternal	   obesity,	   leads	   to	   heightened	   dysmetabolic	   and	   obesity	   related	   liver	  
sequelae,	   of	   greater	   severity	   than	   that	   induced	  by	   the	  obesogenic	   diet	   alone.	  	  
Therefore,	  maternal	  obesity	  through	  developmental	  programming,	  via	  changes	  
induced	  during	  in	  utero	  and	  early	  peri-­‐natal	  development,	  may	  be	  compounding	  
the	   effects	   of	   excess	   calories	   consumed	   as	   an	   adult,	   leading	   to	   a	   worsened	  
obesogenic	  and	  liver	  phenotype	  with	  irreversible	  fibrosis.	  
	  
Having	  developed	  a	  novel	  and	  pathophysiologically	  complete	  model	  of	  NAFLD,	  
Chapters	   6	   and	   7	   will	   investigate	   the	   mechanisms	   by	   which	   developmental	  



















6	  Investigation	  of	  Mechanisms	  through	  
which	  Maternal	  Obesity	  Programs	  
Offspring	  NAFLD:	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6.	   Investigation	   of	   Mechanisms	   through	   which	   Maternal	   Obesity	   Programs	  




The	  rising	  population	  prevalence	  of	  NAFLD	  (155)	  may	  be	  partially	  explained	  by	  
the	  increasing	  availability	  of	  cheap	  energy	  dense	  foods.	  	  	  Additionally,	  this	  may	  
be	   compounded	   by	   maternal	   obesity	   influencing	   eventual	   offspring	   liver	  
phenotype,	   through	   dysmetabolic	   changes	   induced	   during	   in	   utero	   and	  
perinatal	   development,	   as	   previously	   reported	   in	   Chapters	   3	   and	   4	   (51)	   and	  
subsequently	  reported	  by	  other	  groups	  (64,	  180).	  	  
	  
Programmed	  metabolic	   and	  hepatic	   abnormalities	   by	   peri-­‐natal	   over-­‐nutrition	  
may	   then	   be	   amplified	   in	   the	   context	   of	   a	   post-­‐natal	   hyper-­‐calorific	  
environment.	   	  This	  can	  cause	  development	  of	  the	  more	  severe	  form,	  NASH,	  as	  
reported	   in	   Chapter	   3	   or	   promote	   insulin	   resistance	   and	   perturb	   hepatic	  
mitochondrial	  function	  as	  has	  been	  reported	  by	  other	  groups	  (20,	  64,	  198).	  	  	  
	  
Hepatosteatosis	  and	  insulin	  resistance	  are	  considered	  to	  be	  the	  initiating	  factors	  
in	   the	   pathophysiological	   cascade	   underpinning	   NAFLD.	   	   Its	   pathogenesis	   is	  
propagated	   by	   the	   adipokines,	   tumour	   necrosis	   factor-­‐alpha	   (TNF-­‐α)	   and	  
interleukin-­‐6	   (IL-­‐6)	   (199)	   through	   generation	   of	   reactive	   oxygen	   species,	   ROS	  
(200).	  	  Importantly,	  the	  hepatic	  innate	  immune	  system	  has	  also	  been	  implicated	  
in	   liver	   pathophysiology,	   through	   contribution	   to	   the	   pro-­‐inflammatory	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response	  mediated	  by	  the	  cytokines,	  IL-­‐12	  and	  IL-­‐18	  (120).	  	  More	  specifically,	  it	  
has	   been	   suggested	   that	   an	   imbalance	  of	   hepatic	   Th1	   cytokines,	   produced	  by	  
innate	   immune	  cells,	   is	  a	  common	  pathogenic	  mechanism	   in	   insulin	  resistance	  
and	  NAFLD	  (121).	  	  	  	  
	  
The	   hepatic	   innate	   immune	   system	   largely	   comprises	   of	   Kupffer	   (phagocytic),	  
natural	   killer	   (NK)	  and	  natural	   killer	  T	   (NK-­‐T)	   cells.	   	  Other	  components	   include	  
acute-­‐phase	   proteins	   (APP),	   pattern	   recognition	   receptors	   and	   complement	  
factors	   (119).	   	   Kupffer	   cells	   (KC)	   constitute	   the	   majority	   of	   the	   body’s	  
macrophage	   population.	   	   They	   make	   up	   approximately	   20%	   of	   hepatic	   non-­‐
parenchymal	  cells	  (i.e	  cells	  other	  than	  hepatocytes)	  and	  reside	  in	  liver	  sinusoids.	  	  
KCs	   are	   responsible	   for	   eliminating	   blood	   borne	   pathogens,	   clearance	   of	  
bacteria	  and	  generating	  ROS	  and	  pro-­‐inflammatory	  cytokines,	  which	  potentiate	  
immune	  responses	  indicative	  of	  hepatocyte	  injury	  (119).	  	  	  
	  
NK-­‐T	  cells	  are	  a	  unique	   lymphocytic	   sub-­‐population	   that	  possess	   the	  ability	   to	  
produce	   both	   pro-­‐	   and	   anti-­‐inflammatory	   cytokines,	   thereby	   modulating	   the	  
eventual	   inflammatory	   response.	   Invariant	   NK-­‐T	   cells	   or	   iNK-­‐T	   cells	   are	  
predominately	  found	  in	  the	  livers	  of	  the	  C57BL/6J	  mouse	  strain	  and	  are	  able	  to	  
recognise	  lipids	  and	  glycolipids	  presented	  by	  CD1d	  molecules.	  	  As	  such,	  this	  cell	  
type	  is	  implicated	  in	  metabolic	  liver	  disease	  (201).	  	  NKT	  cell	  autoreactivity	  is	  also	  
regulated	   by	   KC	   derived	   cytokines,	   dietary	   factors	   through	   CD1d	   mediated	  
antigen	   presentation	   and	   sympathetic	   nervous	   system	   outputs	   such	   as	  
noradrenaline	  (121,	  201).	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Attenuation	  of	  hepatosteatosis	  post	  Kupffer	  cell	  (KC)	  ablation	  in	  a	  NASH	  model	  
has	   been	   reported	   (202).	   	   It	   is	   thought	   that	   KC-­‐mediated	   cytokine	  production	  
impairs	   lipid	   peroxidation	   and	   propagates	   insulin	   resistance,	   culminating	   in	  
hepatosteatosis	  (203).	  	  Moreover,	  KC	  activation	  and	  defective	  phagocytosis	  has	  
been	   reported	   in	   the	   induction	   and	   potentiation	   of	   NAFLD	   (204,	   205).	  
Additionally,	   Natural	   Killer	   T	   (NK-­‐T)	   cells	   which	   can	   mediate	   an	   anti-­‐
inflammatory	   response,	   are	   selectively	   reduced	   in	   the	  ob/ob	  mouse	  model	   of	  
NAFLD	   (126).	   	   Therefore,	   investigation	   of	   mechanisms	   that	   associate	   lipid	  
metabolism	  with	  inflammation,	  such	  as	  the	  hepatic	  innate	  immune	  system	  may	  
divulge	  the	  mechanistic	  pathway	  by	  which	  maternal	  obesity	  programs	  offspring	  
NAFLD.	  	  	  
	  
Here,	   the	   aims	  were	   to	   investigate	   the	  mechanistic	   role	  of	   the	  hepatic	   innate	  
immune	   system	   in	   a	   pathophysiologically	   relevant	   model	   of	   programmed	  




6.2.1	  Animal	  Experimentation	  
Female	   C57BL/6J	  mice	   (n	   =	   20	   per	   group)	   (Charles	   River	   Laboratories,	  UK),	   of	  
first	  order	  parity,	  approximately	  100	  days	  old	  were	  allowed	  7	  days	  to	  habituate	  
following	  transfer	  to	  the	  facility	  and	  fed	  standard	  laboratory	  chow	  (RM1,	  Special	  
Dietary	  Services,	  energy	  3.5	  kcal/g)	  ad	  libitum.	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Following	  acclimatisation,	  female	  mice	  were	  randomised	  to	  either	  a	  control	  or	  
experimental	   group	   and	   fed	   standard	   chow	   or	   a	   semi-­‐synthetic	   energy-­‐rich,	  
highly	   palatable	   obesogenic	   diet	   	   (Special	   Dietary	   Services,	   energy	   4.5	   kcal/g)	  
supplemented	  with	   sweetened	  condensed	  milk	   (Nestle)	   admixed	  with	  mineral	  
mix	  (AIN93G,	  Special	  Dietary	  Services,	  125	  mg/pot)	  ad	  libitum.	  	  	  
	  
Dams	   were	   maintained	   on	   their	   respective	   diets	   for	   6-­‐8	   weeks.	   	   Upon	  
attainment	   of	   an	   average	   30%	   increase	   in	   body	   weight	   of	   the	   experimental	  
group,	  mice	  were	  entered	  into	  the	  breeding	  protocol.	  	  All	  animals	  were	  treated	  
in	  accordance	  with	  The	  Animals	  (Scientific	  Procedures)	  Act,	  UK,	  1986	  guidelines.	  
	  
Pregnant	   dams	   were	   continued	   on	   their	   pre-­‐conception	   diets	   throughout	  
pregnancy	  and	  lactation.	  	  During	  pregnancy,	  maternal	  weight	  and	  dietary	  intake	  
were	  recorded	  weekly.	  	  Dams	  were	  allowed	  to	  deliver	  spontaneously	  and	  litter	  
size	  standardised.	   	  Subgroups	  of	  female	  offspring	  (n	  =	  20)	  born	  to	  and	  suckled	  
by	  lean	  dams	  or	  born	  to	  and	  suckled	  by	  obese	  dams	  were	  weaned	  on	  to	  either	  
normo-­‐calorific	   or	   semi	   synthetic	   obesogenic	   diet	   with	   condensed	   milk	  
supplementation,	   constituting	   a	   diet	   high	   in	   sugar	   and	   fat	   (Figure	   2.6).	   	   All	  
readouts	  were	  compared	  to	  the	  control	  group,	  offspring	  of	  lean	  suckled	  by	  lean	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6.2.2	  Tissue	  Collection	  
Offspring	  liver	  tissue	  was	  differentially	  preserved	  for	  use	  in	  gene	  expression	  and	  
FACS	  analysis,	   immunohistochemistry	  and	  histology.	   	  Briefly,	  whole	   liver	  tissue	  
was	  snap	  frozen	  in	  liquid	  nitrogen,	  preserved	  in	  RNAlater	  solution	  or	  dissected	  
using	  middle	  orientation	  and	   stored	   in	  10%	  neutral	  buffered	   formalin	  prior	   to	  
paraffin	  embedding.	  	  	  
	  
6.2.3	  Liver	  Mononuclear	  Cell	  (MNC)	  Fraction	  Isolation	  
After	   sacrifice,	   the	   liver	   was	   perfused	   with	   5ml	   PBS	   via	   the	   portal	   vein	   and	  
homogenised.	   	   Total	   liver	   cells	   were	   then	   re-­‐suspended	   in	   perfusate	   buffer	  
containing	   HBSS	   (Ca2+,	   Mg2+),	   collagenase	   (0.01%)	   and	   DNase	   I	   (0.001%).	  	  
Following	   filtration	   through	   70μm	   cell	   strainer,	   the	   pelleted	   cells	   were	   re-­‐
suspended	   in	   RPMI	   and	   layered	   with	   24%	   optiprep.	   	   Subsequent	   to	  
centrifugation,	  mononuclear	   cells	  were	   isolated	  at	   the	  40/60%	   interface.	   	   The	  
cells	   were	   washed	   once	   with	   a	   perfusate	   buffer	   containing	   	   HBSS	   (free	   Ca2+,	  
Mg2+),	   BSA	   (0.25%)	   and	   DNase	   I	   (0.001%)	   and	   supplemented	   with	   complete	  
culture	   media	   (RPMI,	   FBS	   (10%),	   PCN	   100U/ml,	   Strep	   100μg/ml,	   L-­‐glutamine	  
200mM).	  	  Cell	  types	  were	  determined	  using	  microscopy.	  
	  
6.2.4	  Reactive	  Oxygen	  Species	  Detection	  
KC	  derived	  ROS	  was	  assayed	  using	  the	  Total	  ROS	  Detection	  Kit	  (ENZO-­‐51011).	  	  In	  
brief,	  cell	  preparations	  were	  stimulated	  using	  LPS	  (E.coli	  0111:B4,	  Sigma	  Aldrich)	  
and	  incubated	  for	  30	  minutes	  at	  37°C.	  	  Samples	  were	  then	  washed	  and	  cells	  re-­‐
suspended	  in	  ROS	  detection	  solution,	   incubated	  with	  TruStain	  FcX	  (anti-­‐mouse	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CD16/32)	   and	   stained	   with	   F4/80	   antibody	   (AbD	   Serotec).	   	   Subsequent	   flow	  
cytometric	  analysis	  is	  detailed	  below.	  
	  
6.2.5	  Kupffer	  Cell	  Phagocytosis	  
Microspheres	   (Fluoresbrite@YG	   Microspheres	   1.00μm)	   were	   incubated	   with	  
total	   MNC	   suspension	   for	   20	   minutes	   at	   37°C.	   	   Reaction	   was	   stopped	   by	  
addition	   of	   2ml	   ice	   cold	   PBS.	   	   The	   cell	   preparations	   were	   then	   washed	   and	  
incubated	   with	   TruStain	   FcX	   (anti-­‐mouse	   CD16/32)	   and	   stained	   with	   F4/80	  
antibody.	  	  Subsequent	  flow	  cytometric	  analysis	  is	  detailed	  below.	  
	  
6.2.6	  FACS	  (Fluorescent	  Activated	  Cell	  Sorting)	  Analysis	  	  
Cell	   preparations	   were	   stained	   with	   CD3-­‐FITC/NK1.1-­‐PerCp	   and	   F4/80	   clone	  
BM8-­‐PerCP-­‐Cy5.5	   antibodies	   (AbD	   Serotec)	   for	   identification	   of	   NKT	   and	   KC	  
respectively.	  	  Cells	  were	  incubated	  at	  4°C	  for	  20	  minutes	  followed	  by	  addition	  of	  
1ml	  FACS	  buffer	   (Biolegend)	  and	  centrifugation.	   	  Cells	  were	   re-­‐suspended	   in	  a	  
final	  volume	  of	  100μl	  FACS	  buffer	  and	  analysed	  by	   flow	  cytometry	   (BD	  LSR	   II).	  	  
Quantification	  of	  data	  was	  performed	  using	  FlowJo	  5.6.1.	  
	  
6.2.7	  Gene	  Expression	  of	  Pro-­‐inflammatory	  Cytokines	  
Real	  Time	  Polymerase	  Chain	  Reaction	  (RT-­‐PCR)	  was	  performed	  using	  QuantiTect	  
SYBR	  Green	  PCR	  System	  with	  HotStar	  Taq	  DNA	  Polymerase	  (Qiagen).	  	  Quantitect	  
Primer	  Assays	   (Qiagen)	  using	  SYBR	  green	  based	  detection	  were	  used	   for	   IL-­‐12	  
and	  IL-­‐18.	  	  Expression	  of	  target	  genes	  was	  normalised	  to	  GAPDH	  expression.	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6.2.8	  Histology	  
Offspring	   liver	   sections	   at	   6	   months	   of	   age	   were	   formalin	   (10%)	   fixed	   and	  
paraffin	   embedded	   prior	   to	   sectioning.	   	   All	   sections	   were	   then	   stained	   with	  
haematoxylin	  and	  eosin	  (H&E)	  and	  Masson’s	  Trichrome	  to	  assess	  steatosis	  and	  
inflammation	  and	  fibrosis,	  respectively.	  	  The	  Brunt-­‐Kleiner	  NAFLD	  Activity	  Score	  
was	   used	   to	   quantitatively	   assess	   the	   degree	   of	   injury	   by	   an	   expert	   liver	  
pathologist	  blinded	  to	  the	  identity	  of	  the	  groups.	  
	  
6.2.9	  Immunohistochemistry	  	  
Immunohistochemical	   detection	   of	   KC	   was	   performed	   on	   paraffin	   embedded	  
sections	  treated	  with	  proteinase	  K,	  a	  primary	  rat	  anti-­‐mouse	  F4/80	  monoclonal	  
antibody	   (1/100,	   Serotec)	   and	   a	   secondary	   rabbit	   anti-­‐rat	   immunoglobulin	  
(ImmPRESS	  anti-­‐rat	  Ig	  (Peroxidase)	  Polymer	  Detection	  Kit,	  Vector	  Laboratories).	  	  
Peroxidase	   activity	  was	   demonstrated	   using	   ImmPact	  DAB	   (diaminobenzidine-­‐
based)	  peroxidise	  substrate	  kit	  (Vector	  Laboratories).	  	  The	  slides	  were	  counter-­‐
stained	  with	  hematoxylin.	  	  	  
	  
6.2.10	  Statistical	  Analysis	  
Multiple	   comparisons	   on	   a	   single	   data	   set	   were	   performed	   using	   ANOVA	  
followed	   by	   Tukey’s	   post	   hoc	   test	   and	   expressed	   as	   mean	   ±	   SEM	   unless	  
otherwise	   stated.	   	   Interactions	   between	   maternal	   obesity	   and	   the	   post-­‐natal	  
diet	   were	   investigated	   using	   two-­‐way	   (2x2	   factorial)	   ANOVA	   through	   data	  
analysis	   software	   (GraphPad	  Prism	  5.0).	   	  p	  <	  0.05	  was	   regarded	  as	   significant.	  	  
Sample	  size	  per	  group;	  n	  =	  5,	  1	  from	  each	  litter.	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6.3	  Results	  
	  
6.3.1	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
induces	  histological	  evidence	  of	  non-­‐alcoholic	  steatohepatits	  at	  6	  months.	  
To	   validate	   the	   experimental	   model	   prior	   to	   investigation	   of	   potential	  
mechanisms,	   histological	   assessment	   of	   hepatosteatosis	   and	   liver	   injury	   was	  
performed.	   	   Greater	   fat	   infiltration	   in	   offspring	   exposed	   to	   a	   post-­‐weaning	  
obeogenic	   diet	   (OffCon-­‐OD)	   compared	   to	   controls	   (OffCon-­‐SC)	   was	   observed.	  	  
Prior	  exposure	  to	  maternal	  obesity	  followed	  by	  a	  post-­‐weaning	  obesogenic	  diet	  
resulted	  in	  exacerbated	  and	  profound	  hepatosteatosis	  at	  6	  months.	  	  In	  parallel	  
with	   hepatosteatosis,	   there	   was	   clear	   evidence	   of	   histological	   liver	   injury	   as	  
confirmed	   by	   the	   increased	   Brunt-­‐Kleiner	   NAFLD	   Activity	   Score	   in	   OffOb-­‐OD	  
(Figure	   6.1).	   	   Moreover,	   an	   independent	   effect	   of	   maternal	   obesity	   on	   the	  
NAFLD	  Activity	  Score	  was	  observed	  with	  two-­‐way	  ANOVA	  analysis.	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Figure	  6.1	  Histological	  Evidence	  of	  Hepatic	   Injury	  and	  Steatosis	  at	  6	  months:	  
(A)	   Representative	   H&E	   sections	   and	   (B)	   NAFLD	   Activity	   Score.	   	   Offspring	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exposure	   to	  maternal	   obesity	   in	   the	   context	  of	   a	   post-­‐weaning	  hyper-­‐calorific	  
diet	  significantly	  exacerbated	  hepatosteatosis	  and	  liver	  injury.	  	  Offspring	  of	  lean	  
suckled	   by	   lean	   weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	   offspring	   of	   lean	  
suckled	  by	  lean	  weaned	  on	  to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  
suckled	   by	   obese	   weaned	   on	   to	   standard	   chow	   –	   OffOb-­‐SC	   and	   offspring	   of	  
obese	  suckled	  by	  obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐OD.	  	  n	  =	  4-­‐6	  per	  
group,	   values	   shown	   are	   mean	   ±	   SEM,	   one-­‐way	   ANOVA.	   	   	   *Mean	   values	  
significantly	   greater	   than	   OffCon-­‐SC	   (p	   <	   0.01).	   #	   Mean	   values	   significantly	  
greater	  than	  OffCon-­‐OD	  (p	  <	  0.01).	  
	  
6.3.2	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
significantly	  impairs	  Kupffer	  cell	  function	  at	  6	  months	  
The	   hepatic	   non-­‐parenchymal	   cell	   fraction	  was	   investigated	   in	   order	   to	   study	  
the	  mechanisms	  underlying	   the	  observed	  offspring	   steatohepatitis	  phenotype.	  	  
Focussing	   on	   KCs,	   the	   population,	   as	   determined	   by	   FACS	   analysis	   and	  
corroborated	   by	   immunohistochemical	   staining,	   was	   significantly	   increased	   in	  
offspring	  exposed	  to	  maternal	  obesity	  and	  fed	  an	  obesogenic	  diet	  post-­‐weaning	  
(OffOb-­‐OD).	   	   Although	   an	   upward	   trend	   in	   KC	   number	   was	   observed	   for	  
offspring	   only	   fed	   a	   post-­‐weaning	   obesogenic	   diet,	   the	   increase	   was	   not	   of	  
statistical	   significance.	   	   Importantly,	   KC	   numbers	   observed	   in	   OffCon-­‐SC	   and	  
OffOb-­‐SC	  were	   similar,	   confirming	   that	   the	   exponential	   increase	   in	   OffOb-­‐OD	  
was	  not	  just	  due	  to	  longer	  hyper-­‐calorific	  exposure	  (Figure	  6.2).	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Despite	   their	   increased	   numbers,	   KC	   phagocytic	   function	   was	   impaired	   in	  
offspring	  exposed	  to	  maternal	  obesity	  and	  fed	  an	  obesogenic	  diet	  post-­‐weaning	  
compared	  to	  all	  other	  groups.	  	  In	  contrast,	  KC	  ROS	  production	  was	  significantly	  
increased	  upon	   lipopolysaccharide	   stimulation	   in	   the	   same	  group	   (Figure	  6.2).	  	  
Two-­‐way	   ANOVA	   analysis	   confirmed	   significant	   interactions	   between	   the	  
maternal	   and	  post-­‐weaning	  obesogenic	  environments	   for	  KC	  derived	  ROS	  and	  
phagocytosis,	   thereby	   suggesting	   that	   maternal	   obesity	   is	   a	   prerequisite	   for	  
impaired	   KC	   functionality	   that	   manifests	   in	   the	   context	   of	   a	   post-­‐weaning	  
obesogenic	  diet.	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Figure	   6.2	   Kupffer	   cell	   function	   at	   6	   months:	   (A)	   KC	   population	   assay,	   (B)	  
Immunohistochemical	   detection	   of	   KCs,	   (C)	   KC	   derived	   ROS	   and	   (D)	   KC	  
phagocytic	   activity.	   	   KC	   functionality	   is	   profoundly	   impaired	   in	   OffOb-­‐OD.	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Offspring	   of	   lean	   suckled	   by	   lean	   weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	  
offspring	  of	   lean	   suckled	  by	   lean	  weaned	  on	   to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  
offspring	  of	  obese	   suckled	  by	  obese	  weaned	  on	   to	   standard	  chow	  –	  OffOb-­‐SC	  
and	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐
OD.	   	   n	   =	   4-­‐6	   per	   group,	   values	   shown	   are	   mean	   ±	   SEM,	   one-­‐way	   ANOVA.	  	  	  
*Mean	   values	   significantly	   greater	   than	   OffCon-­‐SC	   (p	   <	   0.01).	   #	  Mean	   values	  
significantly	  greater	  than	  OffCon-­‐OD	  (p	  <	  0.01).	  
	  
6.3.3	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
significantly	  attenuates	  the	  NK-­‐T	  cell	  population	  at	  6	  months	  
NK-­‐T	  cell	  number	  as	  determined	  by	  FACS	  analysis	  was	   significantly	   reduced	   in	  
offspring	   fed	   a	   post-­‐natal	   obesogenic	   diet	   (OffCon-­‐OD).	   	   Prior	   exposure	   to	  
maternal	   obesity	   in	   addition,	   enhanced	   this	   attenuation	   (OffOb-­‐OD)	   (Figure	  
6.3).	   	  Moreover,	  main	  effects	  were	  observed	  for	  both	  maternal	  and	  post-­‐natal	  
diets	  with	  a	  significant	  interaction	  between	  these	  2	  variables	  for	  offspring	  NKT	  
cell	  number	  (two-­‐way	  ANOVA	  analysis).	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Figure	  6.3	  NK-­‐T	  cell	  population	  assay	  at	  6	  months:	  	  Reduced	  NK-­‐T	  cell	  numbers	  
observed	  in	  OffOb-­‐OD.	  	  Offspring	  of	  lean	  suckled	  by	  lean	  weaned	  on	  to	  standard	  
chow	  –	  OffCon-­‐SC;	  offspring	  of	   lean	  suckled	  by	   lean	  weaned	  on	  to	  obesogenic	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diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  standard	  
chow	   –	   OffOb-­‐SC	   and	   offspring	   of	   obese	   suckled	   by	   obese	   weaned	   on	   to	  
obesogenic	  diet	  –	  OffOb-­‐OD.	  	  n	  =	  4-­‐6	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM,	  
one-­‐way	  ANOVA.	  	  	  *Mean	  values	  significantly	  greater	  than	  OffCon-­‐SC	  (p	  <	  0.01).	  
#	  Mean	  values	  significantly	  greater	  than	  OffCon-­‐OD	  (p	  <	  0.01).	  
	  
6.3.4	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
induces	  up-­‐regulation	  of	  Th1	  polarised	  cytokines	  
The	  pro-­‐inflammatory	  cytokines,	  IL-­‐12	  and	  IL-­‐18	  were	  significantly	  up-­‐regulated	  
in	   offspring	   exposed	   to	   maternal	   obesity	   and	   fed	   an	   obesogenic	   diet	   post-­‐
weaning	   (OffOb-­‐OD).	   	   These	   pro-­‐inflammatory	   cytokines,	   produced	   by	   KCs	   of	  
the	   M1	   (pro-­‐inflammatory)	   phenotype,	   corroborate	   the	   observation	   of	  
increased	   KC	   number	   in	   the	   same	   group.	   	   Additionally,	   there	   was	   an	  
independent	  effect	  of	  maternal	  obesity	  on	  IL-­‐12	  expression	  with	  evidence	  of	  an	  
interaction	   between	   maternal	   obesity	   and	   the	   post-­‐natal	   diet	   forIL-­‐18	  
expression	  (Figure	  6.4).	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Figure	   6.4	   Th1	   Polarised	   Cytokines	   at	   6	   months:	   (A)	   IL-­‐12	   and	   (B)	   IL-­‐18.	  	  
Cytokines	   were	   up-­‐regulated	   in	   OffOb-­‐OD.	   	   Offspring	   of	   lean	   suckled	   by	   lean	  
weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	   offspring	   of	   lean	   suckled	   by	   lean	  
weaned	  on	  to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  
weaned	   on	   to	   standard	   chow	   –	   OffOb-­‐SC	   and	   offspring	   of	   obese	   suckled	   by	  
obese	  weaned	   on	   to	   obesogenic	   diet	   –	  OffOb-­‐OD.	   	   n	   =	   4-­‐6	   per	   group,	   values	  
shown	  are	  mean	  ±	  SEM,	  one-­‐way	  ANOVA.	   	   	  *Mean	  values	  significantly	  greater	  
than	  OffCon-­‐SC	  (p	  <	  0.01).	  #	  Mean	  values	  significantly	  greater	  than	  OffCon-­‐OD	  




Previous	   chapters	   have	   shown	   that	   offspring	   exposed	   to	   maternal	   obesity	  
during	  gestation	  and	  lactation	  develop	  a	  dysmetabolic	  phenotype	  with	  evidence	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of	   liver	   injury	   at	   3	  months	   and	   that	   exposure	   limited	   to	   the	   immediate	   post-­‐
natal	   environment	   profoundly	   exacerbates	   NAFLD	   (51).	   	   	   In	   a	   more	  
physiologically	   relevant	   and	   translational	   model,	   it	   was	   reported	   that	   the	  
maternal	   and	   post-­‐natal	   environments	   interacted	   to	   further	   propagate	  
progression	  of	  NAFLD.	  	  It	  is	  here	  shown	  that	  the	  hepatic	  innate	  immune	  system	  
may	   be	   involved	   in	   offspring	   NAFLD	   development	   programmed	   by	   maternal	  
obesity.	  	  
	  
Prior	   to	   mechanistic	   investigation,	   histological	   evidence	   of	   NAFLD	   was	  
confirmed	   and	   quantitative	  morphometrical	   analysis	   using	   the	  NAFLD	   Activity	  
Score	  was	  used	   to	  assess	   the	  extent	  of	   injury.	   	  Offspring	  exposed	   to	  maternal	  
obesity	   and	   fed	   an	   obesogenic	   diet	   post-­‐weaning	   developed	  NASH,	   the	  more	  
severe	  form	  of	  NAFLD	  compared	  to	  all	  other	  groups.	   	  Such	  findings	  have	  been	  
corroborated	   by	   other	   groups	   using	   a	   high	   fat	   diet	   in	   a	   similar	   experimental	  
paradigm	  (64,	  180).	  
	  
Here	   it	   is	   now	   shown	   that	   innate	   immune	   dysregulation	   is	   profound	   in	   the	  
group	   fed	  an	  obesogenic	  diet	  with	  prior	  exposure	   to	  maternal	  obesity.	   	  These	  
novel	  findings	  suggest	  that	  maternal	  obesity	  program	  offspring	  susceptibility	  to	  
NAFLD	  via	  perturbation	  of	  the	  innate	  immune	  system.	  	  	  
	  
6.4.1	  Kupffer	  Cells	  
The	   current	   paradigm	   for	   the	   pathogenesis	   of	   NAFLD	   holds	   fat	   accumulation	  
and	   insulin	  resistance	  as	  prerequisites	   for	  disease	  development.	   	  These	   insults	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then	   sensitise	   the	   liver	   to	   secondary	   injurious	   effects	   driven	   by	   pro-­‐
inflammatory	   and	   pro-­‐fibrotic	   cytokines	   (206).	   	   Therefore,	   investigation	   of	  
mechanisms	   that	   associate	   lipid	   metabolism	   with	   inflammation,	   such	   as	   the	  
hepatic	  innate	  immune	  system	  may	  divulge	  the	  underlying	  pathophysiology.	  
	  
Moreover,	  KC	  activation	  and	  defective	  phagocytosis	  have	  been	  reported	  in	  the	  
induction	   and	   potentiation	   of	   NAFLD	   (204,	   205).	   	   It	   has	   been	   suggested	   that	  
steatosis	  may	  disrupt	  sinusoid	  microcirculation	  and	  hepatocellular	  clearance	  of	  
microbial	   antigens,	   all	   of	   which	   activate	   KCs	   (207).	   	   KCs,	   the	   liver’s	   resident	  
macrophages,	   account	   for	   80-­‐90%	   of	   the	   total	   fixed	   tissue	   macrophage	  
population	  in	  the	  body	  (208)	  and	  were	  up-­‐regulated	  here	  in	  offspring	  fed	  a	  post-­‐
natal	  obesogenic	  diet	  with	  prior	  exposure	  to	  maternal	  obesity.	   	  These	  findings	  
are	  corroborated	  in	  a	  rat	  model	  of	  NASH	  where	  KCs	  are	  recruited	  and	  activated	  
following	  exposure	  to	  a	  high	  fat	  diet	  (209).	  	  	  	  	  
	  
6.4.2	  Reactive	  Oxygen	  Species	  (ROS)	  	  
KCs	   are	   also	   able	   to	   directly	   generate	   ROS	   via	   the	  NADPH	  oxidase-­‐dependent	  
and	   the	   xanthine	   oxidase-­‐dependent	   pathways	   (210).	   KC	   derived	   ROS	   is	   well	  
documented	   in	   alcoholic	   liver	   disease	   (ALD)	   (205),	   which	   bears	   histological	  
resemblance	   to	   NAFLD.	   	   As	   such,	   KC	   mediated	   ROS	   has	   been	   implicated	   in	  
NAFLD	  pathogenesis.	  	  Direct	  evidence	  of	  elevated	  ROS	  production	  by	  KCs,	  rising	  
proportionately	  with	   increased	  KC	  numbers	   in	  programmed	  offspring	  exposed	  
to	  a	  post-­‐natal	  obesogenic	  diet,	   is	  reported	  here.	   	  Moreover,	   two-­‐way	  ANOVA	  
analysis	   confirmed	   the	   presence	   of	   significant	   interactions	   between	   the	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maternal	  and	  post-­‐natal	  environments	   in	  generating	   the	  observed	  phenotype.	  	  
These	   findings	   are	   in	   keeping	   with	   previous	   reports	   of	   gross	   hepatic	   ROS	  
production	  mediating	  NAFLD	  in	  a	  rodent	  model	  (211).	  
	  
6.4.3	  Th1	  Polarised	  Cytokines	  	  
KCs	   possess	   the	   ability	   of	   functional	   polarisation	   to	   release	   pro-­‐inflammatory	  
(M1	   phenotype)	   or	   anti-­‐inflammatory	   (M2	   phenotype)	   cytokines	   (203).	   	   Such	  
M1	  phenotypic	  cytokines	  include	  IL-­‐12	  and	  IL-­‐18,	  both	  of	  which	  we	  report	  here	  
to	  be	  up-­‐regulated	  in	  offspring	  exposed	  to	  maternal	  obesity	  plus	  an	  obesogenic	  
diet	   post-­‐weaning.	   	   Additionally,	   it	   has	   been	   shown	   here	   that	   there	   is	   an	  
independent	   effect	   of	  maternal	   diet	   on	   IL-­‐12	   expression	   with	   evidence	   of	   an	  
interaction	   between	   maternal	   obesity	   and	   the	   post-­‐natal	   diet	   for	   IL-­‐18	  
expression.	  	  It	  is	  also	  well	  documented	  that	  these	  M1	  phenotypic	  cytokines	  are	  
up-­‐regulated	  in	  response	  to	  increased	  oxidation	  of	  free	  fatty	  acids	  (154).	  	  	  
	  
More	  recently,	  M1	  macrophage	  activation	  has	  been	  directly	  correlated	  with	  the	  
severity	   of	   NASH	   in	   an	   MCD	   mouse	   model	   through	   comparison	   of	   disease	  
progression	   in	   M1	   (C57BL/6J)	   and	   M2	   (Balb/c)	   macrophage	   biased	   rodents	  
(212).	   	   Additionally,	   IL-­‐18	   has	   been	   shown	   to	   regulate	   NAFLD	   progression	  
through	   modulation	   of	   the	   gut	   microbiota	   (213).	   	   These	   findings	   confirm	   a	  
contributory	  role	  of	  macrophage	  responses	  in	  NAFLD.	  	  	  	  
	  
IL-­‐12	   is	   the	  most	  potent	   soluble	   activator	  of	   Th1	   cells	   (214),	  which	  are	   a	   sub-­‐
group	  of	  T	  helper	   lymphocytes	  capable	  of	  producing	   further	  pro-­‐inflammatory	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cytokines	   and	   inducing	   cellular	   immunity.	   	   T	   helper	   cells	   are	   thus	   able	   to	  
regulate	   immune	   responses	   through	   activation	   of	   these	   cells	   and	   the	   anti-­‐
inflammatory	   cytokine	   producing	   cells,	   Th2	   (119).	   	   The	   evident	   Th1	   polarised	  
state	  may	  therefore	  be	  largely	  contributable	  to	  the	  observed	  NASH	  phenotype	  
in	  OffOb-­‐OD.	  	  
	  
6.4.4	  Kupffer	  Cell	  Phagocytic	  Function	  
Rodents	   possess	   at	   least	   two	   KC	   subtypes,	   determined	   by	   the	   extent	   of	  
phagocytic	   capacity.	   	  Reduced	  phagocytic	   function	   in	   the	  context	  of	   increased	  
KC	   number	   is	   reported	   here.	   	   	   These	   findings	   are	   corroborated	   by	   previous	  
studies	   in	   rodent	   models	   of	   obesity	   and	   NAFLD	   and	   in	   patients	   with	   biopsy	  
proven	   NASH	   (215,	   216).	   	   Additionally,	   main	   effects	   were	   observed	   for	   both	  
maternal	  and	  post-­‐natal	  diets	  with	  a	  significant	  interaction	  between	  these	  two	  
variables	  for	  impaired	  KC	  phagocytosis.	  	  Impaired	  KC	  phagocytosis	  evokes	  over-­‐
production	  and	  sensitivity	  to	  the	  aforementioned	  key	  inflammatory	  mediators,	  
enhancing	   hepatic	   inflammation	   and	   further	   propagating	   injury	   in	   NAFLD.	  	  
Moreover,	   	   reduced	  clearance	  of	  dead	  cells	  and	   lipopolysaccharide	  generate	  a	  
hyper-­‐endotoxaemic	  state	  to	  potentiate	  pro-­‐inflammatory	  pathways	  (205).	  
	  
6.4.5	  NK-­‐T	  Cells	  
Regarding	   NK-­‐T	   cells,	   these	   are	   presently	   thought	   to	   modulate	   inflammatory	  
responses	   by	   achieving	   a	   balance	   between	   Th-­‐1	   and	   Th-­‐2	   polarisation	   states	  
within	  the	  liver.	  	  NK-­‐T	  cell	  depletion	  has	  been	  associated	  with	  worsened	  NAFLD	  
phenotypes,	  not	  only	  in	  this	  present	  study	  but	  also	  in	  the	  ob/ob	  leptin	  deficient	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mice	  (126)	  and	   in	  models	  of	  diet-­‐induced	  NAFLD	  (217).	   	  Here,	   it	   is	  shown	  that	  
maternal	   obesity	   interacts	   with	   the	   post-­‐weaning	   diet	   to	   influence	   NK-­‐T	   cell	  
numbers.	   	   The	   mechanism	   under-­‐pinning	   the	   inverse	   relationship	   between	  
hepatosteatosis	  and	  NK-­‐T	  cells	  or	  their	  subtypes	  is	  unclear.	  We	  report	  here	  an	  
increase	   in	   the	   expression	   of	   IL-­‐12,	   in	   offspring	   exposed	   to	   maternal	   obesity	  
and/or	   a	   post-­‐natal	   obesogenic	   diet.	   This	   increase	   in	   IL-­‐12	   expression	   is	   of	  
pathogenic	  relevance	  because	  IL-­‐12	  has	  been	  shown	  to	  promote	  NK-­‐T	  cell	  death	  
(127).	  	  	  
	  
However,	   it	   is	   also	   known	   that	   fatty	   acids	   from	   impaired	   lipid	  metabolism	   or	  
high	  dietary	   intake	  of	   fat	   induce	   invariant	  and	  non-­‐variant	  NK-­‐T	  cell	  depletion	  
via	   altered	   CD1d	   antigen	   presentation	   by	   hepatocytes	   (121,	   201).	   	   It	   is	   not	  
known	  how	  these	  fatty	  acids	  alter	  endogenous	  lipid	  ligands	  although	  it	  has	  been	  
suggested	  by	  Ichi	  and	  colleagues,	  that	  alterations	  in	  liver	  ceramides,	  which	  are	  
likely	  antigens	  for	  NK-­‐T	  cells,	  may	  be	  responsible	  (218).	  	  Additionally,	  it	  has	  been	  
suggested	   that	   hepatosteatosis	   reduces	   hepatic	   CD1d	   expression	   as	   lipid	  
loading	  reduces	  trafficking	  of	  CD1d	  to	  the	  cell	  surface,	  further	  reducing	  antigen	  
presenting	   capabilities	   to	   NK-­‐T	   cells	   in	   the	   ob/ob	   mouse	   model	   (125).	   	   So	  
therefore,	   reduction	   of	   NK-­‐T	   cell	   mediated	   anti-­‐inflammatory	   cytokine	  
responses	  may	  be	  the	  result	  of	  impaired	  CD1d	  dependent	  antigen	  presentation	  
to	   NK-­‐T	   cells	   in	   addition	   to	   KC	   mediated	   cytokine	   depletion	   of	   NKT	   cells,	  
potentiating	  NAFLD	  progression.	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Given	   that	  CD1d	   is	  also	  necessary	   for	  maintaining	  NKT	  cell	  homeostasis	   (125),	  
measurement	   of	   hepatocyte	   CD1d	   expression	   would	   provide	   further	  
information	   about	   the	   mechanistic	   association	   between	   programmed	   NAFLD	  
and	  selective	  NKT	  cell	  depletion.	  	  This	  study	  relies	  upon	  NK1.1	  immunoselection	  
to	   innumerate	   NKT	   cell	   number.	   	   However,	   given	   that	   NK1.1	   cell	   surface	  
expression	  varies	  with	  cell	  maturation,	  activation	  and	  positively	  selects	  all	  NKT	  
cell	   subtypes,	   these	   preliminary	   findings	   and	   their	   putative	   association	   in	  
programmed	  NAFLD	  must	  be	  confirmed	  in	  NKT	  cells	  co-­‐expressing	  the	  invariant	  




In	   conclusion,	   it	   has	   been	   shown	   that	   a	   post-­‐natal	   obesogenic	   diet,	   in	   the	  
context	   of	   prior	   exposure	   to	   maternal	   obesity,	   leads	   to	   heightened	   hepatic	  
injury	   indicative	  of	   non-­‐alcoholic	   steatohepatitis,	   of	   greater	   severity	   than	   that	  
induced	   by	   the	   obesogenic	   diet	   alone.	   Therefore,	   maternal	   obesity	   through	  
developmental	   programming,	   via	   changes	   induced	   during	   gestation	   and	  
lactation,	   may	   be	   compounding	   the	   effects	   of	   a	   hyper-­‐calorific	   post-­‐weaning	  
environment,	  causing	  a	  worsened	  hepatic	  phenotype.	  	  
	  
Offspring	   exposed	   to	   maternal	   obesity	   and	   a	   post-­‐natal	   obesogenic	   diet,	  
uniquely	   have	   significant	   disturbance	   of	   the	   hepatic	   innate	   immune	   system,	  
with	   reduced	   NK-­‐T	   cell	   populations,	   probably	   secondary	   to	   demonstrated	  
increased	  IL-­‐12	  expression,	  along	  with	  increases	  in	  Kupffer	  cell	  numbers,	  which	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have	   perturbed	   phagocytic	   function	   but	   raised	   ROS	   production,	   further	  
propagating	  liver	  injury.	  	  
The	  mechanisms	  of	  programming	  are	  unknown,	  although	  it	  is	  accepted	  that	  its	  
aetiopathogeneis	   is	   multifactorial.	   	   Given	   the	   complex	   pathogenic	   pathways	  
implicated	   in	   programmed	   offspring	   NAFLD	   by	   maternal	   over-­‐nutrition,	   it	   is	  
likely	   that	   changes	   at	   the	   cellular,	   sub-­‐cellular	   and	   epigenetic	   level	   are	  
responsible.	  	  Having	  preliminarily	  investigated	  cellular	  responses	  of	  the	  hepatic	  
innate	   immune	   system	   to	   maternal	   obesity,	   Chapter	   7	   will	   investigate	   the	  





























7	  Investigation	  of	  Mechanisms	  through	  
which	  Maternal	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7	   Investigation	   of	   Mechanisms	   through	   which	   Maternal	   Obesity	   Programs	  
Offspring	  NAFLD	  –	  A	  Role	  for	  Molecular	  Circadian	  Rhythms	  	  	  
	  
7.1	  Introduction	  	  
	  
The	  biological	  circadian	  clock	   is	  a	   transcriptional	  mechanism	  that	  synchronises	  
physiological	  and	  behavioural	  processes	  to	  co-­‐ordinate	  daily	  rhythms	  in	  feeding	  
behaviour,	  rest/activity	  and	  energy	  utilisation	  within	  a	  24	  hour	  light/dark	  cycle	  
(72,	  219).	  	  The	  molecular	  machinery	  encoding	  the	  biological	  clock,	  contained	  in	  
almost	  every	   cell	  of	   the	  body,	   involves	  a	   transcriptional/translational	  negative	  
feedback	  loop	  in	  which	  the	  transactivation	  of	  E-­‐box	  containing	  genes	  by	  CLOCK	  
(circadian	   locomotor	   output	   kaput	   cycles)	   and	   BMAL1	   (brain	   and	  muscle	   anrt	  
like	   1)	   is	   inhibited	  by	   the	   repressors,	   Periods	   and	  Cryptochromes.	   	   Regulatory	  
accessory	   pathways	   involving	   REV-­‐ERB-­‐α	   and	   other	   members	   of	   the	   nuclear	  
receptor	   family	   stabilise	   the	   circadian	   clock	   through	   repressive	   and	   inductive	  
activities	  on	  BMAL1	  (219).	  	  	  
	  
This	   cyclical	   process	   occurs	   in	   the	   suprachiasmatic	   nucleus	   (SCN)	   of	   the	  
hypothalamus,	   as	   well	   as	   in	   most	   mammalian	   cells,	   to	   achieve	   metabolic	  
homeostasis.	  	  	  The	  molecular	  machinery	  in	  the	  SCN	  is	  referred	  to	  as	  the	  master	  
clock	   and	   is	   the	   pace-­‐setter	   for	   all	   peripheral	   clocks.	   	   The	   master	   clock	   is	  
predominantly	  entrained	  by	  light,	  given	  the	  direct	  nervous	  connection	  between	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the	   retina	   and	   the	   hypothalamus	   via	   the	   retino-­‐hypothalamic-­‐tract	   (RHT).	   	   In	  
addition	  to	  light	  entrainment	  via	  the	  SCN,	  peripheral	  clocks	  have	  been	  shown	  to	  
be	  entrainable	  by	  nutrients	  and	  temperature	  (70,	  220).	  	  The	  synchronisation	  of	  
the	  central	  and	  peripheral	  clocks	   is	  achieved	  through	  autonomic	  activity,	  body	  
temperature	  and	  hormones	  (221,	  222).	  	  Glucocorticoid	  signalling,	  as	  an	  example	  
of	   such	   a	   systemic	   cue,	   has	   been	   shown	   to	   regulate	   transcription	   of	   a	   few	  
canonical	   clock	  genes	   in	  peripheral	   cells	   (223,	  224)	  as	  well	   as	   synchronise	   the	  
liver	  clock	  in	  vivo	  (225).	  	  	  	  	  
	  
The	   association	   between	   the	   molecular	   circadian	   clock	   and	   metabolism	   has	  
been	   highlighted	   in	   numerous	   experimental	   models	   including	   homozygous	  
CLOCK	  mutant	  mice	  which	  have	  been	   reported	   to	   be	  hyperphagic,	   obese	   and	  
hyper-­‐leptinaemic	  and	  develop	  hepatosteatosis	  (72).	  	  Moreover,	  a	  high	  fat	  diet	  
in	   rodents	   has	   been	   reported	   to	   alter	   the	   expression	   and	   rhythmicity	   of	  
canonical	   circadian	   clock	   genes	   and	   nuclear	   receptors,	   which	   regulate	   clock	  
transcription	  factors	  in	  peripheral	  tissues	  (73).	  	  Additionally,	  expression	  of	  genes	  
encoding	  lipogenesis,	  lipolysis	  and	  gluconeogenesis	  have	  been	  shown	  to	  posses	  
rhythmic	   variation	   over	   a	   circadian	   period,	   suggesting	   that	   there	   is	   a	   close	  
association	   between	   metabolism	   and	   the	   periodicity	   of	   transcription	  
programmed	  by	  the	  circadian	  clock	  (71,	  226-­‐228).	  	  	  	  
	  
Interestingly,	   an	   increased	   susceptibility	   to	   obesity,	   dysmetabolism,	  
cardiovascular	  disease	  and	  cancer	  has	  been	  observed	  in	  shift	  workers	  exposed	  
to	  prolonged	  periods	  of	  darkness	  or	  unnatural	  exposure	  to	  light	  and	  dark	  (229-­‐
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231).	  	  It	  was	  suggested	  that	  the	  observed	  increased	  risk	  was	  due	  to	  the	  inhibited	  
synchronisation	  of	  the	  biological	  master	  clock	  with	  environmental	  cues,	  causing	  
central	  and	  systemic	  disruption	  of	  normal	  circadian	  rhythms	  (230).	  	  	  	  
	  
A	   growing	   body	   of	   evidence	   demonstrates	   the	   effects	   of	   disrupted	   circadian	  
rhythms	  on	  metabolic	  homeostasis,	  but	  much	   less	  evidence	  documenting	  how	  
metabolic	  processes	  alter	   the	  circadian	  clock	  exists.	   	   In	  a	  diet	   induced	  obesity	  
rodent	   model,	   Bass	   and	   colleagues	   demonstrated	   behavioural	   and	   molecular	  
disruption	   of	   circadian	   rhythms	   (72).	   	   These	   findings	   are	   supported	   by	   earlier	  
observations	  of	  metabolic	  transcripts	  binding	  to	  promoter	  regions	  of	  CLOCK	  and	  
BMAL1	   and	   demonstration	   of	   transcription	   factors	   involved	   in	   adipogenesis	  
such	  as	  REV-­‐ERB-­‐α,	  regulating	  the	  molecular	  clock	  machinery	  (232).	  
	  
So,	  therefore,	  an	  established	  association	  between	  nutrient	  status	  and	  pathways	  
governing	   circadian	   transcription	   exists.	   	   It	   is	   thus	   plausible	   that	   the	   hyper-­‐
calorific	   maternal	   milieu	   could	   alter	   circadian	  molecular	   circuitry	   in	   the	   liver,	  
increasing	   offspring	   susceptibility	   to	   metabolic	   liver	   disease	   such	   as	   NAFLD.	  	  
Here,	   the	   aims	   were	   to	   investigate	   the	   mechanistic	   role	   of	   hepatic	   circadian	  
rhythms	   in	   a	   pathophysiologically	   relevant	   model	   of	   programmed	   offspring	  
NAFLD	   induced	   via	   maternal	   obesity	   and	   a	   post-­‐weaning	   hyper-­‐calorific,	  








7.2.1	  Animal	  Experimentation	  
Female	   C57BL/6J	  mice	   (n	   =	   20	   per	   group)	   (Charles	   River	   Laboratories,	  UK),	   of	  
first	  order	  parity,	  approximately	  100	  days	  old	  were	  allowed	  7	  days	  to	  habituate	  
following	   transfer	   to	   the	   facility	   and	   fed	   standard	   chow	   RM1	   (Special	   Dietary	  
Services,	  energy	  3.5	  kcal/g)	  ad	  libitum.	  
Following	  acclimatisation,	  female	  mice	  were	  randomised	  to	  either	  a	  control	  or	  
experimental	   group	   and	   fed	   standard	   chow	   or	   a	   semi-­‐synthetic	   energy-­‐rich,	  
highly	   palatable	   obesogenic	   diet	   	   (Special	   Dietary	   Services,	   energy	   4.5	   kcal/g)	  
supplemented	  with	   sweetened	  condensed	  milk	   (Nestle)	   admixed	  with	  mineral	  
mix	  (Special	  Dietary	  Services,	  125	  mg/pot)	  ad	  libitum.	  	  All	  mice	  were	  maintained	  
on	  a	  12:12	  LD	  cycle.	  
	  
Dams	   were	   maintained	   on	   their	   respective	   diets	   for	   6-­‐8	   weeks	   and	  
macronutrient	  and	  calorific	   intake	  were	  calculated	  from	  measured	  daily	   intake	  
of	  pellets	  and	  milk	  	  	  Upon	  attainment	  of	  mean	  30%	  increase	  in	  body	  weight	  of	  
the	   experimental	   group,	   mice	   were	   entered	   into	   the	   breeding	   protocol.	   	   All	  
animals	   were	   treated	   in	   accordance	   with	   The	   Animals	   (Scientific	   Procedures)	  
Act,	  UK,	  1986	  guidelines.	  
	  
Pregnant	   dams	   were	   continued	   on	   their	   pre-­‐conception	   diets	   throughout	  
pregnancy	  and	  lactation.	  	  During	  pregnancy,	  maternal	  weight	  and	  dietary	  intake	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were	  recorded	  weekly.	  Subgroups	  of	  male	  and	  female	  offspring	  (n	  =	  20)	  born	  to	  
and	  suckled	  by	  lean	  dams	  or	  born	  to	  and	  suckled	  by	  obese	  dams	  were	  weaned	  
on	  to	  either	  normo-­‐calorific	  or	  semi	  synthetic	  obesogenic	  diet	  with	  condensed	  
milk	  supplementation,	  constituting	  a	  diet	  high	  in	  sugar	  and	  fat	  as	  per	  Phase	  4	  of	  
the	   model	   (Figure	   2.6).	   	   All	   readouts	   were	   compared	   to	   the	   control	   group,	  
offspring	   of	   lean	   suckled	   by	   lean	   dams	   and	   weaned	   onto	   standard	   chow	  
(OffCon-­‐SC).	  	  At	  6	  months,	  offspring	  were	  sacrificed	  at	  4	  hourly	  intervals	  across	  
the	  24	  hour	  LD	  cycle	  to	  obtain	  liver	  tissue.	  	  	  
	  
7.2.2	  Body	  and	  Liver	  Weights	  
Offspring	   bodyweight	   was	   measured	   prior	   to	   sacrificing	   using	   a	   schedule-­‐1	  
method.	  	  Livers	  were	  excised	  and	  weights	  recorded	  using	  a	  balance	  accurate	  to	  
4	  decimal	  places.	  
	  
7.2.3	  Tissue	  Collection	  
Offspring	   liver	   tissue	   was	   differentially	   preserved	   for	   use	   in	   gene	   expression	  
analysis,	  histology	  and	  methylation	  analysis.	  	  Briefly,	  whole	  liver	  tissue	  was	  snap	  
frozen	   in	   liquid	   nitrogen,	   preserved	   in	   RNAlater	   solution	   or	   dissected	   using	  
middle	  orientation	  and	  stored	  in	  10%	  neutral	  buffered	  formalin	  prior	  to	  paraffin	  
embedding.	  	  Offspring	  blood	  was	  collected	  via	  cardiac	  puncture	  or	  inferior	  vena	  
cava	  cannulation	  using	  heparinised	  syringes.	  	  The	  blood	  was	  centrifuged	  at	  3000	  
x	  g	  for	  10	  minutes	  at	  4˚C	  and	  decanted	  plasma	  stored	  at	  -­‐20˚C	  until	  biochemical	  
analysis.	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7.2.4	  Serum	  Analysis	  
Alanine	   transaminase	   was	   measured	   by	   the	   local	   clinical	   biochemistry	  
department.	  
	  
7.2.5	  Liver	  Tissue	  Triglyceride	  
Whole	   liver	   tissue	   triglyceride	  was	   determined	   by	   an	   adaptation	   of	   the	   Folch	  
Method	   using	   an	   enzymatic	   colorimetric	   assay	   (UNIMATE	   5	   TRIG,	   Roche	   BC1.	  	  
Sussex,	  UK).	   	  Approximately	  0.05g	  of	   liver	   tissue	  per	   sample	  was	  used	  and	  all	  
results	  normalised	  to	  sample	  quantity.	  
	  
7.2.6	   Gene	   Expression	   of	   Pro-­‐inflammatory	   and	   Fibrogenic	   Cytokines	   and	  
Canonical	  Circadian	  Transcripts	  
Real	  Time	  Polymerase	  Chain	  Reaction	  (RT-­‐PCR)	  was	  performed	  using	  QuantiTect	  
SYBR	   Green	   PCR	   System	   with	   HotStar	   Taq	   DNA	   Polymerase	   (Qiagen).	   	   Gene	  
specific	   primers	   were	   designed	   for	   IL-­‐6,	   TNF-­‐α,	   α–Smooth	   Muscle	   Actin	   (α-­‐
SMA),	  transforming	  growth	  factor-­‐β	  (TGF-­‐β)	  and	  collagen	  Type	  1-­‐α2	  (Col	  1-­‐α2)	  
(Table	   2.3).	   	   Quantitect	   Primer	   Assays	   (Qiagen)	   using	   SYBR	   green	   based	  
detection	  were	   used	   for	   CLOCK,	   BMAL1,	   Period	   1,	   Period	   2,	   Cryptochrome	   1,	  
Cryptochrome	   2	   and	   REV-­‐ERB-­‐α	   (Table	   2.4).	   	   Expression	   of	   target	   genes	   was	  
normalised	  to	  GAPDH	  expression.	  	  
	  
7.2.7	  Histology	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Offspring	   liver	   sections	   at	   6	   months	   of	   age	   were	   formalin	   (10%)	   fixed	   and	  
paraffin	   embedded	   prior	   to	   sectioning.	   	   All	   sections	   were	   then	   stained	   with	  
haematoxylin	  and	  eosin	  (H&E)	  and	  Masson’s	  Trichrome	  to	  assess	  steatosis	  and	  
inflammation	  and	  fibrosis,	  respectively.	  	  The	  Brunt-­‐Kleiner	  NAFLD	  Activity	  Score	  
was	   used	   to	   quantitatively	   assess	   the	   degree	   of	   injury	   by	   an	   expert	   liver	  
pathologist	  blinded	  to	  the	  identity	  of	  the	  groups.	  
	  
7.2.8	  Statistical	  Analysis	  
Multiple	  comparisons	  on	  a	  single	  data	  set	  were	  performed	  using	  one-­‐way	  and	  
two-­‐way	  (2x2	  factorial)	  ANOVA	  followed	  by	  Tukey’s	  post	  hoc	  test	  and	  expressed	  
as	   mean	   ±	   SEM	   unless	   otherwise	   stated.	   	   Cosinor	   analysis	   was	   used	   to	  
determine	  rhythmicity	  within	  a	  24	  hour	  period,	  evaluating	  the	  mesor	  (circadian	  
rhythm	  adjusted	  mean	  based	  on	  the	  parameters	  of	  a	  cosine	  function),	  timing	  of	  
the	   oscillatory	   crest	   and	   amplitude.	   	   p	   <	   0.05	   was	   regarded	   as	   significant.	  	  




7.3.1	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐natal	  obesogenic	  diet	  
induces	  non-­‐alcoholic	  steatohepatitis	  (NASH)	  and	  hepatic	  fibrosis	  at	  6	  months	  
To	   validate	   the	   experimental	   model	   prior	   to	   investigation	   of	   potential	  
mechanisms,	   biochemical	   and	   histological	   assessment	   of	   hepatosteatosis	   and	  
liver	  injury	  was	  performed.	  	  Main	  effects	  were	  observed	  for	  both	  maternal	  and	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post-­‐natal	  diets	  with	  a	   significant	   interaction	  between	   these	   two	  variables	   for	  
offspring	  liver	  weight,	  serum	  ALT,	  hepatic	  TG	  and	  NAS.	  	  	  
	  
Greater	   fat	   infiltration	   in	  offspring	  exposed	  to	  a	  post-­‐weaning	  obesogenic	  diet	  
(OffCon-­‐OD)	  compared	  to	  controls	  (OffCon-­‐SC)	  was	  observed.	  	  Prior	  exposure	  to	  
maternal	   obesity	   followed	   by	   a	   post-­‐weaning	   obesogenic	   diet	   resulted	   in	  
exacerbated	   and	   profound	   hepatosteatosis	   with	   development	   of	   NASH	   as	  
evidenced	  by	  histological	  liver	  injury,	  confirmed	  by	  the	  increased	  Brunt-­‐Kleiner	  
NAFLD	  Activity	  Score	  >	  5.	   	  Additionally,	   serum	  ALT,	  hepatomegaly	  and	  hepatic	  
tissue	  triglyceride	  concentrations	  were	  significantly	  raised	  in	  offspring	  exposed	  
to	  both	  periods	  of	  hyper-­‐nutritional	  insult	  (Figure	  7.1).	  	  	  
	  
Moreover,	   these	   offspring	   developed	   pericellular	   fibrosis	   at	   6	   months	   as	  
confirmed	   by	   Masson’s	   Trichrome	   staining	   for	   collagen	   (Figure	   7.2).	   	   The	  
disproportionately	   enhanced	   fatty	   liver	   phenotype	   in	   OffOb-­‐OD	   is	   due	   to	  
interactions	  between	  maternal	  obesity	  and	  the	  post-­‐weaning	  obesogenic	  diet	  as	  
confirmed	   by	   two-­‐way	   ANOVA	   for	   serum	   ALT,	   hepatomegaly	   and	   hepatic	  
triglyceride	  content	  (p	  <	  0.05).	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Figure	  7.1	  Biochemical	  Evidence	  of	  Hepatic	   Injury	  and	  Steatosis	  at	  6	  months:	  
(A)	  Liver	  Weight,	  (B)	  Serum	  ALT,	  (C)	  Hepatic	  Triglyceride	  Content	  and	  (D)	  NAFLD	  
Activity	  Score.	  	  Offspring	  exposure	  to	  maternal	  obesity	  in	  the	  context	  of	  a	  post-­‐
weaning	  hyper-­‐calorific	  diet	  significantly	  exacerbated	  hepatosteatosis	  and	  liver	  
injury.	  	  Offspring	  of	  lean	  suckled	  by	  lean	  weaned	  on	  to	  standard	  chow	  –	  OffCon-­‐
SC;	  offspring	  of	   lean	   suckled	  by	   lean	  weaned	  on	   to	  obesogenic	  diet	  –	  OffCon-­‐
OD;	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  standard	  chow	  –	  OffOb-­‐
SC	   and	   offspring	   of	   obese	   suckled	   by	   obese	  weaned	   on	   to	   obesogenic	   diet	   –	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OffOb-­‐OD.	   	  n	  =	  5	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM,	  one-­‐way	  ANOVA.	  	  	  
*Mean	   values	   significantly	   greater	   than	   OffCon-­‐SC	   (p	   <	   0.05).	   #Mean	   values	  
significantly	   greater	   than	   OffCon-­‐OD	   (p	   <	   0.05).	   	   §Mean	   values	   significantly	  
greater	  than	  OffOb-­‐SC	  (p	  <	  0.05).	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Figure	  7.2	  Histological	  Evidence	  of	  Hepatic	  Steatosis	  and	  Fibrosis	  at	  6	  months:	  
(A)	   Representative	   H&E	   sections	   and	   (B)	   Representative	   Masson’s	   Trichrome	  
sections.	   	   Offspring	   exposure	   to	   maternal	   obesity	   in	   the	   context	   of	   a	   post-­‐
weaning	   hyper-­‐calorific	   diet	   significantly	   exacerbated	   hepatosteatosis	   and	  
fibrosis.	   	   Offspring	   of	   lean	   suckled	   by	   lean	   weaned	   on	   to	   standard	   chow	   –	  
OffCon-­‐SC;	   offspring	   of	   lean	   suckled	   by	   lean	  weaned	   on	   to	   obesogenic	   diet	   –	  
OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  standard	  chow	  –	  
OffOb-­‐SC	   and	   offspring	   of	   obese	   suckled	   by	   obese	  weaned	   on	   to	   obesogenic	  
diet	  –	  OffOb-­‐OD.	   	  n	  =	  4-­‐6	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM,	  one-­‐way	  
ANOVA.	  	  	  *Mean	  values	  significantly	  greater	  than	  OffCon-­‐SC	  (p	  <	  0.05).	  #Mean	  
values	   significantly	   greater	   than	   OffCon-­‐OD	   (p	   <	   0.05).	   	   §Mean	   values	  
significantly	  greater	  than	  OffOb-­‐SC	  (p	  <	  0.05).	  
	  
7.3.2	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐weaning	  obesogenic	  
diet	  disrupts	  rhythmic	  expression	  of	  canonical	  circadian	  activators	  in	  the	  liver	  
mRNA	   transcripts	   of	   BMAL1,	   an	   activator	   of	   the	   transcriptional-­‐translation	  
feedback	   loop	   governing	   biological	   circadian	   rhythms,	   was	   significantly	  
perturbed	   following	   exposure	   to	   a	   post-­‐weaning	   obesogenic	   diet.	   	   Gene	  
expression	   was	   further	   attenuated	   following	   additional	   exposure	   to	  maternal	  
obesity.	   	  Moreover	   peak	   expression	   of	   BMAL1	   transcripts	   in	   control	   offspring	  
and	   those	  exposed	   to	  only	  maternal	  obesity	  were	  observed	  at	  CT20	  or	  at	   the	  
beginning	  of	   the	   light	   phase	  of	   the	  24	  hour	  period.	   	  However,	   amplitudes	   for	  
OffCon-­‐OD	  and	  OffOb-­‐OD	  were	  recorded	  at	  CT12	  and	  CT16,	  respectively,	  or	   in	  
the	  dark	  phase	  (Figure	  7.3).	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Exposure	  to	  a	  post-­‐weaning	  obesogenic	  diet	  had	  negligible	  affects	  on	  rhythmic	  
transcription	   of	   CLOCK	   over	   the	   24	   hour	   period	   as	   compared	   to	   controls.	  	  
Interestingly,	  exposure	  to	  maternal	  obesity	  alone	  induced	  a	  significant	  increase	  
in	   mRNA	   expression	   at	   CT16	   or	   at	   the	   end	   of	   the	   dark	   phase.	   	   Additional	  
exposure	   to	   maternal	   obesity	   induced	   a	   biphasic	   circadian	   rhythm	   of	   CLOCK	  
gene	   expression	  with	  maxima	   observed	   at	   CT12	   (dark	   phase)	   and	   CT20	   (light	  
phase)	  (Figure	  7.3).	   	  Moreover,	  two-­‐way	  ANOVA	  analysis	  revealed	  a	  significant	  
interaction	  between	  the	  maternal	  and	  post-­‐natal	  environments	  for	  CLOCK	  gene	  
expression	   at	   CT16	   (p	   =	   0.0127).	   	   So	   therefore,	   exposure	   to	  maternal	   obesity	  
and	   a	   post-­‐weaning	   obesogenic	   diet	   significantly	   disrupts	   normal	   circadian	  
rhythms	  of	  activating	  canonical	  clock	  genes	  in	  offspring	  with	  induced	  NAFLD.	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Figure	   7.3	   Hepatic	   circadian	   gene	   expression	   of	   BMAL1	   and	   CLOCK	   are	  
disrupted	   in	   offspring	   with	   programmed	   NAFLD:	   (A)	   BMAL1	   mRNA	   and	   (B)	  
CLOCK	  mRNA.	  	  Offspring	  of	  lean	  suckled	  by	  lean	  weaned	  on	  to	  standard	  chow	  –	  
OffCon-­‐SC;	   offspring	   of	   lean	   suckled	   by	   lean	  weaned	   on	   to	   obesogenic	   diet	   –	  
	   244	  
OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  standard	  chow	  –	  
OffOb-­‐SC	   and	   offspring	   of	   obese	   suckled	   by	   obese	  weaned	   on	   to	   obesogenic	  
diet	  –	  OffOb-­‐OD.	   	  Solid	  bars	   -­‐	  dark,	   clear	  bars	   -­‐	   light.	   	  n	  =	  5	  per	  group,	  values	  
shown	  are	  mean	  ±	  SEM,	  one-­‐way	  ANOVA.	   	   	  *Mean	  values	  significantly	  greater	  
than	  OffCon-­‐SC	  (p	  <	  0.05).	  #Mean	  values	  significantly	  greater	  than	  OffCon-­‐OD	  (p	  
<	  0.05).	  	  §Mean	  values	  significantly	  greater	  than	  OffOb-­‐SC	  (p	  <	  0.05).	  
	  
7.3.3	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐weaning	  obesogenic	  
diet	  disrupts	  rhythmic	  expression	  of	  canonical	  circadian	  repressors	  in	  the	  liver	  
The	  Cryptochrome	   (Cry)	  and	  Period	   (Per)	  genes	  are	  negative	   regulators	  of	   the	  
core	  clock	  molecular	  network,	  repressing	  BMAL	  and	  CLOCK	  co-­‐transcription	  and	  
therefore	   cellular	   circadian	   rhythmicity.	   	   Cry	   1	  was	   significantly	   attenuated	   in	  
offspring	  exposed	  to	  a	  post-­‐weaning	  obesogenic	  diet	  and/or	  maternal	  obesity	  at	  
CT20	   compared	   to	  OffOb-­‐SC	   and	  OffCon-­‐SC.	   	   Additionally,	   peak	   expression	   of	  
this	   circadian	   transcript	   in	  OffCon-­‐OD	  and	  OffOb-­‐OD	  was	  observed	  at	  CT12	  or	  
the	  dark	  phase	  unlike	  control	  offspring	  in	  which	  the	  amplitude	  was	  observed	  in	  
the	  light	  phase	  (CT20)	  (Figure	  7.4).	  	  	  
	  
Cry	   2	   however,	   showed	  minimal	   diurnal	   or	   circadian	   variation	   in	   transcription	  
over	   the	   24	   hour	   period	   in	  OffCon-­‐SC	   and	  OffCon-­‐OD.	   	   Exposure	   to	  maternal	  
obesity	   however,	   induced	   a	   significant	   increase	   in	   expression	   at	   CT12,	   which	  
was	  profoundly	  exacerbated	  in	  offspring	  additionally	  exposed	  to	  a	  post-­‐weaning	  
obesogenic	  diet	  at	  CT16.	  	  There	  was	  an	  independent	  effect	  of	  maternal	  obesity	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on	   Cry	   2	  mRNA	   expression	   at	   CT16	   (p	   =	   0.0143)	  with	   evidence	   of	   interaction	  
between	  the	  maternal	  and	  post-­‐natal	  diets	  (p	  =	  0.0428)	  (Figure	  7.4).	  
Similar	   rhythmic	   disturbance	   following	   exposure	   to	   maternal	   obesity	   was	  
observed	   for	   Per1	   transcription.	   	   OffOb-­‐SC	   displayed	   increased	   expression	  
compared	  to	  all	  other	  groups	  at	  CT12	  (dark	  phase).	  	  The	  control	  group	  similarly	  
peaked	   at	   this	   time	   point,	   although	   relative	   transcript	   expression	   was	  
significantly	   less.	   	   Alternatively,	   exposure	   to	   a	   post-­‐weaning	   obesogenic	   diet	  
induced	  peak	  transcription	  in	  the	  light	  phase	  at	  CT20	  with	  enhanced	  expression	  
in	  offspring	  exposed	  to	  maternal	  obesity	  in	  addition	  (Figure	  7.4).	  	  	  There	  was	  an	  
independent	  effect	  of	  maternal	  obesity	  on	  Per1	  mRNA	  expression	  at	  CT20	  (p	  =	  
0.0028)	  with	  evidence	  of	  a	  significant	   interaction	  between	  maternal	  and	  post-­‐
natal	  diets	  (p	  =	  0.0008).	  
	  
Offspring	   exposure	   to	   maternal	   obesity	   and	   a	   post-­‐weaning	   obesogenic	   diet	  
significantly	  increased	  gene	  expression	  of	  Per2	  at	  CT12	  compared	  to	  those	  fed	  a	  
hyper-­‐calorific	   diet	   post-­‐weaning	   only	   or	   the	   control	   group.	   	   Again,	   an	  
independent	  effect	  of	  maternal	  obesity	  on	  rhythmic	  transcription	  of	  Per2	  at	  this	  
time	  point	  was	  observed	  (p	  <	  0.0001)	   	   (Figure	  7.4).	   	  So	  therefore,	  exposure	  to	  
maternal	  obesity	  and/or	  an	  obesogenic	  diet	  post-­‐weaning,	  significantly	  perturbs	  
normal	   rhythmic	   expression	  of	   the	   period	   and	   cryptochrome	   genes	   over	   a	   24	  
hour	   period.	   	   More	   specifically,	   gene	   expression	   of	   Per1,	   Per2	   and	   Cry	   2	   is	  
enhanced	  whilst	   Cry1	   is	   attenuated	   at	   given	  CT	   points	  within	   the	   sampled	   24	  
hour	  period.	  	  This	  is	  attributable	  to	  independent	  maternal	  effects	  and	  significant	  
interactions	  between	  the	  maternal	  and	  post-­‐natal	  diets.	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Figure	   7.4	  Hepatic	   circadian	   gene	   expression	   of	   Period	   and	   Cryptochrome	   is	  
disrupted	   in	   offspring	   with	   programmed	   NAFLD:	   (A)	   Cry1	   mRNA,	   (B)	   Cry2	  
mRNA,	   (C)	  Per1	  mRNA	  and	   (D)	  Per2	  mRNA.	   	  Offspring	  of	   lean	   suckled	  by	   lean	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weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	   offspring	   of	   lean	   suckled	   by	   lean	  
weaned	  on	  to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  
weaned	   on	   to	   standard	   chow	   –	   OffOb-­‐SC	   and	   offspring	   of	   obese	   suckled	   by	  
obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐OD.	  	  Solid	  bars	  -­‐	  dark,	  clear	  bars	  –	  
light.	  n	  =	  5	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM,	  one-­‐way	  ANOVA.	  	  	  *Mean	  
values	  significantly	  greater	  than	  OffCon-­‐SC	  (p	  <	  0.05).	  #Mean	  values	  significantly	  
greater	   than	   OffCon-­‐OD	   (p	   <	   0.05).	   	   §Mean	   values	   significantly	   greater	   than	  
OffOb-­‐SC	  (p	  <	  0.05).	  
	  
7.3.4	   Offspring	   exposure	   to	   maternal	   obesity	   and/or	   a	   post-­‐weaning	  
obesogenic	  diet	  attenuates	  rhythmic	  expression	  of	  REV-­‐ERB-­‐α	  in	  the	  liver	  
REV-­‐ERB-­‐α	   is	  an	  accessory	  regulator	  of	   the	  molecular	  clock	  through	  repressive	  
induction	  of	  BMAL1.	   	  Exposure	  to	  maternal	  obesity	  and/or	  an	  obesogenic	  diet	  
significantly	   attenuated	   REV-­‐ERB-­‐α	   expression	   at	   CT4	   compared	   to	   OffCon-­‐SC	  
and	  OffOb-­‐SC.	  	  Rhythmic	  expression	  of	  this	  gene	  was	  otherwise	  similar	  across	  all	  
groups	  within	   the	   24	   hour	   period.	   	   These	   findings	   corroborate	   the	   decreased	  
BMAL1	  expression	  observed	  in	  OffCon-­‐OD	  and	  OffOb-­‐OD	  (Figure	  7.5).	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Figure	   7.5	   Hepatic	   circadian	   gene	   expression	   of	   REV-­‐ERB-­‐α	   is	   disrupted	   in	  
offspring	   exposed	   to	   a	   post-­‐weaning	   obesogenic	   diet:	   (A)	   REV-­‐ERB-­‐α	  mRNA.	  	  	  
Offspring	   of	   lean	   suckled	   by	   lean	   weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	  
offspring	  of	   lean	   suckled	  by	   lean	  weaned	  on	   to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  
offspring	  of	  obese	   suckled	  by	  obese	  weaned	  on	   to	   standard	  chow	  –	  OffOb-­‐SC	  
and	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐
OD.	  	  Solid	  bars	  -­‐	  dark,	  clear	  bars	  –	  light.	  n	  =	  5	  per	  group,	  values	  shown	  are	  mean	  
±	  SEM,	  one-­‐way	  ANOVA.	  	  	  *Mean	  values	  significantly	  greater	  than	  OffCon-­‐SC	  (p	  
<	  0.05).	  #Mean	  values	  significantly	  greater	  than	  OffCon-­‐OD	  (p	  <	  0.05).	   	  §Mean	  
values	  significantly	  greater	  than	  OffOb-­‐SC	  (p	  <	  0.05).	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7.3.5	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐weaning	  obesogenic	  
diet	  induces	  phase	  advances	  in	  the	  circadian	  expression	  of	  CLOCK,	  BMAL1	  and	  
Per2	  in	  the	  liver	  
Offspring	   exposure	   to	   maternal	   obesity	   and	   a	   post-­‐weaning	   obesogenic	   diet	  
induces	   phase	   advances	   in	   the	   rhythmic	   expression	   of	   CLOCK	   and	   BMAL1	  
compared	   to	   controls.	   	   More	   specifically,	   transcription	   of	   CLOCK	   occurs	  
approximately	  3.3	  hours	  earlier	  in	  OffOb-­‐OD	  compared	  to	  OffCon-­‐SC	  (p	  <	  0.05).	  	  
Interestingly,	   exposure	   to	   a	   hyper-­‐calorific	   diet	   post-­‐weaning	   alone	   has	   no	  
effect	   on	   phase	   shifts	   as	   evidenced	   by	   a	   similar	   phase	   advance	   of	   3	   hours	   in	  
OffOb-­‐OD	   compared	   to	  OffCon-­‐OD	   (p	   <	   0.05)	  with	  no	   significant	  difference	   in	  
phase	   shift	   between	   OffCon-­‐OD	   and	   OffCon-­‐SC	   (Figure	   7.6).	   	   Therefore,	   the	  
insult	  of	  maternal	  obesity	  is	  necessary	  to	  induce	  a	  phase	  shift	  in	  hepatic	  CLOCK	  
transcription.	  	  	  	  	  
	  
Similarly,	   a	   phase	   advance	   of	   approximately	   1.9	   hours	   was	   observed	   for	   the	  
transcription	   of	   BMAL1	   in	   OffOb-­‐OD	   compared	   to	   OffCon-­‐SC	   (p	   <	   0.05).	   	   A	  
significant	  shift	  in	  phase	  was	  not	  observed	  in	  offspring	  exposed	  to	  only	  a	  post-­‐
weaning	  obesogenic	  diet	  or	  maternal	  obesity,	  further	  affirming	  the	  interactions	  
between	  the	   in	  utero	  and	  post-­‐natal	  environments	   in	  generating	  the	  observed	  
NAFLD	  phenotype	  (Figure	  7.6).	  	  	  
	  
Additionally,	  a	  significant	  phase	  advance	  of	  2	  hours	  for	  the	  transcription	  of	  Per2	  
was	   observed	   in	   offspring	   exposed	   to	   maternal	   obesity	   and	   a	   post-­‐weaning	  
obesogenic	  diet	  compared	  to	  those	  exposed	  only	  to	  maternal	  obesity	  (p	  <	  0.05).	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This	   phase	   shift	   was	   not	   due	   to	   the	   post-­‐weaning	   diet	   alone	   as	   a	   significant	  
difference	   between	   OffOb-­‐OD	   and	   OffCon-­‐OD	  was	   not	   observed	   (Figure	   7.6).	  	  
This	   supports	   the	   preceding	   findings	   of	   an	   interaction	   between	   the	  maternal	  
and	  post-­‐natal	  environments	  responsible	  for	  the	  observed	  phenotype.	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Figure	   7.6	   Maternal	   obesity	   and	   a	   post-­‐weaning	   obesogenic	   diet	   induces	  
phase	  advances	  of	   core	   canonical	   clock	  genes	   in	  offspring	  with	  programmed	  
NAFLD:	   (A)	  CLOCK	  mRNA,	  (B)	  BMAL1	  mRNA	  and	  (C)	  Per2	  mRNA.	   	   	  Offspring	  of	  
lean	  suckled	  by	  lean	  weaned	  on	  to	  standard	  chow	  –	  OffCon-­‐SC;	  offspring	  of	  lean	  
suckled	  by	  lean	  weaned	  on	  to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  
suckled	   by	   obese	   weaned	   on	   to	   standard	   chow	   –	   OffOb-­‐SC	   and	   offspring	   of	  
obese	  suckled	  by	  obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐OD.	   	  n	  =	  5	  per	  
group,	  cosinor	  analysis.	  	  	  	  
	  
7.3.6	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐weaning	  obesogenic	  
diet	  disrupts	  rhythmic	  expression	  of	  hepatic	  inflammatory	  markers	  implicated	  
in	  NAFLD	  pathogenesis	  
Interleukin-­‐6	   (IL-­‐6),	   a	   pleiotropic	   and	   pro-­‐inflammatory	   cytokine	   implicated	   in	  
NAFLD	   pathogenesis	   is	   shown	   here	   for	   the	   first	   time,	   to	   have	   a	   circadian	  
secretion	   pattern	   in	   murine	   liver.	   	   OffCon-­‐SC	   and	   OffOb-­‐SC	   display	   similar	  
biphasic	   circadian	   secretion	   patterns	   whereas	   offspring	   exposed	   to	   a	   post-­‐
weaning	   obesogenic	   diet	   display	   only	   one	   peak	   or	   nadir	   at	   CT12.	   	   Given	   the	  
discrete	   differences	   in	   maxima	   and	   minima	   of	   circadian	   IL-­‐6	   expression	   in	  
OffCon-­‐OD	   and	   OffOb-­‐OD,	   it	   could	   be	   suggested	   that	   there	   is	   constitutive	  
expression	  of	  this	  pro-­‐inflammatory	  cytokine	  (Figure	  7.7).	  
	  
Tumour	   necrosis	   factor	   alpha	   (TNF-­‐α)	   however,	   did	   not	   exhibit	   circadian	  
secretion	  patterns	   in	  the	   liver,	  although	  peak	  expression	  of	   this	   transcript	  was	  
observed	  at	  CT20	  in	  offspring	  exposed	  to	  maternal	  obesity	  and	  a	  post-­‐weaning	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obesogenic	  diet	  compared	  to	  all	  other	  groups	  (p	  <	  0.05).	  	  Moreover,	  there	  was	  
an	  independent	  effect	  of	  maternal	  obesity	  on	  peak	  transcription	  (p	  =	  0.0063)	  as	  
revealed	  by	  two-­‐way	  ANOVA	  analysis	  (Figure	  7.7).	  	  	  
	  
Figure	  7.7	  Maternal	  obesity	  and	  a	  post-­‐weaning	  obesogenic	  diet	  disrupts	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rhythmic	   expression	   of	   hepatic	   inflammatory	   markers	   in	   offspring:	   (A)	   IL-­‐6	  
mRNA	  and	  (B)	  TNF-­‐α	  mRNA.	   	   	  Offspring	  of	   lean	  suckled	  by	   lean	  weaned	  on	  to	  
standard	   chow	   –	   OffCon-­‐SC;	   offspring	   of	   lean	   suckled	   by	   lean	   weaned	   on	   to	  
obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  to	  
standard	  chow	  –	  OffOb-­‐SC	  and	  offspring	  of	  obese	  suckled	  by	  obese	  weaned	  on	  
to	  obesogenic	  diet	  –	  OffOb-­‐OD.	   	  Solid	  bars	   -­‐	  dark,	  clear	  bars	  –	   light.	  n	  =	  5	  per	  
group,	   values	   shown	   are	   mean	   ±	   SEM,	   one-­‐way	   ANOVA.	   	   	   *Mean	   values	  
significantly	   greater	   than	   OffCon-­‐SC	   (p	   <	   0.05).	   #Mean	   values	   significantly	  
greater	   than	   OffCon-­‐OD	   (p	   <	   0.05).	   	   §Mean	   values	   significantly	   greater	   than	  
OffOb-­‐SC	  (p	  <	  0.05).	  
	  
7.3.7	  Offspring	  exposure	  to	  maternal	  obesity	  and	  a	  post-­‐weaning	  obesogenic	  
diet	  disrupts	  rhythmic	  expression	  of	  hepatic	  fibrogenic	  markers	  implicated	  in	  
NAFLD	  pathogenesis	  
The	   rhythmic	   expression	   of	   alpha	   smooth	  muscle	   actin	   (α-­‐SMA),	   a	  marker	   of	  
hepatic	   stellate	   cell	   activation	   –	   the	   liver’s	   principal	   fibrogenic	   cell,	   was	  
perturbed	   in	   offspring	   exposed	   to	   maternal	   obesity	   and	   fed	   a	   post-­‐weaning	  
obesogenic	  diet	  as	  evidenced	  by	  significantly	  increased	  transcription	  at	  CT8	  and	  
CT20	   compared	   to	   all	   other	   groups	   (p	   <	   0.05).	   	   Moreover,	   there	   was	   an	  
independent	   effect	   of	   maternal	   obesity	   on	   α-­‐SMA	   transcription	   at	   CT8	   (p	   =	  
0.0237).	  	  	  
	  
Similarly,	   these	   offspring	   exposed	   to	   maternal	   obesity	   and	   a	   post-­‐weaning	  
obesogenic	   diet	   displayed	   marked	   increases	   in	   transcription	   of	   transforming	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growth	  factor	  beta	  (TGF-­‐β)	  and	  collagen	  in	  the	  dark	  phase	  of	  the	  circadian	  cycle	  
compared	   to	   all	   other	   groups	   (p	   <	   0.05).	   	   Additionally,	   there	   was	   an	  
independent	   effect	   of	   maternal	   obesity	   for	   collagen	   expression	   at	   CT16	   (p	   =	  
0.0772).	   	   So	   therefore,	  exposure	   to	  maternal	  obesity	   in	   the	  context	  of	  a	  post-­‐
weaning	   obesogenic	   diet	   disrupts	   effects	   rhythmic	   transcription	   of	   these	  
fibrogenic	  markers	  (Figure	  7.8).	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Figure	  7.8	  Maternal	  obesity	  and	  a	  post-­‐weaning	  obesogenic	  diet	  disrupts	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rhythmic	   expression	   of	   hepatic	   fibrogenic	   markers	   in	   offspring:	   (A)	   α-­‐SMA	  
mRNA,	   (B)	   TGF-­‐β	   mRNA	   and	   (C)	   collagen	   type	   1	   mRNA.	   	   	   Offspring	   of	   lean	  
suckled	   by	   lean	   weaned	   on	   to	   standard	   chow	   –	   OffCon-­‐SC;	   offspring	   of	   lean	  
suckled	  by	  lean	  weaned	  on	  to	  obesogenic	  diet	  –	  OffCon-­‐OD;	  offspring	  of	  obese	  
suckled	   by	   obese	   weaned	   on	   to	   standard	   chow	   –	   OffOb-­‐SC	   and	   offspring	   of	  
obese	  suckled	  by	  obese	  weaned	  on	  to	  obesogenic	  diet	  –	  OffOb-­‐OD.	  	  Solid	  bars	  -­‐	  
dark,	  clear	  bars	  –	  light.	  n	  =	  5	  per	  group,	  values	  shown	  are	  mean	  ±	  SEM,	  one-­‐way	  
ANOVA.	  	  	  *Mean	  values	  significantly	  greater	  than	  OffCon-­‐SC	  (p	  <	  0.05).	  #Mean	  
values	   significantly	   greater	   than	   OffCon-­‐OD	   (p	   <	   0.05).	   	   §Mean	   values	  




Disruption	  of	  central	  and	  peripheral	  circadian	  rhythms	   in	  humans	  and	  rodents	  
has	   been	   shown	   to	   cause	   metabolic	   disorders	   including	   impaired	   glucose	  
homeostasis	   and	   hyperlipidaemia	   (73,	   219,	   233).	   	   This	   suggests	   a	   causal	  
association	   between	   rhythmic	   circadian	   transcription	   and	   translation	   of	  
canonical	   clock	   genes	   and	  metabolism.	   	   To	   investigate	   whether	   programmed	  
offspring	   NAFLD	   was	   caused	   by	   rhythmic	   disruption	   of	   hepatic	   circadian	  
transcripts,	   24	   hour	   relative	  mRNA	   expression	   of	   all	   canonical	   clock	   genes	   in	  
whole	  murine	   liver	   tissue	  was	   assayed	   and	   compared	   to	   appropriate	   controls	  
and	  experimental	  groups.	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7.4.1	  CLOCK	  and	  BMAL1	  
The	   biological	   circadian	   clock	   is	   a	   transcription-­‐translation	   negative	   feedback	  
loop	  which	  is	  activated	  by	  the	  hetero-­‐dimerisation	  of	  CLOCK	  and	  BMAL1.	  	  In	  this	  
pathophysiologically	   relevant	   model	   of	   programmed	   NAFLD	   in	   offspring,	   it	   is	  
shown	   here	   for	   the	   first	   time	   that	   exposure	   to	   maternal	   obesity	   increased	  
temporal	  expression	  of	  CLOCK	  mRNA	  transcripts,	  peaking	  at	  CT16	  or	  in	  the	  dark	  
phase.	  	  Moreover,	  additional	  insult	  with	  continued	  exposure	  of	  a	  hyper-­‐calorific	  
diet	   in	   post-­‐natal	   life	   induced	   a	   biphasic	   circadian	   pattern	   of	   expression	  with	  
peaks	  observed	  in	  both	  the	  light	  and	  dark	  phases.	  	  	  This	  time	  dependent	  cycling	  
of	  CLOCK	  has	  been	  observed	   in	  other	  diet	   induced	  obesity	  rodent	  models	   (71,	  
73).	  	  	  	  
	  
Rhythmic	   disruption	   of	   CLOCK	   transcription	   in	   the	   liver	   may	   therefore	   be	  
partially	   responsible	   for	   the	  observed	  dysmetabolic	  and	   fatty	   liver	  phenotype.	  	  
Such	  a	  causal	  association	  is	  supported	  by	  earlier	  reports	  of	  adiposity,	   impaired	  
lipid	   metabolism	   and	   insulin	   resistance	   in	   CLOCK	   mutant	   mice	   (71,	   72).	  	  
Although	  a	  high	  fat	  diet	  has	  been	  shown	  to	  alter	  rhythmic	  expression	  of	  CLOCK	  
in	  adipose	  and	  hepatic	  tissue,	  it	  is	  clear	  that	  these	  present	  observations	  are	  not	  
phenomenological	  as	  offspring	  exposed	  to	  only	  an	  obesogenic	  diet	  displayed	  no	  
alteration	  in	  time-­‐dependent	  transcription	  of	  CLOCK	  compared	  to	  controls.	  	  	  
	  
The	   rhythmic	   circadian	   expression	   of	   BMAL1,	   a	   co-­‐activator	   of	   the	   circadian	  
molecular	   network,	   was	   similarly	   disrupted	   following	   exposure	   to	   maternal	  
obesity	   and	   a	   post-­‐weaning	   obesogenic	   diet.	   	   Peak	   transcription	   of	   BMAL1	   in	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OffOb-­‐OD	   was	   observed	   at	   CT12	   or	   in	   the	   dark	   phase,	   although	   overall	   fold	  
change	   was	   significantly	   attenuated	   compared	   to	   controls.	   	   Interestingly,	  
exposure	  to	  an	  obesogenic	  diet	  post-­‐weaning	  also	  caused	  peak	  transcription	  to	  
occur	   in	  the	  dark	  opposed	  to	  the	  light	  phase	  alongside	  controls.	   	  Observations	  
of	   arrhythmic	   BMAL1	   transcription	   are	   in	   keeping	   with	   previous	   reports	   of	  
impaired	   adipogenesis	   and	   hepatic	   carbohydrate	   metabolism	   in	   rodents	   with	  
BMAL1	  ablation	  (234,	  235).	  	  
	  
Moreover,	  profound	  perturbation	  of	  rhythmic	  expression	  of	  CLOCK	  and	  BMAL1	  
in	  offspring	  exposed	  to	  maternal	  obesity	  and	  an	  obesogenic	  diet	  post-­‐weaning	  
was	  evidenced	  by	  phase	  advances	  in	  transcription	  of	  approximately	  3.3	  and	  1.9	  
hours,	   respectively.	   	   Additionally,	   a	   higher	   baseline	   constitutive	   expression	   of	  
CLOCK	  and	  BMAL1	  was	  observed	  from	  greater	  than	  control	  values	  for	  minima	  as	  
determined	  by	  cosinor	  analysis.	   	  Again	  these	  observations	  were	  recorded	  only	  
in	   offspring	   exposed	   to	   both	   an	   adverse	  maternal	   and	   post-­‐natal	   obesogenic	  
environment,	  affirming	  that	  hypercaloriaemia	  is	  not	  predominantly	  responsible	  
for	  altered	  circadian	  cycles	  and	  that	  programming	  via	  maternal	  obesity	  plays	  a	  
pivotal	  role.	  	  	  	  	  	  	  	  
	  
7.4.2	  Period	  and	  Cryptochrome	  
Period	  (Per1	  and	  Per2)	  and	  cryptochrome	  (Cry	  1	  and	  Cry	  2)	  genes	  are	  repressors	  
of	  the	  circadian	  molecular	  machinery	  through	  inactivation	  of	  CLOCK:BMAL1.	  	  In	  
this	   present	   study,	   rhythmic	   expression	   of	   cryptochrome	   within	   a	   circadian	  
period	  in	  the	  murine	  liver	  was	  observed	  as	  with	  previous	  experimental	  studies	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(236).	   	   Offspring	   exposure	   to	   a	   post-­‐weaning	   obesogenic	   diet	   independent	   of	  
maternal	   obesity	   attenuated	   transcription	   of	   Cry1	   with	   peak	   expression	  
occurring	   in	   the	   dark	   phase	   opposed	   to	   the	   light	   phase	   alongside	   controls.	  	  
Interestingly,	   a	   post-­‐weaning	   obesogenic	   diet	   had	   negligible	   effects	   on	   Cry2	  
transcription	  which	  was	   comparable	   to	   control	   values.	   	   Exposure	   to	  maternal	  
obesity	   induced	   a	   significant	   increase	   in	   Cry2	   transcription	   in	   offspring	  which	  
was	  further	  enhanced	   in	  the	  context	  of	  a	  post-­‐weaning	  obesogenic	  diet	   in	  the	  
dark	   phase	   at	   CT12	   and	   CT16,	   respectively.	   	   Therefore	   and	  most	   importantly,	  
offspring	   exposure	   to	   maternal	   obesity	   significantly	   induces	   arrhythmic	  
expression	   of	   Cry2	   and	   as	   such	  may	   be	   in	   part	   responsible	   for	   the	   observed	  
NAFLD	   phenotype.	   	   This	   is	   further	   supported	   by	   reports	   of	   cryptochrome	  
mediated	   regulation	   of	   hepatic	   gluconeogenesis	   and	   cAMP	   signalling,	   re-­‐
affirming	   the	   association	   between	   core	   clock	   genes	   and	   their	   control	   of	  
metabolic	  pathways	  (236).	  	  	  
	  
Both	  period	  genes	  similarly	  expressed	  circadian	   rhythmic	  patterns	   in	   the	   liver.	  	  
Offspring	   exposure	   to	   maternal	   obesity	   enhanced	   Per1	   transcription	   at	   CT12	  
compared	   to	   OffCon-­‐OD	   and	   OffCon-­‐SC.	   	   Exposure	   to	   a	   post-­‐weaning	  
obesogenic	  diet	  and/or	  maternal	  obesity	  induced	  arrhythmic	  Per1	  transcription	  
with	  peak	  values	  attained	  at	  CT20	  or	  the	  light	  phase.	  	  Most	  profound	  alteration	  
of	   circadian	   rhythm	  was	  observed	   in	  OffOb-­‐OD	  compared	   to	  all	   other	   groups.	  	  
This	  is	  the	  first	  report	  of	  Per1	  time-­‐dependent	  transcription	  in	  the	  murine	  liver	  
although	   its	   role	   in	   metabolic	   regulation	   has	   been	   demonstrated	   through	   its	  
effects	  on	  phospholipid	  biosynthesis	  in	  fibroblasts	  ex	  vivo	  (237).	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As	  observed	  with	  Cry2,	  a	  post-­‐weaning	  obesogenic	  diet	  had	  insignificant	  effects	  
on	   Per2	   circadian	   secretion	   patterns	   in	   the	   liver.	   	  Most	   importantly,	   offspring	  
exposure	  to	  maternal	  obesity	  induced	  profound	  increases	  in	  Per2	  transcription	  
at	   CT12	  with	   an	  enhanced	  expression	   in	   those	   additionally	   fed	   an	  obesogenic	  
diet	  post-­‐weaning.	  	  Moreover,	  offspring	  exposure	  to	  maternal	  obesity	  induced	  a	  
phase	   advance	   of	   Per2	   transcription.	   	   It	   is	   here	   demonstrated	   that	   temporal	  
changes	  in	  Per2	  expression	  are	  not	  the	  result	  of	  nutrient	  excess	  at	  the	  time	  of	  
analysis	   in	   the	   offspring	   but	   rather	   a	   permanently	   altered	   component	   of	   the	  
molecular	   circadian	   clock	   induced	   by	   maternal	   obesity,	   affecting	   hepatic	  
function	   and	   metabolic	   control.	   	   Moreover,	   independent	   effects	   of	   maternal	  
obesity	  on	  Per1	  and	  Per2	  transcription,	  as	  revealed	  by	  two-­‐way	  ANOVA	  analysis,	  
is	   confirmatory	   of	   a	   mechanistic	   pathway	   by	   which	   offspring	   NAFLD	   is	  
programmed	  by	  maternal	  obesity.	  
	  
Per2	   is	  an	   important	   intermediary	  between	  metabolic	  and	  circadian	  pathways	  
as	  it	  has	  been	  shown	  to	  control	   lipid	  metabolism	  through	  regulation	  of	  PPARγ.	  	  
Importantly,	   it	   has	   been	   reported	   that	   Per2	   deficient	   mice	   display	   profound	  
reduction	  of	  triacylglycerol	  and	  non-­‐esterified	  fatty	  acids	  (238)	  and	  so	  Per2	  acts	  
to	   inhibit	   lipid	   metabolism,	   potentiating	   hepatosteatosis	   as	   observed	   here	   in	  
offspring	  with	  programmed	  NAFLD.	  	  Moreover,	  Per2	  has	  been	  reported	  as	  a	  risk	  
factor	   for	   the	  metabolic	   syndrome	   (239).	   	   These	  previous	   reports	   corroborate	  
our	   findings	   of	   increased	  Per2	   transcription	   in	   offspring	  with	   the	  most	   severe	  
phenotype.	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7.4.3	  REV-­‐ERB-­‐α	  
The	   nuclear	   receptor,	   REV-­‐ERB-­‐α,	   acts	   within	   an	   accessory	   feedback	   loop	   to	  
negatively	   regulate	   clock	   function.	   	   Offspring	   fed	   an	   obesogenic	   diet	   post-­‐
weaning	  displayed	  a	  phase	  delay	   in	  REV-­‐ERB-­‐α	   transcription,	  of	  1.1-­‐1.8	  hours,	  
independent	  of	  maternal	  obesity.	  	  Additionally,	  exposure	  to	  maternal	  obesity	  in	  
the	  context	  of	  a	  post-­‐weaning	  obesogenic	  diet	  significantly	  reduced	  REV-­‐ERB-­‐α	  
transcription	   at	   CT4.	   	   These	   findings	   of	   reduced	   relative	  mRNA	   expression	   in	  
profoundly	   hepatosteatotic	   offspring	   are	   corroborated	   by	   observations	   of	  
hyperlipidaemia	  in	  REV-­‐ERB-­‐α	  null	  mice	  (240).	  	  	  	  It	  may	  therefore	  be	  suggested	  
that	   the	   more	   profound	   phenotype	   observed	   in	   offspring	   programmed	   via	  
maternal	  obesity	  and	  fed	  an	  obesogenic	  diet	  post-­‐weaning,	  is	  in	  part	  caused	  by	  
reduced,	  rhythmic	  REV-­‐ERB-­‐α	  transcription	  in	  the	  liver.	  	  
	  
7.4.4	   Impact	   of	   circadian	   desynchronisation	   on	   hepatic	   inflammatory	   and	  
fibrogenic	  pathways	  
A	  corollary	  of	  the	  aforementioned	  findings	  is	  circadian	  desynchronisation	  in	  the	  
liver	  induced	  by	  offspring	  exposure	  to	  maternal	  obesity	  in	  the	  context	  of	  a	  post-­‐
weaning	   obesogenic	   diet.	   	   It	   is	   evident	   from	   previous	   reports	   and	   present	  
findings	   that	   these	   canonical	   clock	   genes	   affect	   metabolic	   physiology.	   	   It	   is,	  
additionally	   now	   shown	   here	   that	   these	   circadian	   genes	   regulate	   hepatic	  
inflammatory	  and	  fibrogenic	  pathways	  implicated	  in	  NAFLD	  pathogenesis.	  
	  
Rhythmic	  expression	  of	  IL-­‐6	  in	  offspring	  liver	  and	  programmed	  NAFLD	  are	  novel	  
findings.	   	   However,	   offspring	   exposure	   to	   maternal	   obesity	   and/or	   an	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obesogenic	   diet	   post-­‐weaning	   ablates	   normal	   biphasic	   rhythmic	   circadian	  
transcription	   of	   IL-­‐6	   (241).	   	   Additionally,	   significantly	   enhanced	   TNF-­‐α	  
transcription	   is	   observed	   at	   CT20	   in	   OffOb-­‐OD	   compared	   to	   all	   other	   groups.	  	  
Unsurprisingly,	   this	   rhythmic	   disruption	   occurs	   in	   offspring	   with	   the	   most	  
profound	  circadian	  desynchronisation.	  	  	  
	  
Similarly,	  circadian	  secretion	  patterns	  for	  the	  fibrogenic	  markers,	  α-­‐SMA,	  TGF-­‐β	  
and	   collagen	   type	   1,	   are	   shown	   for	   the	   first	   time	   in	  murine	   liver,	   NAFLD	   and	  
programmed	  NAFLD.	  	  Offspring	  exposure	  to	  maternal	  obesity	  in	  the	  context	  of	  a	  
post-­‐weaning	   obesogenic	   diet	  most	   significantly	   perturbs	   rhythmic	   expression	  
of	   these	   fibrogenic	   markers.	   	   Moreover,	   relative	   mRNA	   transcription	   is	  
enhanced	   in	  this	  group	  (OffOb-­‐OD)	  compared	  to	  controls	  or	  those	  fed	  only	  an	  
obesogenic	   diet	   post-­‐weaning.	   	   Peak	   transcription	   of	   α-­‐SMA	   precede	   that	   of	  
TGF-­‐β	  and	  collagen,	  as	  observed	   in	   the	   light	  and	  dark	  phase,	   respectively.	   	   So	  
therefore,	   canonical	   clock	   genes	   regulate	   hepatic	   pro-­‐inflammatory	   and	   pro–





Nutrient	  excess	  or	  a	  hyper-­‐calorific	  milieu	  during	  in	  utero	  development	  interacts	  
with	   the	   post-­‐natal	   obesogenic	   environment	   to	   induce	   permanent	   changes	   in	  
the	  hepatic	  molecular	  circadian	  clock.	  	  The	  resulting	  circadian	  desynchrony	  not	  
only	   affects	   metabolic	   homeostasis	   as	   demonstrated	   here	   and	   previously	   by	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other	   groups,	   but	   also	   identifies	   hepatic	   pro-­‐inflammatory	   and	  pro–fibrogenic	  
pathways	   involved	   in	   NAFLD	   pathogenesis	   as	   ‘clock	   output	   pathways’.	  	  
Mechanistically,	   it	   may	   be	   suggested	   that	   programming	   via	   maternal	   obesity	  
alters	   physiological	   functioning	   of	   the	   hepatic	   molecular	   circadian	   network	  
during	   development	   plasticity	   in	   offspring,	   causing	   rhythmic	   disruption	   and	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8	  General	  Discussion	  
	  
8.1	  Initial	  Aims	  
	  
The	   aims	   of	   this	   PhD	  were	   to	   determine	   if	  maternal	   obesity	   during	   gestation	  
and/or	   lactation	   predisposed	  offspring	   to	   development	   of	   dysmetabolism	  and	  
NAFLD	   and	   secondarily	   to	   investigate	   the	   responsible	   mechanisms.	   	   The	  
following	  aims	  were	  specifically	  examined:	  
	  
a.	   The	   effect(s)	   of	   exposure	   to	   maternal	   obesity	   on	   offspring	  
dysmetabolism	  and	  NAFLD	  in	  adulthood.	  
	  
b.	  The	  independent	  effect(s)	  of	  the	  in	  utero	  and	  immediate	  post-­‐partum	  
period	   i.e.	   lactation,	   on	   offspring	   susceptibility	   and	   development	   of	  
dysmetabolism	  and	  NAFLD	  in	  adulthood.	  	  
	  
c.	  To	  develop	  a	  uniquely	  pathophysiologically	  relevant	  model	  of	  NAFLD	  
in	  which	  to	  further	  study	  the	  interaction	  between	  in	  utero	  exposure	  and	  
the	   post-­‐weaning	   environment	   in	   programming	   development	   of	  
offspring	  dysmetabolism	  and	  NAFLD	  in	  adulthood.	  
	  
d.	   To	   investigate	   the	   natural	   progression	   of	   NAFLD	   in	   programmed	  
offspring	   and	   ascertain	   whether	   exposure	   to	   maternal	   obesity	   primes	  
accelerated	  disease	  development,	  cirrhosis	  or	  malignancy.	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e.	   To	   examine	   the	   role	   of	   the	   hepatic	   innate	   immune	   system	   as	   a	  
putative	   mechanistic	   pathway	   through	   which	   maternal	   over-­‐nutrition	  
programs	   offspring	   propensity	   to	   dysmetabolism	   and	   NAFLD	   in	  
adulthood.	  
	  
f.	   To	   examine	   the	   role	   of	   the	   peripheral	   circadian	   system	   as	   an	  
alternative,	   but	   putative	  mechanistic	   pathway	   through	  which	  maternal	  
over-­‐nutrition	   programs	   offspring	   propensity	   to	   dysmetabolism	   and	  
NAFLD	  in	  adulthood.	  
	  
The	   rationale	   for	   these	   investigations	   originate	   from	   observations	   of	   global	  
paediatric	  and	  adult	  obesity	  pandemics	  alongside	  increases	  in	  the	  prevalence	  of	  
obesity	   in	   women	   of	   childbearing	   age	   (1,	   6).	   	   In	   tandem,	   the	   prevalence	   of	  
NAFLD	   is	   rising	  and	   is	  now	   the	  most	   common	  chronic	   liver	  disease	  worldwide	  
(176,	   242,	   243).	   	   Obesity	   is	   pivotal	   in	   the	   aetiopathogenesis	   of	   NAFLD	   and	  
through	   systematic	   investigation,	   this	   study	   here,	   shows	   that	   exposure	   to	  
maternal	  obesity	  is	  also	  a	  significant	  contributory	  factor.	  
	  
8.2	  The	  Developmental	  Programming	  Model	  
	  
Four	   phases	   of	   the	   maternal	   over-­‐nutrition	   programming	   model	   were	  
developed	   in	   this	   study.	   	   In	   attempts	   to	   investigate	   the	   long-­‐term	   effects	   of	  
programming	   via	   maternal	   obesity,	   offspring	   were	   initially	   weaned	   on	   to	   a	  
normo-­‐calorific	   diet.	   	   In	   a	   non-­‐physiological	   experimental	   paradigm,	  we	  were	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able	   to	   delineate	   the	   contributory	   roles	   of	   the	   in	   utero	   versus	   the	   ex	   utero	  
environment.	   	   So	   that	   observed	   findings	   could	   be	   extrapolated	   to	   the	   clinical	  
scenario	   and	   potential	   therapeutic	   and	   preventative	   applications	   realised,	   the	  
element	   of	   cross-­‐fostering	   was	   removed	   and	   alternative	   post-­‐weaning	   diets	  
introduced.	  	  	  
	  
Further	   refinement	  of	   this	  model	   included	   feeding	  of	   a	   composite	  obesogenic	  
diet,	  unlike	  other	  maternal	  over-­‐nutrition	  models	  which	  use	  either	  high	   fat	  or	  
sugar	   and	   thus	   are	   atypical	   of	   a	   western	   diet	   (5).	   	   A	   derivative	   of	   these	  
experimental	   phases	   is	   the	   introduction	   of	   a	   novel	   and	   pathophysiologically	  
relevant	  model	  of	  NAFLD.	  	  
	  
Experimental	   obesity	   models	   are	   either	   nutritionally	   induced	   or	   genetically	  
determined.	  	  In	  this	  study	  we	  used	  only	  a	  nutritionally	  induced	  obesity	  model	  as	  
obese	  leptin	  receptor	  deficient	  rodents	  are	  sterile	  and	  therefore	  unsuitable	  for	  
inclusion.	   	  Moreover,	   leptin	  has	  been	   implicated	   in	  programming	  via	  maternal	  
over-­‐	   and	   under-­‐nutrition	   through	   actions	   on	   peripheral	   and	   central	   systems	  
(244).	   	   Therefore,	   leptin	   deficiency	   would	   render	   the	   model	  
pathophysiologically	  incomplete	  with	  biased	  outputs.	  	  	  
	  
An	   epidemiological	   correlate	   of	   this	   study	   is	   now	   needed	   given	   that	   a	   strong	  
association	   between	   maternal	   obesity	   and	   offspring	   NAFLD	   has	   been	   now	  
established	  here.	  	  It	  was	  not	  sought	  to	  investigate	  the	  role	  of	  human	  maternal	  
obesity	   on	   offspring	   NAFLD	   in	   this	   present	   study,	   as	   the	   effects	   of	   nutrient	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excess	   during	   pre-­‐natal	   development	   were	   unknown	   and	   the	   interactions	  
between	  pre-­‐	  and	  post-­‐natal	  environments	  on	  various	  homeostatic	  mechanisms	  
would	  not	  be	  easily	  discernible	  from	  such	  studies	  due	  to	  the	  lack	  of	  appropriate	  
controls	   e.g.	   severity	   of	   obesity	   and	   dietary	   content	   during	   gestation	   and	  
lactation.	  	  	  
	  	  
	  
8.3	  Developmental	  Programming	  of	  Offspring	  NAFLD	  by	  Maternal	  Obesity	  
	  
The	  association	  between	  maternal	  obesity,	  offspring	  hyper-­‐triglyceridaemia	  and	  
propensity	   to	   NAFLD	   development,	   has	   been	   shown	   in	   various	   experimental	  
models	  (27,	  35).	   	  Other	  groups	  have	  speculated	  on	  the	  development	  of	  NAFLD	  
following	   exposure	   to	  maternal	   obesity	   and	   their	   observations	   in	   offspring	   of	  
hepatomegaly	  and	  serum	  hyper-­‐cholesterolaemia	  (36).	  	  	  
	  
Bouanane	  and	  colleagues	  previously	  reported	  a	  permanent	  reduction	  in	  hepatic	  
β-­‐oxidation	   and	   increased	   lipogenesis,	   with	   altered	   composition	   of	   saturated	  
fatty	   acids	   in	   VLDL	   lipids,	   as	   a	   potential	   mechanism	   for	   hepatosteatosis	   in	  
offspring	  born	  to	  high-­‐fat	  fed	  dams	  (144).	  	  In	  parallel,	  increased	  lipogenesis,	  as	  
evidenced	  by	  up-­‐regulated	  SREBP-­‐1	  and	   impaired	   lipolysis	  due	  to	  PPARa	  down	  
regulation,	   has	   been	   reported	   in	   a	   rodent	   model	   of	   maternal	   over-­‐nutrition	  
(145).	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However,	  the	  role	  of	  maternal	  obesity	  in	  programmed	  offspring	  NAFLD	  has	  only	  
now	   been	   comprehensively	   investigated.	   	   Not	   only	   has	   a	   novel	   association	  
between	   programming	   via	   maternal	   obesity	   and	   offspring	   NAFLD	   been	  
reported,	  but	  the	   lactation	  period	  has	  been	  additionally	   identified	  as	  the	  most	  
crucial	  developmental	  window	  in	  which	  offspring	  physiology	  and/or	  structure	  is	  
adversely	   changed.	   	   Continued	   feeding	   of	   a	   hyper-­‐calorific	   diet	   post-­‐weaning	  
disproportionately	  exacerbates	  NAFLD	  due	  to	  interactions	  between	  the	  pre-­‐	  and	  
post-­‐natal	  environments.	  	  	  
	  
Maternal	   obesity	   however,	  may	   not	   be	   the	   only	   determinant	   of	   programmed	  
offspring	   NAFLD	   as	   a	   high	   calorific	   intake	   during	   pregnancy,	   independent	   of	  
maternal	   obesity,	   has	   been	   shown	   to	   program	   hepatic	   injury	   in	   non-­‐human	  
primates	   (146).	   	   Corroboratively,	   Bayol	   and	   colleagues	   report	   hepatosteatosis	  
and	  increased	  oxidative	  stress,	  in	  offspring	  born	  to	  mothers	  fed	  a	  hyper-­‐calorific	  
‘junk’	  diet	  during	  gestation	  and	  lactation,	  independent	  of	  prior	  maternal	  obesity	  
(147).	  
	  
8.4	  Examination	  of	  the	  mechanisms	  involved	  in	  developmental	  programming	  
of	  offspring	  NAFLD	  by	  maternal	  obesity	  
	  
Experimental	  research	  indicates	  that	  nutritional	  perturbations	  in	  the	  intra-­‐	  and	  
extra-­‐uterine	   environment	   increase	   oxidative	   stress	   and	   enhance	   lipogenesis,	  
priming	  offspring	   liver	   to	   an	   increased	   risk	   of	  NAFLD	   in	   adulthood	   (145,	   181).	  	  
However,	   the	   underlying	   mechanisms	   responsible	   for	   programmed	   offspring	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NAFLD	  were	  unknown.	  	  It	  had	  been	  suggested	  that	  maternal	  breast	  milk	  factors	  
may	  act	  on	  central	  neonatal	  energy	  homeostasis	  centres,	  evoking	  hyperphagia	  
and	  subsequent	  obesity	  and	  NAFLD	  (143).	   	  However,	  there	  is	  a	  paucity	  of	  data	  
on	   the	   direct	   effects	   of	   maternal	   obesity	   on	   hepatic	   function.	   	   It	   has	   been	  
recently	  suggested	  in	  a	  diet	  induced	  obesity	  model	  of	  programming	  that	  hepatic	  
mitochondrial	   electron	   transport	   chain	   reactions	   are	   altered;	   increasing	  
oxidative	  stress	  and	  fat	  accumulation	  with	  resultant	  hepatosteatosis	  in	  rodents	  
(64).	  
	  
Additionally,	  alterations	  in	  the	  hepatic	  epigenomic	  profile	  of	  offspring	  exposed	  
to	  maternal	   over-­‐nutrition	   in	   the	   form	   of	   hyper-­‐acetylation	   and	   –methylation	  
have	   been	   reported	   (148).	   	   Godfrey	   et	   al.,	   have	   recently	   corroborated	   these	  
findings	   in	  a	  human	  study,	   reporting	  a	  positive	  correlation	  between	  peri-­‐natal	  
epigenetic	  changes,	   induced	  my	  maternal	  nutritional	   imbalance	  and	  childhood	  
adiposity	  (149).	  	  	  	  	  	  
	  
The	  results	  presented	  here,	  in	  these	  experiments,	  now	  invoke	  a	  role	  for	  hepatic	  
insulin	   signalling,	   the	   hepatic	   innate	   immune	   system	   and	   altered	   biological	  
circadian	   rhythms	   in	   programmed	   NAFLD	   via	   maternal	   obesity.	   	   Insulin	  
resistance	  is	  considered	  crucial	  to	  the	  development	  of	  NAFLD.	  	  Consistent	  with	  
previous	  reports	  of	  insulin	  resistance	  in	  NAFLD	  (245,	  246),	  it	  is	  here	  shown	  that	  
hepatic	   insulin	   signalling	   is	   impaired	   in	   offspring	   exposed	   to	  maternal	   obesity	  
(51)	   and	   may	   therefore	   be	   responsible	   for	   the	   ensuing	   hepatosteatosis	   and	  
NAFLD	   development.	   	   In	   parallel,	   hepatic	   innate	   immune	   dysfunction	   is	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observed	   in	   offspring	   with	   programmed	   NAFLD.	   	   It	   is	   thought	   that	   such	  
perturbation	   is	   responsible	   for	   propagating	   liver	   injury	   in	   the	   context	   of	  
hepatosteatosis	   in	   those	   exposed	   to	  maternal	   obesity	   and	   fed	   an	   obesogenic	  
diet	  post-­‐weaning.	  	  However,	  in	  order	  to	  understand	  the	  mechanistic	  role	  of	  the	  
innate	   immune	   cells	   in	   programmed	   NAFLD	   pathogenesis,	   it	   is	   necessary	   to	  
further	   investigate	   the	   NK-­‐T	   cell	   population	   given	   their	   ability	   to	   exclusively	  
recognise	   lipids	   and	   glycolipids.	   	   This	   could	   involve	   examination	   of	   CD1d	  
expression	  by	  hepatocytes	  and	  ligand	  presentation	  to	  NK-­‐T	  cells.	  	  	  
	  
It	   is	   well	   understood	   that	   many	   pathogenic	   processes	   are	   multi-­‐factorial	  
especially	  those	  involved	  in	  metabolic	  homeostasis.	  	  Therefore,	  assumption	  that	  
a	   single	  mechanistic	   pathway	   is	   responsible	   for	   the	   programmed	   phenotypes	  
would	  be	  incorrect.	  	  Peripheral	  biological	  circadian	  rhythms	  were	  therefore	  also	  
investigated.	   	   It	   is	   shown,	  here	   for	   the	   first	   time,	   that	  maternal	  obesity	   in	   the	  
context	   of	   a	   post-­‐weaning	   obesogenic	   diet	   alters	   biological	   circadian	   rhythms	  
and	   the	   normal	   rhythmicity	   of	   output	   pathways	   implicated	   in	   NAFLD	  
pathogenesis.	   	  Given	   that	   these	   implicated	  pathways	  are	  perturbed	   in	  parallel	  
with	  disease	  severity	  and	  that	  the	  post-­‐weaning	  obesogenic	  diet	  predominantly	  
contributes	  to	  offspring	  phenotype,	  as	  determined	  by	  two-­‐way	  ANOVA	  analysis,	  
it	  is	  necessary	  to	  investigate	  a	  time	  point	  prior	  to	  disease	  on-­‐set.	  	  Such	  suitable	  
time-­‐points	   could	   include	   gestational	   day	   18	   or	   21	   days	   post-­‐partum,	  
immediately	   after	   weaning,	   to	   confirm	   mechanistic	   involvement	   of	   these	  
putative	  pathways.	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These	   identified	   potential	   mechanisms	   are	   not	   however,	   an	   exhaustive	   list.	  	  
Emerging	   evidence	   suggests	   that	   the	   lipotoxicity	   observed	   in	   hepatosteatosis	  
induces	   endoplasmic	   reticulum	   (ER)	   stress,	   propagating	   NAFLD	   disease	  
progression.	   	   ER	   stress	   has	   now	   been	   documented	   in	   several	   experimental	  
models	  of	  steatosis	  (247)	  and	  epidemiological	  studies	  of	  NAFLD	  patients	  (248).	  	  
Most	   recently,	   ER	   stress	   has	   been	   implicated	   in	   programmed	   NAFLD	  
pathogenesis	  across	  three	  generations	  in	  a	  high	  fat	  diet	  induced	  obesity	  model.	  	  
It	  was	  reported	  by	  Li	  and	  colleagues	  that	  NAFLD	  manifestation	  was	  progressive	  
in	  consecutive	  generations	  characterised	  by	  altered	  histone	  methylation	  (249).	  	  	  
	  
8.5	  The	  Relative	  Contributions	  of	  Programming	  by	  Maternal	  Obesity	  and	  the	  
Post-­‐Weaning	  Obesogenic	  Environment	  in	  Offspring	  NAFLD	  
	  
There	  are	  several	  lines	  of	  evidence	  suggesting	  a	  role	  for	  maternal	  obesity	  during	  
gestation	   and	   lactation	   in	   programming	   offspring	   susceptibility	   to	  
dysmetabolism	   in	   adulthood	   (20,	   37,	   244).	   	   It	   is	   here	   shown,	   that	   offspring	  
exposure	   to	   maternal	   obesity	   during	   development	   increases	   susceptibility	   to	  
NAFLD	   in	   adulthood,	   with	   the	   lactation	   period	   most	   crucial	   to	   these	  
programming	  effects.	   	  Given	   that	   all	   offspring	  were	  weaned	  on	   to	   a	   standard	  
chow	  diet	   in	  earlier	  experimental	  paradigms	  (Chapters	  3	  and	  4),	  confirms	  that	  
the	   observed	   phenotype	   is	   due	   to	   adverse	   exposure	   during	   critical	  
developmental	   periods.	   	   It	   cannot	   be	   argued	   that	   disease	   development	   is	  
offspring	  exposed	   to	  maternal	  obesity	   is	   simply	  due	   to	  experience	  of	  a	  hyper-­‐
calorific	   environment	   for	   a	   specified	   period	   of	   time,	   as	   offspring	   exposed	   to	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maternal	  obesity	  in	  gestation	  only	  displayed	  phenotypes	  comparable	  to	  controls	  
(Chapter	  4).	  	  	  
	  
In	   later	   experimental	   paradigms	   which	   involve	   offspring	   weaned	   on	   to	   an	  
obesogenic	   diet,	   it	   is	   apparent	   from	   comparison	   of	   appropriate	   controls	   and	  
two-­‐way	   ANOVA	   analysis,	   that	   the	   eventual	   phenotype	   is	   largely	   and	  
disproportionately	   induced	   by	   the	   post-­‐weaning	   hyper-­‐calorific	   environment.	  	  
This	   however,	   does	   not	   negate	   a	   role	   for	   developmental	   programming	   by	  
maternal	   obesity	   as	   there	   are	   clear	   main	   effects	   of	   maternal	   obesity	   on	  
offspring	   development	   of	   adiposity,	   hepatosteatosis,	   inflammatory	   and	  
fibrogenic	  markers,	  innate	  immune	  dysfunction	  and	  altered	  biological	  circadian	  
rhythms.	   	   It	   is	  also	   important	   to	  note	   that	   there	  are	   interactions	  between	   the	  
maternal	  and	  post-­‐weaning	  environments	  which	  may	  be	  propagating	  the	  NAFLD	  
disease	  state	  in	  offspring.	  	  Such	  a	  contention	  is	  supported	  by	  earlier	  reports	  of	  
accelerated	  adiposity	  and	  hyperphagia	   in	  rodents	  exposed	  to	  maternal	  obesity	  
and	  maintained	  on	  an	  obesogenic	  diet	  throughout	  post-­‐natal	  life	  (55).	  
	  
The	   findings	   in	   this	   thesis	   clearly	   support	   a	   role	   for	   maternal	   obesity	   in	  
increasing	  offspring	  susceptibility	  to	  NAFLD.	  	  However,	  the	  relative	  contribution	  
of	  developmental	  programming	  by	  maternal	  obesity	   in	  NAFLD	  pathogenesis	   is	  
modest.	   	  Given	   that	   the	   rates	  of	  obesity	  amongst	  women	  of	   reproductive	  age	  
are	   rising	   alongside	   offspring	   obesity	   with	   experimental	   evidence	   of	  
transgenerational	   programming	   effects,	   it	   is	   plausible	   that	   the	   role	   of	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programming	   in	   offspring	   NAFLD	   may	   have	   more	   putative	   transgenerational	  
consequences.	  
	  
8.6	  Examination	  of	  Gender	  Differences	  in	  Developmental	  Programming	  
	  
Sex	  specific	  differences	  in	  the	  incidence	  of	  adverse	  events	  during	  gestation	  and	  
early	  neonatal	   life	  are	  well	  documented.	   	   Such	  examples	   include	  male	  gender	  
being	   an	   independent	   risk	   factor	   for	   stillbirth	   (250)	   and	   gestation	   length	  
determined	  by	   fetal	   sex	   (251).	   	   It	   is	   therefore	  plausible	   that	   sexual	   dimorphic	  
patterns	   of	   developmental	   programming	   exist.	   	   The	   literature	   is	   however,	  
conflicting	  dependent	  upon	  the	  pathogeic	  pathway	  being	  investigated.	  	  	  
	  
Offspring	   of	   dams	   exposed	   to	   stress	   during	   late	   gestation	   display	   aberrant	  
hypothalamic-­‐pituitary-­‐adrenal	   (HPA)	   responses	   to	   stress,	   which	   is	   limited	   to	  
only	   females	   (252).	   	   Conversely,	   pre-­‐natal	   exposure	   to	   IL-­‐1β	   induced	   more	  
significant	   alterations	   in	   psychomotor	   development	   and	   behaviour	   in	   males	  
compared	  to	  females	  (253).	  	  Additionally,	  offspring	  exposure	  to	  maternal	  over-­‐
nutrition	   has	   been	   shown	   to	   induce	   hypertension	   and	   decrease	   renal	   rennin	  
activity	  in	  males	  and	  reduce	  vascular	  compliance	  and	  endothelial	  dysfunction	  in	  
females	  (33,	  39,	  254-­‐256).	  
	  
A	   growing	   body	   of	   evidence	   suggesting	   that	   male	   and	   female	   fetuses	   adapt	  
differentially	   to	   developmental	   stressors	   such	   as	   maternal	   obesity.	   	   It	   is	   also	  
suggested	   that	   sex	   steroids	   influence	   development	   of	   programmed	   disease	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states	   in	   an	   organ	   dependent	   manner.	   	   The	   majority	   of	   current	   knowledge	  
stems	  from	  investigation	  of	  programmed	  cardiovascular	  events,	  but	  the	  impact	  
of	  sexual	  dichotomy	  on	  hepatic	  programmed	  disease	  development	  is	  unknown.	  	  	  
	  
Apart	  from	  mechanistic	  investigation	  of	  the	  biological	  circadian	  clock	  in	  hepatic	  
programming,	  only	   female	  offspring	  have	  been	   included	   in	   this	   study.	   	  Due	   to	  
the	  vast	  number	  of	  rodents	  required	  in	  the	  circadian	  experimental	  paradigm,	  it	  
was	  decided	   to	  use	  both	  male	  and	   female	  offspring	   in	  accordance	  with	  Home	  
Office	  Guidelines	  for	  the	  humane	  use	  of	  animals.	   	  However,	  prior	  to	  execution	  
of	   this	   study,	   sex	   specific	   differences	   in	   programmed	   offspring	   NAFLD	   were	  
investigated.	  	  There	  were	  no	  significant	  differences	  in	  phenotypic	  presentation	  
of	  NAFLD	   in	  male	  versus	   female	  offspring	  as	  evidenced	  by	  hepatic	  markers	  of	  
injury	  and	  fibrogenesis	  implicated	  in	  disease	  pathogenesis	  (Appendix	  9.1).	  	  	  	  	  	  	  
	  
	  
8.7	  Future	  Research	  Directions	  	  
	  
8.7.1	  Translation	  to	  the	  human	  situation	  
There	   are	   presently	   no	   parallel	   reports	   of	   programmed	   offspring	   NAFLD	   via	  
maternal	   obesity	   in	   humans.	   	   The	   need	   to	   investigate	   the	   role	   of	   maternal	  
obesity	   on	   offspring	   hepatic	   outcome	   is	   pivotal	   given	   the	   exponential	   rise	   in	  
paediatric	  NAFLD,	  now	  the	  most	   frequent	  chronic	   liver	  disease	   in	  children	  and	  
adolescents	  (257).	  	  Moreover,	  the	  prevalence	  of	  adult	  NAFLD	  is	  rising	  in	  tandem	  
(242).	   	   From	   investigation	   in	   a	   human	   model,	   potential	   preventative	   and	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therapeutic	   interventions	   can	  be	   identified	   in	   an	   attempt	   to	   curb	   the	   present	  
and	  projected	  population	  prevalence	  of	  NAFLD	  and	  its	  adverse	  sequelae.	  
	  
Developmental	  programming	   is	   the	   response	  mounted	  by	  offspring	   to	  various	  
environmental	   stimuli	   during	   critical	   developmental	   periods	   resulting	   in	  
permanent	  alterations	  in	  structure,	  physiology	  and/or	  the	  epigenome.	  	  As	  such,	  
an	   instructive	   and	   confirmatory	   human	   study	   design	   could	   involve	   the	   use	   of	  
monozygotic	   twins	   in	   a	   co-­‐twin	   case	   controlled	   paradigm,	   enabling	   an	  
examination	  of	  the	  environmental	  and	  epigenetic	  contributions	  in	  programmed	  
offspring	  NAFLD	  pathogenesis.	  	  Preliminary	  investigation	  into	  feasibility	  of	  such	  
a	   study	   has	   revealed	   that	   the	   largest	   global	   twin	   database	   exists	   at	   King’s	  
College	   London	   within	   the	   Department	   of	   Twin	   Research	   and	   Genetic	  
Epidemiology,	   housing	   records	   from	   over	   10,000	   mono-­‐	   and	   di-­‐zygotic	   twins	  
including	   detailed	   metabolic	   read-­‐outs.	   	   With	   detailed	   reports	   of	   maternal	  
anthropometry	  and	  peri-­‐natal	  experiences,	  such	  a	  study	  would	  be	  invaluable	  to	  
our	  current	  understanding	  of	  experimental	  associations	  between	  programming	  
and	  offspring	  NAFLD.	  	  	  
	  
8.7.2	  Programming,	  NAFLD	  and	  the	  Gut	  Microbiome	  
The	   gut	   microbiota	   protects	   the	   host	   organism	   against	   digestive	   and	   extra-­‐
digestive	  diseases	  by	  regulating	  metabolism,	  immunity	  and	  forming	  an	  intestinal	  
barrier	  between	  the	  host	  and	  the	  external	  environment	  (258).	  	  Interestingly,	  gut	  
microflora	  has	  been	  found	  to	  be	  altered	  in	  chronic	  liver	  disease.	  	  More	  recently,	  
it	   has	   been	   shown	   to	   influence	   fat	   storage	   and	   energy	   utilisation,	   playing	   a	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direct	  role	  in	  the	  development	  of	  insulin	  resistance	  and	  metabolic	  disease	  (259,	  
260).	   	   In	   addition,	   it	   has	   been	   reported	   that	   obese	   individuals	   have	   fewer	  
Bacteroidetes	   and	  more	   Firmicutes	   than	   their	   lean	   counter-­‐parts,	   resulting	   in	  
altered	  energy	  harvesting	  from	  ingested	  food	  (261).	  	  It	  is	  therefore	  unsurprising	  
that	  the	  gut	  microbiome	  has	  been	  implicated	  in	  NAFLD	  pathogenesis.	  	  
	  
In	   this	   study,	   a	   role	   for	   innate	   immune	   dysfunction	   in	   programmed	   offspring	  
NAFLD	   has	   been	   reported.	   	   This	   may	   be	   in	   response	   to	   an	   altered	   gut	  
microbiome.	   	   It	   is	   thus	   plausible	   that	   maternal	   obesity	   via	   developmental	  
programming	  could	  permanently	  alter	  the	  offspring	  gut	  microbiome,	  increasing	  
susceptibility	  to	  NAFLD	  development	  and	  disease	  progression.	  	  Mechanistically,	  




8.8	  Conclusion	  	  	  	  	  	  
	  
A	   significant	   body	   of	   knowledge	   has	   established	   that	   exposure	   to	   maternal	  
obesity	   during	   neonatal	   development	   has	   long-­‐term	   health	   consequences	   on	  
the	   adult	   organism.	   	   From	   this,	   the	   ‘Developmental	   Origins	   of	   Health	   and	  
Disease’	  hypothesis	  was	  borne.	  	  From	  experimental	  and	  clinical	  investigation	  of	  
this	   hypothesis,	   associations	   between	   maternal	   obesity,	   cardiovascular	   and	  
metabolic	   diseases	   have	   been	   identified.	   	   However,	   implications	   for	  
development	  of	  hepatic	  disease	  were	  scarcely	  investigated	  until	  now.	  	  	  
	   280	  
	  
In	   this	   present	   study,	   a	   confirmatory	   role	   for	   developmental	   programming	   in	  
offspring	   NAFLD	   via	   maternal	   obesity	   and	   the	   responsible	   critical	   window	   of	  
development	   is	  reported.	   	  The	  downstream	  regulatory	  pathways	  perturbed	  by	  
such	   adverse	   exposure	   have	   been	   interrogated	   with	   contributory	   roles	  
identified	  for	  the	  hepatic	  insulin	  signalling,	  innate	  immune	  system	  and	  biological	  
circadian	   clock	   network.	   	   The	   role	   for	   maternal	   obesity	   in	   programming	  
offspring	  NAFLD	  may	  therefore	  explain	  the	  inexorable	  rise	  in	  disease	  prevalence	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9	  Appendix	  
	  
9.1	  Gender	  Differences	  in	  Offspring	  NAFLD	  programmed	  by	  Maternal	  Obesity	  
	  
9.1.1	  Introduction	  
Emerging	  evidence	  suggests	  that	  male	  and	  female	  offspring	  differentially	  adapt	  
to	  developmental	   insults/stimuli	   such	  as	  maternal	  obesity,	   influencing	  disease	  
states.	   	   Sex	   specific	   differences	   in	   offspring	   NAFLD	   programmed	   by	  maternal	  
obesity	   is	   unknown.	   	   Given	   the	   collective	   use	   and	   analysis	   of	   both	  male	   and	  
female	  offspring	  in	  Chapter	  7,	  it	  is	  important	  to	  ascertain	  any	  gender	  influenced	  
bias	  in	  assayed	  markers.	  
	  
9.1.2	  Methods	  
Female	   C57BL6/J	   mice	   were	   fed	   standard	   laboratory	   or	   obesogenic	   chow	   7	  
weeks	   prior	   to	   mating,	   throughout	   gestation	   and	   lactation.	   	   Litters	   were	  
standardised	  to	  6	  pups	  and	  weaned	  on	  to	  either	  a	  standard	  or	  obesogenic	  diet.	  	  
At	   6	   months	   post-­‐partum,	   male	   and	   female	   offspring	   were	   analysed	   for	  
biochemical	   evidence	   of	   liver	   injury	   and	   fibrogenesis.	   	   All	   data	   was	   analysed	  
using	  two-­‐way	  ANOVA;	  p	  <	  0.05	  was	  considered	  statistically	  significant.	  
	  
9.1.3	  Results	  
As	   previously	   reported	   in	   preceding	   chapters,	   exposure	   to	   maternal	   obesity	  
and/or	   an	   obesogenic	   diet	   post-­‐weaning	   induces	   offspring	   adiposity,	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dysmetabolism	   and	   NAFLD.	   	   These	   findings	   are	   consistently	   reproduced	   in	  
preliminary	  analysis	  of	  both	  male	  and	  female	  offspring.	  
	  
9.1.3.1	   Exposure	   to	   maternal	   obesity	   and	   a	   post-­‐weaning	   obesogenic	   diet	  
similarly	  increases	  body	  and	  liver	  weights	  in	  male	  and	  female	  offspring	  
Both	   body	   and	   liver	   weights	   were	   increased	   in	   male	   and	   female	   offspring	  
exposed	   to	  maternal	   obesity	   and	   fed	   a	   post-­‐weaning	   obesogenic	   diet.	   	   There	  
was	  an	   independent	  effect	  of	  gender	  on	  offspring	  body	  weight	  as	   revealed	  by	  
two-­‐way	  ANOVA	  analysis.	   	  No	  statistically	  significant	  gender	  specific	  difference	  
was	  observed	  for	  offspring	  liver	  weight,	  however	  (Figure	  9.1).	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Figure	   9.1:	   Male	   and	   Female	   Offspring	   Body	   and	   Liver	   Weights:	   (A)	   Body	  
weight	  and	  (B)	  Liver	  Weight	  Expressed	  as	  %	  of	  Body	  Weight.	  	  Offspring	  of	  lean	  
(OffCon)	   and	   obese	   (OffOb)	  weaned	   on	   to	   standard	   chow	   (SC)	   or	   obesogenic	  
diet	  (OD).	  	  n	  =	  5/group;	  values	  shown	  are	  mean	  ±	  SEM;	  two-­‐way	  ANOVA.	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9.1.3.2	   Exposure	   to	   maternal	   obesity	   and	   a	   post-­‐weaning	   obesogenic	   diet	  
similarly	  induces	  liver	  injury	  in	  male	  and	  female	  offspring	  
Serum	  ALT	  and	  relative	  gene	  expression	  of	  the	  pro-­‐inflammatory	  cytokines,	  IL-­‐6	  
and	   TNF-­‐α	  were	  most	   profoundly	   increased	   in	   offspring	   exposed	   to	  maternal	  
obesity	   and	   fed	   an	   obesogenic	   diet	   post-­‐weaning.	   	   No	   statistically	   significant	  
gender	  specific	  difference	  was	  observed	  (Figure	  9.2).	  
	  
	  
Figure	  9.2:	  Biochemical	  Evidence	  of	  Liver	  Injury	  in	  Male	  and	  Female	  Offspring:	  
(A)	  Serum	  ALT,	  (B)	  IL-­‐6	  mRNA	  and	  (C)	  TNF-­‐α	  mRNA.	  	  Offspring	  of	  lean	  (OffCon)	  
and	  obese	  (OffOb)	  weaned	  on	  to	  standard	  chow	  (SC)	  or	  obesogenic	  diet	  (OD).	  	  n	  
=	  5/group;	  values	  shown	  are	  mean	  ±	  SEM;	  two-­‐way	  ANOVA.	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9.1.3.3	   Exposure	   to	   maternal	   obesity	   and	   a	   post-­‐weaning	   obesogenic	   diet	  
similarly	  induces	  liver	  fibrogenesis	  in	  male	  and	  female	  offspring	  
The	   relative	  gene	  expression	  of	   the	  hepatic	   fibrogenic	  markers,	  α-­‐SMA,	  TGF-­‐β	  
and	   collagen	   were	   profoundly	   up-­‐regulated	   in	   offspring	   exposed	   to	   maternal	  
obesity	  and	  a	  post-­‐weaning	  obesogenic	  diet.	  	  No	  statistically	  significantly	  gender	  
specific	  difference	  was	  observed	  for	  these	  fibrogenic	  markers	  (Figure	  9.3).	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Figure	   9.3:	   Biochemical	   Evidence	   of	   Liver	   Fibrogenesis	   in	   Male	   and	   Female	  
Offspring:	  (A)	  α-­‐SMA	  mRNA	  (B)	  TGF-­‐β	  mRNA	  and	  (C)	  collagen	  mRNA.	  	  Offspring	  
of	   lean	   (OffCon)	   and	   obese	   (OffOb)	   weaned	   on	   to	   standard	   chow	   (SC)	   or	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Both	  male	  and	  female	  offspring	  exposed	  to	  maternal	  obesity	  and	  fed	  a	  hyper-­‐
calorific	   diet	   post-­‐weaning	   develop	   NAFLD	   in	   adulthood.	   	   Importantly,	   there	  
were	  no	   independent	  effects	  of	  gender	  on	  such	  development	  as	  evidenced	  by	  
similar	  gene	  expression	  of	  liver	  injury	  and	  fibrogenic	  markers	  and	  confirmed	  by	  
two-­‐way	   ANOVA	   analysis.	   	   Of	   note,	   an	   independent	   effect	   of	   gender	   was	  
observed	   for	   offspring	   bodyweight	   which	   corroborates	   early	   reports	   of	   sex	  
specific	  differences	  in	  murine	  body	  weight	  (262).	  	  Therefore,	  combining	  the	  use	  
of	   male	   and	   female	   offspring	   for	   investigation	   of	   NAFLD	   programmed	   by	  
maternal	  obesity	  does	  not	  introduce	  any	  confounding	  effects.	  	  Additionally,	  it	  is	  
shown	   here	   for	   the	   first	   time	   that	   there	   are	   no	   sex	   specific	   differences	   in	  
offspring	  NAFLD	  programmed	  by	  maternal	  obesity.	  	  	  	  
	  
9.2	  Supplementary	  Histology	  	  
	  
9.2.1	  Representative	  H&E	  Sections	  
These	  representative	  sections	  are	  from	  offspring	  aged	  3,	  6	  and	  12	  months.	  	  As	  
observed	   throughout	   the	   thesis,	   offspring	   exposed	   to	  maternal	   obesity	   in	   the	  
context	  of	  a	  post-­‐weaning	  hyper-­‐calorific	  diet	  display	  profound	  hepatosteatosis	  
Figures	  9.4	  –	  9.6).	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9.2.2	  Representative	  Masson’s	  Trichrome	  Sections	  
These	   representative	   sections	   are	   from	   offspring	   aged	   6	   months.	   	   These	  
sections	  are	  displayed	  at	  high	  (x40)	  and	  low	  (x10)	  magnification	  to	  permit	  clear	  
visibility	  of	  peri-­‐cellular	  fibrosis	  in	  offspring	  exposed	  to	  maternal	  obesity	  in	  the	  
context	  of	  a	  post-­‐weaning	  hyper-­‐calorific	  diet	  (Figures	  9.7	  –	  9.8).	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